Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Form 8-K

sec.gov

8-K — ARC Group Acquisition I Corp.

Accession: 0001493152-26-042241

Filed: 2026-09-10

Period: 2026-09-10

CIK: 0002073515

SIC: 6770 (BLANK CHECKS)

Item: Entry into a Material Definitive Agreement

Item: Regulation FD Disclosure

Item: Financial Statements and Exhibits

Documents

8-K — form8-k.htm (Primary)

EX-2.1 (ex2-1.htm)

EX-10.1 (ex10-1.htm)

EX-10.2 (ex10-2.htm)

EX-10.3 (ex10-3.htm)

EX-10.4 (ex10-4.htm)

EX-10.5 (ex10-5.htm)

EX-10.6 (ex10-6.htm)

EX-10.7 (ex10-7.htm)

EX-10.8 (ex10-8.htm)

EX-99.1 (ex99-1.htm)

GRAPHIC (ex99-1_001.jpg)

GRAPHIC (ex99-1_002.jpg)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K

8-K (Primary)

Filename: form8-k.htm · Sequence: 1

false

0002073515

0002073515

2026-09-10

2026-09-10

0002073515

ARCLU:UnitsEachConsistingOfOneClassOrdinaryShareParValue0.0001PerShareOneWarrantAndOneRightToAcquire14Member

2026-09-10

2026-09-10

0002073515

ARCLU:ClassOrdinarySharesIncludedAsPartOfUnitsMember

2026-09-10

2026-09-10

0002073515

ARCLU:RightsIncludedAsPartOfUnitsMember

2026-09-10

2026-09-10

0002073515

ARCLU:WarrantsEachWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember

2026-09-10

2026-09-10

iso4217:USD

xbrli:shares

iso4217:USD

xbrli:shares

UNITED

STATES

SECURITIES

AND EXCHANGE COMMISSION

Washington,

D.C. 20549

FORM

8-K

CURRENT

REPORT

Pursuant

to Section 13 or 15(d) of

the

Securities Exchange Act of 1934

Date

of Report (Date of earliest event reported): September 10, 2026

ARC

Group Acquisition I Corp

(Exact

name of registrant as specified in its charter)

British

Virgin Islands

001-43253

N/A

00-0000000

(State

or other jurisdiction of

incorporation

or organization)

(Commission

File

Number)

(I.R.S.

Employer

Identification

Number)

398

S Mill Avenue, Suite 306, Tempe, AZ 85284

(Address

of principal executive offices, including zip code)

(928)

625-0928

(Registrant’s

telephone number, including area code)

Check

the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under

any of the following provisions

Written communications

pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant

to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications

pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications

pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities

registered pursuant to Section 12(b) of the Act:

Title

of each class

Trading

Symbol(s)

Name

of each exchange on which registered

Units, each consisting of

one Class A ordinary share, par value $0.0001 per share, one warrant, and one right to acquire 1/4th of one Class A ordinary

share

ARCLU

The Nasdaq Stock Market

LLC

Class A ordinary shares

included as part of the Units

ARCL

The Nasdaq Stock Market

LLC

Rights included as part

of the Units

ARCLR

The Nasdaq Stock Market

LLC

Warrants, each warrant exercisable

for one Class A ordinary share at an exercise price of $11.50 per share

ARCLW

The Nasdaq Stock Market

LLC

Indicate

by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2

of the Securities Exchange Act of 1934.

Emerging

growth company ☒

If

an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying

with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item

1.01. Entry into Material Definitive Agreement

Share

Purchase Agreement

On

September 10, 2026, ARC Group Acquisition I Corp, a British Virgin Islands business company (“we,” “our,” or

“Purchaser”), Firstborn Top Capital Sdn. Bhd., a Malaysian private limited company (“Firstborn”), the holders

of all of the ordinary shares (the “Firstborn Shares”) of Firstborn (the “Selling Shareholders”), Datuk Dr. Doris

Wong in the capacity as the representative from and after the Closing (as defined below) for the shareholders of Purchaser (other than

the Selling Shareholders as of immediately prior to the Closing and their successors and assigns), and Ow Ruey Shen, in the capacity

as the representative for the Selling Shareholders from and after the Closing, entered into a share purchase agreement (as it may be

amended, supplemented or otherwise modified from time to time, the “Share Purchase Agreement”): each Selling Shareholder

shall sell, transfer, assign, convey and deliver to Purchaser, and Purchaser shall purchase, acquire and accept from each Selling Shareholder,

their Firstborn Shares, respectively, free and clear of any and all liens and encumbrances, such that all of the issued and outstanding

Firstborn Shares at the Closing shall be sold to and purchased by Purchaser (the transactions contemplated by the foregoing clause the

“Business Combination,” and together with the other transactions contemplated by the Share Purchase Agreement, the “Transactions”).

The

terms of the Share Purchase Agreement, which contains customary representations and warranties, covenants, closing conditions and other

terms relating to the Business Combination and the other Transactions contemplated thereby, are summarized below. Capitalized terms used

in this Current Report on Form 8-K but not otherwise defined herein have the meanings ascribed to them in the Share Purchase Agreement.

General

Effects of the Business Combination

Subject

to the terms and conditions of the Share Purchase Agreement, at the Closing the Business Combination will result in, among other things,

the following:

● all

of the issued and outstanding Firstborn Shares will be exchanged for Class A ordinary shares

of Purchaser (“Purchaser Class A Ordinary Shares”);

● Firstborn

will become a wholly-owned subsidiary of Purchaser; and

● Purchaser

will change its name to “BlueCrest Investment, Inc.”

Transaction

Consideration

The

aggregate consideration to be paid in the Transactions to the Selling Shareholders will consist of: (A) $1,000,000,000, (B) minus the

Closing Net Indebtedness, (C) plus or minus, as applicable, the Working Capital Adjustment, and (D) minus the amount of any unpaid transaction

bonuses and other transaction-related compensation payable in connection with the Transactions, with the resulting amount divided by

the Redemption Price (the “Consideration Shares”). The Working Capital Adjustment shall equal the Net Working Capital Amount

minus the Target Net Working Capital Amount of $618,000, such that the Transaction Consideration shall be increased dollar-for-dollar

to the extent the Net Working Capital Amount exceeds the Target Net Working Capital Amount and decreased dollar-for-dollar to the extent

the Target Net Working Capital Amount exceeds the Net Working Capital Amount. There is no minimum cash condition or minimum cash consideration

in connection with the Closing. Each Selling Shareholder shall have the right to receive at the Closing, a number of Purchaser

Class A Ordinary Shares equal to the aggregate Consideration Shares divided by the number of Firstborn Shares outstanding immediately

prior to the Closing, multiplied by the number of Firstborn Shares held by such Selling Shareholder (the “Conversion Ratio”).

Redemptions

Pursuant

to our charter and the Trust Agreement (defined below), eligible holders of Purchaser Class A Ordinary Shares may elect to redeem all

or a portion of such holder’s Purchaser Class A Ordinary Shares (the “SPAC Share Redemptions”), at the per-share price,

payable in cash, equal to such holder’s pro rata share of Purchaser’s trust account, by tendering the Purchaser Class A Ordinary

Shares of such holder for redemption not later than 5:00 p.m. Eastern Time on the date that is two Business Days prior to the date of

the Extraordinary General Meeting of the holders of Purchaser Class A Ordinary Shares and Class B ordinary shares of Purchaser to be

called for the purpose of voting on proposals related to the Transactions (the “Shareholder Meeting”).

PIPE

Investment

During

the Interim Period, Purchaser and Firstborn shall reasonably cooperate to seek a PIPE Investment pursuant to customary and binding subscription

agreements (the “Subscription Agreements”) with certain investors (the “PIPE Investors”) agreed by Purchaser

and Firstborn, and shall use their respective commercially reasonable efforts to cause the PIPE Investment to close concurrently with

the Closing (the “PIPE Investment”). The terms of the PIPE Investment shall be negotiated and agreed by Purchaser and Firstborn

consistent with market terms, and Purchaser and Firstborn shall negotiate and agree on the choice of placement agent, fees, approach

and target investor universe. Firstborn’s senior management shall participate in any investor meetings and roadshows as reasonably

requested by Purchaser.

Stock

Exchange Listing

Purchaser

Class A Ordinary Shares and warrants to purchase Class A ordinary shares of Purchaser are expected to be listed on The Nasdaq Stock Market

LLC (the “Nasdaq”).

Representations

and Warranties and Covenants

Each

of the parties to the Share Purchase Agreement have made representations, warranties and covenants in the Share Purchase Agreement that

are customary for transactions of this nature.

Conditions

to Each Party’s Obligations

Consummation

of the Transactions is subject to customary conditions of the respective parties, and conditions customary to special purpose

acquisition companies, including the approval of Purchaser’s shareholders and Firstborn’s shareholders. In addition, consummation

of the Transactions is subject to other Closing conditions, including, among others: (a) if required, the expiration of the waiting

period (or extension thereof) under any applicable antitrust laws, (b) the absence of any order, writ, judgment, injunction, temporary

restraining order, stipulation, determination, decree or award entered by or with or under the authority of any governmental entity or

arbitral institution in effect enjoining or prohibiting the consummation of the Transactions, and the absence of any law that makes consummation

of the Transactions illegal or otherwise prohibited, (c) approval by Purchaser shareholders at the Shareholder Meeting of the

Transactions, including, the issuance of any shares in connection with the PIPE Investment, the adoption of an amended and restated memorandum

and articles of association of Purchaser, the adoption of an incentive equity plan, and the appointment of members of Purchaser

board of directors, (d) after giving effect to all SPAC Share Redemptions and the PIPE Investment, Purchaser shall have consolidated

net tangible assets of at least $5,000,001 (as calculated and determined in accordance with Rule 3a51-1(g)(1) of the Securities Exchange

Act) either immediately prior to or upon the Closing after giving effect to the Transactions, (e) the Purchaser Proxy/Registration

Statement shall have become effective, no stop order shall have been issued by the SEC and remain in effect and no proceeding seeking

such a stop order shall have been threatened or initiated by the SEC and remain pending, (f) receipt of approval for listing on Nasdaq

for the Purchaser Class A Ordinary Shares to be issued in connection with the Transactions, and (g) delivery by the other parties of

all Closing deliveries, documents and other items required to be delivered by such parties as required by the Share Purchase Agreement.

Termination

The

Share Purchase Agreement may be terminated under certain customary and limited circumstances at any time prior to the Closing, including,

among others, (i) by the mutual written consent of Purchaser and Firstborn, if the Closing has not occurred by January 31, 2027, subject

to extension if Purchaser secures one or more extensions of the deadline under its organizational documents and IPO prospectus to complete

its initial business combination, (ii) by Purchaser or Firstborn if the Transaction is prohibited by a governmental authority, (iii)

by Purchaser or Firstborn after an uncured breach by a party of the representations, warranties, covenants, or agreements contained in

the Share Purchase Agreement, (iv) by Purchaser or Firstborn after a material adverse effect on Purchaser or Firstborn, respectively,

or (v) by Purchaser if Purchaser’s shareholders do not approve the Transactions.

A

copy of the Share Purchase Agreement is filed with this Current Report on Form 8-K as Exhibit 2.1 and is incorporated herein by reference,

and the foregoing description of the Share Purchase Agreement is qualified in its entirety by reference thereto. The Share Purchase Agreement

contains representations, warranties and covenants that the respective parties made to each other as of the date of the Share Purchase

Agreement or other specific dates. The assertions embodied in those representations, warranties and covenants were made for purposes

of the contract among the respective parties and are subject to important qualifications and limitations agreed to by the parties in

connection with negotiating such agreement. The representations, warranties and covenants in the Share Purchase Agreement are also modified

in important part by the underlying disclosure schedules which are not filed publicly and which are subject to a contractual standard

of materiality different from that generally applicable to shareholders and were used for the purpose of allocating risk among the parties

rather than establishing matters as facts. We do not believe that these schedules contain information that is material to an investment

decision.

Certain

Related Agreements

Sponsor

Support Agreement

Concurrently

with the execution of the Share Purchase Agreement, certain of Purchaser’s Affiliates and MFH 2, LLC, a Delaware limited liability

company (the “Sponsor”), entered into a support agreement (the “Sponsor Support Agreement”), pursuant to which

each such parties agreed to, among other things, (i) appear at the Shareholder Meeting and vote all of its Purchaser Ordinary Shares

it holds or has the power to vote (including any acquired in future) in favor of the Share Purchase Agreement and the Transactions, (ii) be bound by certain transfer restrictions with respect to its Purchaser Securities, and (iii) not redeem any of its Purchaser

Securities and waive any anti-dilution rights with respect to any equity issuance, including the PIPE Investment, on the terms and subject

to the conditions set forth in the Sponsor Support Agreement.

The

foregoing description of the Sponsor Support Agreement does not purport to be complete and is qualified in its entirety by the terms

and conditions of the Sponsor Support Agreement, a form of which is attached hereto as Exhibit 10.1 and is incorporated herein by reference.

Company

Support Agreement

Concurrently

with the execution of the Share Purchase Agreement, the directors, officers and holders of five percent (5%) or more of the voting stock

of Firstborn entered into a support agreement (the “Company Support Agreement”), pursuant to which each such parties agreed

to, vote in favor of the Transactions and against any Alternative Transaction.

The

foregoing description of the Company Support Agreement does not purport to be complete and is qualified in its entirety by the terms

and conditions of the Company Support Agreement, a form of which is attached hereto as Exhibit 10.2 and is incorporated herein by reference.

Registration

Rights Agreement

In

connection with the consummation of the Transactions, Purchaser will enter into a Registration Rights Agreement (the “RRA”)

with certain shareholders of Purchaser and Firstborn. The RRA includes, among other things, the following provisions:

Purchaser

will be required to file a resale shelf registration statement on behalf of Purchaser and Firstborn shareholders party to the agreement

within 30 days after the closing of the Transactions. The RRA also provides certain demand rights and piggyback rights to such

shareholders, subject to certain specified underwriter cutbacks and issuer blackout periods. Purchaser will bear all costs and expenses

incurred in connection with the resale shelf registration statement, any demand registration statement, any underwritten takedown, any

block trade, any piggyback registration statement prior to its withdrawal and all expenses incurred in performing or complying with its

other obligations under the RRA, whether or not the registration statement becomes effective.

The

RRA will terminate with respect to any holder party thereto, on the date that such holder party no longer holds any registrable securities.

The

foregoing description of the RRA does not purport to be complete and is qualified in its entirety by the terms and conditions of the

RRA, a form of which is attached hereto as Exhibit 10.3 and is incorporated herein by reference.

Lock-Up

Agreement

In

connection with the consummation of the Transactions, directors, officers and significant shareholders of Firstborn will enter

into a Lock-Up Agreement (the “Lock-Up Agreement”) with Purchaser, with respect to the Purchaser Class A Ordinary Shares

that will be issued as consideration under the Share Purchase Agreement. The Lock-Up Agreement includes, among other things, the following

provisions:

Signatories

will not be able to transfer any Purchaser Class A Ordinary Shares beneficially owned or otherwise held by them for the same period applicable

to the Sponsor’s lock-up agreement with respect to its founder shares.

The

foregoing description of the Lock-Up Agreement does not purport to be complete and is qualified in its entirety by the terms and conditions

of the Lock-Up Agreement, a form of which is attached hereto as Exhibit 10.4 and is incorporated herein by reference.

Restrictive

Covenant Agreement

In

connection with the consummation of the Transactions, directors, officers and significant shareholders of Firstborn will

enter into a Restrictive Covenant Agreement (the “Restrictive Covenant Agreement”) with Purchaser, providing for, among other

things, non-solicitation and non-competition restrictions for a period of 2 to 4 years from the Closing Date.

The

foregoing description of the Restrictive Covenant Agreement does not purport to be complete and is qualified in its entirety by the terms

and conditions of the Restrictive Covenant Agreement, a form of which is attached hereto as Exhibit 10.5 and is incorporated herein by

reference.

Indemnification

Agreement

In

connection with the consummation of the Transactions, existing and newly appointed directors and officers of Purchaser and Firstborn

will enter into an Indemnification Agreement (the “Indemnification Agreement”) with Purchaser, providing for, among other

things, holding harmless, advancing costs and indemnifying such persons to the fullest extent permitted by applicable law and the Purchaser’s

charter.

The

foregoing description of the Indemnification Agreement does not purport to be complete and is qualified in its entirety by the terms

and conditions of the Indemnification Agreement, a form of which is attached hereto as Exhibit 10.6 and is incorporated herein by reference.

Incentive

Equity Plan

At

or prior to the Closing, Purchaser will adopt an incentive equity plan (the “Incentive Equity Plan”) that will provide for

the grant of equity incentives of Purchaser Class A Ordinary Shares to the directors, officers, employees, consultants and advisors (and

prospective directors, officers, employees, consultants and advisors) following the Closing. Within 30 days after the Closing, Purchaser

will file a registration statement on Form S-8 with respect to the Purchaser Class A Ordinary Shares issuable under the Incentive Equity

Plan, and Purchaser will use reasonable efforts to maintain the effectiveness of the registration statement and maintain the current

status of the prospectus contained therein for so long as awards granted pursuant to the Incentive Equity Plan remain outstanding.

The

foregoing description of the Incentive Equity Plan does not purport to be complete and is qualified in its entirety by the terms

and conditions of the Incentive Equity Plan, a form of which is attached hereto as Exhibit 10.7 and is incorporated herein by

reference.

Executive

Employment Agreement

In

connection with the consummation of the Transactions, each continuing executive officer of Firstborn will enter into an Executive

Employment Agreement (the “Employment Agreement”) with Firstborn with an effective date as of the Closing Date. The Employment

Agreement contains customary terms and conditions, including among others, salary, duties, termination, severance, non-solicitation and

confidentiality provisions.

The

foregoing description of the Employment Agreement does not purport to be complete and is qualified in its entirety by the terms and conditions

of the Employment Agreement, a form of which is attached hereto as Exhibit 10.8 and is incorporated herein by reference.

Item

7.01 Regulation FD Disclosure

On

September 10, 2026, Purchaser issued a press release announcing the execution of the Share Purchase Agreement. The press release is attached

hereto as Exhibit 99.1 and incorporated by reference herein.

The

foregoing Exhibit 99.1 is being furnished pursuant to Item 7.01 and will not be deemed to be filed for purposes of Section 18 of the

Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise be subject to the liabilities of that section,

nor will it be deemed to be incorporated by reference in any filing under the Securities Act or the Exchange Act.

Additional

Information

In

connection with the proposed Business Combination, Purchaser intends to file a registration statement on Form S-4 (as it may be amended

from time to time, the “Form S-4”) with the SEC. The Form S-4 will include a proxy statement/prospectus of Purchaser and

a preliminary prospectus of Purchaser. The definitive proxy statement/prospectus will be sent to all Purchaser shareholders after it

is declared effective by the SEC. Additionally, Purchaser will file other relevant materials with the SEC in connection with the proposed

Business Combination. Copies of the Form S-4, the proxy statement/prospectus and all other relevant materials filed or that will be filed

with the SEC may be obtained free of charge at the SEC’s website at www.sec.gov. The information contained in, or that may be accessed

through, the websites referenced in this press release is not incorporated by reference into, and is not a part of, this press release.

Before making any voting or investment decision, investors and security holders of Purchaser are urged to read the Form S-4, the proxy

statement/prospectus and all other relevant materials filed or that will be filed with the SEC in connection with the proposed Business

Combination because they will contain important information about the proposed Business Combination and the parties to the proposed Business

Combination.

Participants

in the Solicitation

Under

SEC rules, Purchaser and Firstborn and their respective directors and executive officers may be deemed to be participants in the solicitation

of proxies of Purchaser’s shareholders in connection with the proposed Business Combination. Investors and security holders may

obtain more detailed information regarding the names and interests in the proposed Business Combination of Purchaser’s directors

and officers in Purchaser’s filings with the SEC, including Purchaser’s initial public offering final prospectus, which was

filed with the SEC on April 30, 2026, and Purchaser’s subsequent quarterly reports on Form 10-Q and current reports on Form 8-K.

Information regarding the persons who may, under SEC rules, be deemed participants in the solicitation of proxies to Purchaser’s

shareholders in connection with the proposed Business Combination will be included in the proxy statement/prospectus relating to the

proposed Business Combination when it becomes available. You may obtain free copies of these documents as described in the preceding

paragraph.

Forward

Looking Statements

This

Current Report includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the

Private Securities Litigation Reform Act of 1995 with respect to the proposed Business Combination between Purchaser and Firstborn. Words

such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,”

“intend,” “plan,” “may,” “will,” “could,” “should,” “believe,”

“predict,” “potential,” “continue,” “strategy,” “future,” “opportunity,”

“would,” “seem, “ “seek,” “outlook” and similar expressions are intended to identify

such forward-looking statements. Forward-looking statements are predictions, projections and other statements about future events that

are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties that could cause the actual

results to differ materially from the expected results. These statements are based on various assumptions, whether or not identified

in this Current Report. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as,

and must not be relied on by an investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability.

Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. These forward-looking statements

include, without limitation, Firstborn’s and Purchaser’s expectations with respect to anticipated financial impacts of the

proposed Business Combination, the satisfaction of closing conditions to the proposed Business Combination, and the timing of the completion

of the proposed Business Combination.

You

should carefully consider the risks and uncertainties described in the “Risk Factors” section of Purchaser’s initial

public offering prospectus, and its subsequent quarterly reports on Form 10-Q and current reports on Form 8-K. In addition, there will

be risks and uncertainties described in the Form S-4 and other documents filed by Purchaser from time to time with the SEC. These filings

will identify and address other important risks and uncertainties that could cause actual events and results to differ materially from

those contained in the forward-looking statements. Many of these factors are outside Firstborn’s and Purchaser’s control

and are difficult to predict. Many factors could cause actual future events to differ from the forward-looking statements in this Current

Report, including but not limited to: (1) the outcome of any legal proceedings that may be instituted against Purchaser or Firstborn

following the announcement of the proposed Business Combination; (2) the inability to complete the proposed Business Combination, including

due to the inability to concurrently close the Business Combination and related transactions, including any private placement of ordinary

shares or due to failure to obtain approval of the shareholders of Purchaser; (3) the risk that the proposed Business Combination may

not be completed by Purchaser’s Business Combination deadline and the potential failure to obtain an extension of the Business

Combination deadline if sought by Purchaser; (4) the failure to satisfy the conditions to the consummation of the proposed Business Combination,

including the approval by the shareholders of Purchaser, and the receipt of certain governmental and regulatory approvals; (5) delays

in obtaining, adverse conditions contained in, or the inability to obtain necessary regulatory approvals or complete regulatory reviews

required to complete the proposed Business Combination; (6) the occurrence of any event, change or other circumstance that could give

rise to the termination of the Share Purchase Agreement; (7) volatility in the price of Purchaser’s or the combined company’s

securities; (8) the risk that the proposed Business Combination disrupts current plans and operations as a result of the announcement

and consummation of the Business Combination; (9) the inability to recognize the anticipated benefits of the proposed Business Combination,

which may be affected by, among other things, competition, the ability of the combined company to grow and manage growth profitably,

maintain relationships with customers and suppliers and retain key employees; (10) costs related to the proposed Business Combination;

(11) changes in the applicable laws or regulations; (12) the possibility that the combined company may be adversely affected by other

economic, business, and/or competitive factors; (13) the risk of downturns and a changing regulatory landscape in the highly competitive

industry in which Firstborn operates; (14) the impact of the conflicts in the Middles East and Ukraine; (15) the potential inability

of the combined company to raise additional capital needed to pursue its business objectives or to achieve efficiencies regarding other

costs; (16) the enforceability of Firstborn’s intellectual property, including its licenses and related patents, and the potential

infringement on the intellectual property rights of others, cyber security risks or potential breaches of data security; and (17) other

risks and uncertainties described in Purchaser’s initial public offering prospectus, and its subsequent quarterly reports on Form

10-Q, current reports on Form 8-K and to be described in the Form S-4 and other documents to be filed by Purchaser from time to time

with the SEC. These risks and uncertainties may be amplified by the conflicts in the Middle East and Ukraine, which have caused significant

economic uncertainty.

Firstborn

and Purchaser caution that the foregoing list of factors is not exclusive or exhaustive and not to place undue reliance upon any forward-looking

statements, including projections, which speak only as of the date made. None of Firstborn or Purchaser gives any assurance that Firstborn

or Purchaser will achieve its expectations. None of Firstborn or Purchaser undertakes or accepts any obligation to publicly provide revisions

or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, or should circumstances

change, except as otherwise required by securities and other applicable laws.

Disclaimer

This

Current Report is for informational purposes only and is neither an offer to purchase, nor a solicitation of an offer to sell, subscribe

for or buy any securities or the solicitation of any vote in any jurisdiction pursuant to the proposed transactions or otherwise, nor

shall there be any sale, issuance or transfer or securities in any jurisdiction in contravention of applicable law. No offer of securities

shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act.

Item

9.01 Financial Statements and Exhibits.

(d)

Exhibits.

Exhibit

No.

Description

2.1*

Share Purchase Agreement, dated September 10, 2026, by and among ARC Group Acquisition I Corp, Firstborn Top Capital Sdn. Bhd., shareholders of Firstborn Top Capital Sdn. Bhd. and certain representatives.

10.1*

Form of Sponsor Support Agreement.

10.2*

Form of Company Support Agreement.

10.3

Form of Registration Rights Agreement.

10.4

Form of Lock-Up Agreement.

10.5

Form of Restrictive Covenant Agreement.

10.6

Form of Indemnification Agreement.

10.7

Form of Incentive Equity Plan.

10.8

Form of Executive Employment Agreement.

99.1

Joint Press Release of ARC Group Acquisition I Corp. and Firstborn Top Capital Sdn. Bhd., dated September 10, 2026.

104

Cover

Page Interactive Data File (embedded within the Inline XBRL document).

*The

schedules to this Exhibit have been omitted in accordance with Regulation S-K Item 601(b)(2). Purchaser agrees to furnish supplementally

a copy of any omitted schedule to the SEC upon its request; provided, however, that Purchaser may request confidential treatment for

any such schedules so furnished.

SIGNATURES

Pursuant

to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by

the undersigned hereunto duly authorized.

Dated: September 10, 2026

ARC Group Acquisition I Corp

By:

/s/

Datuk Dr. Doris Wong Sing Ee

Name:

Datuk Dr. Doris Wong Sing Ee

Title:

Chief Executive Officer and Director

EX-2.1

EX-2.1

Filename: ex2-1.htm · Sequence: 2

Exhibit

2.1

SHARE

PURCHASE AGREEMENT

DATED

AS OF SEPTEMBER 10, 2026

BY

AND AMONG

ARC

GROUP ACQUISITION I CORP.,

THE

PURCHASER REPRESENTATIVE,

FIRSTBORN

TOP CAPITAL SDN. BHD.,

THE

SELLING SHAREHOLDERS

AND

THE

SHAREHOLDER REPRESENTATIVE

TABLE

OF CONTENTS

Article

I SALE AND PURCHASE OF SHARES

6

1.1

Sale

and Purchase of Company Shares

6

1.2

Rights

Cease to Exist

6

Article

II CONSIDERATION

7

2.1

Transaction

Consideration.

7

2.2

Closing

Statement.

7

2.3

Allocation

Statement.

9

2.4

Fractional

Shares.

9

2.5

Tax

Withholding.

9

Article

III CLOSING

9

3.1

Closing.

9

3.2

Surrender

of Company Shares and Disbursement of Transaction Consideration.

9

3.3

Closing

Transactions.

10

Article

IV REPRESENTATIONS AND WARRANTIES OF THE COMPANY

10

4.1

Organization;

Standing and Power.

10

4.2

Authorization;

Binding Agreement.

10

4.3

Capitalization.

11

4.4

Subsidiaries.

12

4.5

Governmental

Approvals.

12

4.6

Non-Contravention.

12

4.7

Financial

Statements; Internal Controls.

12

4.8

Absence

of Certain Changes.

14

4.9

Compliance

with Laws.

16

4.10

Company

Permits.

17

4.11

Litigation.

17

4.12

Material

Contracts.

17

4.13

Intellectual

Property.

19

4.14

Taxes

Returns and Audits.

21

4.15

Real

Property.

22

4.16

Personal

Property.

23

4.17

Title

to and Sufficiency of Assets.

23

4.18

Employee

Matters.

23

4.19

Benefit

Plans.

24

4.20

Environmental

Matters.

25

4.21

Transactions

with Related Persons.

26

4.22

Insurance.

26

4.23

Books

and Records.

27

4.24

Top

Customers and Suppliers.

27

4.25

Certain

Business Practices.

28

4.26

Compliance

with Privacy Laws, Privacy Policies and Certain Contracts.

29

4.27

Investment

Company Act.

29

4.28

Finders

and Brokers.

29

4.29

Restrictions

on Business Activities.

29

4.30

Fairness

Opinion.

30

4.31

Independent

Investigation.

30

4.32

Information

Supplied.

30

4.33

Disclosure.

30

ii

Article

V REPRESENTATIONS AND WARRANTIES OF THE SELLING SHAREHOLDERS

31

5.1

Authorization

of Agreement; Enforceability.

31

5.2

Conflicts;

Consents of Third Parties.

31

5.3

Ownership

and Transfer of Company Shares.

31

5.4

Litigation.

32

5.5

Financial

Advisors.

32

Article

VI REPRESENTATIONS AND WARRANTIES OF PURCHASER

32

6.1

Organization

and Standing.

32

6.2

Authorization;

Binding Agreement.

32

6.3

Governmental

Approvals.

33

6.4

Non-Contravention.

33

6.5

Capitalization.

33

6.6

SEC

Filings and Purchaser Financials.

34

6.7

Absence

of Certain Changes.

35

6.8

Compliance

with Laws.

35

6.9

Actions;

Orders; Permits.

35

6.10

Taxes

and Returns.

35

6.11

Employees

and Employee Benefit Plans.

36

6.12

Properties.

36

6.13

Material

Contracts.

36

6.14

Transactions

with Affiliates.

36

6.15

Investment

Company Act.

37

6.16

Finders

and Brokers.

37

6.17

Ownership

of Transaction Consideration.

37

6.18

Certain

Business Practices.

37

6.19

Insurance.

37

6.20

Purchaser

Trust Account.

38

6.21

Independent

Investigation.

38

Article

VII COVENANTS

38

7.1

Access

and Information.

38

7.2

Conduct

of Business of the Company.

39

7.3

Conduct

of Business of Purchaser.

42

7.4

Annual

and Interim Financial Statements.

44

7.5

Purchaser

Public Filings.

44

7.6

No

Solicitation.

44

7.7

No

Trading.

45

7.8

Notification

of Certain Matters.

45

7.9

Efforts.

46

7.10

Further

Assurances.

47

7.11

The

Registration Statement.

48

7.12

Public

Announcements.

50

7.13

Confidential

Information.

50

7.14

Documents

and Information.

51

7.15

Post-Closing

Board of Directors and Executive Officers.

52

7.16

Indemnification

of Directors and Officers; Tail Insurance.

52

7.17

Trust

Account Proceeds.

52

7.18

PIPE

Investment.

53

7.19

Incentive

Equity Plan.

53

7.20

Tax

Matters.

53

7.21

Related

Party Matters.

55

iii

Article

VIII NO SURVIVAL

55

8.1

No

Survival.

55

Article

IX CONDITIONS TO CLOSING

56

9.1

Conditions

to Each Party’s Obligations.

56

9.2

Conditions

to Obligations of Purchaser.

56

9.3

Conditions

to Obligations of the Company

58

9.4

Frustration

of Closing Conditions.

59

Article

X TERMINATION AND EXPENSES

59

10.1

Termination

of Agreement.

59

10.2

Effect

of Termination.

60

10.3

Fees

and Expenses.

61

Article

XI WAIVERS AND RELEASES

61

11.1

Waiver

of Claims Against Trust.

61

Article

XII MISCELLANEOUS

62

12.1

Notices.

62

12.2

Binding

Effect; Assignment.

63

12.3

Third

Parties.

63

12.4

Reserved..

63

12.5

Governing

Law; Jurisdiction.

63

12.6

WAIVER

OF JURY TRIAL.

63

12.7

Specific

Performance.

63

12.8

Severability.

63

12.9

Amendment.

64

12.10

Waiver.

64

12.11

Entire

Agreement.

64

12.12

Interpretation.

64

12.13

Counterparts.

65

12.14

Purchaser

Representative.

65

12.15

Shareholder

Representative.

66

12.16

Legal

Representation.

67

Article

XIII RESERVED

68

Article

XIV DEFINITIONS

68

14.1

Certain Definitions.

68

Exhibits

Exhibit

A-1 – Selling Shareholders

Exhibit

A-2 – Allocation Schedule

Exhibit

B – Form of Registration Rights Agreement

Exhibit

C – Form of Executive Employment Agreement

Exhibit

D – Form of Incentive Equity Plan

Exhibit

E – Form of Indemnification Agreement

Exhibit

F – Form of Sponsor Support Agreement

Exhibit

G – Form of Company Support Agreement

Exhibit

H – Form of Lock-Up Agreement

Exhibit

I – Form of Restrictive Covenant Agreement

iv

SHARE

PURCHASE AGREEMENT

THIS

SHARE PURCHASE AGREEMENT (this “Agreement”), dated as of September 10, 2026 (the “Agreement Date”),

is entered into by and among ARC Group Acquisition I Corp., a British Virgin Islands business company (“Purchaser”),

Datuk Dr. Doris Wong in the capacity as the representative from and after the Closing (as defined below) for the shareholders of Purchaser

(other than the Company Security Holders (as defined below) as of immediately prior to the Closing and their successors and assigns)

in accordance with the terms and conditions of this Agreement (the “Purchaser Representative”), Firstborn Top Capital

Sdn. Bhd., a Malaysian private limited company (the “Company”), the holders of Company Shares identified on Exhibit

A-1 hereto (each, a “Selling Shareholder” and collectively, the “Selling Shareholders”), and

Ow Ruey Shen, in the capacity as the representative for the Selling Shareholders (the “Shareholder Representative”).

W

I T N E S S E T H :

WHEREAS,

the Company operates a licensed money lending business committed to providing transparent and accessible financial solutions to individuals

and businesses across Malaysia;

WHEREAS,

Purchaser is a blank check special purpose acquisition company incorporated for the purpose of entering into a merger, share exchange,

asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more operating

businesses or entities through a business combination;

WHEREAS,

the Selling Shareholders own all of the issued and outstanding securities of the Company (the “Company Shares”);

WHEREAS,

the Selling Shareholders desire to sell, transfer, assign, convey and deliver to Purchaser, and Purchaser desires to purchase, acquire

and accept from the Selling Shareholders, all of the Company Shares, for the Transaction Consideration, upon the terms and conditions

set forth herein;

WHEREAS,

the board of directors of the Company and Purchaser have (i) determined that the transactions are fair, advisable and in the best interests

of their respective companies and shareholders, (ii) approved this Agreement, the documents attached as Exhibits hereto (the “Ancillary

Documents”), and the transactions contemplated hereby and thereby, upon the terms and subject to the conditions set forth herein

and therein, and (iii) determined to recommend to their respective shareholders the approval and adoption of this Agreement, the Ancillary

Documents, and the transactions contemplated hereby and thereby;

WHEREAS,

as a condition and inducement to the Company’s willingness to enter into this Agreement, simultaneously with the execution and

delivery of this Agreement, in connection with the transactions contemplated hereby, certain of the Purchaser’s Affiliates and

MFH 2, LLC, a Delaware limited liability company (the “Sponsor”) are entering into the Sponsor Support Agreement in

the form attached as Exhibit F (the “Sponsor Support Agreement”), providing that, among other things, each

such Person shall (i) vote its Purchaser Ordinary Shares in favor of the adoption and approval of this Agreement and the transactions

contemplated hereby and against any Alternative Transaction, (ii) waive any right to redeem any Purchaser Securities it holds and any

anti-dilution rights with respect to any equity issuance, including the PIPE Investment, and (iii) subject its Purchaser Securities to

a lock-up, in each case subject to the limited exceptions set forth therein;

5

WHEREAS,

as a condition and inducement to Purchaser’s willingness to enter into this Agreement, simultaneously with the execution and delivery

of this Agreement, in connection with the transactions contemplated hereby, the directors, officers and holders of five percent (5%)

or more of the voting stock of the Company are entering into a Company Support Agreement in the form attached hereto as Exhibit G

(the “Company Support Agreement”), providing that, among other things, each such Person shall irrevocably agree to

vote in favor of the transactions contemplated hereby and against any Alternative Transaction;

WHEREAS,

in connection with the Closing of the transactions contemplated by this Agreement, certain Key Executives shall have entered into mutually

acceptable Executive Employment Agreements with Purchaser, in substantially the form attached as Exhibit C hereto (each, an “Employment

Agreement”), each of which agreements will become effective as of the Closing;

WHEREAS,

prior to and effective as of the Closing of the transactions contemplated by this Agreement, the officers and directors of Purchaser

and the Company who shall serve in such capacities from and after the Closing shall have been duly elected or appointed thereby, and

shall each have entered into an Indemnification Agreement, the form of which is attached as Exhibit E hereto (the “Indemnification

Agreement”), each of which agreements shall become effective as of the Closing;

WHEREAS,

at the Closing, directors, officers and significant shareholders of the Company as of immediately prior to the Closing Date shall enter

into Lock-Up Agreements with Purchaser in substantially the form attached as Exhibit H hereto (each, a “Lock-Up Agreement”),

subjecting their Purchaser Securities to a lock-up for a period substantially identical to the lock-up applicable to the Sponsor with

respect to its founder shares, and shall enter into Restrictive Covenant Agreements with Purchaser in the form attached as Exhibit

I hereto (each, a “Restrictive Covenant Agreement”), providing for, among other things, non-solicitation and non-competition

restrictions for a period of two (2) to four (4) years from the Closing Date;

WHEREAS,

in connection with the execution and delivery of this Agreement, Purchaser and the Company shall reasonably cooperate to seek to enter

into customary and binding subscription agreements (the “Subscription Agreements”) with certain investors (the “PIPE

Investors”) pursuant to which such PIPE Investors, upon the terms and subject to the conditions set forth therein, may purchase

Purchaser Class A Ordinary Shares at a purchase price of Ten U.S. Dollars ($10.00) per share (the “Private Placement Amount”),

in a private placement or placements (the “Private Placements”) to be consummated concurrently with the Closing (collectively,

the “PIPE Investment”); and

WHEREAS,

certain terms used in this Agreement are defined in Section ‎14.1.

NOW,

THEREFORE, in consideration of the premises and the mutual covenants and agreements hereinafter contained and for other good and valuable

consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereby agree as follows:

Article

I

SALE

AND PURCHASE OF SHARES

1.1

Sale and Purchase of Company Shares. Upon the terms and subject to the conditions contained herein, on the Closing Date, each

Selling Shareholder shall sell, transfer, assign, convey and deliver to Purchaser, and Purchaser shall purchase, acquire and accept from

each Selling Shareholder, that number of Company Shares set forth opposite the name of each Selling Shareholder on Exhibit A-1

hereto, free and clear of any and all Liens and Encumbrances, such that all of the issued and outstanding Company Shares at the Closing

shall be sold to and purchased by Purchaser.

1.2

Rights Cease to Exist. At the Closing, upon payment of the Transaction Consideration to the Selling Shareholders, respectively,

the Selling Shareholders shall cease to have any rights with respect to the Company Shares, except the rights set forth in this Agreement.

That portion of the Transaction Consideration paid to each Selling Shareholder in accordance with the terms hereof shall be deemed to

have been issued in full satisfaction of all rights pertaining to the Company Shares held by each such Selling Shareholder.

6

Article

II

CONSIDERATION

2.1

Transaction Consideration. Subject to the terms and conditions of this Agreement, the total consideration for the purchase of

all issued and outstanding Company Shares (the “Transaction Consideration”) shall be the number of Purchaser Class

A Ordinary Shares (the “Consideration Shares”) equal to: (A) One Billion U.S. Dollars ($1,000,000,000), (B) minus

the Closing Net Indebtedness, (C) plus or minus, as applicable, the Working Capital Adjustment, and (D) minus the amount of any unpaid

transaction bonuses and other transaction-related compensation payable in connection with the transactions contemplated hereby, in each

case as set forth in the Closing Statement, with the resulting amount divided by the Redemption Price. The Working Capital Adjustment

shall equal the Net Working Capital Amount minus the Target Net Working Capital Amount, such that the Transaction Consideration shall

be increased dollar-for-dollar to the extent the Net Working Capital Amount exceeds the Target Net Working Capital Amount and decreased

dollar-for-dollar to the extent the Target Net Working Capital Amount exceeds the Net Working Capital Amount. The Transaction Consideration

may include earn-out shares expressly agreed by Purchaser and the Company in writing and reflected in the Allocation Statement and applicable

Ancillary Documents. For the avoidance of doubt, there is no minimum cash condition or minimum cash consideration in connection with

the Closing. Each Selling Shareholder shall have the right to receive at the Closing a number of Purchaser Class A Ordinary Shares equal

to the aggregate Consideration Shares divided by the number of Company Shares outstanding immediately prior to the Closing, multiplied

by the number of Company Shares held by such Selling Shareholder (the “Conversion Ratio”). All currency amounts in

this Agreement are designated in U.S. Dollars.

2.2

Closing Statement.

(a)

No later than three (3) Business Days prior to the Closing Date (the date of such calculation, the “Calculation Date”),

the Company shall deliver to Purchaser a statement setting forth (A) the Company Closing Cash, (B) the Closing Net Indebtedness, (C)

the Net Working Capital Amount, (D) the amount of unpaid transaction bonuses and other transaction-related compensation payable in connection

with the transactions contemplated hereby, (E) the amount of Transaction Expenses to be paid by the post-Closing combined company, and

(F) a detailed calculation of each of the foregoing, in each case determined in accordance with the Accounting Principles and accompanied

by reasonable supporting schedules and work papers, certified by the Company’s Director (the “Closing Statement”).

The amounts set forth in the Closing Statement shall be estimates for purposes of the Closing and shall be subject to a post-Closing

true-up.

(b)

Within ninety (90) Business Days after the Closing, Purchaser or the Company shall deliver a final true-up statement (the “Preliminary

Final Closing Statement”). Upon receipt of the Preliminary Final Closing Statement, the Shareholder Representative will have

thirty (30) days (the “Review Period”) to review such Preliminary Final Closing Statement and related computations.

In connection with the review of the Preliminary Final Closing Statement, Purchaser will reasonably cooperate with and give, and will

cause the Company to reasonably cooperate with and give, to the Shareholder Representative and its authorized Representatives, reasonable

access during normal business hours to the books and records of the Company, and work papers used in the preparation of the Preliminary

Final Closing Statement and prepared by or for Purchaser or the Company, including historical financial information relating to the Company,

in each case, as the Shareholder Representative or its authorized Representatives may reasonably request for purposes of their review

of the Preliminary Final Closing Statement, to the extent such access does not unreasonably interfere with the operations of Purchaser

or any of its Affiliates (including the Company) and subject to prior execution of customary access letters; provided, that in

no event shall Purchaser or any of its Affiliates (including the Company) be required to provide any documents or other information covered

by the attorney-client privilege, the attorney work product doctrine or other similar protections or in violation of applicable Laws.

If the Shareholder Representative has accepted such Preliminary Final Closing Statement in writing or has not given written notice to

the Purchaser setting forth any objection of the Shareholder Representative to such Preliminary Final Closing Statement (a “Statement

of Objections”) prior to the expiration of the Review Period, then such Preliminary Final Closing Statement will be final and

binding upon the Parties and will be deemed the “Final Closing Statement” for all purposes under this Agreement. Any

Statement of Objections given by the Shareholder Representative pursuant to and in accordance with the terms hereof will specify in reasonable

detail each item that the Shareholder Representative disputes, the amount in dispute, an alternative amount for each such disputed item,

and calculations (including reasonable documentation and support) for each such disputed item, it being understood and agreed that all

items not included in the Statement of Objections shall be deemed final, conclusive and binding on the Parties.

7

(c)

If the Shareholder Representative delivers a Statement of Objections during the Review Period, Purchaser and the Shareholder Representative

will negotiate in good faith to resolve any such objection within thirty (30) days following the receipt by Purchaser of the Statement

of Objections (the “Consultation Period”), and upon any such resolution, the Final Closing Statement will be prepared

in accordance with the agreement of the Shareholder Representative and Purchaser. If the Shareholder Representative and Purchaser are

unable to reach an agreement as to any such objection(s) within the Consultation Period, then either of the Shareholder Representative

or Purchaser may submit such matter to a nationally recognized independent accounting firm as mutually approved by the Shareholder Representative

and Purchaser (which approval shall not be unreasonably withheld, conditioned or delayed) (the “Settlement Accountant”)

for resolution of the remaining disputed matters, which Settlement Accountant shall be engaged by the Shareholder Representative and

Purchaser within five (5) days after the later to occur of (i) the expiration of the Consultation Period and (ii) delivery of written

notice by either the Shareholder Representative or Purchaser to the other of its desire to engage the Settlement Accountant (and the

Shareholder Representative and Purchaser shall execute any agreement reasonably required by the Settlement Accountant in connection with

its engagement). Purchaser and the Shareholder Representative will instruct the Settlement Accountant that the Settlement Accountant

must act as an arbitrator and not an expert and must only consider those items that are properly identified on the Statement of Objections

as in dispute, unless otherwise agreed by mutual written agreement of the Shareholder Representative and Purchaser during the Consultation

Period. The Shareholder Representative and Purchaser will use their respective commercially reasonable efforts to cause the Settlement

Accountant to resolve all disagreements as soon as practicable and in any event within thirty (30) days after the submission of any dispute

to the Settlement Accountant. The Shareholder Representative and Purchaser will instruct the Settlement Accountant that (i) the Settlement

Accountant’s determination must (x) address only the remaining disputed items properly set forth on the Statement of Objections

and (y) be made solely (A) in accordance with the terms and procedures set forth in this Agreement, including the definitions herein

and the Accounting Principles, and (B) on a single written submission and one single written response and accompanying supporting materials

provided by Purchaser and the Shareholder Representative in accordance with the terms and procedures set forth in this Agreement (i.e.,

not on the basis of an independent review) (provided that a copy of such submission and supporting materials shall be provided

by Purchaser or the Shareholder Representative (as applicable) to the other Party concurrent with delivery of such materials to the Settlement

Accountant); and (ii) the Settlement Accountant may not assign a value to any item greater than the greatest value for such item claimed

by either the Shareholder Representative or Purchaser, or less than the smallest value for such item claimed by either the Shareholder

Representative or Purchaser. The costs and expenses of the Settlement Accountant will be borne equally by Purchaser and the Shareholder

Representative. The resolution of the dispute by the Settlement Accountant will be final, binding and non-appealable on the Parties absent

fraud or manifest error, and any Party may seek to enforce such decision in a court of competent jurisdiction. If any disputes are submitted

to the Settlement Accountant pursuant to this Section 2.3(c), the Final Closing Statement will be prepared in accordance

with the decision of the Settlement Accountant and, to the extent applicable, the mutual agreement of Purchaser and the Shareholder Representative.

(d)

Upon determination of the Final Closing Statement in accordance with Section 2.2(b) or ‎Section 2.2(c), as

applicable, any resulting adjustment shall be effected by delivery or return of Purchaser Class A Ordinary Shares or, if agreed by

both Parties, payment of cash.

8

2.3

Allocation Statement. No later than two (2) Business Days prior to the Closing Date, the Company shall deliver to Purchaser a

statement (the “Allocation Statement”) setting forth each Selling Shareholder’s share of the Transaction Consideration,

calculated in accordance with Section 2.1 hereof (by 8:00 PM New York time) certified by the Company’s Director, to be attached

hereto as Exhibit A-2 at the Closing.

2.4

Fractional Shares. Notwithstanding anything to the contrary contained herein, no fraction of a Purchaser Class A Ordinary Share

will be issued by virtue of the transactions contemplated by this Agreement, and each Person who would otherwise be entitled to a fraction

of a Purchaser Class A Ordinary Share (after aggregating all fractional shares of Purchaser Class A Ordinary Shares that otherwise would

be received by such holder) shall instead have the number of shares of Purchaser Class A Ordinary Shares issued to such Person rounded

up in the aggregate to the nearest whole share of Purchaser Class A Ordinary Share.

2.5

Tax Withholding. Notwithstanding anything to the contrary contained in this Agreement, Purchaser and the Company (or any other

Person required to withhold with respect to any payment made under this Agreement) shall be entitled to deduct and withhold from any

Transaction Consideration payable or otherwise deliverable pursuant to this Agreement such amounts as are required to be deducted or

withheld therefrom under any provision of applicable Laws. To the extent that amounts are so deducted or withheld and paid over to the

appropriate Governmental Authority, such amounts shall be treated for all purposes of this Agreement as having been paid to the Person

to whom such amounts would otherwise have been paid.

Article

III

CLOSING

3.1

Closing. Subject to the satisfaction of the conditions set forth in Section 9.1, Section 9.2 and ‎Section

9.3 hereof (or waiver in writing by the party entitled to waive such conditions), the closing of the sale and purchase of the Company

Shares provided for in Section 1.1 hereof (the “Closing”) shall take place via the electronic exchange of documents

on a date and at a time to be agreed upon by Purchaser and the Company, no later than the second Business Day after the satisfaction

or waiver of each condition to the Closing set forth in ‎Article IX hereof (other than conditions that by their nature

are to be satisfied at the Closing, but subject to the satisfaction or waiver of such conditions), unless another time or date, or both,

are agreed to in writing by the Company and Purchaser. The date on which the Closing shall be held is referred to in this Agreement as

the “Closing Date”.

3.2

Surrender of Company Shares and Disbursement of Transaction Consideration.

(a)

At the Closing, each Selling Shareholder shall deliver to Purchaser the share certificate(s), if certificated, and if not certificated,

evidence of ownership representing such Selling Shareholder’s Company Shares (each, a “Company Certificate”

and collectively, the “Company Certificates”). Notwithstanding anything to the contrary contained herein, in the event

that any Company Certificate shall have been lost, stolen or destroyed, in lieu of delivery of a Company Certificate to Company, the

Selling Shareholder may instead deliver to Company an affidavit of lost certificate and indemnity of loss in form and substance reasonably

acceptable to Purchaser and Company (a “Lost Certificate Affidavit”). Any Lost Certificate Affidavit properly delivered

in accordance with this Section ‎3.2(a) shall be treated as a Company Certificate for all purposes of this Agreement.

(b)

Subject to the provisions of this Section 3.2, at the Closing, Purchaser shall issue, or cause its transfer agent,

Efficiency, Inc. to update the register of members of the Purchaser and provide a copy to the Purchaser’s registered agent FH

Corporate Services Ltd. If any portion of the Transaction Consideration is to be delivered or issued to a Person other than the

Person in whose name the surrendered Company Certificate is registered immediately.

9

(c)

prior to the Closing, it shall be a condition to such delivery that (i) the transfer of such Company Shares shall have been permitted

in accordance with the terms of the Company Governing Documents in effect immediately prior to the Closing, (ii) such Company Certificate

shall be properly endorsed or shall otherwise be in proper form for transfer and (iii) the Person requesting such delivery shall pay

to Purchaser or the Company, as applicable, any transfer or other Taxes required as a result of such delivery to a Person other than

the registered holder of such Company Certificate or establish to the satisfaction of Company and Purchaser that such Tax has been paid

or is not payable.

3.3

Closing Transactions. All transactions to be concluded at the Closing pursuant to this Agreement shall be deemed concluded simultaneously

at 12:01 a.m. New York time on the Closing Date. Unless waived, no transaction or delivery to be concluded at the Closing shall be deemed

finally concluded unless and until all such transactions or deliveries are concluded.

Article

IV

REPRESENTATIONS

AND WARRANTIES OF THE COMPANY

Except

as set forth in the disclosure schedules delivered by the Company to Purchaser on the date hereof and the Closing Date (the “Company

Disclosure Schedules”), the Section numbers of which are numbered to correspond to the Section numbers of this Agreement to

which they refer, the Company and the Selling Shareholders, hereby jointly and severally represent and warrant to Purchaser, as of the

Agreement Date and again as of the Closing Date, that:

4.1 Organization;

Standing and Power. The Company is a corporation duly incorporated, validly existing and in good standing under the Malaysian

Companies Act and has all requisite corporate power and authority to own, lease and operate its properties and to carry on its

business as now being conducted. The Company is duly qualified and in good standing in the jurisdiction in which it is incorporated

or registered and in each other jurisdiction where it does business or operates to the extent that the character of the property

owned, or leased or operated by it or the nature of the business conducted by it makes such qualification necessary, except where

the failure to be so qualified, individually or in the aggregate, would not reasonably be expected to be material to the Company.

The Company has the requisite power and authority and all necessary governmental licenses, authorizations, permits, consents and

approvals required to own, lease and operate its properties and to carry on its business as currently conducted, except for those

licenses, authorizations, permits, consents and approvals the absence of which, individually or in the aggregate, would not

reasonably be expected to be material to the Company. Schedule 4.1 lists all jurisdictions in which the Company is qualified

to conduct business and all names other than its legal name under which the Company does business. The Company has provided to

Purchaser accurate and complete copies of its Governing Documents, each as amended to date and as currently in full force and

effect. The Company is not in violation of any provision of its Governing Documents.

4.2

Authorization; Binding Agreement. The Company has all requisite corporate power and authority to execute and deliver this Agreement

and each Ancillary Document to which it is or is required to be a party, to perform the Company’s obligations hereunder and thereunder

and to consummate the transactions contemplated hereby and thereby. The execution and delivery of this Agreement and each Ancillary Document

to which the Company is or is required to be a party and the consummation of the transactions contemplated hereby and thereby, (a) have

been duly and validly authorized by the Company’s board of directors in accordance with the Company’s Governing Documents,

the Malaysian Companies Act and any other applicable Law or any Contract to which the Company or any of its shareholders is a party or

by which it or its securities are bound, and (b) no other corporate proceedings on the part of the Company are necessary to authorize

the execution and delivery of this Agreement and each Ancillary Document to which it is a party or to consummate the transactions contemplated

hereby and thereby. This Agreement has been, and each Ancillary Document to which the Company is or is required to be a party shall be

when delivered, duly and validly executed and delivered by the Company and assuming the due authorization, execution and delivery of

this Agreement and any such Ancillary Document by the other parties hereto and thereto, constitutes, or when delivered shall constitute,

the legal, valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, subject to the

Enforceability Exceptions.

10

4.3

Capitalization.

(a)

The Company has a total of 3,636,400 Company Ordinary Shares issued and outstanding. Prior to giving effect to the transactions contemplated

by this Agreement, all of the issued and outstanding Company Securities are set forth on Schedule 4.3(a), along with the

beneficial and record owners thereof, all of which shares and other equity interests are owned free and clear of any Liens and Encumbrances,

other than those imposed under the Company’s Governing Documents. All of the outstanding Company Securities have been duly authorized,

validly issued, fully paid and non-assessable and are not in violation of any purchase option, right of first refusal, preemptive right,

subscription right or any similar right under any provision of the Malaysian Companies Act and any other applicable Law, the Company’s

Governing Documents or any Contract to which the Company is a party or by which it or its securities are bound. The Company holds no

shares or other equity interests of the Company in its treasury. None of the outstanding shares or other equity interests of the Company

were issued in violation of any applicable securities Laws. The rights, privileges and preferences of the Company Ordinary Shares are

as stated in the Company Governing Documents and as provided by the Malaysian Companies Act.

(b)

There are no outstanding options, warrants, calls, rights, commitments, conversion privileges, preemptive rights, rights of first refusal

or first offer, or other rights or Contracts outstanding to purchase or acquire any Company Securities, nor any commitments, arrangements,

promises, restrictions or obligations for the Company to grant, extend or enter into any such option, warrant, call, right, commitment,

conversion privilege, preemptive right, rights of first refusal or first offer, or other right or Contract or to redeem any Company Securities

to which the Company or any of its shareholders is a party or bound relating to any Company Securities, whether or not outstanding. There

are no outstanding or authorized share appreciation, equity appreciation, phantom equity or similar rights with respect to the Company.

Except as set forth on Schedule 4.3(b), there are no voting trusts, proxies, shareholder agreements or any other agreements

or understandings with respect to the voting of the Company’s equity interests. Except as set forth in the Company’s Governing

Documents, there are no outstanding contractual obligations of the Company to repurchase, redeem or otherwise acquire any equity interests

or securities of the Company, nor has the Company granted any registration rights to any Person with respect to the Company’s equity

securities. All of the Company’s securities have been granted, offered, sold and issued in compliance with all applicable securities

Laws. Except as set forth on Schedule ‎4.3(b), as a result of the consummation of the transactions contemplated by this Agreement,

there are no securities, options, warrants, calls, rights, contracts, commitments, agreements, instruments, arrangements, understandings,

obligations or undertakings of any kind to which the Company is a party or by which any of them is bound obligating (or purporting to

obligate) the Company to (including on a deferred basis) issue, deliver or sell, or cause to be issued, delivered or sold, additional

equity or other ownership interests of the Company, and no rights in connection with any interests, warrants, calls, rights, options

or other securities of the Company accelerate or otherwise become triggered (whether as to vesting, exercisability, convertibility or

otherwise).

(c)

Except as disclosed in the Company Financials or on Schedule 4.3(c), since the date of the Company’s formation, the

Company has not declared or paid any distribution or dividend in respect of its equity interests and has not repurchased, redeemed or

otherwise acquired any equity interests of the Company, and the board of directors of the Company has not authorized any of the foregoing.

(d)

No Changes. Since the close of business on June 30, 2026 and through the date hereof, there has been no change in the outstanding capital

stock of the Company or the number of options, warrants or other rights to purchase capital stock of the Company.

11

4.4

Subsidiaries. The Company has no Subsidiaries.

4.5 Governmental

Approvals. Except as otherwise described in Schedule 4.5, no Consent of or with any Governmental Authority on the part of

the Company is required to be obtained or made in connection with the execution, delivery or performance by the Company of this

Agreement or any Ancillary Documents or the consummation by the Company of the transactions contemplated hereby or thereby other

than (a) such filings as are expressly contemplated by this Agreement, (b) pursuant to Antitrust Laws, (c) the filing with the SEC

of (A) the Registration Statement/Proxy Statement and the declaration of the effectiveness thereof by the SEC and (B) such reports

under Section 13(a) or 15(d) of the Exchange Act as may be required in connection with this Agreement, the Ancillary Documents or

the transactions contemplated hereby or thereby, or (d) any other consents, approvals, authorizations, designations, declarations,

waivers or filings, the absence of which would not have a Material Adverse Effect.

4.6 Non-Contravention.

Except as otherwise described in Schedule ‎4.6, the execution and delivery by the Company of this Agreement and

each Ancillary Document to which the Company is or is required to be a party or otherwise bound, the consummation by the Company of

the transactions contemplated hereby and thereby, and compliance by the Company with any and all of the provisions hereof and

thereof, will not (a) conflict with or violate any provision of the Company’s Governing Documents, (b) subject to obtaining

the Consents from Governmental Authorities referred to in Section ‎4.5 hereof, the waiting periods referred to

therein having expired, and any condition precedent to such Consent or waiver having been satisfied, conflict with or violate any

Law, Order or Consent applicable to the Company or any of its material properties or assets, or (c) (i) violate, conflict with or

result in a breach of, (ii) constitute a default (or an event which, with notice or lapse of time or both, would constitute a

default) under, (iii) result in the termination, withdrawal, suspension, cancellation or modification of, (iv) accelerate the

performance required by the Company under, (v) result in a right of termination or acceleration under, (vi) give rise to any

obligation to make payments or provide compensation under, (vii) result in the creation of any Lien upon any of the properties or

assets of the Company under (other than Permitted Liens), (viii) give rise to any obligation to obtain any third party Consent or

provide any notice to any Person or (ix) give any Person the right to declare a default, exercise any remedy, claim a rebate,

chargeback, penalty or change in delivery schedule, accelerate the maturity or performance, cancel, terminate or modify any right,

benefit, obligation or other term under, any of the terms, conditions or provisions of any Company Material Contract, except in the

cases of clauses (b) and (c), as has not been and would not reasonably be expected to have a Material Adverse Effect on the Company

or its ability to consummate the transactions contemplated by this Agreement or the Ancillary Documents or to perform the

Company’s obligations hereunder or thereunder.

4.7

Financial Statements; Internal Controls.

(a)

As used herein, the term “Company Financials” means the (i) PCAOB-audited consolidated financial statements of the

Company (including, in each case, any related notes thereto), consisting of the consolidated balance sheets of the Company as of December

31, 2025 and December 31, 2024, and the related consolidated audited income statements, changes in shareholder equity and statements

of cash flows for the fiscal years then ended, audited by an independent registered public accounting firm in accordance with PCAOB standards

and prepared in accordance with U.S. GAAP and applicable SEC requirements (the “Audited Company Financials”), and

(ii) the Company-prepared financial statements, consisting of the consolidated unaudited balance sheet of the Company as of June 30,

2026 (the “Interim Balance Sheet Date”) and the related consolidated unaudited income statement, changes in shareholder

equity and statement of cash flows for the six (6) months then ended, prepared in accordance with U.S. GAAP and applicable SEC requirements.

True and correct copies of the Company Financials have been provided to Purchaser. The Company Financials (i) accurately reflect the

books and records of the Company as of the times and for the periods referred to therein, (ii) were prepared in accordance with Applicable

Accounting Standards, consistently applied throughout and among the periods involved (except that the unaudited statements exclude the

footnote disclosures and other presentation items required for Applicable Accounting Standards, and exclude year-end adjustments which

will not be material in amount), (iii) comply in all material respects with all applicable accounting requirements under the Securities

Act and the rules and regulations of the SEC thereunder, and (iv) fairly present in all material respects the consolidated financial

position of the Company as of the respective dates thereof and the consolidated results of the operations and cash flows of the Company

for the periods indicated. The Company has never been subject to the reporting requirements of Sections 13(a) and 15(d) of the Exchange

Act. The Company shall cause any other financial statements required for the Registration Statement or Proxy Statement to be prepared

in accordance with U.S. GAAP and applicable SEC requirements and, where required, audited in accordance with PCAOB standards.

12

(b)

The Company maintains accurate books and records reflecting its assets and Liabilities and maintains proper and adequate internal accounting

controls that provide reasonable assurance that (i) the Company does not maintain any off-the-book accounts and that the Company’s

assets are used only in accordance with the Company’s management directives, (ii) transactions are executed with management’s

authorization, (iii) transactions are recorded as necessary to permit preparation of the financial statements of the Company and to maintain

accountability for the Company’s assets, (iv) access to the Company’s assets is permitted only in accordance with management’s

authorization, (v) the reporting of the Company’s assets is compared with existing assets at regular intervals and verified for

actual amounts, and (vi) accounts, notes and other receivables and inventory are recorded accurately, and proper and adequate procedures

are implemented to effect the collection of accounts, notes and other receivables on a current and timely basis. All of the financial

books and records of the Company are complete and accurate in all material respects and have been maintained in the ordinary course consistent

with past practice and in accordance with applicable Laws. The Company has not been subject to or involved in any material fraud that

involves management or other employees who have a significant role in the internal controls over financial reporting of the Company.

In the past five (5) years, the Company or its Representatives has not received any written complaint, allegation, assertion or claim

regarding the accounting or auditing practices, procedures, methodologies or methods of the Company or its internal accounting controls,

including any material written complaint, allegation, assertion or claim that the Company has engaged in questionable accounting or auditing

practices.

(c)

The Company does not have any Indebtedness other than the Indebtedness set forth on Schedule ‎4.7(c), which schedule sets

forth the amounts (including principal and any accrued but unpaid interest or other obligations) with respect to such Indebtedness.

Except as disclosed on Schedule ‎4.7(c), no Indebtedness of the Company contains any restriction upon (i) the prepayment

of any of such Indebtedness, (ii) the incurrence of Indebtedness by the Company, or (iii) the ability of the Company to grant any

Lien on its property or assets.

(d)

Except as set forth on Schedule ‎4.7(d), the Company is not subject to any material Liabilities or obligations (whether or

not required to be reflected on a balance sheet prepared in accordance with Applicable Accounting Standards), except for those that are

either (i) adequately reflected or reserved on or provided for in the consolidated balance sheet of the Company as of the Interim Balance

Sheet Date contained in the Company Financials or (ii) not material and that were incurred after the Interim Balance Sheet Date in the

ordinary course of business consistent with past practice (other than Liabilities for breach of any Contract or violation of any Law).

(e)

All financial projections with respect to the Company that were delivered by or on behalf of the Company to Purchaser or its Representatives

were prepared in good faith using assumptions that the Company believes to be reasonable.

13

(f)

All accounts, notes and other receivables, whether or not accrued, and whether or not billed, of the Company (the “Accounts

Receivable”) arose from sales actually made or services actually performed in the ordinary course of business and represent

valid obligations to the Company arising from its business. None of the Accounts Receivable are subject to any right of recourse, defense,

deduction, return of goods, counterclaim, offset, or set off on the part of the obligor in excess of any amounts reserved therefore on

the Company Financials. All of the Accounts Receivable are, to the Knowledge of the Company, fully collectible according to their terms

in amounts not less than the aggregate amounts thereof carried on the books of the Company (net of reserves) within ninety (90) days.

In particular, all loan receivables included in Accounts Receivable arose from loans actually originated and funded by the Company in

the ordinary course of its moneylending business pursuant to written loan agreements and related loan documents, and, to the Knowledge

of the Company, constitute valid and binding obligations of the applicable borrowers, subject to the Enforceability Exceptions. Except

as set forth on Schedule 4.7(f), none of the Company’s material loan receivables is subject to any material defense, rescission

right, counterclaim, set-off or right of recoupment, other than as expressly provided in the applicable loan documents or required by

applicable Law, and the Company has not agreed to waive, defer or materially reduce any principal, interest, fee or other amount due

under any material loan except in the ordinary course of business consistent with its written credit and collection policies.

(g)

The Company has established and maintains a system of internal controls over financial reporting designed to provide reasonable assurances

regarding the reliability of financial reporting and the preparation of its consolidated financial statements in accordance with Applicable

Accounting Standards and including those policies and procedures that: (i) require the maintenance of records that, in reasonable detail,

accurately and fairly reflect the transactions and dispositions of the assets of the Company; (ii) provide reasonable assurance that

material information relating to the Company is promptly made known to the officers responsible for establishing and maintaining the

system of internal controls; (iii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of

financial statements in accordance with Applicable Accounting Standards, and that receipts and expenditures of the Company are being

made only in accordance with authorizations of management and the board of directors of the Company; (iv) provide reasonable assurance

that the reporting of assets is compared with existing assets at regular intervals and appropriate action is taken with respect to any

differences; and (v) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition

of the assets of the Company and its Subsidiaries. There are no “material weaknesses” (as defined by the Public Company Accounting

Oversight Board) in the design or operation of the Company’s internal controls, and there is no series of multiple “significant

deficiencies” (as defined by the Public Company Accounting Oversight Board) that collectively represent a “material weakness”

in the design or operation of the Company’s internal controls. Since January 1, 2026, neither the Company (including any current

Company employee/service provider thereof) nor, to the Knowledge of the Company, the Company’s independent auditors have identified

or been made aware of (A) any significant deficiency or material weakness in the system of internal controls utilized by the Company,

(B) any fraud, whether or not material, that involves the Company’s management or other employees who have a role in the preparation

of financial statements or the internal controls utilized by the Company, or (C) any material claim or allegation regarding any of the

foregoing.

(h)

The Company has established and maintains a system of controls and procedures sufficient to (i) provide assurance that any significant

deficiencies or material weaknesses in the design or operation of internal controls which are reasonably likely to materially and adversely

affect the ability to record, process, summarize and report financial information, and any fraud that is detected by the Company, whether

or not material, that involves the Company’s management or other employees who have a role in the preparation of financial statements

or the internal controls utilized by the Company, are adequately and promptly disclosed to the Company’s independent auditors and

the Company’s board of directors and (ii) provide reasonable assurance that access to assets is permitted only in accordance with

management’s general or specific authorization.

4.8 Absence

of Certain Changes. Except as set forth on Schedule 4.8, since January 1, 2026, the Company has conducted its business

only in the ordinary course of business consistent with past practice, has not taken any action or committed or agreed to take any

action that would be prohibited by Section 7.2(b) (without giving effect to Schedule 7.2) if such action were taken on

or after the date hereof without the consent of Purchaser, and has not been, accrued or arisen:

(a)

any event, change or development that has had or would reasonably be expected to have, individually or in the aggregate, a Material Adverse

Effect on the Company;

14

(b)

any merger or consolidation involving the Company, or any acquisition by the Company of any business, whether by purchasing all or substantially

all of the assets of or equity securities of, or otherwise acquiring, any business or corporation, partnership, association or other

business organization or a division thereof;

(c)

any material Contract entered into by the Company, other than in the ordinary course of business and as provided to Purchaser, or any

material amendment or termination of, or default under, any material Contract to which the Company is a party or by which it or any of

them is bound;

(d)

any declaration, setting aside or payment of any dividend on, or other distribution (whether in cash, stock or property) in respect of,

any of the Company’s capital shares, or any purchase, redemption or other acquisition by the Company of any of the Company’s

capital shares or any other securities of the Company or any options, warrants, calls or rights to acquire any such shares or other securities;

(e)

any split, combination, recapitalization, exchange, readjustment or reclassification of any of the Company’s capital shares;

(f)

any granting by the Company, whether orally or in writing, of any (i) increase in compensation or fringe benefits payable or otherwise

due to officers of the Company or (ii) material increase in compensation or fringe benefits payable or otherwise due to any non-officer

employees of the Company whose annual base salary is in excess of $50,000 other than in the ordinary course of business consistent with

past practice;

(g)

(i) any change by the Company of severance, termination or bonus policies and practices (excluding sales commissions), (ii) any change

in the policy of the Company relating to the granting of stock options to its employees, directors and consultants; (iii) any entry by

the Company into, or amendment of, (A) any employment, severance, deferred compensation, termination, change of control or indemnification

agreement or (B) any agreement the benefits of which are contingent or the terms of which are materially altered upon the occurrence

of a transaction involving the Company of the nature contemplated hereby (either alone or upon the occurrence of additional or subsequent

events), or (iv) the establishment, adoption or amendment (except as required by law) of any collective bargaining, bonus, profit-sharing,

thrift, pension, retirement or other similar benefit plan or arrangement covering any director, officer or employee of the Company;

(h)

any material amendment or termination of any Company Material Contract except in accordance with its terms of expiration or in the ordinary

course of business;

(i)

any Contract entered into by the Company relating to its assets or business (including the acquisition or disposition of any assets or

property) or any relinquishment by the Company or any of its Subsidiaries of any Contract or other right, in each case having a stated

contract amount or involving obligations or entitlements with a value of more than $250,000 in each individual case (other than Contracts

with customers, suppliers, distributors and representatives entered into in the ordinary course of business, consistent with past practice);

(j)

any change in any method of accounting principles or practices by the Company, except for any such change required by reason of a concurrent

change in Applicable Accounting Standards;

(k)

any debt, capital lease or other debt or equity financing transaction by the Company or entry into any agreement by the Company in connection

with any such transaction, except for debt or capital leases entered into in the ordinary course of business consistent with past practice

which are not, individually or in the aggregate, material to the Company;

15

(l)

any grants of any material refunds, credits, rebates or other allowances by the Company to any customer, other than in the ordinary course

of business;

(m)

any material change in the level of bad debts or reserves relating to accounts receivable experienced by the Company;

(n)

any material restructuring activities by the Company, including any material reductions in force, or any lease terminations or restructuring

of contracts;

(o)

any license of or Lien on any properties or assets, except licenses and Liens which are not material, individually or in the aggregate,

to the business of the Company;

(p)

any loan, advance or capital contribution by the Company to, or investment in, any Person other than (i) loans or advances to Company

employees/service providers in connection with business related travel and expenses, in each case in the ordinary course of business

consistent with past practice; (ii) loans, advances or capital contributions or investments by the Company to or in any wholly owned

Subsidiary, by any wholly owned Subsidiary in the Company, or by a wholly owned Subsidiary of the Company in any other wholly owned Subsidiary

of the Company; or (iii) loans or advances to vendors consistent with past practice that are not, individually or in the aggregate, material

to the Company;

(q)

any material purchases of fixed assets or other long term assets other than in the ordinary course of business;

(r)

any amendment of any material Tax Returns, any adoption of or change in any material election in respect of Taxes, adoption or change

in any accounting method in respect of Taxes, agreement or settlement of any closing agreement relating to an audit, or consent to any

waiver of the statutory period of limitations in respect of any audit;

(s)

any material revaluation, or any indication that such a revaluation is required under Applicable Accounting Standards, by the Company

of any of its respective assets, including, without limitation, writing down the value of long-term or short-term investments, fixed

assets, goodwill, intangible assets, deferred tax assets, or writing off notes or accounts receivable other than in the ordinary course

of business consistent with past practice;

(t)

any significant deficiency or material weakness identified in the system of internal controls utilized by the Company;

(u)

any settlement of any lawsuit or other proceeding by the Company; or

(v)

any damage, destruction or loss, whether or not covered by insurance, materially and adversely affecting the properties, assets or business

of the Company.

4.9

Compliance with Laws. Since the date of the Company’s formation, the Company is not or has been in material conflict or

material non-compliance with, or in material default or violation of, nor has the Company received, since the date of the Company’s

formation, any written or, to the Knowledge of the Company, oral notice of any material conflict or non-compliance with, or material

default or violation of, any applicable Laws by which it or any of its properties, assets, employees, business, products or operations

are or were bound or affected. There is no agreement, judgment, injunction, order or decree binding upon the Company which has or would

reasonably be expected to have the effect of prohibiting or impairing any business practice of the Company in such a way as to be material

and adverse to the Company, nor, to the Knowledge of the Company, is there any pending investigation or inquiry relating thereto.

16

4.10

Company Permits. The Company (and its employees who are legally required to be licensed by a Governmental Authority in order to

perform his or her duties with respect to his or her employment with the Company), holds all Permits necessary to lawfully conduct in

all material respects its business as presently conducted; to own, lease and operate its assets and properties (collectively, the “Company

Permits”). Without limiting the foregoing, the Company holds and maintains all Company Permits required under applicable Money

Lending Laws to carry on its money lending business, including as a licensed moneylender or credit community business, and holds all

licenses, permits, approvals, advertisement permits, branch approvals, online or digital lending approvals, registrations and authorizations.

The Company has made available to Purchaser true, correct and complete copies of all Company Permits. Except as set forth on Schedule

4.10, all of the Company Permits are in full force and effect, and no suspension or cancellation of any of the Company Permits is

pending or, to the Company’s Knowledge, threatened. The Company is not in violation in any material respect of the terms of any

Company Permit, and the Company has not received any written or, to the Knowledge of the Company, oral notice of any Actions relating

to the revocation or modification of any Company Permit.

4.11 Litigation.

Except as described on Schedule ‎4.11, there is no (a) Action of any nature currently pending or, to the Knowledge

of the Company, threatened in writing, and no such Action has been brought in the past five (5) years; (b) Order now in effect,

pending or outstanding or that was rendered by a Governmental Authority in the past five (5) years, in either case of (a) or (b) by

or against the Company, its (i) current or, to the Knowledge of the Company, former directors or officers, or (ii) equity holders

(provided, that any litigation involving the directors, officers or equity holders of the Company must be directly related to the

Company’s business, securities or assets), or its business, securities, properties or assets (tangible or intangible); or (c)

internal investigations or inquiries now, or to the Knowledge of the Company, being conducted by the Company, the Company’s

board of directors (or any committee thereof) or any third party at the request of any of the foregoing concerning any financial,

accounting, Tax, conflict of interest, illegal activity, fraudulent or deceptive conduct or other misfeasance or malfeasance issues.

The items listed on Schedule ‎4.11, if finally determined adversely to the Company, will not have, either

individually or in the aggregate, a Material Adverse Effect upon the Company. In the past five (5) years, none of the current or

former, officers, senior management or directors of the Company has been charged with, indicted for, arrested for, or convicted of

any felony or any crime involving fraud.

4.12

Material Contracts.

(a)

Schedule ‎4.12(a) sets forth a true, correct and complete list of, and the Company has made available to Purchaser, true,

correct and complete copies of, each Contract to which the Company is a party or by which the Company or any of its properties or assets

is bound or affected (each Contract required to be set forth on Schedule ‎4.12(a), other than a Company Benefit Plan, a “Company

Material Contract”) that:

(i)

contains covenants that materially limit the ability of the Company (A) to compete in any line of business or with any Person or in any

geographic area or to sell, or provide any service or product or solicit any Person, including any non-competition covenants, employee

and customer non-solicit covenants, exclusivity restrictions, rights of first refusal or most-favored pricing clauses or (B) to purchase

or acquire an interest in any other Person;

(ii)

involves any joint venture, profit-sharing, partnership, limited liability company or other similar agreement or arrangement relating

to the formation, creation, operation, management or control of any partnership or joint venture;

(iii)

involves any exchange traded, over the counter or other swap, cap, floor, collar, futures contract, forward contract, option or other

derivative financial instrument or Contract, based on any commodity, security, instrument, asset, rate or index of any kind or nature

whatsoever, whether tangible or intangible, including currencies, interest rates, foreign currency and indices;

17

(iv)

evidences Indebtedness (whether incurred, assumed, guaranteed or secured by any asset) of the Company having an outstanding principal

amount in excess of $20,000;

(v)

involves the acquisition or disposition, directly or indirectly (by merger or otherwise), of assets with an aggregate value in excess

of $100,000 (other than in the ordinary course of business consistent with past practice) or shares or other equity interests of the

Company or another Person;

(vi)

relates to any merger, consolidation or other business combination with any other Person or the acquisition or disposition of any other

entity or its business or material assets or the sale of the Company, its business or material assets;

(vii)

by its terms, individually or with all related Contracts, calls for aggregate payments or receipts by the Company under such Contract

or Contracts of at least $20,000 per year or $100,000 in the aggregate;

(viii)

is with any Top Customer or Top Supplier;

(ix)

obligates the Company to provide continuing indemnification or a guarantee of obligations of a third party after the date hereof in excess

of $20,000;

(x)

is between the Company and any directors, officers or employees of the Company (other than at-will employment arrangements with employees

entered into in the ordinary course of business consistent with past practice), including all non-competition, severance and indemnification

agreements, or any Related Person;

(xi)

obligates the Company to make any capital commitment or expenditure in excess of $20,000 (including pursuant to any joint venture);

(xii)

relates to a material settlement entered into within two (2) years prior to the Agreement Date or under which the Company has outstanding

obligations (other than customary confidentiality obligations);

(xiii)

provides another Person (other than a manager, director or officer of the Company) with a power of attorney;

(xiv)

relates to the development, ownership, licensing or use of any Intellectual Property by, to or from the Company, other than (A) Off-the-Shelf

Software, (B) employee or consultant invention assignment agreements entered into on the Company’s standard form of such agreement,

(C) confidentiality agreements entered into in the ordinary course of business, (D) non-exclusive licenses from customers or distributors

to the Company entered into in the ordinary course of business or (E) feedback and ordinary course trade name or logo rights that are

not material to the Company;

(xv)

relates to the origination, servicing, administration, collection, sale, assignment, participation, securitization, warehouse financing

or other financing of the Company’s Loan Portfolio, or otherwise constitutes a material loan facility, credit facility, loan sale

agreement, servicing agreement, participation agreement, warehouse agreement or similar arrangement relating to the Company’s lending

business;

(xvi)

that will be required to be filed with the Registration Statement under applicable SEC requirements or would otherwise be required to

be filed by the Company as an exhibit for a Form S-1 (or similar successor form) pursuant to Items 601(b)(1), (2), (4), (9) or (10) of

Regulation S-K under the Securities Act as if the Company was the registrant; or

18

(xvii)

is otherwise material to the Company and not described in clauses (i) through (xvi) above.

(b)

Except as disclosed in Schedule 4.12(b), with respect to each Company Material Contract: (i) such Company Material Contract

is valid and binding and enforceable in all respects against the Company and, to the Knowledge of the Company, each other party thereto,

and is in full force and effect (except, in each case, as such enforcement may be limited by the Enforceability Exceptions); (ii) the

consummation of the transactions contemplated by this Agreement will not affect the validity or enforceability of any Company Material

Contract; (iii) the Company is not in breach or default in any material respect, and, to the Knowledge of the Company, no event has occurred

that with the passage of time or giving of notice or both would constitute a material breach or default by the Company, or permit termination

or acceleration by the other party thereto, under such Company Material Contract; (iv) to the Knowledge of the Company, no other party

to such Company Material Contract is in breach or default in any material respect, and no event has occurred that with the passage of

time or giving of notice or both would constitute such a material breach or default by such other party, or permit termination or acceleration

by the Company, under such Company Material Contract; (v) the Company has not received written notice or, to the Company’s Knowledge,

oral notice of an intention by any party to any such Company Material Contract that provides for a continuing obligation by any party

thereto to terminate such Company Material Contract or amend the terms thereof, other than modifications in the ordinary course of business

that do not adversely affect the Company in any material respect; and (vi) the Company has not waived any material rights under any such

Company Material Contract. The Company has no oral Material Contracts which have not been summarized in Schedule ‎4.12(b).

4.13

Intellectual Property.

(a) Schedule

4.13(a)(i) sets forth: (i) all U.S. and foreign registered Patents, Trademarks, Copyrights and Internet Assets and applications

owned or licensed by the Company or otherwise used or held for use by the Company in which the Company is the owner, applicant or

assignee (“Company Registered IP”), specifying as to each item, as applicable: (A) the nature of the item,

including the title, (B) the owner of the item, (C) the jurisdictions in which the item is issued or registered or in which an

application for issuance or registration has been filed and (D) the issuance, registration or application numbers and dates; and

(ii) all material unregistered Intellectual Property owned or purported to be owned by the Company. Schedule 4.13(a)(ii) sets

forth all Intellectual Property licenses, sublicenses and other agreements or permissions (“Company IP Licenses”)

(other than “shrink wrap,” “click wrap,” and “off the shelf” software agreements and other

agreements for Software commercially available on reasonable terms to the public generally with license, maintenance, support and

other fees of less than $20,000 per year (collectively, “Off-the-Shelf Software”), which are not required to be

listed, although such licenses are “Company IP Licenses” as that term is used herein), under which the Company is a

licensee or otherwise is authorized to use or practice any Intellectual Property, and describes (A) the applicable Intellectual

Property licensed, sublicensed or used and (B) any royalties, license fees or other compensation due from the Company, if any. The

Company owns, free and clear of all Liens and Encumbrances (other than Permitted Liens), has valid and enforceable rights in, and

has the unrestricted right to use, sell, license, transfer or assign, all Intellectual Property currently used, licensed or held for

use by the Company, and previously used or licensed by the Company, except for the Intellectual Property that is the subject of the

Company IP Licenses. No item of Company Registered IP that consists of a pending Patent application fails to identify all pertinent

inventors, and for each Patent and Patent application in the Company Registered IP, the Company has obtained valid assignments of

inventions from each inventor. Except as set forth on Schedule ‎4.13(a)(ii), all Company Registered IP is owned

exclusively by the Company without obligation to pay royalties, licensing fees or other fees, or otherwise account to any third

party with respect to such Company Registered IP, and the Company has recorded assignments of all Company Registered IP.

19

(b)

The Company has a valid and enforceable license to use all Intellectual Property that is the subject of the Company IP Licenses applicable

to the Company. The Company IP Licenses include all of the licenses, sublicenses and other agreements or permissions necessary to operate

the Company as presently conducted. The Company has performed all obligations imposed on it in the Company IP Licenses, has made all

payments required to date, and the Company is not, nor, to the Knowledge of the Company, is any other party thereto, in breach or default

thereunder, nor has any event occurred that with notice or lapse of time or both would constitute a default thereunder. The continued

use by the Company of the Intellectual Property that is the subject of the Company IP Licenses in the same manner that it is currently

being used is not restricted by any applicable license of the Company. All registrations for Copyrights, Patents, Trademarks and Internet

Assets that are owned by or exclusively licensed to the Company are valid, in force and in good standing with all required fees and maintenance

fees having been paid with no Actions pending, and all applications to register any Copyrights, Patents and Trademarks are pending and

in good standing, all without challenge of any kind. The Company is not party to any Contract that requires the Company to assign to

any Person all of its rights in any Intellectual Property developed by the Company under such Contract.

(c)

Schedule 4.13(c) sets forth all licenses, sublicenses and other agreements or permissions under which the Company is the

licensor (each, an “Outbound IP License”), and for each such Outbound IP License, describes (i) the applicable Intellectual

Property licensed, (ii) the licensee under such Outbound IP License, and (iii) any royalties, license fees or other compensation due

to the Company, if any. The Company has performed all obligations imposed on it in the Outbound IP Licenses, and the Company is not,

nor, to the Knowledge of the Company, is any other party thereto, in breach or default thereunder, nor has any event occurred that with

notice or lapse of time or both would constitute a default thereunder.

(d)

No Action is pending or, to the Company’s Knowledge, threatened against the Company that challenges the validity, enforceability,

ownership, or right to use, sell, license or sublicense, or that otherwise relates to, any Intellectual Property currently owned, licensed,

used or held for use by the Company, nor, to the Knowledge of the Company, is there any reasonable basis for any such Action. The Company

has not received any written or, to the Knowledge of the Company, oral notice or claim asserting or suggesting that any infringement,

misappropriation, violation, dilution or unauthorized use of the Intellectual Property of any other Person is or may be occurring or

has or may have occurred, as a consequence of the business activities of the Company, nor to the Knowledge of the Company is there a

reasonable basis therefor. There are no Orders to which the Company is a party or is otherwise bound that (i) restrict the rights of

the Company to use, transfer, license or enforce any Intellectual Property owned by the Company, (ii) restrict the conduct of the business

of the Company in order to accommodate a third Person’s Intellectual Property, or (iii) other than the Outbound IP Licenses, grant

any third Person any right with respect to any Intellectual Property owned by the Company. The Company is not currently infringing, or

has, in the past, infringed, misappropriated or violated any Intellectual Property of any other Person in any material respect in connection

with the ownership, use or license of any Intellectual Property owned or purported to be owned by the Company or, to the Knowledge of

the Company, otherwise in connection with the conduct of the respective businesses of the Company. To the Company’s Knowledge,

no third party is currently, or in the past five (5) years has been, infringing upon, misappropriating or otherwise violating any Intellectual

Property owned, licensed by, licensed to, or otherwise used or held for use by the Company (“Company IP”) in any material

respect.

(e)

All officers, directors, employees and independent contractors (to the extent any such independent contractor had access to Intellectual

Property of the Company) of the Company (and each of their respective Affiliates) have assigned to the Company all Intellectual Property

arising from the services performed for the Company by such Persons and all such assignments of Company Registered IP have been recorded.

No current or former officers, employees or independent contractors of the Company have claimed any ownership interest in any Intellectual

Property owned by the Company. To the Knowledge of the Company, there has been no violation of the Company’s policies or practices

related to protection of Company IP or any confidentiality or nondisclosure Contract relating to the Intellectual Property owned by the

Company. The Company has made available to Purchaser true and complete copies of all written Contracts referenced in subsections under

which employees and independent contractors assigned their Intellectual Property to the Company. To the Company’s Knowledge, none

of the employees of the Company is obligated under any Contract, or subject to any Order, that would materially interfere with the use

of such employee’s best efforts to promote the interests of the Company, or that would materially conflict with the business of

the Company as presently conducted or contemplated to be conducted. The Company has taken reasonable security measures in order to protect

the secrecy, confidentiality and value of the material Company IP.

20

(f)

To the Knowledge of the Company, no Person has obtained unauthorized access to third party information and data (including personally

identifiable information or information that can be used to identify a natural person (“personal information”)) in the possession

of the Company, nor has there been any other material compromise of the security, confidentiality or integrity of such information or

data, and no written or, to the Knowledge of the Company, oral complaint relating to an improper use or disclosure of, or a breach in

the security of, any such information or data has been received by the Company. The Company has complied in all material respects with

all applicable Laws and Contract requirements relating to privacy, personal information protection, and the collection, processing and

use of personal information and its own privacy policies and guidelines, if any, each with respect to the Company’s collection,

processing and use of personal information. To the Knowledge of the Company, the operation of the business of the Company has not and

does not violate any right to privacy or publicity of any third person, or constitute unfair competition or trade practices under applicable

Law.

(g)

The consummation of any of the transactions contemplated by this Agreement will not result in the material breach, material modification,

cancellation, termination, suspension of, or acceleration of any payments with respect to, or release of source code because of (i) any

Contract providing for the license or other use of Intellectual Property owned by the Company, or (ii) any Company IP License. Following

the Closing, the Company shall be permitted to exercise, directly or indirectly through its Subsidiaries, all of the Company’s

rights under such Contracts or Company IP Licenses to the same extent that the Company would have been able to exercise had the transactions

contemplated by this Agreement not occurred, without the payment of any additional amounts or consideration other than ongoing fees,

royalties or payments which the Company would otherwise be required to pay in the absence of such transactions.

4.14

Tax Returns and Audits.

(a)

The Company has or will have timely filed, or caused to be timely filed, all federal, state, local and foreign Tax Returns required to

be filed by it (taking into account all available extensions), which Tax Returns are true, accurate, correct and complete in all material

respects, and has paid, collected or withheld, or caused to be paid, collected or withheld, all Taxes required to be paid, collected

or withheld, other than such Taxes for which adequate reserves in the Company Financials have been established. The Company has complied

in all material respects with all applicable Laws relating to Tax.

(b)

There is no Action currently pending or, to the Knowledge of the Company, threatened in writing against the Company by a Governmental

Authority in a jurisdiction where the Company does not file Tax Returns that it is or may be subject to taxation by that jurisdiction.

(c)

The Company is not being audited by any Governmental Authority or has been notified in writing or, to the Knowledge of the Company, orally

by any Governmental Authority that any such audit is contemplated or pending. There are no claims, assessments, audits, examinations,

investigations or other Actions pending against the Company in respect of any Tax, and the Company has not been notified in writing of

any proposed Tax claims or assessments against it (other than, in each case, claims or assessments for which adequate reserves in the

Company Financials have been established). No material adjustment relating to any Tax Return of the Company has been proposed in writing

formally or informally by appropriate Governmental Authorities.

21

(d)

There are no Liens or other Encumbrances with respect to any Taxes upon the Company’s assets, other than Permitted Liens.

(e)

The Company has collected or withheld all Taxes currently required to be collected or withheld by it, and all such Taxes have been paid

to the appropriate Governmental Authorities or set aside in appropriate accounts for future payment when due. The Company has no liability

for unpaid Taxes which have not been accrued for or reserved on the Company balance sheet, whether asserted or unasserted, contingent

or otherwise, which is material to the Company, other than any liability for unpaid Taxes that may have accrued since the date of the

Company balance sheet in connection with the operation of the business of the Company in the ordinary course, including, without limitation,

as a result of acquisitions.

(f)

The Company does not have any outstanding waivers or extensions of any applicable statute of limitations to assess any amount of Taxes.

There are no outstanding requests by the Company for any extension of time within which to file any Tax Return or within which to pay

any Taxes shown to be due on any Tax Return.

(g)

The Company has not made any change in accounting method (except as required by a change in Law) or received a ruling from, or signed

an agreement with, any Governmental Authority that would reasonably be expected to have a material impact on its Taxes following the

Closing.

(h)

The Company does not have any Liability for the Taxes of another Person that are not adequately reflected in the Company Financials (i)

under any applicable Tax Law, (ii) as a transferee or successor, or (iii) by contract or indemnity (excluding commercial agreements entered

into in the ordinary course of business the primary purpose of which is not the sharing of Taxes). The Company is not a party to or bound

by any Tax indemnity agreement, Tax sharing agreement or Tax allocation agreement or similar agreement, arrangement or practice (excluding

commercial agreements, arrangements or practices entered into in the ordinary course of business the primary purpose of which is not

the sharing of Taxes) with respect to Taxes (including advance pricing agreement, closing agreement or other agreement relating to Taxes

with any Governmental Authority) that will be binding on the Company with respect to any period following the Closing Date.

(i)

The Company has not requested, nor is it the subject of or bound by any private letter ruling, technical advice memorandum, closing agreement

or similar ruling, memorandum or agreement with any Governmental Authority with respect to any Taxes, nor is any such request outstanding.

4.15 Real

Property. Schedule 4.15 contains a complete and accurate list of all premises currently leased, licensed or subleased or

otherwise used or occupied by the Company for the operation of the business of the Company, and of all current leases, lease

guarantees, agreements and documents related thereto, including all amendments, terminations and modifications thereof or waivers

thereto (collectively, the “Company Real Property Leases”), as well as the current annual rent and term under

each Company Real Property Lease. The Company has provided to Purchaser a true and complete copy of each of the Company Real

Property Leases. The Company Real Property Leases are valid, binding and enforceable in accordance with their terms and are in full

force and effect, subject to Enforceability Exceptions. To the Knowledge of the Company, no event has occurred which (whether with

or without notice, lapse of time or both or the happening or occurrence of any other event) would constitute a material breach,

default or event of default on the part of the Company or any other party under any of the Company Real Property Leases, and the

Company has not received notice of any such condition. The Company does not own nor has ever owned any real property or any interest

in real property (other than the leasehold interests in the Company Real Property Leases). The Company has no oral Company Real

Property Leases other than those summarized in Schedule ‎4.15. Except as set forth on Schedule ‎4.15,

(i) no party other than the Company has a right to occupy any material premises under the Company Real Property Leases, (ii) the

premises under the Company Real Property Leases are used only for the operation of the business of the Company, (iii) the premises

under the Company Real Property Leases and the physical assets of the Company are, in all material respects, in good condition and

repair and regularly maintained in accordance with standard industry practice, (iv) to the Company’s Knowledge, the premises

under the Company Real Property Leases are in compliance, in all material respects, with applicable legal requirements and (v) the

Company will not be required to incur any material cost or expense for any restoration or surrender obligations, or any other

material costs otherwise qualifying as asset retirement obligations under Financial Accounting Standards Board Statement of

Financial Accounting Standard No. 143 “Accounting for Asset Retirement Obligations,” upon the expiration or earlier

termination of the Company Real Property Leases.

22

4.16 Personal

Property. Each item of Personal Property which is currently owned, used or leased by the Company with a book value or fair

market value of greater than Twenty Thousand Dollars ($20,000) is set forth on Schedule 4.16, along with, to the extent

applicable, a list of lease agreements, lease guarantees, security agreements and other agreements related thereto, including all

amendments, terminations and modifications thereof or waivers thereto (“Company Personal Property Leases”).

Except as set forth in Schedule ‎4.16, all such items of Personal Property are in good operating condition and

repair (reasonable wear and tear excepted consistent with the age of such items) and are suitable for their intended use in the

business of the Company. The operation of the Company’s business as it is now conducted or presently proposed to be conducted

is not in any material respect dependent upon the right to use the Personal Property of Persons other than the Company, except for

such Personal Property that is owned, leased or licensed by or otherwise contracted to the Company. The Company has provided to

Purchaser a true and complete copy of each of the Company Personal Property Leases. The Company Personal Property Leases are valid,

binding and enforceable in accordance with their terms and are in full force and effect. To the Knowledge of the Company, no event

has occurred which (whether with or without notice, lapse of time or both or the happening or occurrence of any other event) would

constitute a default on the part of the Company or any other party under any of the Company Personal Property Leases, and the

Company has not received notice of any such condition. The Company has no oral Company Personal Property Leases other than those

summarized in Schedule ‎4.16.

4.17 Title

to and Sufficiency of Assets. The Company has good and marketable title to, or a valid leasehold interest in or right to use,

all of its assets, free and clear of all Liens and Encumbrances other than (a) Permitted Liens, (b) the rights of lessors under

leasehold interests, (c) Liens specifically identified on the consolidated balance sheet of the Company as of the Interim Balance

Sheet Date and (d) Liens set forth on Schedule 4.17. The assets (including Intellectual Property rights and contractual

rights) of the Company constitute all of the assets, rights and properties that are used in the operation of the businesses of the

Company as it is now conducted or that are used or held by the Company for use in the operation of the businesses of the Company,

and taken together, are adequate and sufficient for the operation of the businesses of the Company as currently

conducted.

4.18

Employee Matters.

(a)

Except as set forth in Schedule 4.18(a), the Company is not a party to any collective bargaining agreement or other Contract

covering any group of employees, labor organization or other representative of any of the employees of the Company, and the Company has

no Knowledge of any activities or proceedings of any labor union or other party to organize or represent such employees. There has not

occurred or, to the Knowledge of the Company, been threatened any strike, slow-down, picketing, work-stoppage, or other similar labor

activity with respect to any such employees. Schedule ‎4.18(a) sets forth all unresolved labor controversies (including unresolved

grievances and age or other discrimination claims other than any workers’ compensation or unemployment claims), if any, that are

pending or, to the Knowledge of the Company, threatened between the Company and Persons employed by or providing services as independent

contractors to the Company. No current officer or employee of the Company has provided the Company with written or oral notice of his

or her plan to terminate his or her employment with the Company.

23

(b)

Except as set forth in Schedule 4.18(b), the Company (i) is and has been in compliance in all material respects with all

applicable Laws respecting employment and employment practices, terms and conditions of employment, tax withholding, occupational health

and safety, wages (including overtime wages), worker classification, and other Laws relating to discrimination, disability, labor relations,

hours of work, pay equity, immigration, workers’ compensation, working conditions, employee scheduling, family and medical leave,

and employee terminations, and has not received written notice that there is any pending Action involving unfair labor practices against

the Company, (ii) is not liable for any material past due arrears of wages or any material penalty for failure to comply with any of

the foregoing, and (iii) is not liable for any material payment to any Governmental Authority with respect to unemployment compensation

benefits, social security or other benefits or obligations for employees, independent contractors or consultants (other than routine

payments to be made in the ordinary course of business and consistent with past practice). Except as set forth in Schedule ‎4.18(b),

there are no Actions pending or, to the Knowledge of the Company, threatened against the Company brought by or on behalf of any applicant

for employment, any current or former employee, any Person alleging to be a current or former employee, or any Governmental Authority,

relating to any such Law or regulation, or alleging breach of any express or implied contract of employment, wrongful termination of

employment, or alleging any other discriminatory, wrongful or tortious conduct in connection with the employment relationship.

(c) Schedule

‎4.18(c) hereto sets forth a complete and accurate list as of the date hereof of all employees of the Company showing for

each as of such date (i) the employee’s name, job title or description, employer, location, salary or hourly rate; and (ii)

wages, bonus, commission or other compensation paid during the fiscal year ending December 31, 2025. Except as set forth on Schedule

4.18(c), (A) no employee is a party to an employment Contract or agreement with the Company that is not terminable “at

will,” and (B) the Company has paid in full to all its employees all wages, salaries, commission, bonuses and other

compensation due to its employees, including overtime compensation, and the Company does not have any obligation or Liability

(whether or not contingent) with respect to severance payments to any such employees under the terms of any agreements or

commitments or any applicable Law, custom, trade or practice. Except as set forth in Schedule 4.18(c), each Company

employee has entered into the Company’s standard form of employee non-disclosure, inventions assignment and restrictive

covenants agreement with the Company (whether pursuant to a separate agreement or incorporated as part of such employee’s

overall employment agreement), copies of all of which agreements have been made available to Purchaser by the Company.

(d)

Schedule ‎4.18(d) contains a list of all independent contractors (including consultants) currently engaged by the Company,

along with a description of the general nature of the work performed, date of retention and rate of remuneration, most recent increase

(or decrease) in remuneration and amount thereof, for each such Person. Except as set forth on Schedule 4.18(d), all of such

independent contractors are a party to a written Contract with the Company. Except as set forth on Schedule 4.18(d), each

such independent contractor has entered into customary covenants regarding confidentiality and assignment of inventions and copyrights

in such Person’s agreement with the Company, a copy of which has been provided to Purchaser by the Company. No material Company

Liability exists under applicable Law related to the classification of any individual as an independent contractor who is currently,

or within the last six (6) years has been, engaged by the Company. Except as set forth in Schedule 4.18(d), each independent

contractor is terminable on fewer than thirty (30) days’ notice, without any obligation of the Company to pay severance or a termination

fee.

4.19

Benefit Plans.

(a)

Set forth on Schedule 4.19(a) is a true and complete list of each Benefit Plan of the Company (each, a “Company

Benefit Plan”). With respect to each Company Benefit Plan, there are no funded benefit obligations for which contributions

have not been made or properly accrued and there are no unfunded benefit obligations that have not been accounted for by reserves, or

otherwise properly footnoted in accordance with Applicable Accounting Standards on the Company Financials.

(b)

Each Company Benefit Plan is and has been operated at all times in compliance with all applicable Laws in all material respects. No fact

exists which could adversely affect the qualified status of such Company Benefit Plans or the exempt status of such trusts.

24

(c)

With respect to each Company Benefit Plan which covers any current or former officer, director, consultant or employee (or beneficiary

thereof) of the Company, the Company has provided to Purchaser accurate and complete copies, if applicable, of: (i) all Company Benefit

Plan documents and agreements and related trust agreements or annuity Contracts (including any amendments, modifications or supplements

thereto); (ii) all summary plan descriptions and summary of material modifications thereto; (iii) the most recent annual and periodic

accounting of plan assets; (iv) the three (3) most recent nondiscrimination testing reports, if applicable under the Malaysian Companies

Act; (v) the most recent determination letter received from the Malaysian authorities, if any; (vi) the most recent actuarial valuation,

if any; and (vii) all material communications with any Governmental Authority within the last three (3) years.

(d)

With respect to each Company Benefit Plan: (i) such Company Benefit Plan has been administered and enforced in all material respects

in accordance with its terms and the Malaysian Companies Act; (ii) no breach of fiduciary duty has occurred; (iii) no Action is pending

or, to the Knowledge of the Company, threatened in writing (other than routine claims for benefits arising in the ordinary course of

administration); (iv) no prohibited transaction, as defined in the Malaysian Companies Act, has occurred, excluding transactions effected

pursuant to a statutory or administration exemption; and (v) all contributions and premiums due through the Closing Date have been made

in all material respects as required under the respective Company Benefit Plan and the Malaysian Companies Act or have been fully accrued

in all material respects on the Company Financials.

(e)

No arrangement exists pursuant to which the Company will be required to “gross up” or otherwise compensate any person because

of the imposition of any excise tax on a payment to such person.

(f)

With respect to each Company Benefit Plan: (i) no such plan provides medical or death benefits with respect to current or former employees

of the Company beyond their termination of employment (other than coverage mandated by Law, which is paid solely by such employees);

and (ii) there are no reserves, assets, surplus or prepaid premiums under any such plan. The Company has complied in all material respects

with the provisions of the Company Benefit Plan and the Malaysian Companies Act, as applicable.

(g)

Except as set forth on Schedule 4.19(g), the consummation of the transactions contemplated by this Agreement and the

Ancillary Documents will not: (i) entitle any individual to severance pay, unemployment compensation or other benefits or

compensation (except as set forth on Schedule 4.19(g)); (ii) accelerate the time of payment or vesting, or increase the

amount of any compensation due, or in respect of, any individual; or (iii) result in or satisfy a condition to the payment of

compensation that would, in combination with any other payment, result in an “excess parachute payment”. The Company has

not incurred any Liability for any Tax imposed under any Malaysian Governmental Authority or any civil liability.

4.20

Environmental Matters. Except as set forth in Schedule ‎4.20:

(a)

The Company is and has been in compliance in all material respects with all applicable Environmental Laws, including obtaining, maintaining

in good standing, and complying in all material respects with all Permits and other governmental authorizations required for its business

and operations by Environmental Laws (“Environmental Permits”), no Action is pending or, to the Company’s Knowledge,

threatened to revoke, modify, or terminate any such Environmental Permit, no legitimate written communication, whether from a Governmental

Authority, citizens group, employee or otherwise, that alleges that the Company is not in such compliance, and, to the Company’s

Knowledge, no facts, circumstances, or conditions currently exist that could adversely affect such continued compliance with Environmental

Laws and Environmental Permits or require capital expenditures to achieve or maintain such continued compliance with Environmental Laws

and Environmental Permits.

(b)

The Company is not the subject of any outstanding Order or Contract with any Governmental Authority or other Person in respect of any

(i) Environmental Laws, (ii) Remedial Action, or (iii) Release or threatened Release of a Hazardous Material. The Company has not retained

or assumed, contractually or by operation of Law, any Liabilities or obligations under any Environmental Laws.

25

(c)

No Action has been commenced or is pending, or to the Company’s Knowledge, threatened against the Company or any assets of the

Company alleging either or both that the Company may be in material violation of any Environmental Law or Environmental Permit or may

have any material Liability under any Environmental Law.

(d)

The Company has not manufactured, treated, stored, disposed of, arranged for or permitted the disposal of, generated, handled or released

any Hazardous Material, or owned or operated any property or facility, in a manner that has given or would reasonably be expected to

give rise to any material Liability or obligation under applicable Environmental Laws. No fact, circumstance, or condition exists in

respect of the Company or any property currently or formerly owned, operated, or leased by the Company or any property to which the Company

arranged for the disposal or treatment of Hazardous Materials that could reasonably be expected to result in the Company incurring any

material Environmental Liabilities.

(e)

There is no investigation of the business, operations, or currently owned, operated, or leased property of the Company or, to the Company’s

Knowledge, previously owned, operated, or leased property of the Company pending or, to the Company’s Knowledge, threatened that

could lead to the imposition of any Liens or Encumbrances under any Environmental Law or material Environmental Liabilities.

(f)

To the Knowledge of the Company, there is not located at any of the properties of the Company any (i) underground storage tanks, (ii)

asbestos-containing material, (iii) equipment containing polychlorinated biphenyls, or (iv) any other hazardous materials.

(g)

The Company has provided to Purchaser all nonprivileged and material assessments, audits, studies, reports, data, analysis and results

of investigations that are in the possession or control of the Company regarding environmental matters pertaining to the environmental

condition of the business of the Company, including the currently or previously owned, leased, or operated properties of the Company.

4.21

Transactions with Related Persons. Except as set forth on Schedule ‎4.21, no officer, director, manager, employee,

trustee or beneficiary of the Company or any of its Affiliates, nor any immediate family member of any of the foregoing (whether directly

or indirectly through an Affiliate of such Person) (each of the foregoing, a “Related Person”) is presently, or in

the past two (2) years, has been, a party to any transaction with the Company, including any Contract or other arrangement (a) providing

for the furnishing of services by, (b) providing for the rental of real property or Personal Property from or (c) otherwise requiring

payments to (other than for services or expenses as directors, officers or employees of the Company in the ordinary course of business

consistent with past practice) any Related Person or any Person in which any Related Person has an interest as an owner, officer, manager,

director, trustee or partner or in which any Related Person has any direct or indirect interest (other than the ownership of securities

representing no more than two percent (2%) of the outstanding voting power or economic interest of a publicly traded company). Except

as set forth on Schedule ‎4.21, the Company has not outstanding any Contract or other arrangement or commitment with

any Related Person, and no Related Person owns any real property or Personal Property, or right, tangible or intangible (including Intellectual

Property) which is used in the business of the Company. The assets of the Company do not include any material receivable or other obligation

from a Related Person, and the liabilities of the Company do not include any material payable or other obligation or commitment to any

Related Person. No Related Person of any Affiliate that is not the Company owns any asset or intellectual property used by the Company

in operating its business.

4.22

Insurance.

(a) Schedule

4.22(a) lists all insurance policies and fidelity bonds (by policy number, insurer, coverage period, coverage amount, annual

premium and type of policy) held by the Company relating to the Company or its business, properties, assets, directors, officers and

employees, copies of which have been provided to Purchaser. Such policies and bonds are written by insurers of recognized financial

responsibility against such risks and losses and in such amounts as is reasonably sufficient for the conduct of the business of the

Company, including to cover the replacement cost of the fixed assets used in the Company’s businesses. All premiums due and

payable under all such insurance policies have been timely paid and the Company is otherwise in material compliance with the terms

of such insurance policies. Each such insurance policy (i) is legal, valid, binding, enforceable and in full force and effect and

(ii) will continue to be legal, valid, binding, enforceable, and in full force and effect on identical terms following the Closing.

The Company does not have any self-insurance or co-insurance programs. In the past five (5) years, the Company has not received any

notice from, or on behalf of, any insurance carrier relating to or involving any adverse change or any change other than in the

ordinary course of business, in the conditions of insurance, any refusal to issue an insurance policy or non-renewal of a

policy.

26

(b)

Schedule 4.22(b) identifies each individual insurance claim in excess of $20,000 made by the Company in the past five (5)

years. The Company has reported to its insurers all claims and pending circumstances that would reasonably be expected to result in a

claim, except where such failure to report such a claim would not be reasonably likely to be material to the Company. To the Knowledge

of the Company, no event has occurred, and no condition or circumstance exists, that would reasonably be expected to (with or without

notice or lapse of time) give rise to or serve as a basis for the denial of any such insurance claim. In the three (3) years preceding

the date hereof, the Company has not made any claim against an insurance policy as to which the insurer is denying or disputing coverage.

4.23

Books and Records. All of the financial books and records of the Company are complete and accurate in all material respects and

have been maintained in the ordinary course of business consistent with past practice and in accordance with applicable Laws and accounting

requirements and the Company Financials are consistent with such books and records. The Company is not a party to, or has any commitment

to become a party to, any “off-balance sheet arrangements” (as defined in Item 303(a) of Regulation S-K of the SEC).

4.24

Top Customers and Suppliers. Schedule ‎4.24 lists, by dollar volume received or paid, as applicable, for each

of (a) the twelve (12) months ended on December 31, 2025 and (b) the period from January 1, 2026 through the Interim Balance Sheet Date,

the five (5) largest customers of the Company (the “Top Customers”) and the five (5) largest suppliers of goods or

services to the Company (the “Top Suppliers”), along with the amounts of such dollar volumes. The relationships of

the Company with such suppliers and customers are good commercial working relationships and (i) no Top Supplier or Top Customer within

the last twelve (12) months has cancelled or otherwise terminated or modified the orders or requirements by more than ten (10) percent

for periods from or after the Agreement Date relative to the amounts prior to December 31, 2025 of such Top Customer or Top Suppliers,

or, to the Company’s Knowledge, intends to cancel or otherwise terminate, any material relationships of such Person with the Company,

(ii) no Top Supplier or Top Customer has during the last twelve (12) months decreased materially or, to the Company’s Knowledge,

threatened to stop, decrease or limit materially, or intends to modify materially its material relationships with the Company or stop,

decrease or limit materially its products or services to the Company or its usage or purchase of the products or services of the Company,

(iii) to the Company’s Knowledge, no Top Supplier or Top Customer intends to refuse to pay any amount due to the Company or seek

to exercise any remedy against the Company, and (iv) the Company has not within the past two (2) years been engaged in any material dispute

concerning its services with any Top Supplier or Top Customer.

27

4.25

Certain Business Practices.

(a)

Neither the Company nor any of its Representatives acting on its behalf has (i) used any funds for unlawful contributions, gifts, entertainment

or other unlawful expenses relating to political activity, (ii) made any unlawful payment to foreign or domestic government officials

or employees, to foreign or domestic political parties or campaigns or violated any provision of the U.S. Foreign Corrupt Practices Act

of 1977, as amended, or any other local or foreign anti-corruption or bribery Law applicable to the Company or (iii) made any other unlawful

payment. Neither the Company nor, to the Knowledge of the Company, any of its Representatives acting on its behalf has directly or indirectly,

used any corporate funds for unlawful contributions, gifts, entertainment or other unlawful expenses relating to political activity,

made, offered or authorized any unlawful payment, whether directly or indirectly, or made, offered or authorized any unlawful bribe,

rebate, payoff, influence payment, kickback or other similar unlawful payment, whether directly or indirectly, to any customer, supplier,

foreign or domestic governmental officials or employees or other Person who is or may be in a position to help or hinder the Company

or assist the Company in connection with any actual or proposed transaction. The Company has established reasonable internal controls

and procedures intended to ensure compliance with such anti-corruption or bribery Law.

(b)

The Company has adopted, implemented and maintained policies, procedures, controls, systems and training reasonably designed to ensure

compliance with applicable anti-money laundering, counter-terrorism financing, counter-proliferation financing, sanctions, targeted financial

sanctions, suspicious transaction reporting, customer due diligence, enhanced due diligence, recordkeeping and risk assessment requirements

applicable to moneylenders in Malaysia. The Company has conducted customer due diligence and, where required, enhanced due diligence

on borrowers, beneficial owners and relevant counterparties; has maintained all required records; has screened customers and counterparties

against applicable sanctions and watchlists; and has timely made all reports required by applicable Law. The Company has not received

any written notice alleging any material deficiency in its AML/CFT or sanctions compliance program.

(c)

Neither the Company nor any of its respective directors or officers, or, to the Knowledge of the Company, any other Representative acting

on behalf of the Company is currently identified on the specially designated nationals or other blocked person list or otherwise currently

subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”)

or on the sanctions lists adopted by the United Nations, European Union or United Kingdom (“UK”), as such lists may

be extended from time to time (“Sanctions List”) and the Company has not in the last five (5) fiscal years, directly

or indirectly, used any funds, or loaned, contributed or otherwise made available such funds to any Subsidiary, joint venture partner

or other Person, in connection with any sales or operations in Cuba, Iran, Syria, Sudan, Myanmar or any other country sanctioned by OFAC

or on the Sanctions List or for the purpose of financing the activities of any Person currently subject to, or otherwise in violation

of, any U.S. sanctions administered by OFAC or the Sanctions List.

(d)

The Company’s origination, documentation, disbursement, servicing and collection of loans, including its advertising and marketing

of money lending services, have been conducted in all material respects in accordance with applicable Money Lending Laws. The Company

maintains complete and accurate borrower files, credit assessment records, security documents, repayment records, receipts, notices,

collection records and statutory registers required by applicable Money Lending Laws. All collection, recovery, enforcement and repossession

activities conducted by or on behalf of the Company have been conducted in material compliance with applicable Law and the Company’s

policies, and neither the Company nor any agent, collector, outsourced service provider or Representative has used harassment, intimidation,

unlawful threats, misleading statements, unfair practices or any other unlawful collection practice in connection with the Company’s

money lending business. Except as set forth on Schedule 4.25(d), the Company has not charged interest, fees, costs or other amounts

in excess of amounts permitted by applicable Law and has not used any collection practice prohibited by applicable Law.

(e)

All advertisements, marketing materials, websites, mobile applications, social media, call scripts, borrower communications and other

promotional materials used by or on behalf of the Company in connection with its money lending business have been approved, licensed

or permitted to the extent required by applicable Law and have not been false, misleading, deceptive or in violation of any Money Lending

Law. The Company’s collection, use, processing, storage, disclosure and transfer of borrower and applicant data in connection with

its money lending business complies in all material respects with applicable privacy, data protection, cybersecurity and confidentiality

Laws and with the Company’s published policies and contractual obligations.

28

4.26

Compliance with Privacy Laws, Privacy Policies and Certain Contracts. Except as set forth on Schedule ‎4.26:

(a)

The Company, and, to the Knowledge of the Company, its officers, directors, managers, employees, agents, subcontractors and vendors to

whom the Company has given access to Personal Data and/or Loan Portfolio information, are and have been at all times, in compliance in

all material respects with all applicable Privacy Laws, and the Company has maintained appropriate safeguards reasonably designed to

protect such information against any loss, damage or unauthorized access, use, disclosure or modification, or breach of security;

(b)

Except as would not, individually or in the aggregate, have a Material Adverse Effect, to the Knowledge of the Company, the Company has

not experienced any loss, damage or unauthorized access, use, disclosure or modification, or breach of security of Personal Data and/or

Loan Portfolio information maintained by or on behalf of the Company (including, to the Knowledge of the Company, by any agent, subcontractor

or vendor of the Company);

(c)

Except as would not, individually or in the aggregate, have a Material Adverse Effect, to the Knowledge of the Company, (i) no Person,

including any Governmental Authority, has made any written claim or commenced any Proceeding with respect to any violation of any Privacy

Law by the Company; (ii) the Company has not been given written notice of any criminal, civil or administrative violation of any Privacy

Law, in any case including any claim or action with respect to any loss, damage or unauthorized access, use, disclosure, modification,

or breach of security, of Personal Data maintained by or on behalf of the Company (including by any agent, subcontractor or vendor of

the Company); and

(d)

To the Knowledge of the Company, all activities conducted by the Company with respect to any Personal Data are permitted under the Contracts

relating to Personal Data.

(e)

To the Knowledge of the Company, each Contract between the Company and a customer of the Company contains all the terms and conditions

that the Company is required to include therein under the Company’s Contracts with its vendors and suppliers.

4.27

Investment Company Act. The Company is not an “investment company” or a Person directly or indirectly “controlled”

by or acting on behalf of an “investment company,” or required to register as an “investment company,” in each

case within the meaning of the Investment Company Act of 1940, as amended.

4.28

Finders and Brokers. Except as set forth in Schedule ‎4.28, the Company has not incurred or will incur, directly

or indirectly, any Liability for any brokerage, finder’s or other fee or commission related to investment banking or similar advisory

services or any similar charges in connection with this Agreement or any transactions contemplated hereby, nor has the Company entered

into any indemnification agreement or arrangement with any Person specifically in connection with this Agreement and the transactions

contemplated hereby.

4.29

Restrictions on Business Activities. Except as set forth in Schedule ‎4.29, the Company is not party to or bound

by any Contract containing any covenant (a) limiting in any material respect the right of the Company to engage or compete in any line

of business, to make use of any material Company Registered IP or to compete with any Person, (b) granting any exclusive distribution

rights, (c) providing “most favored nations” terms for products and services developed or under development by or on behalf

of the Company, or (d) which otherwise adversely affects or would reasonably be expected to adversely affect the right of the Company

to sell or distribute any products and services developed or under development by or on behalf of the Company or material Company Registered

IP or to purchase or otherwise obtain any material software.

29

4.30

Fairness Opinion. The Company has received the written opinion of Strategic Capital Advisory Sdn. Bhd. (“Strategic Capital

Advisory”) dated as of August 21, 2026, to the effect that, as of such date and subject to the assumptions, qualifications

and limitations set forth therein, the Conversion Ratio was fair to the Selling Shareholders from a financial point of view and will

deliver to Purchaser solely for informational purposes a copy of such opinion as soon as practicable after a written copy thereof is

executed. The Company has been authorized by Strategic Capital Advisory to permit the inclusion of such opinion, but only in its entirety

in the Registration Statement and Proxy Statement to the extent permitted by the issuing firm and applicable Law.

4.31

Independent Investigation. The Company has conducted its own independent investigation, review and analysis of the business, results

of operations, prospects, condition (financial or otherwise) or assets of Purchaser, and acknowledges that it has been provided adequate

access to the personnel, properties, assets, premises, books and records, and other documents and data of Purchaser for such purpose.

The Company acknowledges and agrees that: (a) in making its decision to enter into this Agreement and to consummate the transactions

contemplated hereby, it has relied solely upon its own investigation and the express representations and warranties of Purchaser set

forth in this Agreement (including the related portions of Purchaser Disclosure Schedules) and in any certificate delivered to the Company

pursuant hereto; and (b) neither Purchaser nor any of its Representatives have made any representation or warranty as to Purchaser or

this Agreement, except as expressly set forth in this Agreement (including the related portions of Purchaser Disclosure Schedules) or

in any certificate delivered to the Company pursuant hereto.

4.32

Information Supplied. None of the information supplied or to be supplied by the Company expressly for inclusion or incorporation

by reference: (a) in any current report on Form 8-K (or similar successor form), and any exhibits thereto or any other report, form,

registration or other filing made with any Governmental Authority or stock exchange with respect to the transactions contemplated by

this Agreement or any Ancillary Documents; (b) in the Registration Statement; or (c) in the mailings or other distributions to Purchaser’s

shareholders and/or prospective investors with respect to the consummation of the transactions contemplated by this Agreement or in any

amendment to any of the documents identified in (a) through (c), will, when filed, made available, mailed or distributed, as the case

may be, contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary

in order to make the statements therein, in light of the circumstances under which they are made, not misleading. None of the information

supplied or to be supplied by the Company expressly for inclusion or incorporation by reference in any of the Signing Press Release,

the Signing Filing, the Closing Press Release and the Closing Filing will, when filed or distributed, as applicable, contain any untrue

statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements

therein, in light of the circumstances under which they are made, not misleading. Notwithstanding the foregoing, the Company makes no

representation, warranty or covenant with respect to any information supplied by or on behalf of Purchaser or its Affiliates, or any

information provided by the Company and modified in any material respect by Purchaser or any of its Affiliates without the Company’s

prior written approval.

4.33

Disclosure. No representations or warranties by the Company in this Agreement (as modified by the Company Disclosure Schedules)

or the Ancillary Documents, (a) contains or will contain any untrue statement of a material fact, or (b) omits or will omit to state,

when read in conjunction with all of the information contained in this Agreement, the Company Disclosure Schedules and the Ancillary

Documents, any fact necessary to make the statements or facts contained therein not materially misleading. Except for the representations

and warranties expressly made by the Company in this ‎Article IV (as modified by the Company Disclosure Schedules)

or as expressly set forth in an Ancillary Document, neither the Company nor any other Person on its behalf makes any express or implied

representation or warranty with respect to any of the Company, the Company Security Holders, the Company Shares, the business of the

Company, or the transactions contemplated by this Agreement or any of the other Ancillary Documents, and the Company hereby expressly

disclaims any other representations or warranties, whether implied or made by the Company or any of its Representatives. Except for the

representations and warranties expressly made by the Company in this ‎Article IV (as modified by the Company Disclosure

Schedules) or in an Ancillary Document, the Company hereby expressly disclaims all liability and responsibility for any representation,

warranty, projection, forecast, statement or information made, communicated or furnished (orally or in writing) to Purchaser, Purchaser

Representative or any of their respective Representatives (including any opinion, information, projection or advice that may have been

or may be provided to Purchaser, Purchaser Representative or any of their respective Representatives by any Representative of the Company),

including any representations or warranties regarding the probable success or profitability of the businesses of the Company.

30

Article

V

REPRESENTATIONS

AND WARRANTIES OF THE SELLING SHAREHOLDERS

Each

Selling Shareholder, severally, hereby represents to Purchaser, as of the Agreement Date and again as of the Closing, that:

5.1

Authorization of Agreement; Enforceability. Such Selling Shareholder has all requisite power, authority and legal capacity to

execute and deliver this Agreement and each other agreement, document, instrument or certificate contemplated by any Ancillary Document,

or to be executed and delivered by such Selling Shareholder in connection with the consummation of the transactions contemplated by this

Agreement (this Agreement, any Ancillary Document, and all other documents executed and delivered by each Selling Shareholder in connection

with the transactions contemplated by this Agreement collectively referred to herein as the “Selling Shareholder Documents”),

and to consummate the transactions and perform its obligations contemplated hereby and thereby. This Agreement has been, and each other

Selling Shareholder Document will be at or prior to the Closing, duly and validly executed, stamped as necessary, and delivered by such

Selling Shareholder, and (assuming the due authorization, execution and delivery by Purchaser), this Agreement constitutes, and each

other Selling Shareholder Document, when so executed and delivered, will constitute, the legal, valid and binding obligation of such

Selling Shareholder, enforceable against such Selling Shareholder in accordance with their terms.

5.2

Conflicts; Consents of Third Parties.

(a)

None of the execution, delivery and performance by such Selling Shareholder of the Selling Shareholder Documents, the consummation of

the transactions contemplated thereby, or compliance by such Selling Shareholder with any of the provisions thereof will: (i) cause such

Selling Shareholder or the other Parties to this Agreement to breach any Law or Order of any Governmental Authority that is applicable

to such Selling Shareholder; or (ii) conflict with or result in a breach or termination of any of the terms, conditions or provisions

of, or constitute a default under, accelerate any obligations arising under, trigger any payment under, or result in the creation of

any Lien pursuant to, or otherwise adversely affect, in any material respect, any of the terms, conditions or provisions of any material

agreement or instrument to which such Selling Shareholder is a party or by which such Selling Shareholder (or its assets) may be bound,

or constitute a default thereunder.

(b)

No consent, waiver, approval or authorization of, or declaration or filing with, or notification to, any Person (including any spousal

consent or consent of the beneficiary of any trust) or Governmental Authority is required on the part of such Selling Shareholder or

the other Parties to this Agreement in connection with the execution and delivery of the Selling Shareholder Documents, or the compliance

by such Selling Shareholder with any of the provisions thereof, or the consummation of the transactions contemplated thereby.

5.3

Ownership and Transfer of Company Shares. Such Selling Shareholder is the record and beneficial owner of the Company Shares set

forth next to such Selling Shareholder’s name on Exhibit A-1 hereto, free and clear of any and all Liens and Encumbrances.

Such Selling Shareholder has the power and authority to sell, transfer, assign and deliver the Company Shares as provided in this Agreement,

and such delivery will vest in Purchaser good and valid title to the Company Shares, free and clear of any and all Liens and Encumbrances.

31

5.4

Litigation. There are no Legal Proceedings pending, or to the Knowledge of such Selling Shareholder threatened, that are reasonably

likely to prohibit or restrain the ability of such Selling Shareholder to enter into this Agreement or timely to consummate the transactions

contemplated hereby.

5.5

Financial Advisors. No Person has acted, directly or indirectly, as a broker, finder, agent, representative or similar intermediary

for such Selling Shareholder in connection with this Agreement and the transactions contemplated by this Agreement and no other Person

is entitled to any fee or commission or like payment in respect thereof.

Article

VI

REPRESENTATIONS

AND WARRANTIES OF PURCHASER

Except

as set forth in (i) the disclosure schedules delivered by Purchaser to the Company on the date hereof (the “Purchaser Disclosure

Schedules”), the Section numbers of which are numbered to correspond to the Section numbers of this Agreement to which they

refer, or (ii) the SEC Reports that are available on the SEC’s website through EDGAR, Purchaser represents and warrants to the

Company as of the Agreement Date and as of the Closing, as follows:

6.1

Organization and Standing. Purchaser is a British Virgin Islands business company duly incorporated, validly existing and in good

standing under the Laws of the British Virgin Islands. Purchaser has all requisite corporate power and authority to own, lease and operate

its properties and to carry on its business as now being conducted. Purchaser is duly qualified or licensed and in good standing to do

business in each jurisdiction in which the character of the property owned, leased or operated by it or the nature of the business conducted

by it makes such qualification or licensing necessary, except where the failure to be so qualified or licensed or in good standing can

be cured without material cost or expense. Purchaser has heretofore made available to the Company accurate and complete copies of its

Governing Documents, as currently in effect. Purchaser is not in violation of any provision of its Governing Documents in any material

respect.

6.2

Authorization; Binding Agreement. Purchaser has all requisite corporate power and authority to execute and deliver this Agreement

and each Ancillary Document to which it is a party, to perform Purchaser’s obligations hereunder and thereunder and to consummate

the transactions contemplated hereby and thereby, subject to obtaining the Required Purchaser Shareholder Approval. The execution and

delivery of this Agreement and each Ancillary Document to which it is a party and the consummation of the transactions contemplated hereby

and thereby (a) have been duly and validly authorized by the board of directors of Purchaser, and (b) other than the Required Purchaser

Shareholder Approval, no other corporate proceedings, other than as set forth elsewhere in the Agreement, on the part of Purchaser are

necessary to authorize the execution and delivery of this Agreement and each Ancillary Document to which it is a party or to consummate

the transactions contemplated hereby and thereby. This Agreement has been, and each Ancillary Document to which Purchaser is a party

shall be when delivered, duly and validly executed and delivered by Purchaser and, assuming the due authorization, execution and delivery

of this Agreement and such Ancillary Documents by the other parties hereto and thereto, constitutes, or when delivered shall constitute,

the valid and binding obligation of Purchaser, enforceable against Purchaser in accordance with its terms, except to the extent that

enforceability thereof may be limited by applicable bankruptcy, insolvency, reorganization and moratorium laws and other laws of general

application affecting the enforcement of creditors’ rights generally or by any applicable statute of limitation or by any valid

defense of set-off or counterclaim, and the fact that equitable remedies or relief (including the remedy of specific performance) are

subject to the discretion of the court from which such relief may be sought (collectively, the “Enforceability Exceptions”).

Purchaser’s board of directors, by resolutions duly adopted at a meeting duly called and held (i) determined that this Agreement

and transactions contemplated hereby are advisable, fair to, and in the best interests of, Purchaser and its shareholders, (ii) approved

this Agreement and the transactions contemplated by this Agreement in accordance with the BVI Companies Act, (iii) directed that this

Agreement be submitted to Purchaser’s shareholders for approval and (iv) resolved to recommend that Purchaser’s shareholders

adopt this Agreement.

32

6.3 Governmental

Approvals. Except as otherwise described in Schedule 6.3, no Consent of or with any Governmental Authority, on the part

of Purchaser is required to be obtained or made in connection with the execution, delivery or performance by Purchaser of this

Agreement and each Ancillary Document to which it is a party or the consummation by Purchaser of the transactions contemplated

hereby and thereby, other than (a) pursuant to Antitrust Laws, (b) such filings as contemplated by this Agreement, (c) any filings

required with Nasdaq or the SEC with respect to the transactions contemplated by this Agreement, (d) applicable requirements, if

any, of the Securities Act, the Exchange Act, and/or any state “blue sky” securities Laws, and the rules and regulations

thereunder, and (e) where the failure to obtain or make such Consents or to make such filings or notifications, would not reasonably

be expected to have a Material Adverse Effect on Purchaser.

6.4 Non-Contravention.

Except as otherwise described in Schedule 6.4, the execution and delivery by Purchaser of this Agreement and each Ancillary

Document to which it is a party, the consummation by Purchaser of the transactions contemplated hereby and thereby, and compliance

by Purchaser with any of the provisions hereof and thereof, will not (a) subject to obtaining the approval of the Purchaser’s

shareholders, conflict with or violate any provision of Purchaser’s Governing Documents, (b) subject to obtaining the Consents

from Governmental Authorities referred to in Section 6.3 hereof, and the waiting periods referred to therein having expired,

and any condition precedent to such Consent or waiver having been satisfied, conflict with or violate any Law, Order or Consent

applicable to Purchaser or any of their properties or assets, or (c) (i) violate, conflict with or result in a breach of, (ii)

constitute a default (or an event which, with notice or lapse of time or both, would constitute a default) under, (iii) result in

the termination, withdrawal, suspension, cancellation or modification of, (iv) accelerate the performance required by Purchaser

under, (v) result in a right of termination or acceleration under, (vi) give rise to any obligation to make payments or provide

compensation under, (vii) result in the creation of any Lien upon any of the properties or assets of Purchaser under, (viii) give

rise to any obligation to obtain any third party Consent or provide any notice to any Person or (ix) give any Person the right to

declare a default, exercise any remedy, claim a rebate, chargeback, penalty or change in delivery schedule, accelerate the maturity

or performance, cancel, terminate or modify any right, benefit, obligation or other term under, any of the terms, conditions or

provisions of, any Purchaser Material Contract, except for any deviations from any of the foregoing clauses (a), (b) or (c) that

would not reasonably be expected to have a Material Adverse Effect on Purchaser.

6.5

Capitalization.

(a)

Purchaser is authorized to issue up to 500,000,000 Purchaser Class A Ordinary Shares par value $0.0001 per share, 50,000,000 Purchaser

Class B Ordinary Shares, par value $0.0001 per share, and 5,000,000 Purchaser Preference Shares, par value $0.0001 per share. The issued

and outstanding Purchaser Securities as of the Agreement Date are set forth on Schedule ‎6.5(a). There are no issued or outstanding

Purchaser Preference Shares. All issued and outstanding Purchaser Ordinary Shares are duly authorized, validly issued, fully paid and

non-assessable and are not subject to or issued in violation of any purchase option, right of first refusal, preemptive right, subscription

right or any similar right under any provision of the BVI Companies Act, Purchaser’s Governing Documents or any Contract to which

Purchaser is a party. None of the outstanding Purchaser Securities has been issued in violation of any applicable securities Laws.

(b)

Except as set forth in Schedule 6.5(a) or Schedule ‎6.5(b), there are no (i) outstanding options, warrants, puts,

calls, convertible securities, preemptive or similar rights, (ii) bonds, debentures, notes or other Indebtedness having general

voting rights or that are convertible or exchangeable into securities having such rights or (iii) subscriptions or other rights,

agreements, arrangements, Contracts or commitments of any character (other than this Agreement and the Ancillary Documents), (A)

relating to the issued or unissued shares of Purchaser or (B) obligating Purchaser to issue, transfer, deliver or sell or cause to

be issued, transferred, delivered, sold or repurchased any options or shares or securities convertible into or exchangeable for such

shares, or (C) obligating Purchaser to grant, extend or enter into any such option, warrant, call, subscription or other right,

agreement, arrangement or commitment for such capital shares. Other than the Redemption or as expressly set forth in this Agreement,

there are no outstanding obligations of Purchaser to repurchase, redeem or otherwise acquire any Purchaser Securities or to provide

funds to make any investment (in the form of a loan, capital contribution or otherwise) in any Person. Except as set forth in Schedule‎

6.5(b), there are no shareholders agreements, voting trusts or other agreements or understandings to which Purchaser is a party

with respect to the voting of any shares of Purchaser.

33

(c)

All Indebtedness of Purchaser as of the Agreement Date is disclosed on Schedule 6.5(c). No Indebtedness of Purchaser contains

any restriction upon (i) the prepayment of any of such Indebtedness, (ii) the incurrence of Indebtedness by Purchaser or (iii) the

ability of Purchaser to grant any Lien on its properties or assets.

(d)

Since the date of formation of Purchaser, and except as contemplated by this Agreement, Purchaser has not declared or paid any distribution

or dividend in respect of its shares and has not repurchased, redeemed or otherwise acquired any of its shares, and Purchaser’s

board of directors has not authorized any of the foregoing.

6.6

SEC Filings and Purchaser Financials.

(a)

Purchaser, since the IPO, has filed all forms, reports, schedules, statements, registration statements, prospectuses and other

documents required to be filed or furnished by Purchaser with the SEC under the Securities Act and/or the Exchange Act, together

with any amendments, restatements or supplements thereto, and will file all such forms, reports, schedules, statements and other

documents required to be filed subsequent to the Agreement Date. Except to the extent available on the SEC’s web site through

EDGAR, Purchaser has delivered to the Company copies in the form filed with the SEC of all of the following: (i) Purchaser’s

annual reports on Form 10-K for each fiscal year of Purchaser beginning with the first year Purchaser was required to file such a

form, (ii) Purchaser’s quarterly reports on Form 10-Q for each fiscal quarter that Purchaser filed such reports to disclose

its quarterly financial results in each of the fiscal years of Purchaser referred to in clause (i) above, (iii) all other forms,

reports, registration statements, prospectuses and other documents (other than preliminary materials) filed by Purchaser with the

SEC since the beginning of the first fiscal year referred to in clause (i) above (the forms, reports, registration statements,

prospectuses and other documents referred to in clauses (i), (ii) and (iii) above, whether or not available through EDGAR, are,

collectively, the “SEC Reports”) and (iv) all certifications and statements required by (A) Rules 13a-14 or

15d-14 under the Exchange Act, and (B) 18 U.S.C. §1350 (Section 906 of SOX) with respect to any report referred to in clause

(i) above (collectively, the “Public Certifications”). The SEC Reports (x) were prepared in all material respects

in accordance with the requirements of the Securities Act and the Exchange Act, as the case may be, and the rules and regulations

thereunder and (y) did not, as of their respective effective dates (in the case of SEC Reports that are registration statements

filed pursuant to the requirements of the Securities Act) and at the time they were filed with the SEC (in the case of all other SEC

Reports) contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary

in order to make the statements made therein, in the light of the circumstances under which they were made, not misleading. As of

the Agreement Date, there are no outstanding or unresolved comments in comment letters received from the SEC with respect to any SEC

Reports. None of the SEC Reports filed on or prior to the Agreement Date is subject to ongoing SEC review or investigation as of the

Agreement Date. The Public Certifications are each true as of their respective dates of filing. As used in this Section

6.6, the term “file” shall be broadly construed to include any manner permitted by SEC rules and regulations in

which a document or information is furnished, supplied or otherwise made available to the SEC. As of the Agreement Date, (A)

Purchaser Public Units, Purchaser Ordinary Shares, Purchaser Public Rights and Purchaser Public Warrants are listed on Nasdaq, (B)

Purchaser has not received any written deficiency notice from Nasdaq relating to the continued listing requirements of such

Purchaser Securities, (C) there are no Actions pending or, to the Knowledge of Purchaser, threatened against Purchaser by the

Financial Industry Regulatory Authority with respect to any intention by such entity to suspend, prohibit or terminate the quoting

of such Purchaser Securities on Nasdaq and (D) such Purchaser Securities are in compliance with all of the applicable corporate

governance rules of Nasdaq.

34

(b)

The financial statements and notes of Purchaser contained or incorporated by reference in the SEC Reports (the “Purchaser Financials”),

fairly present in all material respects the financial position and the results of operations, changes in shareholders’ equity,

and cash flows of Purchaser at the respective dates of and for the periods referred to in such financial statements, all in accordance

with (i) methodologies of Applicable Accounting Standards applied on a consistent basis throughout the periods involved and (ii) Regulation

S-X or Regulation S-K, as applicable (except as may be indicated in the notes thereto and for the omission of notes and audit adjustments

in the case of unaudited quarterly financial statements to the extent permitted by Regulation S-X or Regulation S-K, as applicable).

(c)

Except as and to the extent reflected or reserved against in Purchaser Financials, Purchaser has not incurred any Liabilities or obligations

of the type required to be reflected on a balance sheet in accordance with Applicable Accounting Standards that are not adequately reflected

or reserved on or provided for in Purchaser Financials, other than Liabilities of the type required to be reflected on a balance sheet

in accordance with Applicable Accounting Standards that have been incurred since Purchaser’s formation in the ordinary course of

business. All debts and Liabilities, whether fixed or contingent, which should be included under Applicable Accounting Standards on a

balance sheet are included in all material respects in Purchaser Financials as of the date of such Purchaser Financial.

6.7

Absence of Certain Changes. As of the Agreement Date, except as set forth in Schedule ‎6.7, Purchaser has (a)

since its formation, conducted no business other than its formation, the public offering of its securities (and the related private offerings),

public reporting and its search for an initial business combination (as such term is used in the IPO Prospectus) (“Business

Combination”) (including the investigation of the Company and the negotiation and execution of this Agreement) and related

activities and (b) since January 1, 2026, not been subject to a Material Adverse Effect on Purchaser.

6.8

Compliance with Laws. Purchaser is, and has since its formation been, in compliance with all Laws applicable to it and the conduct

of its business except for such noncompliance which would not reasonably be expected to have a Material Adverse Effect on Purchaser,

and Purchaser has not received written notice alleging any violation of applicable Law in any material respect by Purchaser. Purchaser

is not under investigation with respect to any violation or alleged violation of, any Law, or judgment, order or decree entered by any

court, arbitrator or Governmental Authority, domestic or foreign, and Purchaser has not previously received any subpoenas from any Governmental

Authority.

6.9

Actions; Orders; Permits. There is no pending or, to the Knowledge of Purchaser, threatened material Action to which Purchaser

is subject which would reasonably be expected to have a Material Adverse Effect on Purchaser. There is no material Action that Purchaser

has pending against any other Person. Purchaser is not subject to any material Orders of any Governmental Authority, nor are any such

Orders pending. Purchaser holds all material Permits necessary to lawfully conduct its business as presently conducted, and to own, lease

and operate its assets and properties, all of which are in full force and effect, except where the failure to hold such Permit or for

such Permit to be in full force and effect would not reasonably be expected to have a Material Adverse Effect on Purchaser.

6.10

Taxes and Returns.

(a)

Purchaser has timely filed, or caused to be timely filed, all material Tax Returns required to be filed by it, which such Tax

Returns are accurate and complete in all material respects, and has paid, collected or withheld, or caused to be paid, collected or

withheld, all material Taxes required to be paid, collected or withheld, other than such Taxes for which adequate reserves in

Purchaser Financials have been established in accordance with Applicable Accounting Standards. Purchaser has complied with all

applicable Laws relating to Taxes. Schedule 6.10(a) sets forth each jurisdiction where Purchaser files or is required to

file a Tax Return. There are no audits, examinations, investigations or other proceedings pending against Purchaser in respect of

any Tax, and Purchaser has not been notified in writing of any proposed Tax claims or assessments against Purchaser (other than, in

each case, claims or assessments for which adequate reserves in Purchaser Financials have been established in accordance with

Applicable Accounting Standards or are immaterial in amount). There are no Liens with respect to any Taxes upon any of

Purchaser’s assets, other than Permitted Liens. Purchaser has no outstanding waivers or extensions of any applicable statute

of limitations to assess any material amount of Taxes. There are no outstanding requests by Purchaser for any extension of time

within which to file any Tax Return or within which to pay any Taxes shown to be due on any Tax Return.

35

(b)

Since the date of its formation, Purchaser has not (i) changed any Tax accounting methods, policies or procedures except as required

by a change in Law, (ii) made, revoked, or amended any material Tax election, (iii) filed any amended Tax Returns or claim for refund

or (iv) entered into any closing agreement affecting or otherwise settled or compromised any material Tax liability or refund.

6.11

Employees and Employee Benefit Plans. Purchaser does not (a) have any paid employees or (b) maintain, sponsor, contribute to or

otherwise have any Liability under, any Benefit Plans.

6.12

Properties. Purchaser does not own, license or otherwise have any right, title or interest in or to any material Intellectual

Property. Purchaser does not own or lease any material real property or material Personal Property.

6.13

Material Contracts.

(a)

Except as set forth on Schedule ‎6.13(a), other than this Agreement and the Ancillary Documents, there are no Contracts to

which Purchaser is a party or by which any of its properties or assets may be bound, subject or affected, which (i) creates or imposes

a Liability greater than $500,000, (ii) may not be cancelled by Purchaser on less than sixty (60) days’ prior notice without payment

of a material penalty or termination fee or (iii) prohibits, prevents, restricts or impairs in any material respect any business practice

of Purchaser as its business is currently conducted, any acquisition of material property by Purchaser, or restricts in any material

respect the ability of Purchaser to engage in business as currently conducted by it or compete with any other Person (each, a “Purchaser

Material Contract”). All Purchaser Material Contracts have been made available to the Company other than those that are exhibits

to the SEC Reports.

(b)

With respect to each Purchaser Material Contract: (i) Purchaser Material Contract was entered into at arms’-length and in the ordinary

course of business; (ii) Purchaser Material Contract is legal, valid, binding and enforceable in all material respects against Purchaser

and, to the Knowledge of Purchaser, the other parties thereto, and is in full force and effect (except, in each case, as such enforcement

may be limited by the Enforceability Exceptions); (iii) Purchaser is not in breach or default in any material respect, and no event has

occurred that with the passage of time or giving of notice or both would constitute such a breach or default in any material respect

by Purchaser, or permit termination or acceleration by the other party, under such Purchaser Material Contract; and (iv) to the Knowledge

of Purchaser, no other party to any Purchaser Material Contract is in breach or default in any material respect, and no event has occurred

that with the passage of time or giving of notice or both would constitute such a breach or default by such other party, or permit termination

or acceleration by Purchaser under any Purchaser Material Contract.

6.14

Transactions with Affiliates. Schedule ‎6.14 sets forth a true, correct and complete list of the Contracts and

arrangements that are in existence as of the Agreement Date under which there are any existing or future Liabilities or obligations between

Purchaser and any (a) present or former director, officer or employee or Affiliate of Purchaser, or any immediate family member of any

of the foregoing, or (b) record or beneficial owner of more than five percent (5%) of Purchaser’s outstanding capital shares as

of the date hereof.

36

6.15

Investment Company Act. Purchaser is not an “investment company” or a Person directly or indirectly “controlled”

by or acting on behalf of an “investment company,” or required to register as an “investment company,” in each

case within the meaning of the Investment Company Act of 1940, as amended.

6.16

Finders and Brokers. Except as set forth on Schedule ‎6.16, no broker, finder or investment banker is entitled

to any brokerage, finder’s or other fee or commission from Purchaser, the Company or any of their respective Affiliates in connection

with the transactions contemplated hereby based upon arrangements made by or on behalf of Purchaser.

6.17

Ownership of Transaction Consideration. All Purchaser Ordinary Shares to be issued and delivered to the Selling Shareholders as

Transaction Consideration in accordance with ‎Article II shall be, upon issuance and delivery of such Purchaser Ordinary

Shares, fully paid and non-assessable, free and clear of all Liens and Encumbrances, other than restrictions arising from applicable

securities Laws, the Lock-Up Agreement provisions, and any Liens and Encumbrances incurred by any Selling Shareholder, and the issuance

and sale of such Purchaser Ordinary Shares pursuant hereto will not be subject to or give rise to any preemptive rights or rights of

first refusal.

6.18

Certain Business Practices.

(a)

Neither Purchaser, nor any of its Representatives acting on its behalf, has (i) used any funds for unlawful contributions, gifts, entertainment

or other unlawful expenses relating to political activity, (ii) made any unlawful payment to foreign or domestic government officials

or employees, to foreign or domestic political parties or campaigns or violated any provision of the U.S. Foreign Corrupt Practices Act

of 1977 or any other local or foreign anti-corruption or bribery Law, (iii) made any other unlawful payment or (iv) since the formation

of Purchaser, directly or indirectly, given or agreed to give any unlawful gift or similar benefit in any material amount to any customer,

supplier, governmental employee or other Person who is or may be in a position to help or hinder Purchaser or assist it in connection

with any actual or proposed transaction.

(b)

The operations of Purchaser are and have been conducted at all times in material compliance with money laundering statutes in all applicable

jurisdictions, the rules and regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered

or enforced by any Governmental Authority, and no Action involving Purchaser with respect to any of the foregoing is pending or, to the

Knowledge of Purchaser, threatened.

(c)

None of Purchaser or any of its directors or officers, or, to the Knowledge of Purchaser, any other Representative acting on behalf of

Purchaser is currently identified on the specially designated nationals or other blocked person list or otherwise currently subject to

any U.S. sanctions administered by the OFAC or is a designated persons of the purposes of the UK consolidated list (https://www.gov.uk/government/publications/financial-sanctions-consolidated-list-of-targets)

and Purchaser has not, in the last five (5) fiscal years, directly or indirectly, used any funds, or loaned, contributed or otherwise

made available such funds to any Subsidiary, joint venture partner or other Person, in connection with any sales or operations in any

other country sanctioned by OFAC or for the purpose of financing the activities of any Person currently subject to, or otherwise in violation

of, any U.S. sanctions administered by OFAC or any UK sanctions regulations which have been made and modified under the Sanctions and

Anti-Money Laundering Act 2018 (“Sanctions Act”) and extended to the BVI by an Overseas Territories Sanctions Order.

6.19

Insurance. Schedule ‎6.19 lists all insurance policies (by policy number, insurer, coverage period, coverage

amount, annual premium and type of policy) held by Purchaser relating to Purchaser or its business, properties, assets, directors, officers

and employees, copies of which have been provided to the Company. All premiums due and payable under all such insurance policies have

been timely paid and Purchaser is otherwise in material compliance with the terms of such insurance policies. All such insurance policies

are in full force and effect, and to the Knowledge of Purchaser, there is no threatened termination of, or material premium increase

with respect to, any of such insurance policies. There have been no insurance claims made by Purchaser. Purchaser has reported to its

insurers all claims and pending circumstances that would reasonably be expected to result in a claim, except where such failure to report

such a claim would not be reasonably likely to have a Material Adverse Effect on Purchaser.

37

6.20

Purchaser Trust Account. As of June 30, 2026, the Trust Account has a balance of no less than $121,464,805. Such monies are invested

solely in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act or money

market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act, and held in trust by Efficiency,

Inc. pursuant to the Trust Agreement. The Trust Agreement is valid and in full force and effect and enforceable in accordance with its

terms (subject to the Enforceability Exceptions) and has not been amended or modified. Purchaser has performed all material obligations

required to be performed by it to date under, and is not in material default or delinquent in performance or any other respect (claimed

or actual) in connection with the Trust Agreement, and, to the Knowledge of Purchaser, no event has occurred which, with due notice or

lapse of time or both, would constitute such a material default thereunder. As of the Agreement Date, there are no claims or proceedings

pending with respect to the Trust Account. There are no separate agreements, side letters or other agreements that would cause the description

of the Trust Agreement in the SEC Reports to be inaccurate in any material respect and/or that would entitle any Person (other than the

underwriters of the IPO, Public Shareholders who shall have elected to redeem their Purchaser Ordinary Shares pursuant to Purchaser’s

Governing Documents (or in connection with an extension of Purchaser’s deadline to consummate a Business Combination) or Governmental

Authorities for Taxes, to any portion of the proceeds in the Trust Account. Prior to the Closing, none of the funds held in the Trust

Account may be released except as described in the Trust Agreement. Upon the consummation of the transactions contemplated hereby, including

the distribution of assets from the Trust Account, the Trust Agreement shall terminate in accordance with its terms.

6.21

Independent Investigation. Purchaser has conducted its own independent investigation, review and analysis of the business, results

of operations, prospects, condition (financial or otherwise) or assets of the Company, and acknowledges that it has been provided adequate

access to the personnel, properties, assets, premises, books and records, and other documents and data of the Company for such purpose.

Purchaser acknowledges and agrees that: (a) in making its decision to enter into this Agreement and to consummate the transactions contemplated

hereby, it has relied solely upon its own investigation and the express representations and warranties of the Company set forth in this

Agreement (including the related portions of the Company Disclosure Schedules) and in any certificate delivered to Purchaser pursuant

hereto, and the information provided by or on behalf of the Company for the Registration Statement; and (b) neither the Company nor its

respective Representatives have made any representation or warranty as to the Company, or this Agreement, except as expressly set forth

in this Agreement (including the related portions of the Company Disclosure Schedules) or in any certificate delivered to Purchaser pursuant

hereto, or with respect to the information provided by or on behalf of the Company for the Registration Statement.

Article

VII

COVENANTS

7.1

Access and Information.

(a)

During the period from the Agreement Date and continuing until the earlier of the termination of this Agreement in accordance with Section

10.1 or the Closing (the “Interim Period”), subject to Section 7.13, the Company shall give, and shall

cause its Representatives to give, Purchaser and its Representatives, at reasonable times during normal business hours and upon reasonable

intervals and notice, reasonable access to all offices and other facilities and to all employees, properties, Contracts, agreements,

commitments, books and records, financial and operating data and other information (including Tax Returns, internal working papers, client

files, client Contracts and director service agreements), of or pertaining to the Company, as Purchaser or its Representatives may reasonably

request regarding the Company and their respective businesses, assets, Liabilities, financial condition, prospects, operations, management,

employees and other aspects (including unaudited quarterly financial statements, including a consolidated quarterly balance sheet and

income statement, a copy of each material report, schedule and other document filed with or received by a Governmental Authority pursuant

to the requirements of applicable securities Laws, and independent public accountants’ work papers (subject to the consent or any

other conditions required by such accountants, if any)) and cause each of the Company’s Representatives to reasonably cooperate

with Purchaser and its Representatives in their investigation; provided, however, that Purchaser and its Representatives shall conduct

any such activities in such a manner as not to unreasonably interfere with the business or operations of the Company; and provided further,

the Company shall not be required to provide, or cause to be provided to, Purchaser or any of its Representatives any information (i)

if and to the extent doing so would (A) violate any Law to which the Company is subject, (B) result in the disclosure of any trade secrets

of third parties in breach of any Contract with such third party, (C) violate any legally-binding obligation of the Company with respect

to confidentiality, non-disclosure or privacy or (D) jeopardize protections afforded to the Company under the attorney-client privilege

or the attorney work product doctrine; provided that in each case the Company shall cooperate with Purchaser to effect disclosure of

such information in a manner which does not result in such a breach, violation or jeopardization.

38

(b)

During the Interim Period, subject to Section 7.13, Purchaser shall give, and shall cause its Representatives to give, the

Company and its Representatives, at reasonable times during normal business hours and upon reasonable intervals and notice, reasonable

access to all offices and other facilities and to all employees, properties, Contracts, agreements, commitments, books and records, financial

and operating data and other information (including Tax Returns, internal working papers, client files, client Contracts and director

service agreements), of or pertaining to Purchaser or its Subsidiaries, as the Company or its Representatives may reasonably request

regarding Purchaser, its Subsidiaries and their respective businesses, assets, Liabilities, financial condition, prospects, operations,

management, employees and other aspects (including unaudited quarterly financial statements, including a consolidated quarterly balance

sheet and income statement, a copy of each material report, schedule and other document filed with or received by a Governmental Authority

pursuant to the requirements of applicable securities Laws, and independent public accountants’ work papers (subject to the consent

or any other conditions required by such accountants, if any)) and cause each of Purchaser’s Representatives to reasonably cooperate

with the Company and its Representatives in their investigation; provided, however, that the Company and its Representatives shall conduct

any such activities in such a manner as not to unreasonably interfere with the business or operations of Purchaser or any of its Subsidiaries.

7.2

Conduct of Business of the Company.

(a)

Unless Purchaser shall otherwise consent in writing (such consent not to be unreasonably withheld, conditioned or delayed), during the

Interim Period, except as expressly contemplated by this Agreement or the Ancillary Documents or as set forth on Schedule 7.2,

the Company shall (i) conduct its business, in all material respects, in the ordinary course of business consistent with past practice,

(ii) comply with all Laws applicable to the Company and its business, assets and employees, including applicable Money Lending Laws concerning

loan origination, documentation, servicing, collections, interest, fees, advertising, borrower information and recordkeeping, and (iii)

take all commercially reasonable measures necessary or appropriate to preserve intact, in all material respects, its business organization,

to keep available the services of its managers, directors, officers, employees and consultants, and to preserve the possession, control

and condition of its material assets, all as consistent with past practice.

(b)

Without limiting the generality of Section 7.2(a) and except as contemplated by the terms of this Agreement or the Ancillary

Documents as set forth on Schedule 7.2, during the Interim Period, without the prior written consent of Purchaser (such

consent not to be unreasonably withheld, conditioned or delayed), the Company shall not:

(i)

amend, waive or otherwise change, in any respect, its Governing Documents, except as required by applicable Law and to effect the transactions

contemplated by this Agreement and the Ancillary Documents;

(ii)

authorize for issuance, issue, grant, sell, pledge, dispose of or propose to issue, grant, sell, pledge or dispose of any of its equity

securities or any options, warrants, commitments, subscriptions or rights of any kind to acquire or sell any of its equity securities,

or other securities, including any securities convertible into or exchangeable for any of its shares or other equity securities or securities

of any class and any other equity-based awards or engage in any hedging transaction with a third Person with respect to such securities;

39

(iii)

split, combine, recapitalize or reclassify any of its shares or other equity interests or issue any other securities in respect thereof

or pay or set aside any dividend or other distribution (whether in cash, equity or property or any combination thereof) in respect of

its equity interests, or directly or indirectly redeem, purchase or otherwise acquire or offer to acquire any of its securities (except

for the repurchase of Company Ordinary Shares from former employees, non-employee directors and consultants in accordance with agreements

as in effect on the date hereof providing for the repurchase of shares in connection with any termination of service;

(iv)

incur, create, assume, prepay or otherwise become liable for any Indebtedness (directly, contingently or otherwise) in excess of $20,000

individually or $100,000 in the aggregate, make a loan or advance to or investment in any third party (other than advancement or reimbursement

of expenses to employees in the ordinary course of business or loans in the ordinary course of business), or guarantee or endorse any

Indebtedness, Liability or obligation of any Person in excess of $20,000 individually or $100,000 in the aggregate or as required to

consummate the transactions contemplated by this Agreement or the Ancillary Documents;

(v)

increase the wages, salaries or compensation of its employees other than in the ordinary course of business, consistent with past practice,

and in any event not in the aggregate by more than five percent (5%), or make or commit to make any bonus payment (whether in cash, property

or securities) other than in the ordinary course of business consistent with past practice, to any employee, or materially increase other

benefits of employees generally other than in the ordinary course of business consistent with past practice, or enter into, establish,

materially amend or terminate any Company Benefit Plan with, for or in respect of any current consultant, officer, manager director or

employee, in each case other than as required by applicable Law, pursuant to the terms of any Company Benefit Plans, pursuant to the

terms of this Agreement or the Ancillary Documents, in the ordinary course of business consistent with past practice;

(vi)

make or rescind any material election relating to Taxes, settle any claim, action, suit, litigation, proceeding, arbitration, investigation,

audit or controversy relating to Taxes, file any amended Tax Return or claim for refund, or make any material change in its accounting

or Tax policies or procedures, in each case except as required by applicable Law or in compliance with Applicable Accounting Standards;

(vii)

transfer or license to any Person or otherwise extend, materially amend or modify, permit to lapse or fail to preserve any material Company

Registered IP, Company IP Licenses or other Company IP (excluding non-exclusive licenses of Company IP to Company customers in the ordinary

course of business consistent with past practice), or disclose to any Person who has not entered into a confidentiality agreement any

Trade Secrets;

(viii)

terminate, or waive or assign any material right under, any Company Material Contract or enter into any Contract that would be a Company

Material Contract, in any case outside of the ordinary course of business consistent with past practice, other than any termination at

the end of the term of such Company Material Contract pursuant to the terms thereof, or as required to consummate the transactions contemplated

by this Agreement or the Ancillary Documents;

(ix)

fail to maintain its books, accounts and records in all material respects in the ordinary course of business consistent with past practice;

40

(x)

establish any Subsidiary or enter into any new line of business;

(xi)

fail to use commercially reasonable efforts to keep in force material insurance policies or replacement or revised policies providing

insurance coverage with respect to its assets, operations and activities in such amount and scope of coverage substantially similar to

that which is currently in effect;

(xii)

revalue any of its material assets or make any material change in accounting methods, principles or practices, except to the extent required

to comply with Applicable Accounting Standards and after consulting with the Company’s outside auditors;

(xiii)

waive, release, assign, settle or compromise any claim, action or proceeding (including any suit, action, claim, proceeding or investigation

relating to this Agreement or the transactions contemplated hereby), other than waivers, releases, assignments, settlements or compromises

that involve only the payment of monetary damages (and not the imposition of equitable relief on, or the admission of wrongdoing by,

the Company or its Affiliates) not in excess of $20,000 (individually or $100,000 in the aggregate), or otherwise pay, discharge or satisfy

any Actions, Liabilities or obligations, unless such amount has been reserved in the Company Financials;

(xiv)

close or materially reduce its activities, or effect any layoff or other personnel reduction or change, at any of its facilities;

(xv)

acquire, including by merger, consolidation, acquisition of equity interests or assets, or any other form of business combination, any

corporation, partnership, limited liability company, other business organization or any division thereof, or any material amount of assets

outside the ordinary course of business consistent with past practice;

(xvi)

make capital expenditures in excess of $20,000 individually for any project or set of related projects or $100,000 in the aggregate,

other than pursuant to the terms of a Company Material Contract in effect on the Agreement Date;

(xvii)

adopt a plan of complete or partial liquidation, dissolution, merger, consolidation, restructuring, recapitalization or other reorganization;

(xviii)

voluntarily incur any Liability or obligation (whether absolute, accrued, contingent or otherwise) in excess of $20,000 individually

or $100,000 in the aggregate other than pursuant to the terms of a Company Material Contract or Company Benefit Plan;

(xix)

sell, lease, license, transfer, exchange or swap, mortgage or otherwise pledge or encumber (including securitizations), or otherwise

dispose of any material portion of its properties, assets or rights;

(xx)

enter into any agreement, understanding or arrangement with respect to the voting of equity securities of the Company;

(xxi)

take any action that would reasonably be expected to significantly delay or impair the obtaining of any Consents of any Governmental

Authority to be obtained in connection with this Agreement;

(xxii)

accelerate the collection of any trade receivables or delay the payment of trade payables or any other liabilities other than in the

ordinary course of business consistent with past practice;

41

(xxiii)

materially amend any underwriting, pricing, credit approval, collection or loan servicing policies, except as required by applicable

Law or a Governmental Authority;

(xxiv)

enter into, amend, waive or terminate (other than terminations in accordance with their terms) any transaction with any Related Person

(other than compensation and benefits and advancement of expenses, in each case, provided in the ordinary course of business consistent

with past practice); or

(xxv)

authorize or agree to do any of the foregoing actions.

7.3

Conduct of Business of Purchaser.

(a)

Unless the Company shall otherwise consent in writing (such consent not to be unreasonably withheld, conditioned or delayed), during

the Interim Period, except as expressly contemplated by this Agreement or the Ancillary Documents or as set forth on Schedule

7.3, Purchaser shall, and shall cause its Subsidiaries to, (i) conduct their respective businesses, in all material respects, in

the ordinary course of business consistent with past practice, (ii) comply with all Laws applicable to Purchaser and its

Subsidiaries and their respective businesses, assets and employees, and (iii) take all commercially reasonable measures necessary or

appropriate to preserve intact, in all material respects, their respective business organizations, to keep available the services of

their respective managers, directors, officers, employees and consultants, and to preserve the possession, control and condition of

their respective material assets, all as consistent with past practice. Notwithstanding anything to the contrary in this Section

‎7.3, nothing in this Agreement shall prohibit or restrict Purchaser from extending, in accordance with Purchaser’s

Governing Documents and the IPO Prospectus, the deadline by which it must complete its Business Combination (an

“Extension”), and no consent of any other Party shall be required in connection therewith.

(b)

Without limiting the generality of Section 7.3(a) and except as contemplated by the terms of this Agreement or the Ancillary

Documents (including as contemplated by any PIPE Investment consented to by the Company in accordance with Section ‎7.18) or as set

forth on Schedule 7.3, during the Interim Period, without the prior written consent of the Company (such consent not to be

unreasonably withheld, conditioned or delayed), Purchaser shall not, and shall cause its Subsidiaries not to:

(i)

amend, waive or otherwise change, in any respect, its Governing Documents except as required by applicable Law;

(ii)

authorize for issuance, issue, grant, sell, pledge, dispose of or propose to issue, grant, sell, pledge or dispose of any of its equity

securities or any options, warrants, commitments, subscriptions or rights of any kind to acquire or sell any of its equity securities,

or other securities, including any securities convertible into or exchangeable for any of its equity securities or other securities of

any class and any other equity-based awards, other than the issuance of Purchaser Securities issuable upon conversion or exchange of

outstanding Purchaser Securities in accordance with their terms, or engage in any hedging transaction with a third Person with respect

to such securities;

(iii)

split, combine, recapitalize or reclassify any of its shares or other equity interests or issue any other securities in respect thereof

or pay or set aside any dividend or other distribution (whether in cash, equity or property or any combination thereof) in respect of

its shares or other equity interests, or directly or indirectly redeem, purchase or otherwise acquire or offer to acquire any of its

securities;

42

(iv)

incur, create, assume, prepay or otherwise become liable for any Indebtedness (directly, contingently or otherwise) in excess of $500,000

individually or $1,000,000 in the aggregate, make a loan or advance to or investment in any third party, or guarantee or endorse any

Indebtedness, Liability or obligation of any Person (provided, that this Section 7.3(b)(iv) shall not prevent Purchaser from borrowing

funds necessary to finance its ordinary course administrative costs and expenses and Expenses incurred in connection with the consummation

of the transactions contemplated by this Agreement (including any PIPE Investment and the reasonable costs and expenses necessary for

any Extensions (such expenses, “Extension Expenses”)), up to aggregate additional Indebtedness during the Interim

Period of $3,000,000;

(v)

make or rescind any material election relating to Taxes, settle any claim, action, suit, litigation, proceeding, arbitration, investigation,

audit or controversy relating to Taxes, file any amended Tax Return or claim for refund, or make any material change in its accounting

or Tax policies or procedures, in each case except as required by applicable Law or in compliance with Applicable Accounting Standards;

(vi)

amend, waive or otherwise change the Trust Agreement in any manner adverse to Purchaser;

(vii)

terminate, waive or assign any material right under any Purchaser Material Contract or enter into any Contract that would be a Purchaser

Material Contract;

(viii)

fail to maintain its books, accounts and records in all material respects in the ordinary course of business consistent with past practice;

(ix)

establish any Subsidiary or enter into any new line of business;

(x)

fail to use commercially reasonable efforts to keep in force insurance policies or replacement or revised policies providing insurance

coverage with respect to its assets, operations and activities in such amount and scope of coverage substantially similar to that which

is currently in effect;

(xi)

revalue any of its material assets or make any material change in accounting methods, principles or practices, except to the extent required

to comply with Applicable Accounting Standards and after consulting Purchaser’s outside auditors;

(xii)

waive, release, assign, settle or compromise any claim, action or proceeding (including any suit, action, claim, proceeding or investigation

relating to this Agreement or the transactions contemplated hereby), other than waivers, releases, assignments, settlements or compromises

that involve only the payment of monetary damages (and not the imposition of equitable relief on, or the admission of wrongdoing by,

Purchaser or its Subsidiary) not in excess of $100,000 individually or $500,000 in the aggregate, or otherwise pay, discharge or satisfy

any Actions, Liabilities or obligations, unless such amount has been reserved in Purchaser Financials;

(xiii)

acquire, including by merger, consolidation, acquisition of equity interests or assets, or any other form of business combination, any

corporation, partnership, limited liability company, other business organization or any division thereof, or any material amount of assets

outside the ordinary course of business;

(xiv)

make capital expenditures in excess of $100,000 individually for any project (or set of related projects) or $500,000 in the aggregate

(excluding for the avoidance of doubt, incurring any Expenses);

(xv)

adopt a plan of complete or partial liquidation, dissolution, merger, consolidation, restructuring, recapitalization or other reorganization

(other than with respect to the transactions contemplated by this Agreement);

43

(xvi)

voluntarily incur any Liability or obligation (whether absolute, accrued, contingent or otherwise) in excess of $100,000 individually

or $500,000 in the aggregate (excluding the incurrence of any Expenses) other than pursuant to the terms of a Contract in existence as

of the Agreement Date or entered into in the ordinary course of business or in accordance with the terms of this Section ‎7.3

during the Interim Period;

(xvii)

sell, lease, license, transfer, exchange or swap, mortgage or otherwise pledge or encumber (including securitizations), or otherwise

dispose of any material portion of its properties, assets or rights;

(xviii)

enter into any agreement, understanding or arrangement with respect to the voting of Purchaser Securities;

(xix)

take any action that would reasonably be expected to significantly delay or impair the obtaining of any Consents of any Governmental

Authority to be obtained in connection with this Agreement; or

(xx)

authorize or agree to do any of the foregoing actions.

7.4

Annual and Interim Financial Statements. During the Interim Period, within thirty (30) calendar days following the end of each

three-month quarterly period and each fiscal year, the Company shall deliver to Purchaser an unaudited consolidated income statement

and an unaudited consolidated balance sheet of the Company for the period from the Interim Balance Sheet Date through the end of such

calendar month, quarterly period or fiscal year and the applicable comparative period in the preceding fiscal year, in each case accompanied

by a certificate of the Director and Chief Financial Officer of the Company to the effect that all such financial statements fairly present

the financial position and results of operations of the Company as of the date or for the periods indicated, in accordance with Applicable

Accounting Standards, subject to year-end audit adjustments and excluding footnotes (collectively, the “Interim Financial Statements”).

From the date hereof through the Closing Date, the Company will also promptly deliver to Purchaser copies of any audited consolidated

financial statements of the Company that the Company’s independent registered public accounting firm may issue.

7.5

Purchaser Public Filings. During the Interim Period, Purchaser will keep current all of its public filings with the SEC and will

otherwise comply in all material respects with applicable securities Laws and shall use its reasonable best efforts prior to the Closing

to maintain the listing of Purchaser Public Units, Purchaser Ordinary Shares, Purchaser Public Rights and Purchaser Public Warrants on

Nasdaq; provided, that the Parties acknowledge and agree that from and after the Closing, the Parties intend to list on Nasdaq

only Purchaser Ordinary Shares and Purchaser Public Warrants. Purchaser shall cause the ticker under which Purchaser Ordinary Shares

and Purchaser Public Warrants are listed for trading on Nasdaq to be changed to “BCIN” and “BCINW”, respectively,

and have Purchaser Ordinary Shares and Purchaser Public Warrants listed for trading with such trading ticker.

7.6

No Solicitation.

(a)

For purposes of this Agreement, (i) an “Acquisition Proposal” means any inquiry, proposal or offer, or any indication

of interest in making an offer or proposal, from any Person or group at any time relating to an Alternative Transaction, and (ii) an

“Alternative Transaction” means (A) with respect to the Company and its Affiliates, a transaction (other than the

transactions contemplated by this Agreement or a proposed PIPE Investment) concerning the sale of (x) all or any material part of the

business or assets of the Company (other than in the ordinary course of business consistent with past practice) or (y) any of the shares

or other equity interests or profits of the Company, in any case, whether such transaction takes the form of a sale of shares or other

equity interests, assets, merger, consolidation, issuance of debt securities, management Contract, joint venture or partnership, or otherwise

and (B) with respect to Purchaser and its Affiliates, a transaction (other than the transactions contemplated by this Agreement) concerning

a Business Combination involving Purchaser.

44

(b)

During the Interim Period, in order to induce the other Parties to continue to commit to expend management time and financial resources

in furtherance of the transactions contemplated hereby, each Party shall not, and shall cause its Representatives not to, without the

prior written consent of the Company and Purchaser, directly or indirectly, (i) solicit, assist, initiate or facilitate the making, submission

or announcement of, or intentionally encourage, any Acquisition Proposal, (ii) furnish any non-public information regarding such Party

or its Affiliates or their respective businesses, operations, assets, Liabilities, financial condition, prospects or employees to any

Person or group (other than a Party to this Agreement or their respective Representatives) in connection with or in response to an Acquisition

Proposal, (iii) engage or participate in discussions or negotiations with any Person or group with respect to, or that could reasonably

be expected to lead to, an Acquisition Proposal, (iv) approve, endorse or recommend, or publicly propose to approve, endorse or recommend,

any Acquisition Proposal, (v) negotiate or enter into any letter of intent, agreement in principle, acquisition agreement or other similar

agreement related to any Acquisition Proposal, or (vi) release any third Person from, or waive any provision of, any confidentiality

agreement to which such Party is a party; provided, however, that nothing in this Section 7.6 shall prohibit any Party or its

Representatives from pursuing, negotiating or consummating the PIPE Investment or otherwise taking actions expressly permitted by this

Agreement in connection with the PIPE Investment.

(c)

Each Party shall notify the others as promptly as practicable (and in any event within 48 hours) in writing of the receipt by such Party

or any of its Representatives of (i) any bona fide inquiries, proposals or offers, requests for information or requests for discussions

or negotiations regarding or constituting any Acquisition Proposal or any bona fide inquiries, proposals or offers, requests for information

or requests for discussions or negotiations that could reasonably be expected to result in an Acquisition Proposal, and (ii) any request

for non-public information relating to such Party or its Affiliates in connection with any Acquisition Proposal, specifying in each case

the material terms and conditions thereof (including a copy thereof if in writing or a written summary thereof if oral) and the identity

of the party making such inquiry, proposal, offer or request for information. Each Party shall keep the others promptly informed of the

status of any such inquiries, proposals, offers or requests for information. During the Interim Period, each Party shall, and shall cause

its Representatives to, immediately cease and cause to be terminated any solicitations, discussions or negotiations with any Person with

respect to any Acquisition Proposal and shall, and shall direct its Representatives to, cease and terminate any such solicitations or

discussions. The Company represents and warrants that neither it nor any of its Affiliates or equity holders is a party to or bound by

any binding or non-binding agreement or understanding with respect to any transaction that would constitute an Alternative Transaction.

7.7

No Trading. The Company and each Selling Shareholder acknowledge and agree that they are aware, and that their respective Affiliates

are aware (and each of their respective Representatives is aware or, upon receipt of any material nonpublic information of Purchaser,

will be advised) of the restrictions imposed by U.S. federal securities laws and the rules and regulations of the SEC and Nasdaq promulgated

thereunder or otherwise (the “Federal Securities Laws”) and other applicable foreign and domestic Laws on a Person

possessing material nonpublic information about a publicly traded company. The Company and each Selling Shareholder hereby agree that,

while it is in possession of such material nonpublic information, they shall not purchase or sell any securities of Purchaser, communicate

such information to any third party, take any other action with respect to Purchaser in violation of such Laws, or cause or encourage

any third party to do any of the foregoing.

45

7.8

Notification of Certain Matters. During the Interim Period, each Party shall give prompt notice to the other Parties if such Party

or its Affiliates: (a) fails to comply with or satisfy any covenant, condition or agreement to be complied with or satisfied by it or

its Affiliates hereunder in any material respect; (b) receives any notice or other communication in writing from any third party (including

any Governmental Authority) alleging (i) that the Consent of such third party is or may be required in connection with the transactions

contemplated by this Agreement or (ii) any non-compliance with any Law by such Party or its Affiliates; (c) receives any notice or other

communication from any Governmental Authority in connection with the transactions contemplated by this Agreement; (d) discovers any fact

or circumstance that, or becomes aware of the occurrence or non-occurrence of any event the occurrence or non-occurrence of which, would

reasonably be expected to cause or result in any of the conditions to the Closing set forth in ‎Article IX not being

satisfied or the satisfaction of those conditions being materially delayed; or (e) becomes aware of the commencement or threat, in writing,

of any Action against such Party or any of its Affiliates, or any of their respective properties or assets, or, to the Knowledge of such

Party, any officer, director, partner, member or manager, in his, her or its capacity as such, of such Party or of its Affiliates with

respect to the consummation of the transactions contemplated by this Agreement. No such notice shall constitute an acknowledgement or

admission by the Party providing the notice regarding whether or not any of the conditions to the Closing have been satisfied or in determining

whether or not any of the representations, warranties or covenants contained in this Agreement have been breached.

7.9

Efforts.

(a)

Subject to the terms and conditions of this Agreement, each Party shall use its reasonable best efforts, and shall cooperate fully with

the other Parties, to take, or cause to be taken, all actions and to do, or cause to be done, all things reasonably necessary, proper

or advisable under applicable Laws and regulations to consummate the transactions contemplated by this Agreement (including the receipt

of all applicable Consents of Governmental Authorities) and to comply as promptly as practicable with all requirements of Governmental

Authorities applicable to the transactions contemplated by this Agreement.

(b)

In furtherance and not in limitation of Section ‎7.9(a), to the extent required under any Laws that are designed to prohibit, restrict

or regulate actions having the purpose or effect of monopolization or restraint of trade (“Antitrust Laws”), each

Party hereto agrees to make any required filing or application under Antitrust Laws, as applicable, at such Party’s sole cost and

expense, with respect to the transactions contemplated hereby as promptly as practicable, to supply as promptly as reasonably practicable

any additional information and documentary material that may be reasonably requested pursuant to Antitrust Laws and to take all other

actions reasonably necessary, proper or advisable to cause the expiration or termination of the applicable waiting periods under Antitrust

Laws as soon as practicable, including by requesting early termination of the waiting period provided for under the Antitrust Laws. Each

Party shall, in connection with its efforts to obtain all requisite approvals and authorizations for the transactions contemplated by

this Agreement under any Antitrust Law, use its commercially reasonable efforts to: (i) cooperate in all respects with each other Party

or its Affiliates in connection with any filing or submission and in connection with any investigation or other inquiry, including any

proceeding initiated by a private Person; (ii) keep the other Parties reasonably informed of any communication received by such Party

or its Representatives from, or given by such Party or its Representatives to, any Governmental Authority and of any communication received

or given in connection with any proceeding by a private Person, in each case regarding any of the transactions contemplated by this Agreement;

(iii) permit a Representative of the other Parties and their respective outside counsel to review any communication given by it to, and

consult with each other in advance of any meeting or conference with, any Governmental Authority or, in connection with any proceeding

by a private Person, with any other Person, and to the extent permitted by such Governmental Authority or other Person, give a Representative

or Representatives of the other Parties the opportunity to attend and participate in such meetings and conferences; (iv) in the event

a Party’s Representative is prohibited from participating in or attending any meetings or conferences, the other Parties shall

keep such Party promptly and reasonably apprised with respect thereto; and (v) use commercially reasonable efforts to cooperate in the

filing of any memoranda, white papers, filings, correspondence or other written communications explaining or defending the transactions

contemplated hereby, articulating any regulatory or competitive argument, and/or responding to requests or objections made by any Governmental

Authority.

46

(c)

As soon as reasonably practicable following the Agreement Date, the Parties shall reasonably cooperate with each other and use (and shall

cause their respective Affiliates to use) their respective commercially reasonable efforts to prepare and file with Governmental Authorities

requests for approval of the transactions contemplated by this Agreement and shall use all commercially reasonable efforts to have such

Governmental Authorities approve the transactions contemplated by this Agreement. Each Party shall give prompt written notice to the

other Parties if such Party or any of its Representatives receives any notice from such Governmental Authorities in connection with the

transactions contemplated by this Agreement, and shall promptly furnish the other Parties with a copy of such Governmental Authority

notice. If any Governmental Authority requires that a hearing or meeting be held in connection with its approval of the transactions

contemplated hereby, whether prior to the Closing or after the Closing, each Party shall arrange for Representatives of such Party to

be present for such hearing or meeting. If any objections are asserted with respect to the transactions contemplated by this Agreement

under any applicable Law or if any Action is instituted (or threatened to be instituted) by any applicable Governmental Authority or

any private Person challenging any of the transactions contemplated by this Agreement or any Ancillary Document as violative of any applicable

Law or which would otherwise prevent, materially impede or materially delay the consummation of the transactions contemplated hereby

or thereby, the Parties shall use their commercially reasonable efforts to resolve any such objections or Actions so as to timely permit

consummation of the transactions contemplated by this Agreement and the Ancillary Documents, including in order to resolve such objections

or Actions which, in any case if not resolved, could reasonably be expected to prevent, materially impede or materially delay the consummation

of the transactions contemplated hereby or thereby. In the event any Action is instituted (or threatened to be instituted) by a Governmental

Authority or private Person challenging the transactions contemplated by this Agreement, or any Ancillary Document, the Parties shall,

and shall cause their respective Representatives to, reasonably cooperate with each other and use their respective commercially reasonable

efforts to contest and resist any such Action and to have vacated, lifted, reversed or overturned any Order, whether temporary, preliminary

or permanent, that is in effect and that prohibits, prevents or restricts consummation of the transactions contemplated by this Agreement

or the Ancillary Documents.

(d)

Prior to the Closing, each Party shall use its commercially reasonable efforts to obtain any Consents of Governmental Authorities or

other third Persons as may be necessary for the consummation by such Party or its Affiliates of the transactions contemplated by this

Agreement or required as a result of the execution or performance of, or consummation of the transactions contemplated by, this Agreement

by such Party or its Affiliates, and the other Parties shall provide reasonable cooperation in connection with such efforts.

7.10

Further Assurances. The Parties hereto shall further cooperate with each other and use their respective commercially reasonable

best efforts to take or cause to be taken all actions, and do or cause to be done all things, necessary, proper or advisable on their

part under this Agreement and applicable Laws to consummate the transactions contemplated by this Agreement as soon as reasonably practicable,

including preparing and filing as soon as practicable all documentation to effect all necessary notices, reports and other filings.

47

7.11

The Registration Statement.

(a)

As promptly as practicable after the Agreement Date, Purchaser shall prepare with the cooperation and assistance of the Company, and

file with the SEC a registration statement on Form S-4 (as amended or supplemented from time to time, and including the Proxy

Statement contained therein, the “Registration Statement”) in connection with the registration under the

Securities Act of Purchaser Ordinary Shares to be issued under this Agreement as the Transaction Consideration, which Registration

Statement will also contain a proxy statement (as amended, the “Proxy Statement”) for the purpose of soliciting

proxies from Purchaser Shareholders for the matters to be acted upon at the Extraordinary General Meeting and providing the Public

Shareholders an opportunity in accordance with Purchaser’s Governing Documents and the IPO Prospectus to have their Purchaser

Ordinary Shares redeemed (the “Redemption”) in conjunction with the shareholder vote on Purchaser Shareholder

Approval Matters. The Proxy Statement shall include proxy materials for the purpose of soliciting proxies from Purchaser

shareholders to vote, at an extraordinary general meeting of Purchaser shareholders to be called and held for such purpose (the

“Extraordinary General Meeting”), in favor of resolutions approving (i) as an ordinary resolution, the adoption

and approval of this Agreement and the transactions contemplated hereby or referred to herein, including, to the extent required,

the issuance of any shares in connection with the PIPE Investment, by the holders of Purchaser Ordinary Shares in accordance with

Purchaser’s Governing Documents and IPO Prospectus, the Securities Act, the BVI Companies Act, the Malaysian Companies Act,

and the rules and regulations of the SEC and Nasdaq, (ii) as a special resolution, the adoption and approval of an Amended and

Restated Memorandum and Articles of Association of Purchaser, including a change of the name of Purchaser to “BlueCrest

Investment, Inc.,” (iii) as an ordinary resolution, adoption and approval of a new equity incentive plan in substantially the

form attached as Exhibit D hereto (the “New Equity Incentive Plan”), which will provide for awards for up

to a number of Purchaser Ordinary Shares mutually acceptable to Purchaser and the Company, (iv) as an ordinary resolution, the

appointment of the members of the Post-Closing Board in accordance with Section 7.15 hereof, and (v) as an ordinary

resolution (or, if required by applicable Law or the Purchaser’s Governing Documents, as a special resolution), such other

matters as the Company and Purchaser shall hereafter mutually determine to be necessary or appropriate in order to effect the

transactions contemplated by this Agreement and in connection with the Business Combination and each other proposal that either the

SEC or Nasdaq (or the respective staff members thereof) indicates is necessary in its comments to the Registration Statement/Proxy

Statement or in correspondence related thereto (the approvals described in foregoing clauses (i) through (v), collectively, the

“Purchaser Shareholder Approval Matters”), and (vi) as an ordinary resolution, the adjournment of the

Extraordinary General Meeting, if necessary to permit further solicitation of proxies because there are not sufficient votes to

approve and adopt any of the foregoing. If on the date for which the Extraordinary General Meeting is scheduled, Purchaser has not

received proxies representing a sufficient number of shares to obtain the Required Purchaser Shareholder Approval, whether or not a

quorum is present, Purchaser may make one or more successive postponements or adjournments (as permitted by the Purchaser’s

Governing Documents) of the Extraordinary General Meeting. In connection with the Registration Statement, Purchaser will file with

the SEC financial and other information about the transactions contemplated by this Agreement in accordance with applicable Law and

applicable proxy solicitation and registration statement rules set forth in Purchaser’s Governing Documents, the Securities

Act, the BVI Companies Act and the rules and regulations of the SEC and Nasdaq. Purchaser shall cooperate and provide the Company

(and its counsel) with a reasonable opportunity to review and comment on the Registration Statement and any amendment or supplement

thereto prior to filing the same with the SEC, and Purchaser shall consider any such comments timely made in good faith. In

connection with Purchaser’s preparation of the Registration Statement, Proxy Statement and any other filings required to be

made by Purchaser with the SEC under the Securities Act, or any responses to any comments from the SEC related thereto, the Company

and Selling Shareholders shall provide, and shall use its best efforts to cause its Representatives including legal and accounting

representatives to provide, all cooperation reasonably requested by Purchaser that is customary in connection with the preparation

of any such filings or responses, including but not limited to, obtaining the consents of any auditor to the inclusion of the

financial statements of the Company or any of its Subsidiaries in the Registration Statement, Proxy Statement and other filings with

the SEC. The Company shall provide Purchaser with such information concerning the Company and its shareholders, officers, directors,

employees, assets, Liabilities, condition (financial or otherwise), business and operations that may be required or appropriate for

inclusion in the Registration Statement, Proxy Statement or in any amendments or supplements thereto, or any other filings with the

SEC. The Company shall ensure that all information provided by the Company, the Selling Shareholders and their respective

representatives to Purchaser for inclusion or incorporation by reference in the Registration Statement, Proxy Statement, or any

other filings with the SEC, shall be true and correct and not contain any untrue statement of a material fact or omit to state a

material fact required to be stated therein or necessary in order to make the statements made, in light of the circumstances under

which they were made, not misleading. Any filing fees related to the filing of the Registration Statement with the SEC as

contemplated by this Section ‎7.11(a) shall be borne by Purchaser.

48

(b)

Purchaser shall take any and all reasonable and necessary actions required to satisfy the requirements of the Securities Act, the Exchange

Act and other applicable Laws in connection with the Registration Statement, the Extraordinary General Meeting and the Redemption. Each

of Purchaser and the Company shall, and shall cause each of its Subsidiaries to, make their respective directors, officers and employees,

upon reasonable advance notice, available to the Company, Purchaser and, after the Closing, Purchaser Representative, and their respective

Representatives in connection with the drafting of the public filings with respect to the transactions contemplated by this Agreement,

including the Registration Statement, and responding in a timely manner to comments from the SEC. Each Party shall promptly correct any

information provided by it for use in the Registration Statement (and other related materials) if and to the extent that such information

is determined to have become false or misleading in any material respect or as otherwise required by applicable Laws. If at any time

prior to the Closing, any information relating to the Company or Purchaser, or any of their respective directors, officers or Affiliates,

is discovered by the Company or Purchaser that is required to be set forth in an amendment or supplement to the Proxy Statement so that

such document would not include any misstatement of a material fact or omit to state any material fact required to be stated therein

or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, the Party that

discovers such information shall promptly notify the other Party. Purchaser shall amend or supplement the Registration Statement and

cause the Registration Statement, as so amended or supplemented, to be filed with the SEC and to be disseminated to Purchaser shareholders,

in each case as and to the extent required by applicable Laws and subject to the terms and conditions of this Agreement and Purchaser’s

Governing Documents; provided, however, that Purchaser shall not amend or supplement the Registration Statement without prior consultation

with the Company as is reasonable under the circumstances.

(c)

Purchaser, with the assistance of the other Parties, shall promptly respond to any SEC comments on the Registration Statement and shall

otherwise use its commercially reasonable efforts to cause the Registration Statement to “clear” comments from the SEC and

become effective. Purchaser shall provide the Company with copies of any written comments, and shall inform the Company of any material

oral comments, that Purchaser or its Representatives receive from the SEC or its staff with respect to the Registration Statement, the

Extraordinary General Meeting and the Redemption promptly after the receipt of such comments and shall give the Company and its counsel

a reasonable opportunity under the circumstances to review and comment on any proposed written or material oral responses to such comments,

including, to the extent permitted by the SEC, participation by the Company or its counsel in any discussions or meetings with the SEC,

and Purchaser shall consider any such comments timely made in good faith under the circumstances.

(d)

As soon as practicable following the Registration Statement “clearing” comments from the SEC and becoming effective, Purchaser

shall distribute the Registration Statement to Purchaser’s shareholders and the Selling Shareholders, and, pursuant thereto, shall

call the Extraordinary General Meeting in accordance with the Securities Act for a date no later than sixty (60) days following the effectiveness

of the Registration Statement.

(e)

Purchaser shall comply with all applicable Laws, any applicable rules and regulations of Nasdaq, Purchaser’s Governing Documents

and this Agreement in the preparation, filing and distribution of the Registration Statement, any solicitation of proxies thereunder,

the calling and holding of the Extraordinary General Meeting and the Redemption. Purchaser shall apply for, and shall take commercially

reasonable actions to cause, Purchaser Ordinary Shares to be issued in connection with the transactions to be approved for listing on

Nasdaq as of the Closing.

49

7.12

Public Announcements.

(a)

The Parties agree that during the Interim Period no public release, filing or announcement concerning this Agreement or the Ancillary

Documents or the transactions contemplated hereby or thereby shall be issued by any Party or any of their Affiliates without the prior

written consent of Purchaser and the Company (which consent shall not be unreasonably withheld, conditioned or delayed). The Parties

acknowledge and affirm the confidentiality agreement dated June 22, 2026 between Purchaser and the Company (the “NDA”),

which remains in effect. Notwithstanding the foregoing, Purchaser and its Representatives may, on a confidential basis, share this Agreement

and Company information approved by the Company (such approval not to be unreasonably withheld, conditioned or delayed) with selected

existing public shareholders and potential co-investors who have been informed of the confidential nature of the information and agreed

to keep it confidential, in order to gauge support for the transactions contemplated hereby and the PIPE Investment, and the Company

shall reasonably cooperate with those efforts, including by making its Director and other senior management reasonably available for

discussions, presentations and meetings. The foregoing restrictions shall not apply to any release, filing or announcement required by

applicable Law or the rules or regulations of any securities exchange, in which case the applicable Party shall use commercially reasonable

efforts to allow the other Parties reasonable time to comment on, and arrange for any required filing with respect to, such release or

announcement in advance of its issuance.

(b)

The Parties shall mutually agree upon and, as promptly as practicable after the execution of this Agreement (but in any event within

four (4) Business Days thereafter), issue a press release announcing the execution of this Agreement (the “Signing Press Release”).

Promptly after the issuance of the Signing Press Release, Purchaser shall file a current report on Form 8-K (the “Signing Filing”)

with the Signing Press Release and a description of this Agreement as required by Federal Securities Laws, which the Company shall review,

comment upon and approve (which approval shall not be unreasonably withheld, conditioned or delayed) prior to filing (with the Company

reviewing, commenting upon and approving such Signing Filing in any event no later than the third (3rd) Business Day after

the execution of this Agreement); provided that Purchaser provides the Company with a reasonable amount of time to complete such review,

comment and approval prior to the third (3rd) Business Day after the date thereof. The Parties shall mutually agree upon and,

as promptly as practicable after the Closing (but in any event within four (4) Business Days thereafter), issue a press release announcing

the consummation of the transactions contemplated by this Agreement (the “Closing Press Release”). Promptly after

the issuance of the Closing Press Release, Purchaser shall file a current report on Form 8-K (the “Closing Filing”)

with the Closing Press Release and a description of the Closing as required by Federal Securities Laws which the Shareholder Representative

and Purchaser Representative shall review, comment upon and approve (which approval shall not be unreasonably withheld, conditioned or

delayed) prior to filing. In connection with the preparation of the Signing Press Release, the Signing Filing, the Closing Filing, the

Closing Press Release, or any other report, statement, filing notice or application made by or on behalf of a Party to any Governmental

Authority or other third party in connection with the transactions contemplated hereby, each Party shall, upon request by any other Party,

furnish the Parties with all information concerning themselves, their respective directors, officers and equity holders, and such other

matters as may be reasonably necessary or advisable in connection with the transactions contemplated hereby, or any other report, statement,

filing, notice or application made by or on behalf of a Party to any third party and/or any Governmental Authority in connection with

the transactions contemplated hereby.

7.13

Confidential Information.

(a)

The Company, the Selling Shareholders and the Shareholder Representative hereby agree that during the Interim Period and, in the event

that this Agreement is terminated in accordance with ‎Article X, for a period of two (2) years after such termination, they

shall, and shall cause their respective Representatives to: (i) treat and hold in strict confidence any Purchaser Confidential Information,

and will not use for any purpose (except in connection with the consummation of the transactions contemplated by this Agreement or the

Ancillary Documents, performing their obligations hereunder or thereunder, enforcing their rights hereunder or thereunder, or in furtherance

of their authorized duties on behalf of Purchaser or its Subsidiaries), nor directly or indirectly disclose, distribute, publish, disseminate

or otherwise make available to any third party any Purchaser Confidential Information without Purchaser’s prior written consent;

and (ii) in the event that the Company, any Selling Shareholder or the Shareholder Representative or any of their respective Representatives,

during the Interim Period or, in the event that this Agreement is terminated in accordance with ‎Article X, for a period of

two (2) years after such termination, becomes legally compelled to disclose any Purchaser Confidential Information, (A) provide Purchaser

to the extent legally permitted with prompt written notice of such requirement so that Purchaser or an Affiliate thereof may seek, at

Purchaser’s cost, a protective Order or other remedy or waive compliance with this Section 7.13(a), and (B) in the

event that such protective Order or other remedy is not obtained, or Purchaser waives compliance with this Section 7.13(a), furnish

only that portion of such Purchaser Confidential Information which is legally required to be provided as advised in writing by outside

counsel and to exercise its commercially reasonable efforts to obtain assurances that confidential treatment will be accorded such Purchaser

Confidential Information. In the event that this Agreement is terminated and the transactions contemplated hereby are not consummated,

the Company, each Selling Shareholder and the Shareholder Representative shall, and shall cause their respective Representatives to,

promptly deliver to Purchaser or destroy (at Purchaser’s election) any and all copies (in whatever form or medium) of Purchaser

Confidential Information and destroy all notes, memoranda, summaries, analyses, compilations and other writings related thereto or based

thereon; provided, however, that the Company and the Shareholder Representative and their respective Representatives shall be entitled

to keep any records required by applicable Law or bona fide record retention policies; and provided, further, that any Purchaser Confidential

Information that is not returned or destroyed shall remain subject to the confidentiality obligations set forth in this Agreement.

50

(b)

Purchaser hereby agrees that during the Interim Period and, in the event that this Agreement is terminated in accordance with ‎Article

X, for a period of two (2) years after such termination, it shall, and shall cause its Representatives to: (i) treat and hold in

strict confidence any Company Confidential Information, and will not use for any purpose (except in connection with the consummation

of the transactions contemplated by this Agreement or the Ancillary Documents, performing its obligations hereunder or thereunder or

enforcing its rights hereunder or thereunder), nor directly or indirectly disclose, distribute, publish, disseminate or otherwise make

available to any third party any of the Company Confidential Information without the Company’s prior written consent; and (ii)

in the event that Purchaser or any of its Representatives, during the Interim Period or, in the event that this Agreement is terminated

in accordance with ‎Article X for a period of two (2) years after such termination, becomes legally compelled to disclose

any Company Confidential Information, (A) provide the Company to the extent legally permitted with prompt written notice of such requirement

so that the Company may seek, at the Company’s sole expense, a protective Order or other remedy or waive compliance with this Section

‎7.13(b) and (B) in the event that such protective Order or other remedy is not obtained, or the Company waives compliance with

this Section 7.13(b), furnish only that portion of such Company Confidential Information which is legally required to be

provided as advised in writing by outside counsel and to exercise its commercially reasonable efforts to obtain assurances that confidential

treatment will be accorded such Company Confidential Information. In the event that this Agreement is terminated and the transactions

contemplated hereby are not consummated, Purchaser shall, and shall cause its Representatives to, promptly deliver to the Company or

destroy (at Purchaser’s election) any and all copies (in whatever form or medium) of Company Confidential Information and destroy

all notes, memoranda, summaries, analyses, compilations and other writings related thereto or based thereon; provided, however, that

Purchaser and its Representatives shall be entitled to keep any records required by applicable Law or bona fide record retention policies;

and provided, further, that any Company Confidential Information that is not returned or destroyed shall remain subject to the confidentiality

obligations set forth in this Agreement. Notwithstanding the foregoing, Purchaser and its Representatives shall be permitted to disclose

any and all Company Confidential Information to the extent required by all applicable Laws.

7.14

Documents and Information. After the Closing Date, Purchaser and the Company shall, and shall cause their respective Subsidiaries

to, until the seventh (7th) anniversary of the Closing Date, retain all books, records and other documents pertaining to the

business of the Company in existence on the Closing Date and make the same available for inspection and copying by Purchaser Representative

during normal business hours of the Company and its Subsidiaries, as applicable, upon reasonable request and upon reasonable notice.

No such books, records or documents shall be destroyed after the seventh (7th) anniversary of the Closing Date by Purchaser

or its Subsidiaries (including the Company) without first advising Purchaser Representative in writing and giving Purchaser Representative

a reasonable opportunity to obtain possession thereof.

51

7.15

Post-Closing Board of Directors and Executive Officers.

(a)

The Parties shall take all necessary action, including causing certain directors of Purchaser to resign, so that effective as of the

Closing, the Board of Directors of Purchaser, as the surviving public company, will consist of five (5) individuals (the “Post-Closing

Board”). Effective as of immediately prior to the Closing, the Parties shall take all necessary action to designate and appoint

to the Post-Closing Board: four (4) persons designated by Purchaser prior to the Closing, at least three (3) of whom shall be required

to qualify as independent directors under SEC and Nasdaq rules (the “Purchaser Designees”), and one (1) person designated

by the Company prior to the Closing (together with the Purchaser Designees, the “Post-Closing Directors”). At or prior

to the Closing, each Post-Closing Director shall sign an Indemnification Agreement, in form and substance reasonably acceptable to Purchaser,

the Company and each Post-Closing Director in substantially the form attached hereto as Exhibit E.

(b)

The Parties shall take all action necessary, including causing executive officers to resign as necessary, so that the individuals serving

as the executive officers of Purchaser immediately after the Closing will be the current management team of the Company immediately prior

to the Closing, unless the Company, in consultation with Purchaser, reasonably determines that another qualified person should serve

in a particular role; any such replacement shall be subject to Purchaser’s prior written approval, not to be unreasonably withheld,

conditioned or delayed.

7.16

Indemnification of Directors and Officers; Tail Insurance.

(a)

The Parties agree that all rights to exculpation, indemnification and advancement of expenses existing in favor of the current or

former directors and officers of Purchaser and each Person who served as a director, officer, member, trustee or fiduciary of

another corporation, partnership, joint venture, trust, pension or other employee benefit plan or enterprise at the request of

Purchaser (the “D&O Indemnified Persons”) as provided in their respective Governing Documents or under any

indemnification, employment or other similar agreements between any D&O Indemnified Person and Purchaser, in each case as in

effect on the Agreement Date, shall survive the Closing and continue in full force and effect in accordance with their respective

terms to the extent permitted by applicable Law. The provisions of this Section ‎7.16 shall survive the consummation of

the transactions contemplated by this Agreement and are intended to be for the benefit of, and shall be enforceable by, each of the

D&O Indemnified Persons and their respective heirs and representatives.

(b)

For the benefit of Purchaser’s and the Company’s directors and officers, Purchaser shall be permitted prior to the Closing

to obtain, and the Company shall fully pay the premium for, a “tail” insurance policy that provides coverage for up to a

six-year period from and after the Closing for events occurring prior to the Closing (the “D&O Tail Insurance”)

that is substantially equivalent to and in any event not less favorable in the aggregate than Purchaser’s existing policy or, if

substantially equivalent insurance coverage is unavailable, the best available coverage. If obtained, Purchaser shall maintain the D&O

Tail Insurance in full force and effect, and continue to honor the obligations thereunder, and the Company shall timely pay or caused

to be paid all premiums with respect to the D&O Tail Insurance.

7.17

Trust Account Proceeds. Immediately upon the Closing, the cash of Purchaser, as the post-Closing combined company, including the

funds remaining in the Trust Account after payments for the Redemption and any proceeds received from the PIPE Investment, shall first

be used to pay (i) Purchaser’s accrued but unpaid Expenses, including transaction expenses, deferred IPO fees, deferred advisor

fees and obligations owed to the Sponsor, and (ii) any other accrued and unpaid expenses and Liabilities of Purchaser properly payable

at the Closing. Any remaining cash shall be used for working capital and general corporate purposes of the post-Closing combined company.

For the avoidance of doubt, Transaction Expenses incurred by the Company (and not any Transaction Expenses incurred solely by a Selling

Shareholder) shall be funded by the post-Closing combined company without reducing the Transaction Consideration, except for unpaid transaction

bonuses and other transaction-related compensation expressly deducted under Section 2.1.

52

7.18

PIPE Investment. During the Interim Period, Purchaser and the Company shall reasonably cooperate to seek a PIPE Investment pursuant

to customary and binding Subscription Agreements with PIPE Investors agreed by Purchaser and the Company, and shall use their respective

commercially reasonable efforts to cause the PIPE Investment to close concurrently with the Closing. The terms of the PIPE Investment

shall be negotiated and agreed by Purchaser and the Company consistent with market terms, and Purchaser and the Company shall negotiate

and agree on the choice of placement agent, fees, approach and target investor universe. In no event shall any new promote or any additional

shares of Purchaser be issued to the Sponsor, upon conversion of existing founder shares or otherwise, attributable to the PIPE Investment.

Purchaser and the Company shall, and shall cause their respective Representatives to, cooperate with each other and their respective

Representatives in connection with the PIPE Investment, including having the Company’s senior management participate in investor

meetings and roadshows as reasonably requested by Purchaser, and use their respective commercially reasonable efforts to cause the PIPE

Investment to occur. Purchaser shall use its commercially reasonable best efforts to satisfy the conditions of the PIPE Investors’

closing obligations contained in the Subscription Agreements and consummate the transactions contemplated thereby. Each of Purchaser

and, as applicable, the Company, shall, and shall cause its Affiliates to, use commercially reasonable best efforts to avoid being in

breach or default under the Subscription Agreements. Purchaser may, but shall not be required to, enter into additional Subscription

Agreements with additional PIPE Investors, including in the event of an actual or threatened material breach or default by a PIPE Investor

or if Purchaser reasonably believes in good faith that such PIPE Investor is unwilling or unable to consummate its investment, and any

such additional Subscription Agreements shall become part of the PIPE Investment. If Purchaser elects to seek such additional Subscription

Agreements containing terms substantially different from the Subscription Agreements then in effect, the Company’s prior written

consent shall be required, not to be unreasonably withheld, delayed or conditioned. Purchaser and the Company shall deliver to each other

true, correct and complete copies of each Subscription Agreement and any other Contract with a PIPE Investor that could affect the obligation

of such PIPE Investor to contribute its applicable portion of the aggregate gross proceeds of the PIPE Investment. The Company shall

not enter into any Contract with a PIPE Investor during the Interim Period without the prior written consent of Purchaser, not to be

unreasonably withheld, delayed or conditioned.

7.19

Incentive Equity Plan. Prior to the Closing Date, Purchaser and the Company shall agree upon and Purchaser shall approve and adopt

the Incentive Equity Plan in substantially the form attached hereto as Exhibit D (with such changes as may be agreed by Purchaser

and the Company). The Company’s existing long-term employee equity compensation plan shall not be cashed out as part of the Acquisition,

and the Incentive Equity Plan shall absorb and reconstitute that plan. Within thirty (30) days after the Closing, Purchaser shall file

a registration statement on Form S-8 (or other applicable form) with respect to the Purchaser Class A Ordinary Shares issuable under

the Incentive Equity Plan, and Purchaser shall use reasonable efforts to maintain the effectiveness of such registration statement (and

maintain the current status of the prospectus contained therein) for so long as awards granted pursuant to the Incentive Equity Plan

remain outstanding.

7.20

Tax Matters.

(a)

The Selling Shareholders shall prepare or cause to be prepared at their own expense and the Company shall file or cause to be filed all

Tax Returns of the Company for all taxable periods ending on or prior to the Closing Date (“Pre-Closing Periods”)

that are filed after the Closing Date, other than any Tax Return due for the short tax period ending on the Closing Date (the “Final

Pre-Closing Period”). The Shareholder Representative shall provide Purchaser with a copy of the Tax Returns prepared under

this Section 7.20(a) at least twenty (20) days prior to the filing of such Tax Returns, and the Selling Shareholders will

incorporate any reasonable comments made by Purchaser within such 20-day period; provided, that nothing herein shall require the

Company to file any Tax Return that, in the opinion of Purchaser’s tax advisors, is not complete and accurate; provided, further,

that the Selling Shareholders shall not take any position or apply any methodology in preparing any such Tax Return that is not consistent

with the Tax practices and methodologies consistently applied in the ordinary course of business by the Company and its Subsidiaries

in the preparation of its Tax Returns relating to prior taxable periods (such as, for example and without limitation, practices with

respect to the calculation of depreciation expense deductions), provided that such practices and methodologies comply with applicable

Law. Except as required by Law, without the prior written consent of the Shareholder Representative (which consent shall not be unreasonably

withheld, conditioned or delayed), neither the Company, any of its Subsidiaries, Purchaser nor any Affiliate of the Company, the Subsidiaries

or Purchaser shall file any amended Tax Return with respect to any such period. To the extent permitted by applicable Law, neither the

Company nor its Subsidiaries shall carry back any Tax attribute to any such period. Purchaser shall have the right to handle, defend,

conduct and control any Tax Claim relating to any Tax refund arising by operation of the preceding sentence; provided, that Purchaser

shall consult periodically with the Shareholder Representative as to strategic and tactical issues for pursuing any Tax Claim and shall

consider in good faith any suggestions made by the Shareholder Representative about the conduct of such Tax Claim. Purchaser shall not

have the right to compromise or settle any such Tax Claim relating to a refund without the prior consent of the Shareholder Representative,

which consent shall not be unreasonably withheld, conditioned or delayed.

53

(b)

Purchaser shall prepare (or cause to be prepared) and file (or cause to be filed) when due (taking into account all extensions properly

obtained) all Tax Returns required to be filed by or with respect to the Company and its Subsidiaries relating to: (i) the Final Pre-Closing

Period; and (ii) taxable periods that begin before and end after the Closing Date (“Straddle Periods”). Purchaser

shall deliver to the Shareholder Representative copies of each such Tax Return relating to the Final Pre-Closing Period and Straddle

Periods, along with a statement (a “Tax Statement”) showing the pre-Closing portion of any Liability in respect of

any Taxes required to be paid with such Tax Return (computed in accordance with Section 7.20(d)), at least twenty (20) days

prior to the due date for filing such Tax Return, and shall permit the Shareholder Representative to review and comment on such Tax Return

and Tax Statement prior to filing. Purchaser shall not file any such Tax Return relating to the Final Pre-Closing Period and Straddle

Periods without the prior written consent of the Shareholder Representative (which shall not be unreasonably withheld, conditioned or

delayed); provided that the failure of the Shareholder Representative to deliver written consent to Purchaser prior to the due

date for filing such Tax Return shall be deemed to constitute consent. If the parties have not resolved any dispute relating to any such

Tax Return prior to the due date for filing such Tax Return, then Purchaser shall file such Tax Return as prepared, but such filing shall

not prejudice the rights of any party to pursue such dispute.

(c)

Not later than two (2) days prior to the due date for the payment of Taxes on any Tax Returns relating to Pre-Closing Periods or Straddle

Periods, the Shareholder Representative for and on behalf of the Selling Shareholders shall pay to Purchaser the amount of cash Taxes

payable shown on the Tax Return (in the case of a Pre-Closing Period other than the Final Pre-Closing Period) or the Tax Statement (in

the case of the Final Pre-Closing Period and a Straddle Period).

(d)

The Company and each Subsidiary will, unless prohibited by applicable Law, close the taxable year of the Company and each Subsidiary

as of the close of business on the Closing Date. If applicable Law does not permit the Company or any Subsidiary to close its taxable

year on the Closing Date, the Taxes, if any, attributable to such Straddle Period shall be allocated: (i) to the Selling Shareholders

for the period up to and including the close of business on the Closing Date; and (ii) to Purchaser for the period subsequent to the

Closing Date, pursuant to the following methodology: (x) Taxes, other than those referred to in clause (y) below, shall be allocated

by means of a closing of the books and records of the Company and its Subsidiaries as of the close of the Closing Date, provided

that exemptions, allowances or deductions that are calculated on an annual basis (including, but not limited to, depreciation and amortization

deductions) shall be allocated between the period ending on the Closing Date and the period after the Closing Date in proportion to the

number of days in each such period, and (y) property Taxes and ad valorem Taxes shall be allocated between the period ending on the Closing

Date and the period after the Closing Date in proportion to the number of days in each such period. For the avoidance of doubt, all management

bonuses, severance payments, interest payments and deductible financing costs and expenses accrued or paid by the Company or its Subsidiaries

on or prior to the Closing Date, including, without limitation, the Transaction Expenses, shall be treated as incurred in a Pre-Closing

Period or the pre-Closing portion of the Straddle Period, as appropriate.

54

(e)

Notwithstanding any other provisions hereof, if an audit or other proceeding is commenced, an adjustment is proposed or any other claim

is made by any taxing authority with respect to a Tax liability of the Company or any Subsidiary relating to a Pre-Closing Period, the

Final Pre-Closing Period or the pre-Closing portion of any Straddle Period (a “Tax Claim”), Purchaser shall promptly

notify the Shareholder Representative of such audit or other proceeding, proposed adjustment or claim. Purchaser shall have the right

to handle, defend, conduct and control any such Tax Claim; provided, that Purchaser shall consult periodically with the Shareholder

Representative as to strategic and tactical issues for pursuing any Tax Claim and shall consider in good faith any suggestions made by

the Shareholder Representative about the conduct of such audit or contest. Purchaser shall not have the right to compromise or settle

any such Tax Claim which would result in an increased Tax liability or a decreased refund to the Shareholder Representative without the

prior consent of the Shareholder Representative, which consent shall not be unreasonably withheld, conditioned or delayed.

(f)

Any refunds (and any interest received thereon) of any Tax imposed on the Company or any Subsidiary for any Pre-Closing Period, the Final

Pre-Closing Period or the pre-Closing portion of any Straddle Period (determined in accordance with Section ‎7.20(d)) shall

be payable to the Selling Shareholders.

(g)

Following the Closing, Purchaser and the Shareholder Representative shall provide each other with such assistance as may reasonably be

requested by any of them in connection with the preparation of any Tax Return, any audit or other examination by any taxing authority,

or any judicial or administrative proceedings relating to Liability for Taxes of the Company and its Subsidiaries. The party requesting

assistance hereunder shall reimburse the other for reasonable out-of-pocket expenses incurred in providing such assistance. Purchaser

and the Shareholder Representative shall preserve and cause to be preserved all information, returns, books, records and documents relating

to any Liabilities for Taxes of the Company and its Subsidiaries with respect to a taxable period until the later of sixty (60) days

after the expiration of all applicable statutes of limitations and extensions thereof; or the conclusion of all litigation with respect

to Taxes for such period.

7.21

Related Party Matters. At or prior to the Closing, any and all assets, Intellectual Property, Contracts and benefits accruing

to the Company that are either held or licensed by any Affiliates of the Company and are used or to be used in the business of the Company

shall be transferred to the Company to the satisfaction of Purchaser. The Company shall not have, and shall not enter into, any related-party

transaction that is not bona fide, on arm’s-length terms, necessary for the Company’s business and approved in writing by

Purchaser before it is entered into. The Company shall provide Purchaser with complete copies of all agreements and other documentation

relating to such transactions.

Article

VIII

NO

SURVIVAL

8.1

No Survival. Representations and warranties of the Company, Purchaser and the Selling Shareholders contained in this Agreement

or in any certificate or instrument delivered by or on behalf of the Company, Purchaser or the Selling Shareholders pursuant to this

Agreement shall not survive the Closing, and from and after the Closing, the Company, Purchaser, and the Selling Shareholders and their

respective Representatives shall not have any further obligations, nor shall any claim be asserted or action be brought against the Company,

Purchaser or the Selling Shareholders or their respective Representatives with respect thereto. The covenants and agreements made by

the Company and Purchaser in this Agreement or in any certificate or instrument delivered pursuant to this Agreement, including any rights

arising out of any breach of such covenants or agreements, shall not survive the Closing, except for those covenants and agreements contained

herein and therein that by their terms apply or are to be performed in whole or in part after the Closing (which such covenants shall

survive the Closing and continue until fully performed in accordance with their terms).

55

Article

IX

CONDITIONS

TO CLOSING

9.1

Conditions to Each Party’s Obligations. The obligations of each Party to consummate the transactions contemplated by this

Agreement shall be subject to the satisfaction or written waiver (where permissible) by the Company, Selling Shareholders and Purchaser,

as applicable, of the following conditions:

(a)

Required Purchaser Shareholder Approval. Purchaser Shareholder Approval Matters that are submitted to the vote of the shareholders

of Purchaser at the Extraordinary General Meeting in accordance with the Proxy Statement shall have been approved by the requisite vote

of the shareholders of Purchaser at the Extraordinary General Meeting in accordance with Purchaser’s Governing Documents, applicable

Law and the Proxy Statement (the “Required Purchaser Shareholder Approval”).

(b)

Antitrust Laws. Any waiting period (and any extension thereof) applicable to the consummation of this Agreement under any Antitrust

Laws shall have expired or been terminated.

(c)

Requisite Regulatory Approvals. All Consents required to be obtained from or made with any Governmental Authority in order to

consummate the transactions contemplated by this Agreement shall have been obtained or made.

(d)

Requisite Consents. The Consents required to be obtained from or made with any third Person (other than a Governmental Authority)

in order to consummate the transactions contemplated by this Agreement that are set forth in Schedule ‎9.1(d) shall have each

been obtained or made.

(e)

No Adverse Law or Order. No Governmental Authority shall have enacted, issued, promulgated, enforced or entered any Law (whether

temporary, preliminary or permanent) or Order that is then in effect and which has the effect of making the transactions or agreements

contemplated by this Agreement illegal or which otherwise prevents or prohibits consummation of the transactions contemplated by this

Agreement.

(f)

Net Tangible Assets Test. Upon the Closing, after giving effect to the Redemption and any PIPE Investment, Purchaser shall

have net tangible assets of at least $5,000,001.

(g)

Appointment of Directors and Officers. The post-Closing directors and officers of Purchaser, as the surviving public company,

identified on Schedule ‎9.1(g) shall have been duly elected or appointed effective as of the Closing, consistent with the

requirements of Purchaser’s Governing Documents, each to hold office in accordance until their respective successors are duly elected

or appointed and qualified or their earlier death, resignation or removal, and each such director and officer shall have entered into

an Indemnification Agreement.

(h)

Registration Statement. The Registration Statement shall have been declared effective by the SEC and shall remain effective

as of the Closing, and no stop order or similar order shall be in effect with respect to the Registration Statement.

(i)

Nasdaq Listing. The Purchaser Class A Ordinary Shares issued as Consideration Shares shall have been approved for listing on Nasdaq,

subject to official notice of issuance.

9.2 Conditions

to Obligations of Purchaser. In addition to the conditions specified in Section ‎9.1, the obligations of

Purchaser to consummate the other transactions contemplated by this Agreement are subject to the satisfaction or written waiver (by

Purchaser) of the following conditions:

(a)

Representations and Warranties. All of the representations and warranties of the Company and the Selling Shareholders set forth

in this Agreement and in any certificate delivered by or on behalf of the Company or the Selling Shareholders pursuant hereto shall be

true and correct on and as of the Agreement Date and on and as of the Closing Date as if made on the Closing Date, except for (i) those

representations and warranties that address matters only as of a particular date (which representations and warranties shall have been

accurate as of such date), and (ii) any failures to be true and correct that (without giving effect to any qualifications or limitations

as to materiality or Material Adverse Effect), individually or in the aggregate, have not had and would not reasonably be expected to

have a Material Adverse Effect on, or with respect to, the Company or the Selling Shareholders, as the case may be.

56

(b)

Agreements and Covenants. The Company and the Selling Shareholders shall have performed in all material respects all of their

respective obligations and complied in all material respects with all of their respective agreements and covenants under this Agreement

to be performed or complied with thereby on or prior to the Closing Date.

(c)

No Material Adverse Effect. No Material Adverse Effect shall have occurred with respect to the Company or any Selling Shareholder

since the Agreement Date which is continuing and uncured.

(d)

Certain Ancillary Documents. Each Executive Employment Agreement, Restrictive Covenant Agreement, Lock-Up Agreement, Indemnification

Agreement and Registration Rights Agreement required to be executed at or before the Closing shall be in full force and effect in accordance

with its terms, effective as of the Closing.

(e)

Closing Deliveries.

(i)

Officer Certificate. Purchaser shall have received a certificate from the Company, dated as the Closing Date, signed by the chief

executive officer of the Company in such capacity, certifying as to the satisfaction of the conditions specified in Sections ‎9.2(a),

‎9.2(b) and ‎9.2(c).

(ii) Secretary

Certificate. The Company shall have delivered to Purchaser a certificate executed by the Company’s Secretary certifying as

to the validity and effectiveness of, and attaching (A) copies of the Company’s Governing Documents as in effect as of the

Closing, (B) the requisite resolutions of the Company’s board of directors and shareholders authorizing and approving the

execution, delivery and performance of this Agreement and each Ancillary Document to which the Company is or is required to be a

party or bound and the consummation of the transactions contemplated hereby and thereby, the adoption by the Company of the Company

Amended Charter in a form acceptable to Purchaser, and the election of Company officers and directors listed on Schedule

9.1(e) and (C) the incumbency of officers of the Company authorized to execute this Agreement or any Ancillary Document to which

the Company is or is required to be a party or otherwise bound.

(iii)

Good Standing. The Company shall have delivered to Purchaser good standing certificates (or similar documents applicable for such

jurisdictions) for the Company certified as of a date no earlier than twenty (20) days prior to the Closing Date from the proper Governmental

Authority of the Company’s jurisdiction of organization and from each other jurisdiction in which the Company is qualified to do

business as a foreign corporation or other entity as of the Closing, in each case to the extent that good standing certificates or similar

documents are generally available in such jurisdictions.

(iv)

Certified Company Amended Charter. The Company shall have filed the Company Amended Charter, and shall have delivered to Purchaser

a copy thereof, in effect as of immediately prior to the Closing, certified by the proper Governmental Authority.

(v)

Registration Rights Agreement. The Registration Rights Agreement, providing customary demand and piggyback registration rights

subject to customary exceptions and limitations, shall have been duly executed and delivered by the Parties thereto in form and substance

reasonably satisfactory to Purchaser.

57

(vi)

Executive Employment Agreements. Purchaser shall have received Executive Employment Agreements duly executed by each applicable

Key Executive, in each case effective as of the Closing, in form and substance reasonably satisfactory to Purchaser, including customary

confidentiality, non-competition, non-solicitation and assignment of inventions provisions.

(vii)

Indemnification Agreements. The Company shall have delivered to Purchaser copies of Indemnification Agreements duly executed by

each officer and director of the Company.

(viii)

Share Certificates and Transmittal Documents. Each Selling Shareholder shall have delivered to Purchaser Company Certificate(s)

representing all Company Shares held by such Selling Shareholder, duly endorsed in blank or accompanied by share transfer powers, if

certificated, and/or such other transmittal documents required for transfer on the books of the Company and acceptable to Purchaser.

(ix)

Convertible Securities. Purchaser shall have received evidence reasonably acceptable to Purchaser that the Company shall have

terminated, extinguished and cancelled in full any outstanding Company Convertible Securities.

(x)

PCAOB and U.S. GAAP Financial Statements. Purchaser shall have received the PCAOB-audited annual Company Financials and any other

financial statements, auditor consents and related deliverables required for the Registration Statement and Proxy Statement, each prepared

in accordance with U.S. GAAP and applicable SEC requirements, in form and substance reasonably satisfactory to Purchaser and its counsel.

(xi)

Resignations. Purchaser shall have received written resignations, effective as of the Closing, of each of the directors

and officers of the Company listed on Schedule ‎9.2(e)(xi) prior to the Closing.

(xii)

Restrictive Covenant Agreement. Purchaser shall have received Restrictive Covenant Agreements duly executed by the significant

shareholders of the Company listed on Schedule ‎9.2(e)(xii), in each case effective as of the Closing.

(xiii)

Lock-Up Agreement. The Company shall have delivered to Purchaser copies of Lock-Up Agreements duly executed by each officer and

director of the Company and each holder of five percent (5%) or more of the Company’s voting stock listed on Schedule ‎9.2(e)(xiii),

in each case effective as of the Closing.

9.3

Conditions to Obligations of the Company. In addition to the conditions specified in Section 9.1, the obligations of the

Company to consummate the transactions contemplated by this Agreement are subject to the satisfaction or written waiver (by the Company)

of the following conditions:

(a)

Representations and Warranties. All of the representations and warranties of Purchaser set forth in this Agreement and in any

certificate delivered by or on behalf of Purchaser pursuant hereto shall be true and correct on and as of the date of this Agreement

and on and as of the Closing Date as if made on the Closing Date, except for (i) those representations and warranties that address matters

only as of a particular date (which representations and warranties shall have been accurate as of such date), and (ii) any failures to

be true and correct that (without giving effect to any qualifications or limitations as to materiality or Material Adverse Effect), individually

or in the aggregate, have not had and would not reasonably be expected to have a Material Adverse Effect on, or with respect to, Purchaser.

58

(b)

Agreements and Covenants. The Purchaser shall have performed in all material respects all of Purchaser’s obligations and

complied in all material respects with all of Purchaser’s agreements and covenants under this Agreement to be performed or complied

with by it on or prior to the Closing Date.

(c)

No Purchaser Material Adverse Effect. No Material Adverse Effect shall have occurred with respect to Purchaser since the date

of this Agreement which is continuing and uncured.

(d)

Closing Deliveries.

(i)

Officer Certificate. The Purchaser shall have delivered to the Company a certificate, dated as of the Closing Date, signed by

an executive officer of Purchaser in such capacity, certifying as to the satisfaction of the conditions specified in Sections ‎9.3(a),

‎9.3(b) and ‎9.3(c).

(ii)

Secretary Certificate. The Purchaser shall have delivered to the Company a certificate from its secretary or other executive officer

certifying as to, and attaching, (A) copies of Purchaser’s Governing Documents as in effect as of the Closing Date (after giving

effect to the transactions contemplated hereby), (B) the resolutions of Purchaser’s board of directors authorizing and approving

the execution, delivery and performance of this Agreement and each of the Ancillary Documents to which it is a party or by which it is

bound, and the consummation of the transactions contemplated hereby and thereby, (C) evidence that the Required Purchaser Shareholder

Approval has been obtained and (D) the incumbency of officers authorized to execute this Agreement or any Ancillary Document to which

Purchaser is or is required to be a party or otherwise bound.

(iii)

Good Standing. The Purchaser shall have delivered to the Company a good standing certificate (or similar documents applicable

for such jurisdictions) for Purchaser certified as of a date no earlier than thirty (30) days prior to the Closing Date from the proper

Governmental Authority of Purchaser’s jurisdiction of organization and from each other jurisdiction in which Purchaser is qualified

to do business as a foreign entity as of the Closing, in each case to the extent that good standing certificates or similar documents

are generally available in such jurisdictions.

(iv)

Registration Rights Agreement. The Registration Rights Agreement, providing customary demand and piggyback registration rights

subject to customary exceptions and limitations, shall have been duly executed and delivered by the Parties thereto in form and substance

reasonably satisfactory to the Company and Purchaser.

9.4

Frustration of Closing Conditions. A Party may not rely on the failure of any condition set forth in Sections ‎9.1

to ‎9.3, as the case may be, if such failure was caused by such Party’s failure to comply in any material way

with any material provision of this Agreement.

Article

X

TERMINATION

AND EXPENSES

10.1

Termination of Agreement. This Agreement may be terminated prior to the Closing as follows:

(a)

by mutual written consent of the Company and Purchaser;

(b)

by written notice by the Company or Purchaser if any of the conditions to the Closing set forth in ‎Article IX have not been

satisfied or waived by January 31, 2027 (the “Expiration Date”) (provided, that if Purchaser seeks and obtains one

or more Extensions, Purchaser shall have the right with respect to each extension, by providing written notice thereof to the Company

and the Shareholder Representative, to extend the Expiration Date for an additional period equal to the shortest of (i) three (3) additional

months, (ii) the period ending on the last date for Purchaser to consummate its Business Combination as described in the IPO Prospectus

pursuant to such Extension and (iii) such period as determined by Purchaser); provided, however, the right to terminate this Agreement

under this Section 10.1(b) shall not be available to a Party if the breach or violation by such Party or its Affiliates of

any representation, warranty, covenant or obligation under this Agreement was the cause of, or resulted in, the failure of the Closing

to occur on or before the Expiration Date;

59

(c)

the Company may terminate this Agreement by giving written notice to Purchaser at any time prior to the Closing if: (i) Purchaser

has materially breached any covenant, representation or warranty in any material respect contained in this Agreement, or if any

representation or warranty of Purchaser shall have become untrue or inaccurate, in any case, which would result in the failure of a

condition set forth in Section 9.3(a) or Section 9.3(b) to be satisfied (treating the Closing Date for such

purposes as the Agreement Date or, if later, the date of such breach), and (ii) such breach is not curable or, if curable, has not

been cured within the earlier of (A) thirty (30) days after written notice of such breach or inaccuracy is provided to Purchaser or

(B) the Expiration Date; provided that the Company shall not have the right to terminate this Agreement pursuant to this Section

10.1(c) if either the Company or any Selling Shareholder is in material breach of any covenant, representation or warranty

contained in this Agreement on the date of such written notice;

(d)

Purchaser may terminate this Agreement by giving written notice to the Company at any time prior to the Closing if: (i) the Company or

any Selling Shareholder has materially breached any covenant, representation or warranty in any material respect contained in this Agreement,

or if any representation or warranty of such Parties shall have become untrue or inaccurate, in any case, which would result in the failure

of a condition set forth in Sections 9.2(a) or ‎9.2(b) to be satisfied (treating the Closing Date for such purposes

as the Agreement Date or, if later, the date of such breach), and (ii) such breach is not curable or, if curable, such breach has not

been cured within the earlier of (A) thirty (30) days after written notice of such breach or inaccuracy is provided to the Company or

(B) the Expiration Date (so long as Purchaser is not then in material breach of any covenant, representation or warranty contained in

this Agreement); or

(e)

by the Company or Purchaser if there shall be in effect a final non-appealable Order of a Governmental Authority of competent jurisdiction

permanently restraining, enjoining or otherwise prohibiting the consummation of the transactions contemplated hereby; it being agreed

that the parties hereto shall use commercially reasonable efforts to appeal any adverse determination which is not non-appealable (and

pursue such appeal with reasonable diligence); provided, however, that the right to terminate this Agreement under this

Section 10.1(e) will not be available to any Party whose failure to fulfill any material covenant or agreement under this Agreement

has been the cause of or resulted in the action or event described in this Section ‎10.1(e) occurring;

(f)

by written notice by Purchaser to the Company and the Shareholder Representative if there shall have been a Material Adverse Effect on

the Company following the Agreement Date which is uncured for at least twenty (20) days after written notice of such Material Adverse

Effect is provided by Purchaser to the Company; or

(g)

by written notice by Purchaser to the Company and the Shareholder Representative, if the Extraordinary General Meeting is held (including

any adjournment or postponement thereof) and has concluded, Purchaser’s shareholders have duly voted, and the Required Purchaser

Shareholder Approval was not obtained.

10.2

Effect of Termination. This Agreement may only be terminated in the circumstances described in Section 10.1 and pursuant

to a written notice delivered by the applicable Party to the other applicable Parties, which sets forth the basis for such termination,

including the provision of Section 10.1 under which such termination is made. In the event of the valid termination of this Agreement

pursuant to Section 10.1, this Agreement shall forthwith become void, and there shall be no Liability on the part of any Party

or any of their respective Representatives, and all rights and obligations of each Party shall cease, except: (i) Sections 7.12,

‎7.13, ‎10.3, ‎11.1, ‎Article XIV and this Section

10.2 shall survive the termination of this Agreement, and (ii) nothing herein shall relieve any Party from Liability for any willful

breach of any representation, warranty, covenant or obligation under this Agreement or any Fraud Claim against such Party, in either

case, prior to termination of this Agreement (in each case of clauses (i) and (ii) above, subject to Section ‎11.1).

Without limiting the foregoing, and except as provided in Section 10.3 and this Section ‎10.2 (but subject to Section

11.1) and subject to the right to seek injunctions, specific performance or other equitable relief in accordance with Section

12.7, the Parties’ sole right prior to the Closing with respect to any breach of any representation, warranty, covenant or

other agreement contained in this Agreement by another Party or with respect to the transactions contemplated by this Agreement shall

be the right, if applicable, to terminate this Agreement pursuant to Section ‎10.1.

60

10.3

Fees and Expenses. Subject to Sections ‎7.3, ‎11.1, ‎Article VII

and ‎Article XIV, all Expenses incurred in connection with this Agreement and the transactions contemplated

hereby shall be paid by the Party incurring such Expenses; provided, however, that if the Closing occurs, all Transaction Expenses incurred

by the Company (and not any Transaction Expenses incurred solely by a Selling Shareholder) shall be funded by the post-Closing combined

company without reducing the Transaction Consideration, except for unpaid transaction bonuses and other transaction-related compensation

expressly deducted under Section 2.1, and any filing fees or similar fees relating to regulatory or governmental approvals shall

be borne by Purchaser. As used in this Agreement, “Expenses” shall include all out-of-pocket expenses (including all

fees and expenses of counsel, accountants, investment bankers, financial advisors, financing sources, experts and consultants to a Party

hereto or any of its Affiliates) incurred by a Party or on its behalf in connection with or related to the authorization, preparation,

negotiation, execution or performance of this Agreement or any Ancillary Document related hereto and all other matters related to the

consummation of this Agreement. With respect to Purchaser, Expenses shall include any and all expenses, filing fees, costs and deferred

expenses (including fees or commissions payable to the underwriters and any legal fees) of the IPO, upon consummation of a Business Combination

and any Extension Expenses.

Article

XI

WAIVERS

AND RELEASES

11.1

Waiver of Claims Against Trust. Reference is made to the IPO Prospectus. The Company, each Selling Shareholder and the Shareholder

Representative each represents and warrants that it has read the IPO Prospectus and understands that Purchaser has established the Trust

Account containing the proceeds of the IPO and the overallotment shares acquired by Purchaser’s underwriters and from certain private

placements occurring simultaneously with the IPO (including interest accrued from time to time thereon) for the benefit of Purchaser’s

public shareholders (including overallotment shares acquired by Purchaser’s underwriters) (the “Public Shareholders”)

and that, except as otherwise described in the IPO Prospectus, Purchaser may disburse monies from the Trust Account only: (a) to the

Public Shareholders in the event they elect to redeem their Purchaser Ordinary Shares in connection with the consummation of its Business

Combination or in connection with an amendment to Purchaser’s Governing Documents to extend Purchaser’s deadline to consummate

a Business Combination, (b) to the Public Shareholders if Purchaser fails to consummate a Business Combination within twelve (12) months

after the closing of the IPO, subject to extension, (c) with respect to any interest earned on the amounts held in the Trust Account,

amounts necessary to pay for any taxes, and (d) to Purchaser after or concurrently with the consummation of a Business Combination. For

and in consideration of Purchaser entering into this Agreement and for other good and valuable consideration, the receipt and sufficiency

of which is hereby acknowledged, the Company, each Selling Shareholder and the Shareholder Representative, on behalf of itself and its

Affiliates, hereby agree that, notwithstanding anything to the contrary in this Agreement, none of the Company, any Selling Shareholder

or the Shareholder Representative, nor any of their respective Affiliates, has or shall at any time hereafter have any right, title,

interest or claim of any kind in or to any monies in the Trust Account or distributions therefrom, or make any claim against the Trust

Account (including any distributions therefrom), regardless of whether such claim arises as a result of, in connection with or relating

in any way to, this Agreement or any proposed or actual business relationship between Purchaser or any of its Representatives, on the

one hand, and the Company, any Selling Shareholder, the Shareholder Representative or any of their respective Representatives, on the

other hand, or any other matter, and regardless of whether such claim arises based on contract, tort, equity or any other theory of legal

liability (collectively, the “Released Claims”). The Company, each Selling Shareholder and the Shareholder Representative,

on behalf of itself and its Affiliates, hereby irrevocably waive any Released Claims that any such Party or any of its Affiliates may

have against the Trust Account (including any distributions therefrom) now or in the future as a result of, or arising out of, any negotiations,

contracts or agreements with Purchaser or its Representatives and will not seek recourse against the Trust Account (including any distributions

therefrom) for any reason whatsoever (including for an alleged breach of this Agreement or any other agreement with Purchaser or its

Affiliates). The Company, each Selling Shareholder and the Shareholder Representative each agrees and acknowledges that such irrevocable

waiver is material to this Agreement and specifically relied upon by Purchaser and its Affiliates to induce Purchaser to enter into this

Agreement, and each such Party further intends and understands such waiver to be valid, binding and enforceable against such Party and

each of its Affiliates under applicable Law. To the extent that the Company, any Selling Shareholder or the Shareholder Representative

or any of their respective Affiliates commences any Action based upon, in connection with, relating to or arising out of any matter relating

to Purchaser or its Representatives, which proceeding seeks, in whole or in part, monetary relief against Purchaser or its Representatives,

each such Party hereby acknowledges and agrees that its and its Affiliates’ sole remedy shall be against funds held outside of

the Trust Account and that such claim shall not permit such Party or any of its Affiliates (or any Person claiming on its behalf or in

lieu of it) to have any claim against the Trust Account (including any distributions therefrom) or any amounts contained therein. If

the Company, any Selling Shareholder or the Shareholder Representative or any of their respective Affiliates commences any Action based

upon, in connection with, relating to or arising out of any matter relating to Purchaser or its Representatives that seeks, in whole

or in part, relief against the Trust Account (including any distributions therefrom) or the Public Shareholders, whether in the form

of money damages or injunctive relief, Purchaser and its Representatives, as applicable, shall be entitled to recover from the Company,

each Selling Shareholder, the Shareholder Representative and their respective Affiliates, as applicable, the associated legal fees and

costs in connection with any such Action, in the event Purchaser or its Representatives, as applicable, prevails in such Action. This

Section ‎11.1 shall survive termination of this Agreement for any reason and continue indefinitely.

61

Article

XII

MISCELLANEOUS

12.1

Notices. All notices, consents, waivers and other communications hereunder shall be in writing and shall be deemed to have been

duly given when delivered (i) in person, (ii) by facsimile or other electronic means (including e-mail), with affirmative confirmation

of receipt, (iii) one Business Day after being sent, if sent by reputable, nationally recognized overnight courier service or (iv) three

(3) Business Days after being mailed, if sent by registered or certified mail, pre-paid and return receipt requested, in each case to

the applicable Party at the following addresses (or at such other address for a Party as shall be specified by like notice):

If

to Purchaser, to:

ARC

Group Acquisition I Corp.

398

S Mill Avenue,

Suite

306,

Tempe,

AZ 85284

Attn:

Datuk Dr. Doris Wong

Telephone

No.:

E-mail:

with

a copy (which will not constitute notice) to:

Rimon,

P.C.

1050

Connecticut Avenue, NW, Suite 500

Washington,

DC 20036

Attn:

Debbie A. Klis Esq.

Mark

C Lee, Esq.

Telephone

No.: (202) 935-3390

Email:

deborrah.klis@rimonlaw.com

mark.c.lee@rimonlaw.com

If

to Purchaser Representative, to:

Datuk

Dr. Doris Wong c/o ARC Group Acquisition I Corp.

398

S Mill Avenue,

Suite

306,

Tempe,

AZ 85284

Telephone

No.:

E-mail:

with

a copy (which will not constitute notice) to:

Rimon,

P.C.

1050

Connecticut Avenue, NW, Suite 500

Washington,

DC 20036

Attn:

Debbie A. Klis Esq.

Mark

C Lee, Esq.

Telephone

No.: (202) 935-3390

Email:

deborrah.klis@rimonlaw.com

mark.c.lee@rimonlaw.com

If

to the Company, to:

Firstborn

Top Capital Sdn. Bhd.

13A-3A,

Q Sentral, 2A

Jalan

Stesen Sentral 2

KL

Sentral, Kuala Lumpur

Wilayah

Persekutuan 50470

Malaysia

Attn:

Ow Ruey Shen

Telephone

No.:

E-mail:

with

a copy (which will not constitute notice) to:

Rohamat

& Ling

Unit

1009, 10th Floor, Menara PJ,

Amcorp

Trade Centre,

No.

18 Jalan Persiaran Barat,

46050

Petaling Jaya, Selangor.

Attn:

Mark Wong Kah Kit

Telephone

No.: 03-7932 5115

E-mail:

mark@r-ling.com

If

to the Selling Shareholders or the Shareholder Representative, at the respective address specified in Exhibit A-1.

With

a copy (which will not constitute notice) to:

Rohamat

& Ling

Unit

1009, 10th Floor, Menara PJ,

Amcorp

Trade Centre,

No.

18 Jalan Persiaran Barat,

46050

Petaling Jaya, Selangor.

Attn:

Mark Wong Kah Kit

Telephone

No.: 03-7932 5115

E-mail:

mark@r-ling.com

62

12.2

Binding Effect; Assignment. This Agreement and all of the provisions hereof shall be binding upon and inure to the benefit of

the Parties hereto and their respective successors and permitted assigns. This Agreement shall not be assigned by operation of Law or

otherwise without the prior written consent of Purchaser and the Company (and after the Closing, Purchaser Representative and the Shareholder

Representative), and any assignment without such consent shall be null and void; provided that no such assignment shall relieve

the assigning Party of its obligations hereunder.

12.3

Third Parties. Except for the rights of the D&O Indemnified Persons set forth in Section ‎7.16, which the

Parties acknowledge and agree are express third party beneficiaries of this Agreement, nothing contained in this Agreement or in any

instrument or document executed by any party in connection with the transactions contemplated hereby shall create any rights in, or be

deemed to have been executed for the benefit of, any Person that is not a Party hereto or thereto or a successor or permitted assign

of such a Party.

12.4

Reserved..

12.5

Governing Law; Jurisdiction. This Agreement shall be governed by, construed and enforced in accordance with the Laws of the State

of Delaware without regard to the conflict of laws principles thereof. All Actions arising out of or relating to this Agreement shall

be heard and determined exclusively in the Chancery Court of the State of Delaware (or in any other court in the State of Delaware or

any appellate court thereof) (the “Specified Courts”). Each Party hereto hereby (a) submits to the exclusive jurisdiction

of any Specified Court for the purpose of any Action arising out of or relating to this Agreement brought by any Party hereto and (b)

irrevocably waives, and agrees not to assert by way of motion, defense or otherwise, in any such Action, any claim that it is not subject

personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that the

Action is brought in an inconvenient forum, that the venue of the Action is improper, or that this Agreement or the transactions contemplated

hereby may not be enforced in or by any Specified Court. Each Party agrees that a final judgment in any Action shall be conclusive and

may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by Law. Each Party irrevocably consents

to the service of the summons and complaint and any other process in any other Action relating to the transactions contemplated by this

Agreement, on behalf of itself, or its property, by personal delivery of copies of such process to such Party at the applicable address

set forth in Section ‎12.1. Nothing in this Section ‎12.5 shall affect the right of any Party to

serve legal process in any other manner permitted by Law.

12.6

WAIVER OF JURY TRIAL. EACH PARTY HERETO HEREBY WAIVES TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW ANY RIGHT IT MAY HAVE

TO A TRIAL BY JURY WITH RESPECT TO ANY ACTION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT OR THE

TRANSACTIONS CONTEMPLATED HEREBY. EACH PARTY HERETO (A) CERTIFIES THAT NO REPRESENTATIVE OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY

OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF ANY ACTION, SEEK TO ENFORCE THAT FOREGOING WAIVER AND (B) ACKNOWLEDGES

THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS

IN THIS SECTION ‎12.6.

12.7

Specific Performance. Each Party acknowledges that the rights of each Party to consummate the transactions contemplated hereby

are unique, recognizes and affirms that in the event of a breach of this Agreement by any Party, money damages may be inadequate and

the non-breaching Parties may not have an adequate remedy at law, and agrees that irreparable damage would occur in the event that any

of the provisions of this Agreement were not performed by an applicable Party in accordance with their specific terms or were otherwise

breached. Accordingly, each Party shall be entitled to seek an injunction or restraining order to prevent breaches of this Agreement

and to seek to enforce specifically the terms and provisions hereof, including the obligations to execute and deliver the Ancillary Documents

and consummate the transactions contemplated hereby, without the requirement to post any bond or other security or to prove that money

damages would be inadequate, this being in addition to any other right or remedy to which such Party may be entitled under this Agreement,

at law or in equity.

12.8

Severability. In case any provision in this Agreement shall be held invalid, illegal or unenforceable in a jurisdiction, such

provision shall be modified or deleted, as to the jurisdiction involved, only to the extent necessary to render the same valid, legal

and enforceable, and the validity, legality and enforceability of the remaining provisions hereof shall not in any way be affected or

impaired thereby nor shall the validity, legality or enforceability of such provision be affected thereby in any other jurisdiction.

Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the Parties will substitute

for any invalid, illegal or unenforceable provision a suitable and equitable provision that carries out, so far as may be valid, legal

and enforceable, the intent and purpose of such invalid, illegal or unenforceable provision.

63

12.9

Amendment. This Agreement may be amended, supplemented or modified only by execution of a written instrument signed by Purchaser,

the Company, Purchaser Representative and the Shareholder Representative.

12.10

Waiver. Purchaser on behalf of itself and its Affiliates, the Company on behalf of itself and its Affiliates, and the Shareholder

Representative on behalf of itself and the Selling Shareholders, may in its sole discretion (i) extend the time for the performance of

any obligation or other act of any other non-Affiliated Party hereto, (ii) waive any inaccuracy in the representations and warranties

by such other non-Affiliated Party contained herein or in any document delivered pursuant hereto and (iii) waive compliance by such other

non-Affiliated Party with any covenant or condition contained herein. Any such extension or waiver shall be valid only if set forth in

an instrument in writing signed by the Party or Parties to be bound thereby (including by Purchaser Representative or Shareholder Representative

in lieu of such Party to the extent provided in this Agreement). Notwithstanding the foregoing, no failure or delay by a Party in exercising

any right hereunder shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or further

exercise of any other right hereunder. Notwithstanding the foregoing, any waiver of any provision of this Agreement after the Closing

shall also require the prior written consent of Purchaser Representative.

12.11

Entire Agreement. This Agreement and the documents or instruments referred to herein, including any exhibits and schedules attached

hereto, which exhibits and schedules are incorporated herein by reference, together with the Ancillary Documents, embody the entire agreement

and understanding of the Parties hereto in respect of the subject matter contained herein. There are no restrictions, promises, representations,

warranties, covenants or undertakings, other than those expressly set forth or referred to herein or the documents or instruments referred

to herein, which collectively supersede all prior agreements and the understandings among the Parties with respect to the subject matter

contained herein. The Parties expressly disclaim, renounce, and waive any and all rights pursuant to, all prior verbal negotiations and

agreements related to the subject matter hereof.

12.12

Interpretation. The table of contents and the Article and Section headings contained in this Agreement are solely for the purpose

of reference, are not part of the agreement of the Parties and shall not in any way affect the meaning or interpretation of this Agreement.

In this Agreement, unless the context otherwise requires: (a) any pronoun used shall include the corresponding masculine, feminine or

neuter forms, and words in the singular, including any defined terms, include the plural and vice versa; (b) reference to any Person

includes such Person’s successors and assigns but, if applicable, only if such successors and assigns are permitted by this Agreement,

and reference to a Person in a particular capacity excludes such Person in any other capacity; (c) any accounting term used and not otherwise

defined in this Agreement or any Ancillary Document has the meaning assigned to such term in accordance with Applicable Accounting Standards;

(d) “including” (and with correlative meaning “include”) means including without limiting the generality of any

description preceding or succeeding such term and shall be deemed in each case to be followed by the words “without limitation”;

(e) the words “herein,” “hereto,” and “hereby” and other words of similar import shall be deemed

in each case to refer to this Agreement as a whole and not to any particular Section or other subdivision of this Agreement; (f) the

word “if” and other words of similar import when used herein shall be deemed in each case to be followed by the phrase “and

only if”; (g) the term “or” means “and/or”; (h) any reference to the term “ordinary course”

or “ordinary course of business” shall be deemed in each case to be followed by the words “consistent with past practice;”

(i) any agreement, instrument, insurance policy, Law or Order defined or referred to herein or in any agreement or instrument that is

referred to herein means such agreement, instrument, insurance policy, Law or Order as from time to time amended, modified or supplemented,

including (in the case of agreements or instruments) by waiver or consent and (in the case of statutes, regulations, rules or orders)

by succession of comparable successor statutes, regulations, rules or orders and references to all attachments thereto and instruments

incorporated therein; (j) except as otherwise indicated, all references in this Agreement to the words “Section,” “Article,”

“Schedule” and “Exhibit” are intended to refer to Sections, Articles, Schedules and Exhibits to this Agreement;

and (k) the term “Dollars” or “$” means United States dollars. Any reference in this Agreement to a Person’s

directors shall include any member of such Person’s governing body and any reference in this Agreement to a Person’s officers

shall include any Person filling a substantially similar position for such Person. Any reference in this Agreement or any Ancillary Document

to a Person’s shareholders or shareholders shall include any applicable owners of the equity interests of such Person, in whatever

form, including with respect to Purchaser its shareholders under the BVI Companies Act, as then applicable, or its Governing Documents.

The Parties have participated jointly in the negotiation and drafting of this Agreement. Consequently, in the event an ambiguity or question

of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the Parties hereto, and no presumption

or burden of proof shall arise favoring or disfavoring any Party by virtue of the authorship of any provision of this Agreement. To the

extent that any Contract, document, certificate or instrument is represented and warranted to by the Company to be given, delivered,

provided or made available by the Company, in order for such Contract, document, certificate or instrument to have been deemed to have

been given, delivered, provided and made available to Purchaser or its Representatives, such Contract, document, certificate or instrument

shall have been posted to the electronic data site maintained on behalf of the Company for the benefit of Purchaser and its Representatives

and Purchaser and its Representatives have been given access to the electronic folders containing such information.

64

12.13

Counterparts. This Agreement and each Ancillary Document may be executed and delivered (including by facsimile or other electronic

transmission) in one or more counterparts, and by the different Parties hereto in separate counterparts, each of which when executed

shall be deemed to be an original but all of which taken together shall constitute one and the same agreement.

12.14

Purchaser Representative.

(a)

Purchaser, on behalf of itself and its Subsidiaries, successors and assigns, by execution and delivery of this Agreement, hereby irrevocably

appoints Datuk Dr. Doris Wong, in the capacity as Purchaser Representative, as each such Person’s agent, attorney-in-fact and representative,

with full power of substitution to act in the name, place and stead of such Person, to act on behalf of such Person from and after the

Closing in connection with: (i) terminating, amending or waiving on behalf of such Person any provision of this Agreement or any Ancillary

Documents to which Purchaser Representative is a party or otherwise has rights in such capacity (together with this Agreement, the “Purchaser

Representative Documents”); (ii) signing on behalf of such Person any releases or other documents with respect to any dispute

or remedy arising under any Purchaser Representative Documents; (iii) employing and obtaining the advice of legal counsel, accountants

and other professional advisors as Purchaser Representative, in its reasonable discretion, deems necessary or advisable in the performance

of its duties as Purchaser Representative and to rely on their advice and counsel; (iv) incurring and paying reasonable out-of-pocket

costs and expenses, including fees of brokers, attorneys and accountants incurred pursuant to the transactions contemplated hereby, and

any other reasonable out-of-pocket fees and expenses allocable or in any way relating to such transaction or any indemnification claim;

and (v) otherwise enforcing the rights and obligations of any such Persons under any Purchaser Representative Documents, including giving

and receiving all notices and communications hereunder or thereunder on behalf of such Person; provided, that the Parties acknowledge

that Purchaser Representative is specifically authorized and directed to act on behalf of, and for the benefit of, the holders of Purchaser

Securities (other than the Company Security Holders immediately prior to the Closing and their respective successors and assigns). All

decisions and actions by Purchaser Representative shall be binding upon Purchaser and its Subsidiaries, successors and assigns, and neither

they nor any other Party shall have the right to object, dissent, protest or otherwise contest the same. The provisions of this Section

12.14 are irrevocable and coupled with an interest. Purchaser Representative hereby accepts its appointment and authorization

as Purchaser Representative under this Agreement.

65

(b)

Purchaser Representative shall not be liable for any act done or omitted under any Purchaser Representative Document as Purchaser Representative

while acting in good faith and without willful misconduct or gross negligence, and any act done or omitted pursuant to the advice of

counsel shall be conclusive evidence of such good faith. Purchaser shall indemnify, defend and hold harmless Purchaser Representative

from and against any and all losses incurred without gross negligence, bad faith or willful misconduct on the part of Purchaser Representative

(in his capacity as such) and arising out of or in connection with the acceptance or administration of Purchaser Representative’s

duties under any Purchaser Representative Document, including the reasonable fees and expenses of any legal counsel retained by Purchaser

Representative. In no event shall Purchaser Representative in such capacity be liable hereunder or in connection herewith for any indirect,

punitive, special or consequential damages. Purchaser Representative shall be fully protected in relying upon any written notice, demand,

certificate or document that it in good faith believes to be genuine, including facsimiles or copies thereof, and no Person shall have

any Liability for relying on Purchaser Representative in the foregoing manner. In connection with the performance of its rights and obligations

hereunder, Purchaser Representative shall have the right at any time and from time to time to select and engage, at the cost and expense

of Purchaser, attorneys, accountants, investment bankers, advisors, consultants and clerical personnel and obtain such other professional

and expert assistance, maintain such records and incur other out-of-pocket expenses, as Purchaser Representative may deem necessary or

appropriate from time to time. All of the indemnities, immunities, releases and powers granted to Purchaser Representative under this

Section 12.14 shall survive the Closing and continue indefinitely.

(c)

The Person serving as Purchaser Representative may resign upon ten (10) days’ prior written notice to Purchaser and the Shareholder

Representative, provided, that Purchaser Representative appoints in writing a replacement Purchaser Representative. Each successor Purchaser

Representative shall have all of the power, authority, rights and privileges conferred by this Agreement upon the original Purchaser

Representative, and the term “Purchaser Representative” as used herein shall be deemed to include any such successor Purchaser

Representatives.

12.15

Shareholder Representative.

(a)

The Selling Shareholders, on behalf of themselves and their successors and assigns, by execution and delivery of this Agreement, hereby

irrevocably appoint Ow Ruey Shen, in the capacity as the Shareholder Representative, as each such Person’s agent, attorney-in-fact

and representative, with full power of substitution to act in the name, place and stead of such Person, to act on behalf of such Person

from and after the Closing in connection with: (i) terminating, amending or waiving on behalf of such Person any provision of this Agreement

or any Ancillary Documents to which the Shareholder Representative is a party or otherwise has rights in such capacity (together with

this Agreement, the “Shareholder Representative Documents”); (ii) signing on behalf of such Person any releases or

other documents with respect to any dispute or remedy arising under any Shareholder Representative Documents; (iii) employing and obtaining

the advice of legal counsel, accountants and other professional advisors as the Shareholder Representative, in its reasonable discretion,

deems necessary or advisable in the performance of its duties as the Shareholder Representative and to rely on their advice and counsel;

(iv) incurring and paying reasonable out-of-pocket costs and expenses, including fees of brokers, attorneys and accountants incurred

pursuant to the transactions contemplated hereby, and any other reasonable out-of-pocket fees and expenses allocable or in any way relating

to such transaction or any indemnification claim; and (v) otherwise enforcing the rights and obligations of any such Persons under any

Shareholder Representative Documents, including giving and receiving all notices and communications hereunder or thereunder on behalf

of such Person; provided, that the Parties acknowledge that the Shareholder Representative is specifically authorized and directed

to act on behalf of, and for the benefit of, all Selling Shareholders and their respective successors and assigns. All decisions and

actions by the Shareholder Representative shall be binding upon each Selling Shareholder and its successors and assigns, and neither

they nor any other Party shall have the right to object, dissent, protest or otherwise contest the same. The provisions of this Section

12.15 are irrevocable and coupled with an interest. The Shareholder Representative hereby accepts its appointment and authorization

as the Shareholder Representative under this Agreement.

(b)

Any other Person, including the Purchaser Representative, Purchaser and the Company, may conclusively and absolutely rely, without inquiry,

upon any actions of the Shareholder Representative as the acts of the Selling Shareholders under any Shareholder Representative Documents.

The Purchaser Representative, Purchaser and the Company shall be entitled to rely conclusively on the instructions and decisions of the

Shareholder Representative as to (i) any payment instructions provided by the Shareholder Representative or (ii) any other actions required

or permitted to be taken by the Shareholder Representative hereunder, and no Selling Shareholder shall have any cause of action against

the Purchaser Representative, Purchaser or the Company for any action taken by any of them in reliance upon the instructions or decisions

of the Shareholder Representative. The Purchaser Representative, Purchaser and the Company shall not have any Liability to any Selling

Shareholder for any allocation or distribution among the Selling Shareholders by the Shareholder Representative of payments made to or

at the direction of the Shareholder Representative. All notices or other communications required to be made or delivered to a Selling

Shareholder under any Shareholder Representative Document shall be made to the Shareholder Representative for the benefit of such Selling

Shareholder, and any notices so made shall discharge in full all notice requirements of the other parties hereto or thereto to such Selling

Shareholder with respect thereto. All notices or other communications required to be made or delivered by a Selling Shareholder shall

be made by the Shareholder Representative (except for a notice under Section ‎12.15(d) of the replacement of the Shareholder

Representative).

66

(c)

The Shareholder Representative shall not be liable for any act done or omitted under any Shareholder Representative Document as the Shareholder

Representative while acting in good faith and without willful misconduct or gross negligence, and any act done or omitted pursuant to

the advice of counsel shall be conclusive evidence of such good faith. The Selling Shareholders shall indemnify, defend and hold harmless

the Shareholder Representative from and against any and all losses incurred without gross negligence, bad faith or willful misconduct

on the part of the Shareholder Representative (in his capacity as such) and arising out of or in connection with the acceptance or administration

of the Shareholder Representative’s duties under any Shareholder Representative Document, including the reasonable fees and expenses

of any legal counsel retained by the Shareholder Representative. In no event shall the Shareholder Representative in such capacity be

liable hereunder or in connection herewith for any indirect, punitive, special or consequential damages. The Shareholder Representative

shall be fully protected in relying upon any written notice, demand, certificate or document that it in good faith believes to be genuine,

including facsimiles or copies thereof, and no Person shall have any Liability for relying on the Shareholder Representative in the foregoing

manner. In connection with the performance of its rights and obligations hereunder, the Shareholder Representative shall have the right

at any time and from time to time to select and engage, at the cost and expense of the Selling Shareholders, attorneys, accountants,

investment bankers, advisors, consultants and clerical personnel and obtain such other professional and expert assistance, maintain such

records and incur other out-of-pocket expenses, as the Shareholder Representative may deem necessary or appropriate from time to time.

All of the indemnities, immunities, releases and powers granted to the Shareholder Representative under this Section ‎12.15

shall survive the Closing and continue indefinitely.

(d)

The Person serving as the Shareholder Representative may resign upon ten (10) days’ prior written notice to the other Parties to

this Agreement, provided that the Shareholder Representative appoints in writing a replacement Shareholder Representative and provides

written notice of the identity of such successor to the other Parties hereto. Each successor Shareholder Representative shall have all

of the power, authority, rights and privileges conferred by this Agreement upon the original Shareholder Representative, and the term

“Shareholder Representative” as used herein shall be deemed to include any such successor Shareholder Representatives.

12.16

Legal Representation. The Parties agree that, notwithstanding the fact that Rimon, P.C. and Rohamat & Ling may have, prior

to Closing, jointly represented Purchaser, Purchaser Representative and/or Sponsor in connection with this Agreement, the Ancillary Documents

and the transactions contemplated hereby and thereby, and have also represented Purchaser and/or its Affiliates in connection with matters

other than the transaction that is the subject of this Agreement, Rimon, P.C. and Rohamat & Ling will be permitted in the future,

after Closing, to represent Sponsor, Purchaser Representative or their respective Affiliates in connection with matters in which such

Persons are adverse to Purchaser or any of its Affiliates, including any disputes arising out of, or related to, this Agreement. Additionally,

the Parties agree that Rimon, P.C. and Rohamat & Ling will be permitted in the future, after Closing, to represent Purchaser in connection

with matters in which Purchaser is adverse to the Company, Shareholder Representative or any of its Affiliates, including any disputes

arising out of, or related to, this Agreement. The Company and the Shareholder Representative, who are or have the right to be represented

by independent counsel in connection with the transactions contemplated by this Agreement, hereby agree, in advance, to waive (and to

cause their Affiliates to waive) any actual or potential conflict of interest that may hereafter arise in connection with Rimon, P.C.’s

future representation of one or more of Purchaser, Sponsor, Purchaser Representative or their respective Affiliates in which the interests

of such Person are adverse to the interests of the Company and/or the Shareholder Representative or any of their respective Affiliates,

including any matters that arise out of this Agreement or that are substantially related to this Agreement or to any prior representation

by Rimon, P.C. or Rohamat & Ling of Purchaser, Sponsor, Purchaser Representative or any of their respective Affiliates. The Parties

acknowledge and agree that, for the purposes of the attorney-client privilege, Sponsor and Purchaser Representative shall each be deemed

a client of Rimon, P.C. and Rohamat & Ling with respect to the negotiation, execution and performance of this Agreement and the Ancillary

Documents. All such communications shall remain privileged after the Closing and the privilege and the expectation of client confidence

relating thereto shall belong solely to Sponsor and Purchaser Representative, shall be controlled by Sponsor and Purchaser Representative

and shall not pass to or be claimed by Purchaser or the Company; provided, further, that nothing contained herein shall be deemed

to be a waiver by Purchaser or any of its Affiliates (including, after the Closing Date, the Company and its Affiliates) of any applicable

privileges or protections that can or may be asserted to prevent disclosure of any such communications to any third party.

67

Article

XIII

RESERVED

Article

XIV

DEFINITIONS

14.1

Certain Definitions.

(a)

For purposes of this Agreement, the following terms shall have the meanings specified in this Section ‎14.1:

“Accounting

Principles” means U.S. GAAP as in effect at the date of the financial statement to which it refers and to which such standards

are applicable, or if there is no such financial statement, then as of the Closing Date, using and applying the same accounting principles,

practices, procedures, policies and methods (with consistent classifications, judgments, elections, inclusions, exclusions and valuation

and estimation methodologies) used and applied by the Company in the preparation of the latest Audited Company Financials.

“Applicable

Accounting Standards” means U.S. GAAP as in effect from time to time and applicable to the financial statement or calculation

to which it refers.

“Action”

means any notice of noncompliance or violation, or any claim, demand, charge, action, suit, litigation, audit, settlement, complaint,

stipulation, assessment or arbitration, or any request (including any request for information), inquiry, hearing, proceeding or investigation,

by or before any Governmental Authority.

“Affiliate”

means, with respect to any Person, any other Person directly or indirectly Controlling, Controlled by, or under common Control with such

Person. For the avoidance of doubt, the Sponsor shall be deemed to be Affiliates of Purchaser prior to the Closing.

“Agreement”

has the meaning set forth in the Recitals.

“Amended

and Restated Memorandum and Articles of Association” means Purchaser’s amended and restated memorandum and articles of

association, governed by the BVI Companies Act, as amended from time-to-time.

68

“Ancillary

Documents” means each agreement, instrument or document attached hereto as an Exhibit, and the other agreements, certificates

and instruments to be executed or delivered by any of the Parties hereto in connection with or pursuant to this Agreement.

“Antitrust

Laws” means the Sherman Act, as amended, the Clayton Act, as amended, the HSR Act, the Federal Trade Commission Act, as amended,

all applicable non-U.S. anti-trust laws and all other applicable Laws and Orders issued by a Governmental Authority that are designed

or intended to prohibit, restrict or regulate actions having the purpose or effect of monopolization or restraint of trade or lessening

of competition through merger or acquisition.

“Audited

Company Financials” has the meaning set forth in Section ‎4.7(a).

“Benefit

Plans” of any Person means any and all deferred compensation, executive compensation, incentive compensation, equity purchase

or other equity-based compensation plan, severance or termination pay, holiday, vacation or other bonus plan or practice, hospitalization

or other medical, life or other insurance, supplemental unemployment benefits, profit sharing, pension, or retirement plan, program,

agreement, commitment or arrangement, and each other employee benefit plan, program, agreement or arrangement, including each employee

benefit plan maintained or contributed to or required to be contributed to by a Person for the benefit of any employee or terminated

employee of such Person, or with respect to which such Person has any Liability, whether direct or indirect, actual or contingent, whether

formal or informal, and whether legally binding or not.

“Business

Day” means any day other than a Saturday, Sunday or a legal holiday on which commercial banking institutions in New York, New

York and the British Virgin Islands are authorized to close for business, excluding as a result of “stay at home,” “shelter-in-place,”

“non-essential employee” or any other similar orders or restrictions or the closure of any physical branch locations at the

direction of any governmental authority so long as the electronic funds transfer systems, including for wire transfers, of commercially

banking institutions in New York, New York and the British Virgin Islands are generally open for use by customers on such day.

“BVI

Companies Act” means the BVI Business Companies Act, (Revised Edition 2020) as amended from time to time.

“Calculation

Date” has the meaning set forth in Section 2.2(a).

“Cash”

means the aggregate amount of cash, bank deposits and marketable securities, in each case as defined in accordance with Applicable Accounting

Standards. For the avoidance of doubt, Cash shall (a) include checks, wires and drafts deposited for the account of the Company but not

yet reflected as available proceeds in the Company’s account and (b) be reduced by the sum of (i) any outstanding checks issued

by the Company and (ii) any cash overdrafts and negative balances in the Company’s account.

“Chairman”

means Datuk Dr. Doris Wong in her capacity as Chairman of the Company.

“Closing”

has the meaning set forth in Section ‎3.1.

“Closing

Date” has the meaning set forth in Section ‎3.1.

“Closing

Net Indebtedness” means, as of immediately before the effective time of the Closing, (i) the aggregate amount of all Indebtedness

of the Company, less (ii) the Closing Company Cash, in each case of clauses (i) and (ii), on a consolidated basis and as determined in

accordance with the Accounting Principles.

“Closing

Statement” has the meaning set forth in Section 2.2(a).

69

“Code”

means Malaysian Code on Take-Overs and Mergers 2016.

“Company”

has the meaning set forth in the Recitals.

“Company

Governing Documents” means the Company’s Governing Documents, as amended from time to time.

“Company

Benefit Plan” has the meaning set forth in Section ‎4.19.

“Company

Closing Cash” means the amount of the Company’s Cash as of 12:01 a.m. on the Closing Date.

“Company

Confidential Information” means all confidential or proprietary documents and information concerning the Company, furnished

in connection with this Agreement or the transactions contemplated hereby; provided, however, that Company Confidential Information

shall not include any information which, (i) at the time of disclosure by the Company or any of its Representatives, is generally available

publicly and was not disclosed in breach of this Agreement or (ii) at the time of disclosure by the Company or any of its Representatives

to Purchaser or any of its Representatives, was previously known by such receiving party without violation of Law or any confidentiality

obligation by the Person receiving such Company Confidential Information.

“Company

Convertible Securities” means, collectively, any warrants or rights to subscribe for or purchase any capital shares of the

Company or securities convertible into or exchangeable for, or that otherwise confer on the holder any right to acquire any capital shares

of the Company.

“Company

Financials” has the meaning set forth in Section ‎4.7(a).

“Company

Ordinary Shares” means the ordinary shares of the Company.

“Company

Securities” means, collectively, the Company Ordinary Shares, the Company Convertible Securities and any other securities of

the Company.

“Company

Security Holders” means, collectively, the holders of Company Securities.

“Company

Shares” has the meaning set forth in the Recitals.

“Company

Support Agreement” means the Company Support Agreement in the form of Exhibit G hereto.

“Confidential

Information” has the meaning set forth in Section ‎7.13.

“Consent”

means any consent, approval, waiver, authorization or Permit of, or notice to or declaration or filing with any Governmental Authority

or any other Person.

“Consultation

Period” has the meaning set forth in Section 2.2(c).

“Contract”

means all contracts, agreements, binding arrangements, bonds, notes, indentures, mortgages, debt instruments, purchase order, licenses

(and all other contracts, agreements or binding arrangements concerning Intellectual Property), franchises, leases and other instruments

or obligations of any kind, written or oral (including any amendments and other modifications thereto).

70

“Control”

of a Person means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies

of such Person, whether through the ownership of voting securities, by contract, or otherwise. “Controlled,” “Controlling”

and “under common Control with” have correlative meanings. Without limiting the foregoing a Person (the “Controlled

Person”) shall be deemed Controlled by (a) any other Person (i) owning beneficially, as meant in Rule 13d-3 under the Exchange

Act, securities entitling such Person to ten percent (10%) or more of the votes for election of directors or equivalent governing authority

of the Controlled Person or (ii) entitled to be allocated or receive ten percent (10%) or more of the profits, losses, or distributions

of the Controlled Person; (b) an officer, director, general partner, partner (other than a limited partner), manager, or member (other

than a member having no management authority that is not a Person described in clause (a) above) of the Controlled Person; or (c) a spouse,

parent, lineal descendant, sibling, aunt, uncle, niece, nephew, mother-in-law, father-in-law, sister-in-law, or brother-in-law of an

Affiliate of the Controlled Person or a trust for the benefit of an Affiliate of the Controlled Person or of which an Affiliate of the

Controlled Person is a trustee.

“Copyrights”

means any works of authorship, mask works and all copyrights therein, including all renewals and extensions, copyright registrations

and applications for registration and renewal, and non-registered copyrights.

“Encumbrances”

means, with respect to any asset, any mortgage, deed of trust, lien, pledge, charge, security interest, title retention device, collateral

assignment, adverse claim, restriction or other encumbrance of any kind in respect of such asset (including any restriction on the voting

of any security, any restriction on the transfer of any security or other asset, any restriction on the receipt of any income derived

from any asset, any restriction on the use of any asset and any restriction on the possession, exercise or transfer of any other attribute

of ownership of any asset). For purposes of clarification only, an inability to sell a security without registering such security for

sale under the Securities Act or other securities laws of any jurisdiction or other restrictions arising from applicable securities laws

of any jurisdiction shall not represent an Encumbrance.

“Environmental

Law” means any and all applicable Laws relating to pollution, human health and safety (to the extent related to Hazardous Materials),

or protection of the environment (including natural resources), or the use, storage, emission, distribution, transport, handling, disposal

or release of, or exposure of any Person to, Hazardous Materials.

“Environmental

Liabilities” means, in respect of any Person, all Liabilities, obligations, responsibilities, Remedial Actions, losses, damages,

costs, and expenses (including all reasonable fees, disbursements, and expenses of counsel, experts, and consultants and costs of investigation

and feasibility studies), fines, penalties, sanctions, and interest incurred as a result of any claim or demand by any other Person or

in response to any violation of Environmental Law, whether known or unknown, accrued or contingent, whether based in contract, tort,

implied or express warranty, strict liability, criminal or civil statute, to the extent based upon, related to, or arising under or pursuant

to any Environmental Law, Environmental Permit, Order, or Contract with any Governmental Authority or other Person, that relates to any

environmental, health or safety condition, violation of Environmental Law, or a Release or threatened Release of Hazardous Materials.

“Environmental

Permits” has the meaning set forth in Section ‎4.20.

“Exchange

Act” means the U.S. Securities Exchange Act of 1934, as amended.

“Expiration

Date” has the meaning set forth in Section ‎10.1(b).

“Extension”

has the meaning set forth in Section ‎7.3(a).

“Extension

Expenses” has the meaning set forth in Section ‎7.3(b)(iv).

“Final

Closing Statement” has the meaning set forth in Section 2.2(b).

“Final

Pre-Closing Period” has the meaning set forth in Section ‎7.20(a).

71

“Fraud

Claim” means any claim based in whole or in part upon fraud, willful misconduct or intentional misrepresentation.

“GAAP”

means generally accepted accounting principles in the United States in effect as of the date hereof.

“Governing

Documents” means, with respect to any Person that is an entity, its certificate of incorporation or formation, bylaws, operating

agreement, memorandum and articles of association or similar organizational documents, in each case, as amended.

“Governmental

Authority” means any federal, state, local, foreign or other governmental, quasi-governmental or administrative body, instrumentality,

department or agency or any court, tribunal, administrative hearing body, arbitration panel, commission, or other similar dispute-resolving

panel or body.

“Hazardous

Material” means any waste, gas, liquid or other substance or material that is defined, listed or designated as a “hazardous

substance,” “pollutant,” “contaminant,” “hazardous waste,” “regulated substance,”

“hazardous chemical,” or “toxic chemical” (or by any similar term) under any Environmental Law, or any other

material regulated, or that could result in the imposition of Liability or responsibility, under any Environmental Law, including petroleum

and its by-products, asbestos, polychlorinated biphenyls, radon, mold, and urea formaldehyde insulation.

“IFRS”

means the International Financial Reporting Standards in effect as of the date hereof.

“Indebtedness”

of any Person means, without duplication, (a) all indebtedness of such Person for borrowed money (including the outstanding principal

and accrued but unpaid interest), (b) all obligations for the deferred purchase price of property or services (other than trade payables

incurred in the ordinary course of business), (c) any other indebtedness of such Person that is evidenced by a note, bond, debenture,

credit agreement or similar instrument, (d) all obligations of such Person under leases that should be classified as capital leases in

accordance with Applicable Accounting Standards, (e) all obligations of such Person for the reimbursement of any obligor on any line

or letter of credit, banker’s acceptance, guarantee or similar credit transaction, in each case, that has been drawn or claimed

against, (f) all obligations of such Person in respect of acceptances issued or created, (g) all interest rate and currency swaps, caps,

collars and similar agreements or hedging devices under which payments are obligated to be made by such Person, whether periodically

or upon the happening of a contingency, (h) all obligations secured by an Lien on any property of such Person, (i) any premiums, prepayment

fees or other penalties, fees, costs or expenses associated with payment of any Indebtedness of such Person and (j) all obligations described

in clauses (a) through (i) above of any other Person which is directly or indirectly guaranteed by such Person or which such Person has

agreed (contingently or otherwise) to purchase or otherwise acquire or in respect of which it has otherwise assured a creditor against

loss.

“Intellectual

Property” means all of the following as they exist in any jurisdiction throughout the world: Patents, Trademarks, Copyrights,

Trade Secrets, Internet Assets, Software and other intellectual property, and all licenses, sublicenses and other agreements or permissions

related to the preceding property.

“Interim

Balance Sheet Date” has the meaning set forth in Section ‎4.7(a).

“Interim

Period” has the meaning set forth in Section ‎7.1(a).

“Interim

Financial Statements” has the meaning set forth in Section ‎7.4.

“Internet

Assets” means any and all domain name registrations, web sites and web addresses and related rights, items and documentation

related thereto, and applications for registration therefor.

72

“IPO”

means the initial public offering of Purchaser Public Units pursuant to the IPO Prospectus.

“IPO

Prospectus” means the final prospectus of Purchaser dated as of April 30, 2026, and filed with the SEC on April 30, 2026 (File

No. 333-288410).

“IPO

Underwriter” means IB Capital, LLC.

“IRS”

means the Internal Revenue Service.

“Key

Executives” means Mr. Ow Ruey Shen.

“Knowledge”

means, (i) with respect to the Company, the actual knowledge of the Key Executives and directors of the Company, after reasonable inquiry,

or (ii) with respect to any other Party, (A) if an entity, the actual knowledge of its directors and executive officers, after reasonable

inquiry, or (B) if a natural person, the actual knowledge of such Party after reasonable inquiry.

“Law”

means any federal, state, local, municipal, foreign or other law, statute, legislation, principle of common law, ordinance, code, edict,

decree, proclamation, treaty, convention, rule, regulation, directive, requirement, writ, injunction, settlement, Order or Consent that

is or has been issued, enacted, adopted, passed, approved, promulgated, made, implemented or otherwise put into effect by or under the

authority of any Governmental Authority.

“Liabilities”

means any and all liabilities, Indebtedness, Actions or obligations of any nature (whether absolute, accrued, contingent or otherwise,

whether known or unknown, whether direct or indirect, whether matured or unmatured, whether due or to become due and whether or not required

to be recorded or reflected on a balance sheet under Applicable Accounting Standards), including Tax liabilities due or to become due.

“Lien”

means any mortgage, pledge, security interest, attachment, right of first refusal, option, proxy, voting trust, encumbrance, lien or

charge of any kind (including any conditional sale or other title retention agreement or lease in the nature thereof), restriction (whether

on voting, sale, transfer, disposition or otherwise), any subordination arrangement in favor of another Person, or any filing or agreement

to file a financing statement as debtor under the Uniform Commercial Code or any similar Law.

“Loan

Portfolio” means all loans, advances and other credit accommodations originated, acquired, funded or held by the Company, together

with all related accrued interest, fees, charges, collateral, guarantees and other rights and receivables.

“Lock-Up

Agreement” means the Lock-Up Agreement in the form of Exhibit H hereto.

“Losses”

means losses, liabilities, obligations, damages, notices, actions, suits, proceedings, claims, demands, assessments, judgments, costs,

penalties and expenses, including defense costs, amounts paid in settlement and reasonable attorneys’ and other professionals’

fees and disbursements, but excluding special, incidental, consequential and punitive damages except to the extent awarded to a third

party in connection with a third-party claim.

“Malaysian

Companies Act” means the Laws of Malaysia, Act 125, Companies Act 2016.

73

“Material

Adverse Effect” means, with respect to any specified Person, any fact, event, occurrence, change or effect that has had, or

would reasonably be expected to have, individually or in the aggregate, a material adverse effect upon (a) the business, assets, Liabilities,

results of operations, prospects or condition (financial or otherwise) of such Person and its Subsidiaries, taken as a whole, or (b)

the ability of such Person or any of its Subsidiaries on a timely basis to consummate the transactions contemplated by this Agreement

or the Ancillary Documents to which it is a party or bound or to perform its obligations hereunder or thereunder; provided, however,

that for purposes of clause (a) above, any changes or effects directly or indirectly attributable to, resulting from, relating to or

arising out of the following (by themselves or when aggregated with any other, changes or effects) shall not be deemed to be, constitute,

or be taken into account when determining whether there has or may, would or could have occurred a Material Adverse Effect: (i) general

changes in the financial or securities markets or general economic or political conditions in the country or region in which such Person

or any of its Subsidiaries do business; (ii) changes, conditions or effects that generally affect the industries in which such Person

or any of its Subsidiaries principally operate; (iii) changes in Applicable Accounting Standards or mandatory changes in the regulatory

accounting requirements applicable to any industry in which such Person and its Subsidiaries principally operate; (iv) conditions caused

by acts of God, terrorism, war (whether or not declared) or natural disaster; (v) any failure in and of itself by such Person and its

Subsidiaries to meet any internal or published budgets, projections, forecasts or predictions of financial performance for any period

(provided that the underlying cause of any such failure may be considered in determining whether a Material Adverse Effect has occurred

or would reasonably be expected to occur to the extent not excluded by another exception herein) and (vi) with respect to Purchaser,

the consummation and effects of the Redemption (or any redemption in connection with the Extension); provided further, however,

that any event, occurrence, fact, condition, or change referred to in clauses (i) - (iv) immediately above shall be taken into account

in determining whether a Material Adverse Effect has occurred or could reasonably be expected to occur to the extent that such event,

occurrence, fact, condition, or change has a disproportionate effect on such Person or any of its Subsidiaries compared to other participants

in the industries in which such Person or any of its Subsidiaries primarily conducts its businesses. Notwithstanding the foregoing, with

respect to Purchaser, the amount of the Redemption (or any redemption in connection with the Extension, if any) or the failure to obtain

the Required Purchaser Shareholder Approval shall not be deemed to be a Material Adverse Effect on or with respect to Purchaser.

“Material

Contracts” has the meaning set forth in Section ‎4.12.

“Money

Lending Laws” means, collectively, the Moneylenders Act 1951 of Malaysia (Act 400), the Moneylenders (Control and Licensing)

Regulations 2003 of Malaysia, the Moneylenders (Compounding of Offences) Regulations 2003 of Malaysia, the Consumer Credit Act 2025 of

Malaysia (Act 873), the Anti-Money Laundering, Anti-Terrorism Financing and Proceeds of Unlawful Activities Act 2001, and all other applicable

Laws, guidelines, circulars, directions and requirements of the Ministry of Housing and Local Government, the Registrar of Moneylenders,

Bank Negara Malaysia and any other Governmental Authority having jurisdiction over the Company or its business.

“Nasdaq”

means The Nasdaq Global Market, LLC.

“Net

Working Capital Amount” means, as of the Closing, (i) all current assets of the Company (excluding, without duplication, Closing

Company Cash), on a consolidated basis, minus (ii) all current liabilities of the Company (excluding, without duplication, Indebtedness

and unpaid Transaction Expenses), as determined in accordance with the Accounting Principles.

“Order”

means any order, decree, ruling, judgment, injunction, writ, determination, binding decision, verdict, judicial award or other action

that is or has been made, entered, rendered, or otherwise put into effect by or under the authority of any Governmental Authority.

“Patents”

means any patents, patent applications and the inventions, designs and improvements described and claimed therein, patentable inventions,

and other patent rights (including any divisionals, provisionals, continuations, continuations-in-part, substitutions, or reissues thereof,

whether or not patents are issued on any such applications and whether or not any such applications are amended, modified, withdrawn,

or refiled).

74

“Permits”

means all federal, state, local or foreign or other third-party permits, grants, easements, consents, approvals, authorizations, exemptions,

licenses, franchises, concessions, ratifications, permissions, permits, clearances, confirmations, endorsements, waivers, certifications,

designations, ratings, registrations, qualifications or orders of any Governmental Authority or any other Person.

“Permitted

Liens” means (a) Liens for Taxes or assessments and similar governmental charges or levies, which either are (i) not delinquent

or (ii) being contested in good faith and by appropriate proceedings, and adequate reserves have been established with respect thereto,

(b) other Liens imposed by operation of Law arising in the ordinary course of business for amounts which are not due and payable and

as would not in the aggregate materially adversely affect the value of, or materially adversely interfere with the use of, the property

subject thereto, (c) Liens incurred or deposits made in the ordinary course of business in connection with social security, (d) Liens

on goods in transit incurred pursuant to documentary letters of credit, in each case arising in the ordinary course of business, or (e)

Liens arising under this Agreement or any Ancillary Document.

“Person”

means an individual, corporation, partnership (including a general partnership, limited partnership or limited liability partnership),

limited liability company, association, trust or other entity or organization, including a government, domestic or foreign, or political

subdivision thereof, or an agency or instrumentality thereof.

“Personal

Data” means, with respect to any natural Person, such Person’s name, street address, telephone number, e-mail address,

photograph, social security number, tax identification number, driver’s license number, passport number, credit card number, bank

account number and other financial information, customer or account numbers, account access codes and passwords, any other information

that allows the identification of such Person or enables access to such Person’s financial information or that is defined as “personal

data,” “personally identifiable information,” “personal information,” “protected health information”

or similar term under any applicable Privacy Laws.

“Personal

Property” means any machinery, equipment, tools, vehicles, furniture, leasehold improvements, office equipment, plant, parts

and other tangible personal property.

“PIPE

Investors” has the meaning set forth in the Recitals.

“Privacy

Laws” means all applicable Laws, and the laws of applicable jurisdictions, relating to privacy and protection of Personal Data,

and any and all similar applicable Laws relating to privacy, security, data protection, data availability and destruction and data breach,

including security incident notification.

“Pre-Closing

Periods” has the meaning set forth in Section ‎7.20(a).

“Preliminary

Final Closing Statement” has the meaning set forth in Section 2.2(b).

“Proceeding”

means any action, suit, proceeding, complaint, claim, charge, hearing, labor dispute, inquiry or investigation before or by a Governmental

Authority or an arbitrator.

“Purchaser”

has the meaning set forth in the Recitals.

“Purchaser

Documents” means collectively this Agreement and each other agreement, document, instrument or certificate contemplated by

this Agreement or to be executed by Purchaser in connection with the consummation of the transactions contemplated hereby.

“Purchaser

Class A Ordinary Shares” means the Class A ordinary shares, par value $0.0001 per share, of Purchaser.

75

“Purchaser

Class B Ordinary Shares” means the Class B ordinary shares, par value $0.0001 per share, of Purchaser.

“Purchaser

Confidential Information” means all confidential or proprietary documents and information concerning Purchaser or any of its

Representatives; provided, however, that Purchaser Confidential Information shall not include any information which, (i) at the time

of disclosure by any other Party or any of their respective Representatives, is generally available publicly and was not disclosed in

breach of this Agreement or (ii) at the time of the disclosure by Purchaser or its Representatives to any other Party or any of their

respective Representatives, was previously known by such receiving party without violation of Law or any confidentiality obligation by

the Person receiving such Purchaser Confidential Information. For the avoidance of doubt, from and after the Closing, Purchaser Confidential

Information will include the confidential or proprietary information of the Company.

“Purchaser

Ordinary Shares” means Purchaser Class A Ordinary Shares and Purchaser Class B Ordinary Shares, collectively.

“Purchaser

Preference Shares” means the preference shares, par value $0.0001 per share, of Purchaser.

“Purchaser

Private Units” means the units issued by Purchaser in a private placement to Sponsor at the time of the consummation of the

IPO consisting of one (1) Purchaser Class A Ordinary Share, one (1) Purchaser Public Right and one (1) Purchaser Private Warrant.

“Purchaser

Private Warrants” means one redeemable warrant that was included as part of each Purchaser Private Unit, entitling the holder

of one whole warrant thereof to purchase one (1) Purchaser Class A Ordinary Share at a purchase price of $11.50 per share, subject to

adjustment in accordance with the Warrant Agreement.

“Purchaser

Public Rights” means one right that was included as part of each Purchaser Public Unit, entitling the holder thereof of one

right to receive one-fourth (1/4th) of one (1) Purchaser Class A Ordinary Share at the closing of the Business Combination.

“Purchaser

Public Units” means the units issued in the IPO (including overallotment units acquired by Purchaser’s underwriter) consisting

of one (1) Purchaser Class A Ordinary Share, one (1) Purchaser Public Right and one (1) Purchaser Public Warrant.

“Purchaser

Public Warrants” means one redeemable warrant that was included as part of each Purchaser Public Unit, entitling the holder

thereof of one (1) whole warrant to purchase one (1) Purchaser Class A Ordinary Share at a purchase price of $11.50 per share, subject

to adjustment in accordance with the Warrant Agreement.

“Purchaser

Securities” means Purchaser Units, Purchaser Ordinary Shares, Purchaser Preference Shares, Purchaser Public Rights and Purchaser

Warrants, collectively.

“Purchaser

Units” means Purchaser Private Units and Purchaser Public Units, collectively.

“Purchaser

Warrants” means Purchaser Private Warrants and Purchaser Public Warrants, collectively.

“Purchaser’s

Governing Documents” means the Amended and Restated Memorandum and Articles of Association of Purchaser adopted under the BVI

Companies Act by special resolution passed on April 29, 2026, as amended from time to time.

76

“Redemption”

has the meaning set forth in Section ‎7.11(a).

“Redemption

Price” means an amount equal to the price at which each share of Purchaser Ordinary Shares is redeemed or converted pursuant

to the Redemption (as equitably adjusted for share splits, share dividends, combinations, recapitalizations and the like after the Closing).

“Registration

Rights Agreement” means the Registration Rights Agreement in the form of Exhibit B hereto, pursuant to which certain

shareholders of the Company and Purchaser shall be granted customary demand and piggyback registration rights with respect to registrations

of shares of common stock of Purchaser, subject to customary exceptions and limitations.

“Release”

means any release, spill, emission, leaking, pumping, injection, deposit, disposal, discharge, dispersal, or leaching into the indoor

or outdoor environment, or into or out of any property.

“Remedial

Action” means all actions to (i) clean up, remove, treat, or in any other way address any Hazardous Material, (ii) prevent

the Release of any Hazardous Material so it does not endanger or threaten to endanger public health or welfare or the indoor or outdoor

environment, (iii) perform pre-remedial studies and investigations or post-remedial monitoring and care, or (iv) correct a condition

of noncompliance with Environmental Laws.

“Representatives”

means, as to any Person, such Person’s Affiliates and the respective managers, directors, officers, employees, independent contractors,

consultants, advisors (including financial advisors, counsel and accountants), agents and other legal representatives of such Person

or its Affiliates.

“Restrictive

Covenant Agreement” means the Restrictive Covenant Agreement in the form of Exhibit I hereto.

“Review

Period” has the meaning set forth in Section 2.2(b).

“SEC”

means the U.S. Securities and Exchange Commission (or any successor Governmental Authority).

“Securities

Act” means the Securities Act of 1933, as amended.

“Selling

Shareholder(s)” has the meaning set forth in the Recitals.

“Selling

Shareholder Documents” has the meaning set forth in Section ‎5.1.

“Settlement

Accountant” has the meaning set forth in Section 2.2(c).

“Software”

means any computer software programs, including all source code, object code, and documentation related thereto and all software modules,

tools and databases.

“SOX”

means the U.S. Sarbanes-Oxley Act of 2002, as amended.

“Sponsor”

means MFH 2, LLC, a Delaware limited liability company.

“Sponsor

Support Agreement” means the Sponsor Support Agreement in the form of Exhibit F hereto.

77

“Statement

of Objections” has the meaning set forth in Section 2.2(b).

“Straddle

Periods” has the meaning set forth in Section ‎7.20(b).

“Subscription

Agreements” has the meaning set forth in the Recitals.

“Subsidiary”

means, with respect to any Person, any corporation, partnership, association or other business entity of which (i) if a corporation,

a majority of the total voting power of shares entitled (without regard to the occurrence of any contingency) to vote in the election

of directors, managers or trustees thereof is at the time owned or controlled, directly or indirectly, by that Person or one or more

of the other Subsidiaries of that Person or a combination thereof, or (ii) if a partnership, association or other business entity, a

majority of the partnership or other similar ownership interests thereof is at the time owned or controlled, directly or indirectly,

by any Person or one or more Subsidiaries of that Person or a combination thereof. For purposes hereof, a Person or Persons will be deemed

to have a majority ownership interest in a partnership, association or other business entity if such Person or Persons will be allocated

a majority of partnership, association or other business entity gains or losses or will be or control the managing director, managing

member, general partner or other managing Person of such partnership, association or other business entity. A Subsidiary of a Person

will also include any variable interest entity which is consolidated with such Person under applicable accounting rules.

“Tangible

Assets” means all machinery, office equipment, furniture, fixtures, trade fixtures, vehicles, rolling stock, molds, tools and

other tangible assets (other than inventory or real estate).

“Target

Net Working Capital Amount” means an amount equal to US$618,000.00.

“Tax

Claim” has the meaning set forth in Section ‎7.20(e).

“Tax

Return” means any return, declaration, report, claim for refund, information return or other documents (including any related

or supporting schedules, statements or information) filed or required to be filed in connection with the determination, assessment or

collection of any Taxes or the administration of any Laws or administrative requirements relating to any Taxes.

“Tax

Statement” has the meaning set forth in Section ‎7.20(b).

“Taxes”

means (a) all direct or indirect applicable federal, state, local, foreign and other net income, gross income, gross receipts, sales,

use, value-added, ad valorem, transfer, franchise, profits, license, lease, service, service use, withholding, payroll, employment, social

security and related contributions due in relation to the payment of compensation to employees, excise, severance, stamp, occupation,

premium, property, windfall profits, alternative minimum, estimated, customs, duties or other taxes, fees, assessments or charges of

any kind whatsoever, together with any interest and any penalties, additions to tax or additional amounts with respect thereto, (b) any

Liability for payment of amounts described in clause (a) whether as a result of being a member of an affiliated, consolidated, combined

or unitary group for any period or otherwise through operation of law and (c) any Liability for the payment of amounts described in clauses

(a) or (b) as a result of any tax sharing, tax group, tax indemnity or tax allocation agreement (excluding commercial agreements entered

into in the ordinary course of business the primary purpose of which is not the sharing of Taxes) with, or any other express or implied

agreement to indemnify, any other Person.

“Top

Customers” has the meaning set forth in Section ‎4.24.

“Top

Suppliers” has the meaning set forth in Section ‎4.24.

“Trade

Secrets” means any trade secrets, confidential business information, concepts, ideas, designs, research or development information,

processes, procedures, techniques, technical information, specifications, operating and maintenance manuals, engineering drawings, methods,

know-how, data, mask works, discoveries, inventions, modifications, extensions, improvements, and other proprietary rights (whether or

not patentable or subject to copyright, trademark, or trade secret protection).

78

“Trademarks”

means any trademarks, service marks, trade dress, trade names, brand names, internet domain names, designs, logos, or corporate names

(including, in each case, the goodwill associated therewith), whether registered or unregistered, and all registrations and applications

for registration and renewal thereof.

“Transaction

Expenses” means all fees and expenses of any of the Company or any Selling Shareholder incurred or payable as of the Closing

and not paid prior to the Closing (i) in connection with the consummation of the transactions contemplated hereby, including any amounts

payable to professionals (including investment bankers, brokers, finders, attorneys, accountants and other consultants and advisors)

retained by or on behalf of the Company, (ii) any change in control bonus, transaction bonus, retention bonus, termination or severance

payment or payment relating to terminated options, warrants or other equity appreciation, phantom equity, profit participation or similar

rights, in any case, to be made to any current or former employee, independent contractor, director or officer of the Company at or after

the Closing pursuant to any agreement to which the Company is a party prior to the Closing which become payable (including if subject

to continued employment) as a result of the execution of this Agreement or the consummation of the transactions contemplated hereby and

(iii) any sales, use, real property transfer, stamp, share transfer or other similar transfer Taxes imposed on Purchaser or the Company

in connection with transactions contemplated by this Agreement.

“Trust

Account” means the trust account established by Purchaser with the proceeds from the IPO pursuant to the Trust Agreement in

accordance with the IPO Prospectus.

“Trust

Agreement” means that certain Investment Management Trust Agreement, dated as of April 29, 2026, as it may be amended, by and

between Purchaser and the Trustee, as well as any other agreements entered into related to or governing the Trust Account.

“Trustee”

means Efficiency Inc., in its capacity as trustee under the Trust Agreement.

“Warrant

Agreement” means the Warrant Agreement, dated April 29, 2026, by and between Purchaser and the Trustee.

**

REMAINDER OF PAGE INTENTIONALLY LEFT BLANK **

79

IN

WITNESS WHEREOF, each Party has duly executed and delivered this Agreement or caused this Agreement to be duly executed and delivered

as a deed as of the day and year first above written.

THE

COMPANY:

FIRSTBORN

TOP CAPITAL SDN. BHD.

By:

Name:

Ow

Ruey Shen

Title:

Director

[Signature

Page to Share Purchase Agreement]

SELLING

SHAREHOLDERS:

Name:

WONG CHEE SIN

Ordinary

Shares: 254,548

Name:

OW RUEY SHEN (Corporate Representative of Mastika Heritage Sdn. Bhd.)

Ordinary

Shares: 2,000,020

Name:

LIM YEN CHENG

Ordinary

Shares: 72,728

Name:

LIM ENG KIAN

Ordinary

Shares: 72,728

Name:

YAP ONN LEONG

Ordinary

Shares Held: 145,456

Name:

PHUN YOON YEE

Ordinary

Shares: 72,728

Name:

NG SIN YEE

Ordinary

Shares: 72,728

[Signature

Page to Share Purchase Agreement]

Name:

SOONG SOON WENG

Ordinary

Shares: 72,728

Name:

WANG POH CHEE

Ordinary

Shares: 72,728

Name:

STACY SOH SIOK CHENG

Ordinary

Shares: 72,728

Name:

WANG MOOI CHOO

Ordinary

Shares: 72,728

Name:

PHUAH EE JIE

Ordinary

Shares: 327,276

Name:

NG LEI TENG (Corporate Representative of P88 Capital Sdn. Bhd.)

Ordinary

Shares: 327,276

SHAREHOLDER

REPRESENTATIVE:

Ow

Ruey Shen, solely in his capacity as Shareholder Representative

By:

[Signature

Page to Share Purchase Agreement]

PURCHASER:

ARC

GROUP ACQUISITION I CORP.

By:

Name:

Datuk

Dr. Doris Wong

Title:

Chief

Executive Officer

PURCHASER

REPRESENTATIVE:

Datuk

Dr. Doris Wong, solely in her capacity as Purchaser Representative

By:

[Signature

Page to Share Purchase Agreement]

EXHIBIT

A-1

EXHIBIT

A-2

ALLOCATION

SCHEDULE

Name

and Address of Selling Shareholder

Number

of Company Shares Immediately Prior to Closing

Percentage

of Outstanding Company Shares Prior to Closing

Number

of Purchaser Shares Issuable at Closing

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

EX-10.1

EX-10.1

Filename: ex10-1.htm · Sequence: 3

Exhibit 10.1

SPONSOR

SUPPORT AGREEMENT

This

SPONSOR SUPPORT AGREEMENT (this “Agreement”) is made and entered into as of September 10, 2026, by and among MFH 2,

LLC, a Delaware limited liability company (“Sponsor”), ARC Group Acquisition I Corp., a British Virgin Islands business

company (“Purchaser”), and Firstborn Top Capital Sdn. Bhd., a Malaysian private limited company (the “Company”)

and the officers, directors and shareholders of Purchaser listed on Schedule A hereto (“Purchaser Insiders”).

Any capitalized term used but not defined in this Agreement will have the meaning ascribed to such term in the Share Purchase Agreement

(as defined below).

RECITALS

WHEREAS,

contemporaneously herewith, Purchaser, the Company, the shareholders of the Company (the “Selling Shareholders”) and

a representative of each of the Purchaser and the Company, entered into a share purchase agreement, dated September 10, 2026 (the “Share

Purchase Agreement”), pursuant to which the Selling Shareholders agreed to sell and transfer to Purchaser, and Purchaser

agreed to purchase, acquire and accept from the Selling Shareholders, all of the issued and outstanding capital shares of the Company,

upon the terms and conditions set forth therein (the “Business Combination”);

WHEREAS,

as of the date of this Agreement, the Sponsor and each Purchaser Insider is the holder of record and the “beneficial owner”

(within the meaning of Rule 13d-3 under the Exchange Act) of the issued and outstanding Purchaser Securities set forth opposite such

Person’s name on Schedule A hereto ((all such securities or other equity securities, together with any classes of Purchaser’s

shares, or other equity securities of which ownership of record or the power to vote (including, without limitation, by proxy or power

of attorney) whether by purchase, as a result of a share dividend, share split, recapitalization, combination, reclassification, exchange

or change of such shares, or upon the exercise or conversion of any securities, acquired by such Person after the date hereof and during

the term of this Agreement being collectively referred to herein as the “Subject Securities”);

WHEREAS,

in connection with Purchaser’s initial public offering, Purchaser, Sponsor and certain other parties thereto entered into a letter

agreement, dated April 29, 2026 (the “Letter Agreement”), pursuant to which Sponsor and certain other parties thereto

agreed to certain voting requirements, transfer restrictions and waiver of redemption rights with respect to the securities of Purchaser

owned by them; and

WHEREAS,

in order to induce the Company to enter into the Share Purchase Agreement and consummate the Business Combination, Sponsor and Purchaser

Insiders are each executing and delivering this Agreement.

NOW,

THEREFORE, in consideration of the foregoing, which are incorporated into this Agreement as if fully set forth below, and of the mutual

covenants and agreements contained herein, and intending to be legally bound hereby, the parties hereby agree as follows:

1.

Agreement to Vote. Each of Sponsor and Purchaser Insiders, with respect to the Subject Securities, hereby agrees (and agrees to

execute such documents or certificates evidencing such agreement as the Company may request in connection therewith), irrevocably and

unconditionally, to:

(a)

when any meetings of the shareholders of Purchaser are held, appear at such meeting or otherwise cause the Subject Securities to be counted

as present thereat for the purpose of establishing a quorum;

(b)

vote at any meetings of the shareholders of Purchaser, and in any action by written consent of the shareholders of Purchaser, all of

the Subject Securities (i) in favor of the approval and adoption of the Share Purchase Agreement, the Ancillary Documents and the Business

Combination, (ii) in favor of Purchaser Shareholder Approval Matters and any other matter reasonably necessary to the consummation of

the Business Combination and considered and voted upon by the shareholders of Purchaser, and (iii) against (A) any Acquisition Proposal

relating to an Alternative Transaction with respect to Purchaser and any and all other proposals (x) for a Business Combination involving

Purchaser with other Person(s) (y) that could reasonably be expected to in any material respect delay or impair the ability of Purchaser

to consummate any of the Business Combination, or (z) which are in competition with or materially inconsistent with the Share Purchase

Agreement or the Ancillary Documents or (B) any action or proposal involving Purchaser or Sponsor that is intended, or would reasonably

be expected to prevent, impede, interfere with, delay, postpone or adversely affect in any material respect the Business Combination

or would reasonably be expected to result in any of the conditions to the Closing under the Share Purchase Agreement not being fulfilled;

(c)

execute and deliver all related documentation and take such other action in support of the Share Purchase Agreement, the Ancillary Documents

and the Business Combination, as shall reasonably be requested by the Company, in order to carry out the terms and provisions of this

Section 1, including, without limitation, the execution and delivery of any applicable Ancillary Documents, customary instruments

of conveyance and transfer, and any consent, waiver, governmental filing, and any similar or related documents; and

(d)

except as contemplated by the Share Purchase Agreement or the Ancillary Documents, make, or in any manner participate in, directly or

indirectly, a “solicitation” of “proxies” or consents (as such terms are used in the rules of the SEC) or powers

of attorney or similar rights to vote (other than a proxy granted to a representative of Sponsor to attend the vote of a meeting which

is voted in accordance with this Agreement).

2.

No Transfer. Each of Sponsor and Purchaser Insiders agrees that it shall not, and shall cause its Affiliates not to, except as

otherwise contemplated pursuant to the Share Purchase Agreement, directly or indirectly, (a) sell, assign, transfer (including by operation

of law), redeem, pledge, distribute, dispose of or otherwise encumber any of the Subject Securities (collectively, a “Transfer”)

or otherwise agree to do any of the foregoing (unless the transferee agrees to be bound by this Agreement), (b) deposit any Subject Securities

into a voting trust, enter into a voting agreement or arrangement or grant any proxy or power of attorney with respect thereto (other

than a proxy granted to a representative of Sponsor to attend and vote at a meeting which is voted in accordance with this Agreement),

(c) enter into any contract, option, derivative, hedging or other agreement or arrangement or understanding (including any profit-sharing

arrangement) with respect to, or consent to, a Transfer of any Subject Securities, or (d) take any action that would have the effect

of preventing, impeding, interfering with or adversely affecting its ability to perform its obligations hereunder.

3.

No Redemption. Each of Sponsor and Purchaser Insiders irrevocably and unconditionally agrees that, from the date hereof and until

the termination of this Agreement, it shall not elect to cause or demand that Purchaser redeem any Purchaser Ordinary Shares now or at

any time legally or beneficially owned by Sponsor or Purchaser Insiders, respectively, or submit, tender, or surrender any of its Subject

Securities for redemption.

4.

Waiver of Anti-Dilution Protection. Each of Sponsor and Purchaser Insiders hereby waives (and agrees to execute such documents

or certificates evidencing such waiver as Purchaser and/or the Company may reasonably request), forfeits, surrenders and agrees not to

exercise, assert or claim, to the fullest extent permitted by applicable Law, any anti-dilution protection (if any) pursuant to Purchaser’s

Governing Documents in connection with the transactions contemplated by this Agreement, the Share Purchase Agreement and any other Ancillary

Document. Each of Sponsor and Purchaser Insiders acknowledges and agrees that (i) this Section 4 shall constitute written consent

waiving, forfeiting and surrendering the adjustment anti-dilution protection pursuant to Purchaser’s Governing Documents in connection

with the transactions contemplated by this Agreement, the Share Purchase Agreement and any other Ancillary Document; and (ii) such waiver,

forfeiture and surrender granted hereunder shall only terminate upon the termination of this Agreement.

5.

Letter Agreement. Sponsor and to the extent applicable, Purchaser Insiders, and Purchaser shall comply with, and fully perform

all of their obligations, covenants, and agreements set forth in the Letter Agreement. Without the prior written consent of the Company,

Sponsor and Purchaser hereby agree that from the date hereof until the termination of this Agreement, neither of them shall, or shall

agree to, amend, modify or vary the Letter Agreement, except as otherwise provided for under this Agreement, the Share Purchase Agreement

or any Ancillary Documents. In the event of a conflict between the Letter Agreement and this Agreement, the terms and conditions of this

Agreement shall control.

6.

Representations and Warranties. Each of Sponsor and Purchaser Insiders represents and warrants to the Company as follows:

(a)

It has received and reviewed a copy of the Share Purchase Agreement and this Agreement and has had the opportunity to consult with its

tax and legal advisors.

(b)

The execution, delivery and performance by such Person of this Agreement and the consummation by such Person of the transactions contemplated

hereby do not and will not (i) conflict with or violate any Law or Order applicable to such Person or any agreement to which such Person

is bound, (ii) require any consent, approval or authorization of, declaration, filing or registration with, or notice to, any person

or entity, (iii) result in the creation of any Lien on any Subject Securities (other than pursuant to this Agreement or transfer restrictions

under applicable securities Laws, the Governing Documents of the Purchaser and Sponsor, the Letter Agreement, or the SEC Reports available

on the SEC’s website through EDGAR), or (iv) conflict with or result in a breach of or constitute a default under any provision

of the Governing Documents of such Person, if and as applicable.

(c)

It owns of record and has good, valid and marketable title to all of the Subject Securities free and clear of any Lien (other than pursuant

to this Agreement or transfer restrictions under applicable securities Laws, the Governing Documents of the Purchaser and Sponsor, the

Letter Agreement, or the SEC Reports available on the SEC’s website through EDGAR) and has the sole power (as currently in effect)

to vote the Subject Securities and has the full right, power and authority to sell, transfer and deliver the Subject Securities. It does

not own, directly or indirectly, (i) any other Purchaser Ordinary Shares other than the Subject Securities or (ii) any options, warrants

or other rights to acquire any additional Purchaser Ordinary Shares or any security exercisable for or convertible into the Purchaser

Ordinary Shares other than the Subject Securities.

(d)

It is duly organized, validly existing and in good standing under the Laws of the jurisdiction in which it is organized, and has the

power, authority and capacity to execute, deliver and perform this Agreement, and this Agreement has been duly authorized, executed and

delivered by such Person.

(e)

This Agreement has been duly executed and delivered by such Person and, assuming due authorization, execution and delivery by the other

parties to this Agreement, this Agreement constitutes a legally valid and binding obligation of such Person, enforceable against such

Person in accordance with the terms hereof (except as enforceability may be limited by bankruptcy Laws, other similar Laws affecting

creditors’ rights and general principles of equity affecting the availability of specific performance and other equitable remedies).

(f)

There is no Action pending, or, to the Knowledge of such Person, threatened, against such Person in writing that would reasonably be

expected to materially impair the ability of such Person to perform its obligations hereunder or to consummate the transactions contemplated

by this Agreement or the Business Combination.

(g)

it has never been suspended or expelled from membership in any securities or commodities exchange or association or had a securities

or commodities license or registration denied, suspended or revoked.

(h)

Except as set forth in Purchaser Disclosure Schedule, no broker, finder, investment banker or other Person is entitled to any brokerage

fee, finders’ fee or other commission in connection with this Agreement or any of the respective transactions contemplated hereby,

based upon arrangements made by or on behalf of such Person.

7.

Other Covenants and Agreements.

(a)

Each of Sponsor and Purchaser Insiders agrees to and shall be bound by and subject to Section 7.6 (No Solicitation),

Section 7.12 (Public Announcements), Section 7.13 (Confidential Information), and Section 11.1 (Waiver

of Claims Against Trust) of the Share Purchase Agreement to the same extent as such provisions apply to Purchaser, as if it was directly

party thereto.

(b)

Each of Sponsor and Purchaser Insiders hereby waives, and agrees not to assert or perfect, any rights of appraisal or rights to dissent

from the Business Combination that Sponsor may have by virtue of ownership of the Subject Securities and agrees not to commence or participate

in any claim, derivative or otherwise, against Purchaser relating to the negotiation, execution or delivery of this Agreement or the

Share Purchase Agreement or the consummation of the Business Combination.

(c)

Each of Sponsor and Purchaser Insiders agrees not to take or agree or commit to take any action that would make any representation or

warranty of such Person contained in this Agreement inaccurate in any material respect. Such Person further agrees that it shall use

its reasonable best efforts to cooperate with the Company and Purchaser to effect the Business Combination, the Share Purchase Agreement,

the Ancillary Documents, and the provisions of this Agreement.

(d)

Each of Sponsor and Purchaser Insiders hereby consents to the publication and disclosure in the Form S-4, and the Proxy Statement (and,

as and to the extent otherwise required by applicable securities Laws or the SEC or any other securities authorities, any other documents

or communications provided by Purchaser to any Authority or to securityholders of Purchaser) of such Person’s identity and beneficial

ownership of the Subject Securities and the nature of such Person’s commitments, arrangements and understandings under and relating

to this Agreement and, if deemed appropriate by the Company or the Purchaser, a copy of this Agreement. Each of Sponsor and Purchaser

Insiders will promptly provide any information reasonably requested by the Company or the Purchaser for any regulatory application or

filing made, or approval sought in connection with the Business Combination (including filings with the SEC). Each of Sponsor and Purchaser

Insiders shall not issue any press release or otherwise make any public statements with respect to the Business Combination or the transactions

contemplated herein without the prior written approval of the Purchaser and the Company.

8.

Termination. Other than Section 5, which shall terminate in accordance with the terms of the Letter Agreement and Section

2 as set forth below, this Agreement, and the obligations of each of Sponsor and Purchaser Insiders under this Agreement shall automatically

terminate upon the earliest of: (a) the Closing Date; (b) the termination of the Share Purchase Agreement in accordance with its terms;

or (c) the mutual written agreement of the Company and Purchaser. Other than pursuant to Section 5, which shall terminate in accordance

with the terms of the Letter Agreement, upon termination or expiration of this Agreement, no party shall have any further obligations

or liabilities under this Agreement; provided, however, such termination or expiration shall not relieve any party from

liability for any willful breach of this Agreement occurring prior to its termination. The Transfer restrictions under Section 2

shall terminate upon the earlier of (A) one (1) year following the Business Combination, and (B) subsequent to the completion of the

Business Combination, (x) the date on which the last sale price of the Class A Shares equals or exceeds $12.00 per share (as adjusted

for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any twenty (20) trading days within

any 30-trading day period commencing at least one hundred eighty (180) days after the completion of the Business Combination, or (y)

the date on which Purchaser completes a liquidation, merger, amalgamation, capital stock exchange, reorganization or other similar transaction

that results in all of Purchaser’s Public Shareholders having the right to exchange their Class A Shares for cash, securities or

other property.

9.

Miscellaneous.

(a)

Except as otherwise provided herein or in the Share Purchase Agreement or any Ancillary Document, all costs and expenses incurred in

connection with this Agreement and the transactions contemplated hereby shall be paid by the party incurring such costs and expenses,

whether or not the transactions contemplated hereby are consummated.

(b)

All notices, requests, claims, demands and other communications hereunder shall be in writing and shall be given (and shall be deemed

to have been duly given upon receipt) by delivery in person, by telecopy, e-mail, facsimile or other electronic means, with affirmative

confirmation of receipt, one (1) Business Day after being sent, if sent by reputable, nationally recognized overnight courier service,

or three (3) Business Days after being mailed, if sent by registered or certified mail (postage prepaid, return receipt requested) to

the respective parties at the following addresses (or at such other address for a party as shall be specified in a notice given in accordance

with this Section 9(b)):

To

the Purchaser, to:

ARC

Group Acquisition I Corp.

398

S Mill Avenue,

Suite

306,

Tempe,

AZ 85284

Attn:

Datuk Dr. Doris Wong

Telephone

No.:

E-mail:

To

the Sponsor, to:

MFH

2, LLC

398

S Mill Avenue,

Suite

306,

Tempe,

AZ 85284

Attn:

Datuk Dr. Doris Wong

Telephone

No.:

E-mail:

with

a copy to:

Rimon,

P.C.

1050

Connecticut Avenue, NW, Suite 500

Washington,

DC 20006

Attn:

Debbie A. Klis Esq.; Mark C Lee, Esq.

Telephone

No.: (202) 935-3390

Email:

deborrah.klis@rimonlaw.com; mark.c.lee@rimonlaw.com

To

the Company, to:

Firstborn

Top Capital Sdn. Bhd.

13A-3A,

Q Sentral, 2A

Jalan

Stesen Sentral 2

KL

Sentral, Kuala Lumpur

Wilayah

Persekutuan 50470

Malaysia

Attn:

Wilson Ow

Telephone

No.:

E-mail:

with

a copy to:

Rohamat

& Ling

Unit

1009, 10th Floor, Menara PJ,

Amcorp

Trade Centre,

No.

18 Jalan Persiaran Barat,

46050

Petaling Jaya, Selangor.

Attn:

Mark Wong Kah Kit

Telephone

No.: 03-7932 5115

E-mail:

mark@r-ling.com

(c)

If any term or other provision of this Agreement is invalid, illegal or incapable of being enforced by any rule of law, or public policy,

all other conditions and provisions of this Agreement shall nevertheless remain in full force and effect so long as the economic or legal

substance of the transactions contemplated hereby is not affected in any manner materially adverse to any party. Upon such determination

that any term or other provision is invalid, illegal or incapable of being enforced, the parties hereto shall negotiate in good faith

to modify this Agreement so as to effect the original intent of the parties as closely as possible in a mutually acceptable manner in

order that the transactions contemplated hereby be consummated as originally contemplated to the fullest extent possible.

(d)

This Agreement, the Share Purchase Agreement and the Ancillary Documents constitute the entire agreement among the parties with respect

to the subject matter hereof and supersede all prior agreements and undertakings, both written and oral, among the parties, or any of

them, with respect to the subject matter hereof. This Agreement shall not be assigned (whether pursuant to a merger, by operation of

law or otherwise).

(e)

This Agreement shall be binding upon and inure solely to the benefit of each party hereto, and nothing in this Agreement, express or

implied, is intended to or shall confer upon any other person any right, benefit or remedy of any nature whatsoever under or by reason

of this Agreement.

(f)

The parties hereto agree that irreparable damage may occur in the event any provision of this Agreement is not performed in accordance

with the terms hereof and that the parties shall be entitled to specific performance of the terms hereof, in addition to any other remedy

at law or in equity. Each of the parties agrees that it shall not oppose the granting of an injunction, specific performance, and other

equitable relief when expressly available pursuant to the terms of this Agreement on the basis that the other parties have an adequate

remedy at law or an award of specific performance is not an appropriate remedy for any reason at law or equity. Any party seeking an

injunction or injunctions to prevent breaches or threatened breaches of, or to enforce compliance with this Agreement when expressly

available pursuant to the terms of this Agreement shall not be required to provide any bond or other security in connection with any

such Order.

(g)

This Agreement shall be governed by, and construed in accordance with, the Laws of the State of Delaware applicable to contracts executed

in and to be performed in that State without giving effect to principles or rules of conflict of laws to the extent such principles or

rules would require or permit the application of Laws of another jurisdiction. All actions, suits or proceedings (collectively, “Action”)

arising out of or relating to this Agreement shall be heard and determined exclusively in any federal or state court having jurisdiction

located in Delaware (or in any appellate courts thereof) (the “Specified Courts”). The parties hereto hereby (i) submit

to the exclusive jurisdiction of federal or state courts within the State of Delaware for the purpose of any Action arising out of or

relating to this Agreement brought by any party hereto, and (ii) irrevocably waive, and agree not to assert by way of motion, defense,

or otherwise, in any such Action, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its

property is exempt or immune from attachment or execution, that the Action is brought in an inconvenient forum, that the venue of the

Action is improper, or that this Agreement or the transactions contemplated hereunder may not be enforced in or by any Specified Court.

Each party agrees that a final judgment in any Action shall be conclusive and may be enforced in other jurisdictions by suit on the judgment

or in any other manner provided by Law. Each party irrevocably consents to the service of the summons and complaint and any other process

in any other action or proceeding relating to the transactions contemplated by this Agreement, on behalf of itself, or its property,

by personal delivery of copies of such process to such party at the applicable address set forth in Section 9(b). Nothing in this

Section shall affect the right of any party to serve legal process in any other manner permitted by applicable law.

(h)

WAIVER OF JURY TRIAL. EACH OF THE PARTIES HERETO HEREBY WAIVES TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW ANY RIGHT IT

MAY HAVE TO A TRIAL BY JURY WITH RESPECT TO ANY ACTION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT

OR THE TRANSACTIONS CONTEMPLATED HEREBY. EACH PARTY HERETO (i) CERTIFIES THAT NO REPRESENTATIVE OF ANY OTHER PARTY HAS REPRESENTED,

EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF ANY ACTION, SEEK TO ENFORCE THAT FOREGOING WAIVER AND (ii) ACKNOWLEDGES

THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS

IN THIS SECTION.

(i)

This Agreement may be executed and delivered (including by facsimile or electronic portable document format (.pdf) transmission) in one

or more counterparts, and by the different parties hereto in separate counterparts, each of which when executed shall be deemed to be

an original but all of which taken together shall constitute one and the same agreement.

(j)

Without further consideration, each party shall use commercially reasonable efforts to execute and deliver or cause to be executed and

delivered such additional documents and instruments and take all such further action as may be reasonably necessary or desirable to consummate

the transactions contemplated by this Agreement.

(k)

This Agreement shall not be effective or binding upon Sponsor until such time as the Share Purchase Agreement is executed by each of

the parties thereto.

(l)

If, and as often as, there are any changes in Purchaser or Purchaser Ordinary Shares by way of stock split, stock dividend, combination

or reclassification, or through merger, consolidation, reorganization, recapitalization or business combination, or by any other means,

equitable adjustment shall be made to the provisions of this Agreement as may be required so that the rights, privileges, duties and

obligations hereunder shall continue with respect to Purchaser, Purchaser Insiders, Sponsor and the Subject Securities as so changed,

and the term “Subject Securities” shall be deemed to refer to and include the Subject Securities as well as all such stock

dividends and distributions and any securities into which or for which any or all of the Subject Securities may be changed or exchanged

or which are received in such transaction.

(m)

The titles and subtitles used in this Agreement are for convenience only and are not to be considered in construing or interpreting this

Agreement. In this Agreement, unless the context otherwise requires: (i) any pronoun used in this Agreement shall include the corresponding

masculine, feminine, or neuter forms, and the singular form of nouns, pronouns, and verbs shall include the plural and vice versa; (ii)

“including” (and with correlative meaning “include”) means including without limiting the generality of any description

preceding or succeeding such term and shall be deemed in each case to be followed by the words “without limitation”; (iii)

the words “herein,” “hereto,” and “hereby” and other words of similar import in this Agreement shall

be deemed in each case to refer to this Agreement as a whole and not to any particular section or other subdivision of this Agreement;

and (iv) the term “or” means “and/or”. The Parties have participated jointly in the negotiation and drafting

of this Agreement. Consequently, in the event an ambiguity or question of intent or interpretation arises, this Agreement shall be construed

as if drafted jointly by the Parties hereto, and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue

of the authorship of any provision of this Agreement.

(n)

Any term of this Agreement may be amended, and the observance of any term of this Agreement may be waived (either generally or in a particular

instance, and either retroactively or prospectively) only with the written consent of Purchaser, Purchaser Insiders, the Company and

Sponsor. No failure or delay by a party in exercising any right hereunder shall operate as a waiver thereof. No waivers of or exceptions

to any term, condition, or provision of this Agreement, in any one or more instances, shall be deemed to be or construed as a further

or continuing waiver of any such term, condition, or provision.

(o)

This Agreement is intended to create a contractual relationship among Sponsor, Purchaser Insiders, the Company and Purchaser, and is

not intended to create, and does not create, any agency, partnership, joint venture, or any like relationship among the parties hereto

or among any other shareholders of Purchaser entering into voting agreements with the Company or Purchaser. Each of Sponsor and Purchaser

Insiders has acted independently regarding its decision to enter into this Agreement. Nothing contained in this Agreement shall be deemed

to vest in the Company or Purchaser any direct or indirect ownership or incidence of ownership of or with respect to any Subject Securities.

[Signature

pages follow]

IN

WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

PURCHASER:

ARC

GROUP ACQUISITION I CORP.

By:

Name:

Datuk

Dr. Doris Wong

Title:

Chief

Executive Officer

SPONSOR:

MFH

2, LLC

By:

Name:

Datuk

Dr. Doris Wong

Title:

Chief

Executive Officer

COMPANY:

FIRSTBORN

TOP CAPITAL SDN. BHD.

By:

Name:

Wilson

Ow Ruey Shen

Title:

Chief

Executive Officer

PURCHASER

INSIDERS:

By:

Name:

Datuk

Dr. Doris Wong

Title:

Chief

Executive Officer

[Signature

Page to Sponsor Support Agreement]

Schedule

A

EX-10.2

EX-10.2

Filename: ex10-2.htm · Sequence: 4

Exhibit 10.2

COMPANY

SUPPORT AGREEMENT

This

COMPANY SUPPORT AGREEMENT (this “Agreement”) is made and entered into as of September 10, 2026, by and among ARC Group

Acquisition I Corp., a British Virgin Islands business company (“Purchaser”), Firstborn Top Capital Sdn. Bhd., a Malaysian

private limited company (the “Company”), and the officers, directors and shareholders of the Company listed on Schedule

A hereto (the “Company Shareholders”). Any capitalized term used but not defined in this Agreement will have the

meaning ascribed to such term in the Share Purchase Agreement (as defined below).

RECITALS

WHEREAS,

contemporaneously herewith, Purchaser, the Company, the shareholders of the Company (the “Selling Shareholders”) and

a representative each of Purchaser and the Company, entered into a share purchase agreement, dated September 10, 2026 (the “Share

Purchase Agreement”), pursuant to which the Selling Shareholders agreed to sell and transfer to Purchaser, and Purchaser

agreed to purchase, acquire and accept from the Selling Shareholders, all of the issued and outstanding capital shares of the Company,

upon the terms and conditions set forth therein (the “Business Combination”).

WHEREAS,

as of the date of this Agreement, each Company Shareholder is the holder of record and the “beneficial owner” (within the

meaning of Rule 13d-3 under the Exchange Act) of the issued and outstanding Company Ordinary Shares set forth opposite such Company Shareholder’s

name on Schedule A hereto (all such securities or other equity securities, together with any classes of the Company’s shares,

or other equity securities of which ownership of record or the power to vote (including, without limitation, by proxy or power of attorney)

is hereafter acquired by such Company Shareholder during the period from the date hereof through the termination of this Agreement are

referred to herein as the “Subject Shares”); and

WHEREAS,

in order to induce Purchaser to enter into the Share Purchase Agreement and to consummate the Business Combination, the parties hereto

are executing and delivering this Agreement.

NOW,

THEREFORE, in consideration of the foregoing, which are incorporated into this Agreement as if fully set forth below, and of the mutual

covenants and agreements contained herein, and intending to be legally bound hereby, the parties hereby agree as follows:

1.

Agreement to Vote. Each Company Shareholder, severally and not jointly, with respect to the Subject Shares, hereby agrees (and

agrees to execute such documents or certificates evidencing such agreement as Purchaser may request in connection therewith), irrevocably

and unconditionally, to:

(a)

when any meetings of the shareholders of the Company are held, appear at such meeting or otherwise cause the Subject Shares to be counted

as present thereat for the purpose of establishing a quorum;

(b)

vote at any meetings of the shareholders of the Company, and in any action by written consent of the shareholders of the Company, all

of the Subject Shares (i) in favor of the approval and adoption of the Share Purchase Agreement, the Ancillary Documents and the Business

Combination, (ii) in favor of the approval of any other matter reasonably necessary to the consummation of the Business Combination and

considered and voted upon by the Company Shareholders, and (iii) against (A) any Acquisition Proposal relating to an Alternative Transaction

with respect to the Company and any and all other proposals (x) for a Business Combination involving the Company with other Person(s),

(y) that could reasonably be expected to in any material respect delay or impair the ability of the Company to consummate any of the

Business Combination, or (z) which are in competition with or materially inconsistent with the Share Purchase Agreement or the Ancillary

Documents or (B) any action or proposal involving the Company that is intended, or would reasonably be expected to prevent, impede, interfere

with, delay, postpone or adversely affect in any material respect the Business Combination or would reasonably be expected to result

in any of the conditions to the Closing under the Share Purchase Agreement not being fulfilled;

(c)

execute and deliver all related documentation and take such other action in support of the Share Purchase Agreement, the Ancillary Documents

and the Business Combination, as shall reasonably be requested by Purchaser, in order to carry out the terms and provisions of this Section

1, including, without limitation, the execution and delivery of any applicable Ancillary Documents, customary instruments of conveyance

and transfer, and any consent, waiver, governmental filing, and any similar or related documents; and

(d)

except as contemplated by the Share Purchase Agreement or the Ancillary Documents, not make, or in any manner participate in, directly

or indirectly, a “solicitation” of “proxies” or consents (as such terms are used in the rules of the SEC) or

powers of attorney or similar rights to vote.

2.

Representations and Warranties. Each Company Shareholder, severally and not jointly, represents and warrants to Purchaser and

the Company as follows:

(a)

Such Company Shareholder has received and reviewed a copy of the Share Purchase Agreement and this Agreement and has had the opportunity

to consult with their tax and legal advisors.

(b)

The execution, delivery and performance by such Company Shareholder of this Agreement and the consummation by such Company Shareholder

of the transactions contemplated hereby do not and will not (i) conflict with or violate any Law or Order applicable to such Company

Shareholder or any agreement to which such Company Shareholder is bound, (ii) require any consent, approval or authorization of, declaration,

filing or registration with, or notice to, any person or entity, (iii) result in the creation of any Lien on any Subject Shares of such

Company Shareholder (other than pursuant to this Agreement to the extent applicable), or (iv) conflict with or result in a breach of

or constitute a default under any provision of the Governing Documents of such Company Shareholder, if and as applicable.

(c)

Such Company Shareholder owns of record and has good, valid and marketable title to all of the Subject Shares free and clear of any Lien

(other than pursuant to this Agreement to the extent applicable) and has the sole or shared power (as currently in effect) to vote the

Subject Shares and subject to the Lock-Up Agreement, has the full right, power and authority to sell, transfer and deliver the Subject

Shares. Such Company Shareholder does not own, directly or indirectly, (i) any other Company Securities other than the Subject Shares

or (ii) any options, warrants or other rights to acquire any additional shares of the Company or any security exercisable for or convertible

into Company Securities other than the Subject Shares.

(d)

If such Company Shareholder (i) is not an individual, such Company Shareholder is duly organized, validly existing and in good standing

under the Laws of the jurisdiction in which it is organized, and has the power, authority and capacity to execute, deliver and perform

this Agreement, and this Agreement has been duly authorized, executed and delivered by such Company Shareholder; and (ii) is an individual,

the signature on this Agreement is genuine, such Company Shareholder has legal competence and capacity to execute the same.

(e)

This Agreement has been duly executed and delivered by such Company Shareholder and, assuming due authorization, execution and delivery

by the other parties to this Agreement, this Agreement constitutes a legally valid and binding obligation of such Company Shareholder,

enforceable against such Company Shareholder in accordance with the terms hereof (except as enforceability may be limited by bankruptcy

Laws, other similar Laws affecting creditors’ rights and general principles of equity affecting the availability of specific performance

and other equitable remedies).

(f)

There is no Action pending, or, to the knowledge of such Company Shareholder, threatened, against such Company Shareholder in writing

that would reasonably be expected to materially impair the ability of such Company Shareholder to perform its obligations hereunder or

to consummate the transactions contemplated by this Agreement or the Business Combination.

(g)

Such Company Shareholder has never been suspended or expelled from membership in any securities or commodities exchange or association

or had a securities or commodities license or registration denied, suspended or revoked.

(h)

Except as set forth in the Company Disclosure Schedule, no broker, finder, investment banker or other Person is entitled to any brokerage

fee, finders’ fee or other commission in connection with this Agreement or any of the respective transactions contemplated hereby,

based upon arrangements made by or on behalf of such Company Shareholder.

3.

Other Covenants and Agreements.

(a)

Each Company Shareholder agrees to and shall be bound by and subject to Section 7.6 (No Solicitation), Section 7.12

(Public Announcements), Section 7.13 (Confidential Information), and Section 11.1 (Waiver of Claims Against

Trust) of the Share Purchase Agreement to the same extent as such provisions apply to the Company, as if such Company Shareholder

was directly party thereto.

(b)

Each Company Shareholder hereby waives, and agrees not to assert or perfect, any rights of appraisal or rights to dissent from the Business

Combination that such Company Shareholder may have by virtue of ownership of the Subject Shares and agrees not to commence or participate

in any claim, derivative or otherwise, against Purchaser relating to the negotiation, execution or delivery of this Agreement or the

Share Purchase Agreement or the consummation of the Business Combination.

(c)

Each Company Shareholder agrees not to take or agree or commit to take any action that would make any representation or warranty of such

Company Shareholder contained in this Agreement inaccurate in any material respect. Each Company Shareholder further agrees that it shall

use its reasonable best efforts to cooperate with the Company and Purchaser to effect the Business Combination, the Share Purchase Agreement,

the Ancillary Documents, and the provisions of this Agreement.

(d)

Each Company Shareholder hereby consents to the publication and disclosure in the Form S-4, and the Proxy Statement (and, as and to the

extent otherwise required by applicable securities Laws or the SEC or any other securities authorities, any other documents or communications

provided by the Company to any Authority or to securityholders of the Company) of such Company Shareholder’s identity and beneficial

ownership of the Subject Shares and the nature of such Company Shareholder’s commitments, arrangements and understandings under

and relating to this Agreement and, if deemed appropriate by the Company or the Purchaser, a copy of this Agreement. Each Company Shareholder

will promptly provide any information reasonably requested by the Company or the Purchaser for any regulatory application or filing made

or approval sought in connection with the Business Combination (including filings with the SEC). No Company Shareholder shall issue any

press release or otherwise make any public statements with respect to the Business Combination or the transactions contemplated herein

without the prior written approval of the Purchaser and the Company.

4.

Termination. This Agreement, and the obligations of the Company Shareholders under this Agreement shall automatically terminate

upon the earliest of: (a) the Closing Date; (b) the termination of the Share Purchase Agreement in accordance with its terms; or (c)

the mutual written agreement of the Company Shareholders, the Company and Purchaser. Upon termination or expiration of this Agreement,

no party shall have any further obligations or liabilities under this Agreement; provided, however, such termination or

expiration shall not relieve any party from liability for any willful breach of this Agreement occurring prior to its termination.

5.

Miscellaneous.

(a)

Except as otherwise provided herein or in the Share Purchase Agreement or any Ancillary Document, all costs and expenses incurred in

connection with this Agreement and the transactions contemplated hereby shall be paid by the party incurring such costs and expenses,

whether or not the transactions contemplated hereby are consummated.

(b)

All notices, consents, waivers and other communications hereunder shall be governed by the provisions under the Share Purchase Agreement.

(c)

If any term or other provision of this Agreement is invalid, illegal or incapable of being enforced by any rule of law, or public policy,

all other conditions and provisions of this Agreement shall nevertheless remain in full force and effect so long as the economic or legal

substance of the transactions contemplated hereby is not affected in any manner materially adverse to any party. Upon such determination

that any term or other provision is invalid, illegal or incapable of being enforced, the parties hereto shall negotiate in good faith

to modify this Agreement so as to effect the original intent of the parties as closely as possible in a mutually acceptable manner in

order that the transactions contemplated hereby be consummated as originally contemplated to the fullest extent possible.

(d)

This Agreement, the Share Purchase Agreement and the Ancillary Documents constitute the entire agreement among the parties with respect

to the subject matter hereof and supersede all prior agreements and undertakings, both written and oral, among the parties, or any of

them, with respect to the subject matter hereof. This Agreement shall not be assigned (whether pursuant to a merger, by operation of

law or otherwise).

(e)

This Agreement shall be binding upon and inure solely to the benefit of each party hereto, and nothing in this Agreement, express or

implied, is intended to or shall confer upon any other person any right, benefit or remedy of any nature whatsoever under or by reason

of this Agreement.

(f)

The parties hereto agree that irreparable damage may occur in the event any provision of this Agreement was not performed in accordance

with the terms hereof and that the parties shall be entitled to specific performance of the terms hereof, in addition to any other remedy

at law or in equity. Each of the parties agrees that it shall not oppose the granting of an injunction, specific performance, and other

equitable relief when expressly available pursuant to the terms of this Agreement on the basis that the other parties have an adequate

remedy at law or an award of specific performance is not an appropriate remedy for any reason at law or equity. Any party seeking an

injunction or injunctions to prevent breaches or threatened breaches of, or to enforce compliance with this Agreement when expressly

available pursuant to the terms of this Agreement shall not be required to provide any bond or other security in connection with any

such Order.

(g)

This Agreement shall be governed by, and construed in accordance with, the Laws of the State of Delaware applicable to contracts executed

in and to be performed in that State without giving effect to principles or rules of conflict of laws to the extent such principles or

rules would require or permit the application of Laws of another jurisdiction. All actions, suits or proceedings (collectively, “Action”)

arising out of or relating to this Agreement shall be heard and determined exclusively in any federal or state court having jurisdiction

located in Delaware (or in any appellate courts thereof) (the “Specified Courts”). The parties hereto hereby (i) submit

to the exclusive jurisdiction of federal or state courts within the State of Delaware for the purpose of any Action arising out of or

relating to this Agreement brought by any party hereto, and (ii) irrevocably waive, and agree not to assert by way of motion, defense,

or otherwise, in any such Action, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its

property is exempt or immune from attachment or execution, that the Action is brought in an inconvenient forum, that the venue of the

Action is improper, or that this Agreement or the transactions contemplated hereunder may not be enforced in or by any Specified Court.

Each party agrees that a final judgment in any Action shall be conclusive and may be enforced in other jurisdictions by suit on the judgment

or in any other manner provided by Law. Each party irrevocably consents to the service of the summons and complaint and any other process

in any other action or proceeding relating to the transactions contemplated by this Agreement, on behalf of itself, or its property,

by personal delivery of copies of such process to such party at the applicable address set forth in Section 5(b). Nothing in this

Section shall affect the right of any party to serve legal process in any other manner permitted by applicable law.

(h)

WAIVER OF JURY TRIAL. EACH OF THE PARTIES HERETO HEREBY WAIVES TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW ANY RIGHT IT

MAY HAVE TO A TRIAL BY JURY WITH RESPECT TO ANY ACTION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT

OR THE TRANSACTIONS CONTEMPLATED HEREBY. EACH PARTY HERETO (i) CERTIFIES THAT NO REPRESENTATIVE OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY

OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF ANY ACTION, SEEK TO ENFORCE THAT FOREGOING WAIVER AND (ii) ACKNOWLEDGES

THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS

IN THIS SECTION.

(i)

This Agreement may be executed and delivered (including by facsimile or electronic portable document format (.pdf) transmission) in one

or more counterparts, and by the different parties hereto in separate counterparts, each of which when executed shall be deemed to be

an original but all of which taken together shall constitute one and the same agreement.

(j)

Without further consideration, each party shall use commercially reasonable efforts to execute and deliver or cause to be executed and

delivered such additional documents and instruments and take all such further action as may be reasonably necessary or desirable to consummate

the transactions contemplated by this Agreement.

(k)

This Agreement shall not be effective or binding upon any Company Shareholder until such time as the Share Purchase Agreement is executed

by each of the parties thereto.

(l)

If, and as often as, there are any changes in Company or Company Ordinary Shares by way of stock split, stock dividend, combination or

reclassification, or through merger, consolidation, reorganization, recapitalization or business combination, or by any other means,

equitable adjustment shall be made to the provisions of this Agreement as may be required so that the rights, privileges, duties and

obligations hereunder shall continue with respect to the Company and the Company Shareholders and the Subject Shares as so changed, and

the term “Subject Shares” shall be deemed to refer to and include the Subject Shares as well as all such stock dividends

and distributions and any securities into which or for which any or all of the Subject Shares may be changed or exchanged or which are

received in such transaction.

(m)

The titles and subtitles used in this Agreement are for convenience only and are not to be considered in construing or interpreting this

Agreement. In this Agreement, unless the context otherwise requires: (i) any pronoun used in this Agreement shall include the corresponding

masculine, feminine, or neuter forms, and the singular form of nouns, pronouns, and verbs shall include the plural and vice versa; (ii)

“including” (and with correlative meaning “include”) means including without limiting the generality of any description

preceding or succeeding such term and shall be deemed in each case to be followed by the words “without limitation”; (iii)

the words “herein,” “hereto,” and “hereby” and other words of similar import in this Agreement shall

be deemed in each case to refer to this Agreement as a whole and not to any particular section or other subdivision of this Agreement;

and (iv) the term “or” means “and/or”. The parties have participated jointly in the negotiation and drafting

of this Agreement. Consequently, in the event an ambiguity or question of intent or interpretation arises, this Agreement shall be construed

as if drafted jointly by the parties hereto, and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue

of the authorship of any provision of this Agreement.

(n)

Any term of this Agreement may be amended and the observance of any term of this Agreement may be waived (either generally or in a particular

instance, and either retroactively or prospectively) only with the written consent of Purchaser, the Company Shareholder (acting by majority

in interest of the Subject Shares), and the Company. No failure or delay by a party in exercising any right hereunder shall operate as

a waiver thereof. No waivers of or exceptions to any term, condition, or provision of this Agreement, in any one or more instances, shall

be deemed to be or construed as a further or continuing waiver of any such term, condition, or provision.

(o)

This Agreement is intended to create a contractual relationship among the Company Shareholders, the Company and Purchaser, and is not

intended to create, and does not create, any agency, partnership, joint venture, or any like relationship among the parties hereto or

among any other shareholders of the Company entering into voting agreements with the Company or Purchaser. Each Company Shareholder has

acted independently regarding its decision to enter into this Agreement. Nothing contained in this Agreement shall be deemed to vest

in Company Shareholder, the Company or Purchaser any direct or indirect ownership or incidence of ownership of or with respect to any

Subject Shares.

[Signature

pages follow]

IN

WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

PURCHASER:

ARC

GROUP ACQUISITION I CORP.

By:

Name:

Datuk

Dr. Doris Wong

Title:

Chief

Executive Officer

COMPANY:

FIRSTBORN

TOP CAPITAL SDN. BHD.

By:

Name:

Ow

Ruey Shen

Title:

Director

COMPANY

SHAREHOLDERS:

By:

Name:

Wong

Chee Sin

By:

Name:

Ow

Ruey Shen (Corporate Representative of Mastika Heritage Sdn Bhd)

By:

Name:

Phuah

Ee Jie

By:

Name:

Ng

Lei Teng (Corporate Representative of P88 Capital Sdn. Bhd.)

Schedule

A

EX-10.3

EX-10.3

Filename: ex10-3.htm · Sequence: 5

Exhibit

10.3

Exhibit

B

REGISTRATION

RIGHTS AGREEMENT

This

REGISTRATION RIGHTS AGREEMENT (this “Agreement”), is made and entered into effective as of [●], 2026, by and

among ARC Group Acquisition I Corp., a British Virgin Islands business company (“Purchaser”), MFH 2, LLC, a Delaware

limited liability company (the “Sponsor”), and each of the undersigned parties listed on the signature page hereto

under “Holders” (each such party, together with the Sponsor and any person or entity who hereafter becomes a party to this

Agreement pursuant to Section 5.2 of this Agreement, a “Holder” and collectively the “Holders”).

RECITALS

WHEREAS,

Purchaser, Firstborn Top Capital Sdn. Bhd., a Malaysian private limited company (the “Company”), the shareholders

of the Company (the “Selling Shareholders”) and a representative each of the Company and Purchaser entered into a

share purchase agreement, dated ________, 2026 (the “Share Purchase Agreement”), pursuant to which the Selling Shareholders

agreed to sell and transfer to Purchaser, and Purchaser agreed to purchase, acquire and accept from the Selling Shareholders, all of

the issued and outstanding capital shares of the Company, upon the terms and conditions set forth therein (the “Business Combination”);

WHEREAS,

at the completion of the Business Combination, Purchaser shall issue as consideration to the Selling Shareholders Class A Shares (as

defined below) of Purchaser (the “Consideration Shares”), in exchange for the ordinary shares of the Company held

thereby;

WHEREAS,

Purchaser, the Sponsor and certain Holders named therein are parties to a certain Registration Rights Agreement dated April 29, 2026

(the “Prior Agreement”), pursuant to which Purchaser granted to the Sponsor certain registration rights related to

securities of Purchaser held thereby; and

WHEREAS,

the parties to the Prior Agreement desire to terminate such agreement and enter into this Agreement, effective as of the completion of

the Business Combination, to provide the Sponsor and the Holders with certain registration rights pursuant to the terms and conditions

of this Agreement.

NOW,

THEREFORE, in consideration of the representations, covenants and agreements contained herein, and certain other good and valuable

consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, hereby

agree as follows:

ARTICLE

I

DEFINITIONS

1.1

Definitions. The terms defined in this Article I shall, for all purposes of this Agreement, have the respective

meanings set forth below. Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to such terms in the

Business Combination Agreement.

“Adverse

Disclosure” shall mean any public disclosure of material non-public information, which disclosure, in the good faith judgment

of the Chief Executive Officer or principal financial officer of Purchaser, after consultation with counsel to Purchaser, (i) would be

required to be made in any Registration Statement or Prospectus in order for the applicable Registration Statement or Prospectus not

to contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements contained therein

(in the case of any prospectus and any preliminary prospectus, in the light of the circumstances under which they were made) not misleading,

(ii) would not be required to be made at such time if the Registration Statement were not being filed, and (iii) Purchaser has a bona

fide business purpose for not making such information public.

“Agreement”

shall have the meaning given in the Preamble.

“Board”

shall mean the Board of Directors of Purchaser.

“Business

Combination” shall have the meaning given in the Recitals.

“Class

A Shares” shall mean Class A ordinary shares of Purchaser, par value $0.0001 per share.

“Commission”

shall mean the United States Securities and Exchange Commission.

“Company”

shall have the meaning given in the Preamble.

“Consideration

Shares Lock-up Period” means with respect to the Holders of Consideration Shares, the period ending on the earlier of (A) one

(1) year following the Business Combination and (B) subsequent to the completion of the Business Combination, (x) the date on which the

last sale price of the Class A Shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations,

reorganizations, recapitalizations and the like) for any twenty (20) trading days within any 30-trading day period commencing at least

one hundred eighty (180) days after the completion of the Business Combination, or (y) the date on which Purchaser completes a liquidation,

merger, amalgamation, capital stock exchange, reorganization or other similar transaction that results in all of Purchaser’s Public

Shareholders having the right to exchange their Class A Shares for cash, securities or other property.

“Demand

Registration” shall have the meaning given in subsection 2.2.1.

“Demanding

Holder” shall have the meaning given in subsection 2.2.1.

“Exchange

Act” shall mean the Securities Exchange Act of 1934, as it may be amended from time to time.

“Filing

Date” means, with respect to the Initial Registration Statement required to be filed on or before the 30th calendar day following

the date hereof and, with respect to any additional Registration Statements which may be required pursuant to Sections 2.2 and

2.3, the earliest practical date on which Purchaser is permitted by Commission guidance to file such additional Registration Statement

related to the Registrable Securities; provided, however, that, if the Filing Date falls on a Saturday, Sunday or any other day which

shall be a legal holiday or a day on which the Commission is authorized or required by law or other government actions to close, the

Filing Date shall be the following Business Day.

“Form

S-1” shall have the meaning given in subsection 2.2.1.

“Form

S-3” shall have the meaning given in subsection 2.4.

“Founder

Shares” shall mean 5,175,000 shares of Class B ordinary shares, par value $0.00001 per share, and shall be deemed to include

the Class A Shares issuable upon conversion thereof.

“Holders”

shall have the meaning given in the Preamble.

“Initial

Registration Statement” means the Registration Statement required to be filed pursuant to Section 2.1.

“Insider

Letter” shall mean that certain letter agreement, dated as of April 29, 2026, by and among Purchaser, the Sponsor and each

of Purchaser’s officers and directors.

“Lock-up

Agreement” shall mean that certain Lock-up Agreement, dated [*], 2026.

“Maximum

Number of Securities” shall have the meaning given in subsection 2.2.4.

“Misstatement”

shall mean an untrue statement of a material fact or an omission to state a material fact required to be stated in a Registration Statement

or Prospectus, or necessary to make the statements in a Registration Statement or Prospectus (in the light of the circumstances under

which they were made) not misleading.

“Permitted

Transferees” shall mean any person or entity to whom a Holder of Registrable Securities is permitted to transfer such Registrable

Securities prior to the expiration of the applicable Sponsor Lock-up Period or Consideration Shares Lock-up Period, and to any transferee

thereafter.

“Person”

shall mean an individual, a corporation, a partnership, a joint venture, a trust, an unincorporated organization, a limited liability

company or partnership, a government and any agency or political subdivision thereof.

“Piggyback

Registration” shall have the meaning given in subsection 2.3.1.

“Purchaser”

shall have the meaning given in the Preamble.

“Private

Placement Rights” means the rights included in the Private Placement Units.

“Private

Placement Shares” means the Class A Shares included in the Private Placement Units.

“Private

Placement Units” means an aggregate of 200,000 private placement units purchased by the Sponsor pursuant to the Private Units

Purchase Agreement.

“Private

Placement Warrants” means the warrants included in the Private Placement Units.

“Private

Units Purchase Agreement” means that certain Private Units Purchase Agreement, dated April 29, 2026, by and between Purchaser

and the Sponsor.

“Pro

Rata” shall have the meaning given in subsection 2.1.2.

“Prospectus”

shall mean the prospectus included in any Registration Statement, as supplemented by any and all prospectus supplements and as amended

by any and all post-effective amendments and including all material incorporated by reference in such prospectus.

“Registrable

Security” shall mean (a) the Founder Shares and the Class A Shares issued or issuable upon the conversion of the Founder Shares,

(b) the Private Placement Shares, the Private Placement Warrants, and any Class A Shares issued or issuable upon the exercise of the

Private Placement Warrants and the conversion of the Private Placement Rights, (c) any outstanding Class A Shares or any other equity

security (including the Class A Shares issued or issuable upon the exercise of any other equity security) of Purchaser held by a Holder

as of the date of this Agreement, (d) any equity securities (including the Class A Shares issued or issuable upon the exercise of any

such equity security) of Purchaser issuable upon conversion of any working capital loans in an amount up to $2,500,000 made to Purchaser

by a Holder, (e) the Consideration Shares, and (f) any other equity security of Purchaser issued or issuable by way of a share capitalization

or share split or in connection with a combination of shares, recapitalization, merger, consolidation or reorganization; provided,

however, that, as to any particular Registrable Security, such securities shall cease to be Registrable Securities when: (A) a

Registration Statement with respect to the sale of such securities shall have become effective under the Securities Act and such securities

shall have been sold, transferred, disposed of or exchanged in accordance with such Registration Statement; (B) such securities shall

have been otherwise transferred, new certificates for such securities not bearing a legend restricting further transfer shall have been

delivered by Purchaser and subsequent public distribution of such securities shall not require registration under the Securities Act;

(C) such securities shall have ceased to be outstanding; (D) such securities may be sold without registration pursuant to Rule 144 promulgated

under the Securities Act (or any successor rule promulgated thereafter by the Commission) (but with no volume or other restrictions or

limitations); or (E) such securities have been sold to, or through, a broker, dealer or underwriter in a public distribution or other

public securities transaction.

“Registration”

shall mean a registration effected by preparing and filing a registration statement or similar document in compliance with the requirements

of the Securities Act, and the applicable rules and regulations promulgated thereunder, and such registration statement becoming effective.

“Registration

Expenses” shall mean the out-of-pocket expenses of a Registration, including, without limitation, the following:

(A)

all registration and filing fees (including fees with respect to filings required to be made with the Financial Industry Regulatory Authority

Inc.) and any securities exchange on which the Class A Shares are then listed;

(B)

fees and expenses of compliance with securities or blue sky laws (including reasonable fees and disbursements of outside counsel for

the Underwriters in connection with blue sky qualifications of Registrable Securities);

(C)

printing, messenger, telephone and delivery expenses;

(D)

reasonable fees and disbursements of counsel for Purchaser;

(E)

reasonable fees and disbursements of all independent registered public accountants of Purchaser incurred specifically in connection with

such Registration; and

(F)

reasonable fees and expenses of one (1) legal counsel selected by the Demanding Holders holding the majority of shares to be included

in initiating a Demand Registration to be registered for offer and sale in the applicable Registration.

“Registration

Statement” shall mean any registration statement that covers the Registrable Securities pursuant to the provisions of this

Agreement, including the Prospectus included in such registration statement, amendments (including post-effective amendments) and supplements

to such registration statement, and all exhibits to and all material incorporated by reference in such registration statement.

“Requesting

Holder” shall have the meaning given in subsection 2.2.1.

“Securities

Act” shall mean the Securities Act of 1933, as amended from time to time.

“Sponsor”

shall have the meaning given in the Preamble.

“Sponsor

Lock-up Period” shall mean, with respect to the Founder Shares, Private Placement Shares, the Private Placement Warrants, any

Class A Shares issued or issuable upon the exercise of the Private Placement Warrants, and any Class A Shares issued or issuable upon

the conversion of the Private Placement Rights, the period ending on the earlier of (A) one year following the Business Combination and

(B) subsequent to the completion of the Business Combination, (x) the date on which the last sale price of the Class A Shares equals

or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like)

for any 20 trading days within any 30-trading day period commencing at least 180 days after the completion of the Business Combination,

or (y) the date on which Purchaser completes a liquidation, merger, amalgamation, capital stock exchange, reorganization or other similar

transaction that results in all of Purchaser’s Public Shareholders having the right to exchange their Class A Shares for cash,

securities or other property.

“Underwriter”

shall mean a securities dealer who purchases any Registrable Securities as principal in an Underwritten Offering and not as part of such

dealer’s market-making activities.

“Underwritten

Registration” or “Underwritten Offering” shall mean a Registration in which securities of Purchaser are

sold to an Underwriter in a firm commitment underwriting for distribution to the public.

ARTICLE

II

REGISTRATION

RIGHTS

2.1

Shelf Registration.

2.1.1

On or prior to each Filing Date, Purchaser shall prepare and file with the Commission a Registration Statement covering the resale

of all or such maximum portion of the Registrable Securities as permitted by Commission guidance (provided that, Purchaser shall use

diligent efforts to advocate with the Commission for the registration of all of the Registrable Securities in accordance with the

Commission guidance, including without limitation, the Manual of Publicly Available Telephone Interpretations D.29) that are not

then registered on an effective Registration Statement for an offering to be made on a continuous basis pursuant to Rule 415. Each

Registration Statement filed hereunder shall be on Form S-1 (except if Purchaser is then eligible to register for resale the

Registrable Securities on Form S-3, such registration shall be on Form S-3 in accordance herewith). Subject to the terms of this

Agreement, Purchaser shall use its commercially reasonable efforts to cause a Registration Statement to be declared effective under

the Securities Act as promptly as practicable after the filing thereof, but in any event prior to the applicable Effectiveness Date,

and shall use its commercially reasonable efforts to keep such Registration Statement continuously effective under the Securities

Act until all Registrable Securities covered by such Registration Statement have been sold, or may be sold without volume or

manner-of-sale restrictions pursuant to Rule 144, without the requirement for Purchaser to be in compliance with the current public

information requirement under Rule 144, as determined by the counsel to Purchaser pursuant to a written opinion letter to such

effect, addressed and acceptable to Purchaser’s Transfer Agent and the affected Holders (the “Effectiveness

Period”). Purchaser shall telephonically request effectiveness of a Registration Statement as of 5:00 p.m. New York City

time on a Business Day. Purchaser shall promptly notify the Holders by e-mail of the effectiveness of a Registration Statement on

the same Business Day that Purchaser telephonically confirms effectiveness with the Commission. Purchaser shall, no later than the

second Business Day after the effective date of such Registration Statement, file a final Prospectus with the Commission as required

by Rule 424.

2.1.2

Notwithstanding any other provision of this Agreement, if any Commission guidance sets forth a limitation on the number of Registrable

Securities permitted to be registered on a particular Registration Statement (and notwithstanding that Purchaser used diligent efforts

to advocate with the Commission for the registration of all or a greater portion of Registrable Securities), the number of Registrable

Securities to be registered shall be reduced on a pro rata basis based on the total number of Registrable Securities held by such Holders

(such proportion is referred to herein as “Pro Rata”). In the event of a reduction hereunder, Purchaser shall give

the Holder at least five (5) Business Days prior written notice along with the calculations as to such Holder’s allotment. Promptly

after such Commission guidance is no longer applicable with respect to some or all of the remaining unregistered Registrable Securities,

Purchaser shall file an additional Registration Statement in accordance with this Section 2.1.2 with respect to such Registrable

Securities.

2.1.3

Each Holder agrees to furnish to Purchaser a completed Selling Shareholder Questionnaire within five (5) Business Days following the

date of this Agreement. Each Holder further acknowledges and agrees that it shall not be entitled to be named as a selling security holder

in the Registration Statement or use the Prospectus for offers and resales of Registrable Securities at any time unless such Holder has

returned to Purchaser a completed and signed Selling Shareholder Questionnaire. If a Holder of Registrable Securities returns a Selling

Shareholder Questionnaire after the deadline specified in the previous sentence, Purchaser shall use its commercially reasonable efforts

to take such actions as are required to name such Holder as a selling security holder in the Registration Statement or any pre-effective

or post-effective amendment thereto and to include (to the extent not theretofore included) in the Registration Statement the Registrable

Securities identified in such late Selling Shareholder Questionnaire; provided that Purchaser shall not be required to file an additional

Registration Statement solely for such shares. Each Holder acknowledges and agrees that the information in the Selling Shareholder Questionnaire

will be used by Purchaser in the preparation of the Registration Statement and hereby consents to the inclusion of such information in

the Registration Statement.

2.2

Demand Registration.

2.2.1

Request for Registration. Subject to the provisions of subsection 2.2.4 and Section 2.5 hereof, at any time and

from time to time on or after the date Purchaser consummates the Business Combination, the Holders of at least twenty-five percent (25%)

of the then-outstanding number of Registrable Securities (the “Demanding Holders”) may make a written demand for Registration

of all or part of their Registrable Securities, which written demand shall describe the amount and type of securities to be included

in such Registration and the intended method(s) of distribution thereof (such written demand a “Demand Registration”).

Purchaser shall, within ten (10) days of Purchaser’s receipt of the Demand Registration, notify, in writing, all other Holders

of Registrable Securities of such demand, and each Holder of Registrable Securities who thereafter wishes to include all or a portion

of such Holder’s Registrable Securities in a Registration pursuant to a Demand Registration (each such Holder that includes all

or a portion of such Holder’s Registrable Securities in such Registration, a “Requesting Holder”) shall so notify

Purchaser, in writing, within five (5) days after the receipt by the Holder of the notice from Purchaser. Upon receipt by Purchaser of

any such written notification from a Requesting Holder(s) to Purchaser, such Requesting Holder(s) shall be entitled to have their Registrable

Securities included in a Registration pursuant to a Demand Registration and Purchaser shall use its commercially reasonable efforts to

effect, as soon thereafter as practicable, but not more than forty five (45) days immediately after Purchaser’s receipt of the

Demand Registration, the Registration of all Registrable Securities requested by the Demanding Holders and Requesting Holders pursuant

to such Demand Registration. Under no circumstances shall Purchaser be obligated to effect more than an aggregate of two (2) Registrations

pursuant to a Demand Registration under this subsection 2.2.1 with respect to any or all Registrable Securities; provided,

however, that a Registration shall not be counted for such purposes unless a Form S-1 or any similar long-form registration statement

that may be available at such time (“Form S-1”) has become effective and all of the Registrable Securities requested

by the Requesting Holders to be registered on behalf of the Requesting Holders in such Form S-1 Registration have been sold, in accordance

with Section 3.1 of this Agreement.

2.2.2

Effective Registration. Notwithstanding the provisions of subsection 2.2.1 above or any other part of this Agreement, a

Registration pursuant to a Demand Registration shall not count as a Registration unless and until (i) the Registration Statement filed

with the Commission with respect to a Registration pursuant to a Demand Registration has been declared effective by the Commission and

(ii) Purchaser has complied with all of its obligations under this Agreement with respect thereto; provided, further, that

if, after such Registration Statement has been declared effective, an offering of Registrable Securities in a Registration pursuant to

a Demand Registration is subsequently interfered with by any stop order or injunction of the Commission, federal or state court or any

other governmental agency the Registration Statement with respect to such Registration shall be deemed not to have been declared effective,

unless and until, (i) such stop order or injunction is removed, rescinded or otherwise terminated, and (ii) Demanding Holders holding

a majority in interest of the outstanding Registrable Securities initiating such Demand Registration thereafter affirmatively elect to

continue with such Registration and accordingly notify Purchaser in writing, but in no event later than five (5) days, of such election;

and provided, further, that Purchaser shall not be obligated or required to file another Registration Statement until the

Registration Statement that has been previously filed with respect to a Registration pursuant to a Demand Registration becomes effective

or is subsequently terminated.

2.2.3

Underwritten Offering. Subject to the provisions of subsection 2.2.4 and Section 2.4 hereof, if a majority-in-interest

of the Demanding Holders advise Purchaser as part of their Demand Registration that the offering of the Registrable Securities pursuant

to such Demand Registration shall be in the form of an Underwritten Offering, then the right of such Demanding Holder or Requesting Holder

(if any) to include its Registrable Securities in such Registration shall be conditioned upon such Holder’s participation in such

Underwritten Offering and the inclusion of such Holder’s Registrable Securities in such Underwritten Offering to the extent provided

herein. All such Holders proposing to distribute their Registrable Securities through an Underwritten Offering under this subsection

2.2.3 shall enter into an underwriting agreement in customary form with the Underwriter(s) selected for such Underwritten Offering

by the holders of a majority in interest of shares by Demanding Holders initiating the Demand Registration.

2.2.4

Reduction of Underwritten Offering. If the managing Underwriter or Underwriters in an Underwritten Registration pursuant to a

Demand Registration, in good faith, advises Purchaser, the Demanding Holders and the Requesting Holders (if any) in writing that the

dollar amount or number of Registrable Securities that the Demanding Holders and the Requesting Holders (if any) desire to sell, taken

together with all other Class A Shares or other equity securities that Purchaser desires to sell and the Class A Shares, if any, as to

which a Registration has been requested pursuant to separate written contractual piggy-back registration rights held by any other shareholders

who desire to sell, exceeds the maximum dollar amount or maximum number of equity securities that can be sold in the Underwritten Offering

without adversely affecting the proposed offering price, the timing, the distribution method, or the probability of success of such offering

(such maximum dollar amount or maximum number of such securities, as applicable, the “Maximum Number of Securities”),

then Purchaser shall include in such Underwritten Offering, as follows: (i) first, the Registrable Securities of the Demanding Holders

and the Requesting Holders (if any) (pro rata based on the respective number of Registrable Securities that each Demanding Holder and

Requesting Holder (if any) has requested be included in such Underwritten Registration and the aggregate number of Registrable Securities

that the Demanding Holders and Requesting Holders have requested be included in such Underwritten Registration (such proportion is referred

to herein as “Pro Rata”)) that can be sold without exceeding the Maximum Number of Securities; (ii) second, to the

extent that the Maximum Number of Securities has not been reached under the foregoing clause (i), the Registrable Securities of Holders

(Pro Rata, based on the respective number of Registrable Securities that each Holder has so requested) exercising their rights to register

their Registrable Securities pursuant to subsection 2.2.1 hereof, without exceeding the Maximum Number of Securities; and (iii)

third, to the extent that the Maximum Number of Securities has not been reached under the foregoing clauses (i) and (ii), the Class A

Shares or other equity securities that Purchaser desires to sell, which can be sold without exceeding the Maximum Number of Securities;

and (iv) fourth, to the extent that the Maximum Number of Securities has not been reached under the foregoing clauses (i), (ii) and (iii),

the Class A Shares or other equity securities of other persons or entities that Purchaser is obligated to register in a Registration

pursuant to separate written contractual arrangements with such persons and that can be sold without exceeding the Maximum Number of

Securities.

2.2.5

Demand Registration Withdrawal. A majority-in-interest of the Demanding Holders, or a majority-in-interest of the Requesting Holders

(if any), shall have the right to withdraw from a Registration pursuant to a Demand Registration for any or no reason whatsoever, upon

written notification to Purchaser and the Underwriter or Underwriters (if any) of their intention to withdraw from such Registration

prior to the effectiveness of the Registration Statement filed with the Commission with respect to the Registration of their Registrable

Securities pursuant to such Demand Registration. Notwithstanding anything to the contrary in this Agreement, Purchaser shall be responsible

for the Registration Expenses incurred in connection with a Registration pursuant to a Demand Registration prior to its withdrawal under

this subsection 2.2.5.

2.3

Piggyback Registration.

2.3.1

Piggyback Rights. If, at any time on or after the date Purchaser consummates a Business Combination, Purchaser proposes to file

a Registration Statement under the Securities Act with respect to an offering of equity securities, or securities or other obligations

exercisable or exchangeable for, or convertible into equity securities, for its own account or for the account of shareholders of Purchaser

(or by Purchaser and by the shareholders of Purchaser including, without limitation, pursuant to Section 2.2 hereof), other than

a Registration Statement (i) filed in connection with any employee share option or other benefit plan, (ii) for an exchange offer or

offering of securities solely to Purchaser’s existing shareholders, (iii) for an offering of debt that is convertible into equity

securities of Purchaser or (iv) for a dividend reinvestment plan, then Purchaser shall give written notice of such proposed filing to

all of the Holders of Registrable Securities as soon as practicable but not less than ten (10) days before the anticipated filing date

of such Registration Statement, which notice shall (A) describe the amount and type of securities to be included in such offering, the

intended method(s) of distribution, and the name of the proposed managing Underwriter or Underwriters, if any, in such offering, and

(B) offer to all of the Holders of Registrable Securities the opportunity to register the sale of such number of Registrable Securities

as such Holders may request in writing within five (5) days after receipt of such written notice (such Registration, a “Piggyback

Registration”). Purchaser shall, in good faith, cause such Registrable Securities to be included in such Piggyback Registration

and shall use its best efforts to cause the managing Underwriter or Underwriters of a proposed Underwritten Offering to permit the Registrable

Securities requested by the Holders pursuant to this subsection 2.3.1 to be included in a Piggyback Registration on the same terms

and conditions as any similar securities of Purchaser included in such Registration and to permit the sale or other disposition of such

Registrable Securities in accordance with the intended method(s) of distribution thereof. All such Holders proposing to distribute their

Registrable Securities through an Underwritten Offering under this subsection 2.3.1 shall enter into an underwriting agreement

in customary form with the Underwriter(s) selected for such Underwritten Offering by Purchaser.

2.3.2

Reduction of Piggyback Registration. If the managing Underwriter or Underwriters in an Underwritten Registration that is to be

a Piggyback Registration, in good faith, advises Purchaser and the Holders of Registrable Securities participating in the Piggyback Registration

in writing that the dollar amount or number of the Class A Shares that Purchaser desires to sell, taken together with (i) the Class A

Shares, if any, as to which Registration has been demanded pursuant to separate written contractual arrangements with persons or entities

other than the Holders of Registrable Securities hereunder, (ii) the Registrable Securities as to which registration has been requested

pursuant to Section 2.3 hereof, and (iii) the Class A Shares, if any, as to which Registration has been requested pursuant to

separate written contractual piggy-back registration rights of other shareholders of Purchaser, exceeds the Maximum Number of Securities,

then:

(a)

If the Registration is undertaken for Purchaser’s account, Purchaser shall include in any such Registration (A) first, the Class

A Shares or other equity securities that Purchaser desires to sell, which can be sold without exceeding the Maximum Number of Securities;

(B) second, to the extent that the Maximum Number of Securities has not been reached under the foregoing clause (A), the Registrable

Securities of Holders exercising their rights to register their Registrable Securities pursuant to subsection 2.3.1 hereof, Pro

Rata, which can be sold without exceeding the Maximum Number of Securities; and (C) third, to the extent that the Maximum Number of Securities

has not been reached under the foregoing clauses (A) and (B), the Class A Shares, if any, as to which Registration has been requested

pursuant to written contractual piggy-back registration rights of other shareholders of Purchaser, which can be sold without exceeding

the Maximum Number of Securities;

(b)

If the Registration is pursuant to a request by persons or entities other than the Holders of Registrable Securities, then Purchaser

shall include in any such Registration (A) first, the Class A Shares or other equity securities, if any, of such requesting persons or

entities, other than the Holders of Registrable Securities, which can be sold without exceeding the Maximum Number of Securities; (B)

second, to the extent that the Maximum Number of Securities has not been reached under the foregoing clause (A), the Registrable Securities

of Holders exercising their rights to register their Registrable Securities pursuant to subsection 2.3.1, pro rata based on the

number of Registrable Securities that each Holder has requested be included in such Underwritten Registration and the aggregate number

of Registrable Securities that the Holders have requested to be included in such Underwritten Registration, which can be sold without

exceeding the Maximum Number of Securities; (C) third, to the extent that the Maximum Number of Securities has not been reached under

the foregoing clauses (A) and (B), the Class A Shares or other equity securities that Purchaser desires to sell, which can be sold without

exceeding the Maximum Number of Securities; and (D) fourth, to the extent that the Maximum Number of Securities has not been reached

under the foregoing clauses (A), (B) and (C), the Class A Shares or other equity securities for the account of other persons or entities

that Purchaser is obligated to register pursuant to separate written contractual arrangements with such persons or entities, which can

be sold without exceeding the Maximum Number of Securities.

2.3.3

Piggyback Registration Withdrawal. Any Holder of Registrable Securities shall have the right to withdraw from a Piggyback Registration

for any or no reason whatsoever upon written notification to Purchaser and the Underwriter or Underwriters (if any) of his, her or its

intention to withdraw from such Piggyback Registration prior to the effectiveness of the Registration Statement filed with the Commission

with respect to such Piggyback Registration. Purchaser (whether on its own good faith determination or as the result of a request for

withdrawal by persons pursuant to separate written contractual obligations) may withdraw a Registration Statement filed with the Commission

in connection with a Piggyback Registration at any time prior to the effectiveness of such Registration Statement. Notwithstanding anything

to the contrary in this Agreement, Purchaser shall be responsible for the Registration Expenses incurred in connection with the Piggyback

Registration prior to its withdrawal under this subsection 2.3.3.

2.3.4

Unlimited Piggyback Registration Rights. For purposes of clarity, any Registration effected pursuant to Section 2.3 hereof

shall not be counted as a Registration pursuant to a Demand Registration effected under Section 2.2 hereof.

2.4

Registrations on Form S-3. Holders of Registrable Securities may at any time, and from time to time, request in writing that Purchaser,

pursuant to Rule 415 under the Securities Act (or any successor rule promulgated thereafter by the Commission), register the resale of

any or all of their Registrable Securities on Form S-3 or any similar short form registration statement that may be available at such

time (“Form S-3”); provided, however, that Purchaser shall not be obligated to effect such request through

an Underwritten Offering. Within five (5) days of Purchaser’s receipt of a written request from a Holder or Holders of Registrable

Securities for a Registration on Form S-3, Purchaser shall promptly give written notice of the proposed Registration on Form S-3 to all

other Holders of Registrable Securities, and each Holder of Registrable Securities who thereafter wishes to include all or a portion

of such Holder’s Registrable Securities in such Registration on Form S-3 shall so notify Purchaser, in writing, within ten (10)

days after the receipt by the Holder of the notice from Purchaser. As soon as practicable thereafter, but not more than twelve (12) days

after Purchaser’s initial receipt of such written request for a Registration on Form S-3, Purchaser shall register all or such

portion of such Holder’s Registrable Securities as are specified in such written request, together with all or such portion of

Registrable Securities of any other Holder or Holders joining in such request as are specified in the written notification given by such

Holder or Holders; provided, however, that Purchaser shall not be obligated to effect any such Registration pursuant to

this Section 2.4 if (i) a Form S-3 is not available for such offering; or (ii) the Holders of Registrable Securities, together

with the Holders of any other equity securities of Purchaser entitled to inclusion in such Registration, propose to sell the Registrable

Securities and such other equity securities (if any) at any aggregate price to the public of less than $10,000,000.

2.5

Restrictions on Registration Rights. If (A) during the period starting with the date sixty (60) days prior to Purchaser’s

good faith estimate of the date of the filing of, and ending on a date one hundred and twenty (120) days after the effective date of,

a Company initiated Registration and provided that Purchaser has delivered written notice to the Holders prior to receipt of a Demand

Registration pursuant to subsection 2.2.1 and it continues to actively employ, in good faith, all reasonable efforts to cause

the applicable Registration Statement to become effective; (B) the Holders have requested an Underwritten Registration and Purchaser

and the Holders are unable to obtain the commitment of underwriters to firmly underwrite the offer; or (C) in the good faith judgment

of the Board such Registration would be seriously detrimental to Purchaser and the Board concludes as a result that it is essential to

defer the filing of such Registration Statement at such time, then in each case Purchaser shall furnish to such Holders a certificate

signed by Purchaser’s Chairman of the Board (or President of Purchaser) stating that in the good faith judgment of the Board it

would be seriously detrimental to Purchaser for such Registration Statement to be filed in the near future and that it is therefore essential

to defer the filing of such Registration Statement. In such event, Purchaser shall have the right to defer such filing for a period of

not more than thirty (30) days; provided, however, that Purchaser shall not defer its obligation in this manner more than

once in any 12-month period.

2.6

Block Trades; Other Coordinated Offerings.

2.6.1

Notwithstanding any other provision of this Section 2.6.1, at any time and from time to time when an effective Shelf Registration

is on file with the Commission, if a Demanding Holder wishes to engage in (a) an underwritten registered offering (whether firm commitment

or otherwise) not involving a “road show” or other substantial marketing efforts prior to pricing (commonly referred to as

a “Block Trade”) or (b) an otherwise coordinated “at the market” or similar registered offering through

a broker, sales agent or distribution agent, whether as agent or principal (an “Other Coordinated Offering”), in each

case, with a total offering price reasonably expected to exceed, in the aggregate, either (x) $10,000,000 or (y) all remaining Registrable

Securities held by the Demanding Holder, then such Demanding Holder shall notify Purchaser of the Block Trade or Other Coordinated Offering

at least five (5) business days prior to the day such offering is expected to commence, and Purchaser shall as expeditiously as possible

use its commercially reasonable efforts to facilitate such Block Trade or Other Coordinated Offering; provided that the Demanding Holders

representing a majority of the Registrable Securities wishing to engage in the Block Trade or Other Coordinated Offering shall use commercially

reasonable efforts to work with Purchaser and any Underwriters, brokers, sales agents or placement agents prior to making such request

in order to facilitate preparation of the registration statement, prospectus and other offering documentation related to the Block Trade

or Other Coordinated Offering.

2.6.2

Purchaser may facilitate a Block Trade or Other Coordinated Offering if it determines that sufficient shares shall be traded by any Holder

or Holders that would be more efficiently traded as a block trade.

2.6.3

Prior to the filing of the applicable “red herring” prospectus or prospectus supplement used in connection with a Block Trade

or Other Coordinated Offering, a majority-in-interest of the Demanding Holders initiating such Block Trade or Other Coordinated Offering

shall have the right to submit a notice to Purchaser and the Underwriter(s) if any, of their intention to withdraw from such Block Trade

or Other Coordinated Offering. Notwithstanding anything to the contrary in this Agreement, Purchaser shall be responsible for the Registration

Expenses incurred in connection with a block trade prior to its withdrawal under this Section 2.6.3.

2.6.4

Notwithstanding anything to the contrary in this Agreement, Section 2.3 shall not apply to a Block Trade or Other Coordinated

Offering initiated by a Demanding Holder pursuant to this Section 2.6.4.

2.6.5

Purchaser shall have the right to select the Underwriters, and brokers, sale agents or placement agents (if any) for such Block Trade

or Other Coordinated Offering, in each case, which shall consist of one or more reputable nationally recognized investment banks.

2.6.6

A Holder in the aggregate may demand no more than two (2) Block Trades or Other Coordinated Offerings pursuant to this Section 2.6.6

in any twelve (12) month period.

ARTICLE

III

COMPANY

PROCEDURES

3.1

General Procedures. If at any time on or after the date Purchaser consummates a Business Combination, Purchaser is required to

effect the Registration of Registrable Securities, Purchaser shall use its commercially reasonable efforts to effect such Registration

to permit the sale of such Registrable Securities in accordance with the intended plan of distribution thereof, and pursuant thereto

Purchaser shall, as expeditiously as possible:

3.1.1

prepare and file with the Commission as soon as practicable a Registration Statement with respect to such Registrable Securities and

use its commercially reasonable efforts to cause such Registration Statement to become effective and remain effective until all Registrable

Securities covered by such Registration Statement have been sold;

3.1.2

prepare and file with the Commission such amendments and post-effective amendments to the Registration Statement, and such supplements

to the Prospectus, as may be requested by the Holders or any Underwriter of Registrable Securities or as may be required by the rules,

regulations or instructions applicable to the registration form used by Purchaser or by the Securities Act or rules and regulations thereunder

to keep the Registration Statement effective until all Registrable Securities covered by such Registration Statement are sold in accordance

with the intended plan of distribution set forth in such Registration Statement or supplement to the Prospectus;

3.1.3

prior to filing a Registration Statement or prospectus, or any amendment or supplement thereto, furnish without charge to the Underwriters,

if any, and the Holders of Registrable Securities included in such Registration, and such Holders’ legal counsel, copies of such

Registration Statement as proposed to be filed, each amendment and supplement to such Registration Statement (in each case including

all exhibits thereto and documents incorporated by reference therein), the Prospectus included in such Registration Statement (including

each preliminary Prospectus), and such other documents as the Underwriters and the Holders of Registrable Securities included in such

Registration or the legal counsel for any such Holders may request in order to facilitate the disposition of the Registrable Securities

owned by such Holders;

3.1.4

prior to any public offering of Registrable Securities, use its commercially reasonable efforts to (i) register or qualify the Registrable

Securities covered by the Registration Statement under such securities or “blue sky” laws of such jurisdictions in the United

States as the Holders of Registrable Securities included in such Registration Statement (in light of their intended plan of distribution)

may request and (ii) take such action necessary to cause such Registrable Securities covered by the Registration Statement to be registered

with or approved by such other governmental authorities as may be necessary by virtue of the business and operations of Purchaser and

do any and all other acts and things that may be necessary or advisable to enable the Holders of Registrable Securities included in such

Registration Statement to consummate the disposition of such Registrable Securities in such jurisdictions; provided, however,

that Purchaser shall not be required to qualify generally to do business in any jurisdiction where it would not otherwise be required

to qualify or take any action to which it would be subject to general service of process or taxation in any such jurisdiction where it

is not then otherwise so subject;

3.1.5

cause all such Registrable Securities to be listed on each securities exchange or automated quotation system on which similar securities

issued by Purchaser are then listed;

3.1.6

provide a transfer agent or warrant agent, as applicable, and registrar for all such Registrable Securities no later than the effective

date of such Registration Statement;

3.1.7

advise each seller of such Registrable Securities, promptly after it shall receive notice or obtain knowledge thereof, of the issuance

of any stop order by the Commission suspending the effectiveness of such Registration Statement or the initiation or threatening of any

proceeding for such purpose and promptly use its reasonable best efforts to prevent the issuance of any stop order or to obtain its withdrawal

if such stop order should be issued;

3.1.8

at least five (5) days prior to the filing of any Registration Statement or Prospectus or any amendment or supplement to such Registration

Statement or Prospectus or any document that is to be incorporated by reference into such Registration Statement, furnish a copy thereof

to each seller of such Registrable Securities and its counsel, including, without limitation, providing copies promptly upon receipt

of any comment letters received with respect to any such Registration Statement or Prospectus;

3.1.9

notify the Holders at any time when a Prospectus relating to such Registration Statement is required to be delivered under the Securities

Act, of the happening of any event as a result of which the Prospectus included in such Registration Statement, as then in effect, includes

a Misstatement, and then to correct such Misstatement as set forth in Section 3.4 hereof;

3.1.10

permit a representative of the Holders (such representative to be selected by a majority of the participating Holders), the Underwriters,

if any, and any attorney or accountant retained by such Holders or Underwriter to participate, at each such person’s own expense,

in the preparation of the Registration Statement, and cause Purchaser’s officers, directors and employees to supply all information

reasonably requested by any such representative, Underwriter, attorney or accountant in connection with the Registration; provided,

however, that such representatives or Underwriters enter into a confidentiality agreement, in form and substance reasonably satisfactory

to Purchaser, prior to the release or disclosure of any such information; and provided further, Purchaser may not include the

name of any Holder or Underwriter or any information regarding any Holder or Underwriter in any Registration Statement or Prospectus,

any amendment or supplement to such Registration Statement or Prospectus, any document that is to be incorporated by reference into such

Registration Statement or Prospectus, or any response to any comment letter, without the prior written consent of such Holder or Underwriter

and providing each such Holder or Underwriter a reasonable amount of time to review and comment on such applicable document, which comments

Purchaser shall include unless contrary to applicable law;

3.1.11

obtain a “cold comfort” letter from Purchaser’s independent registered public accountants in the event of an Underwritten

Registration which the participating Holders may rely on, in customary form and covering such matters of the type customarily covered

by “cold comfort” letters as the managing Underwriter may reasonably request, and reasonably satisfactory to a majority-in-interest

of the participating Holders;

3.1.12

on the date the Registrable Securities are delivered for sale pursuant to such Registration, obtain an opinion, dated such date, of counsel

representing Purchaser for the purposes of such Registration, addressed to the Holders, the placement agent or sales agent, if any, and

the Underwriters, if any, covering such legal matters with respect to the Registration in respect of which such opinion is being given

as the Holders, placement agent, sales agent, or Underwriter may reasonably request and as are customarily included in such opinions

and negative assurance letters, and reasonably satisfactory to a majority in interest of the participating Holders;

3.1.13

in the event of any Underwritten Offering, enter into and perform its obligations under an underwriting agreement, in usual and customary

form, with the managing Underwriter of such offering;

3.1.14

make available to its security holders, as soon as reasonably practicable, an earnings statement covering the period of at least twelve

(12) months beginning with the first day of Purchaser’s first full calendar quarter after the effective date of the Registration

Statement which satisfies the provisions of Section 11(a) of the Securities Act and Rule 158 thereunder (or any successor rule

promulgated thereafter by the Commission);

3.1.15

if the Registration involves the Registration of Registrable Securities involving gross proceeds in excess of $50,000,000, use its reasonable

efforts to make available senior executives of Purchaser to participate in customary “road show” presentations that may be

reasonably requested by the Underwriter in any Underwritten Offering; and

3.1.16

otherwise, in good faith, cooperate reasonably with, and take such customary actions as may reasonably be requested by the Holders, in

connection with such Registration.

3.2

Registration Expenses. The Registration Expenses of all Registrations shall be borne by Purchaser. It is acknowledged by the Holders

that the Holders shall bear all incremental selling expenses relating to the sale of Registrable Securities, such as Underwriters’

commissions and discounts, brokerage fees, Underwriter marketing costs and, other than as set forth in the definition of “Registration

Expenses,” all reasonable fees and expenses of any legal counsel representing the Holders.

3.3

Requirements for Participation in Underwritten Offerings. No Person may participate in any Underwritten Offering for equity securities

of Purchaser pursuant to a Registration initiated by Purchaser hereunder unless such person (i) agrees to sell such person’s securities

on the basis provided in any underwriting arrangements approved by Purchaser and (ii) completes and executes all customary questionnaires,

powers of attorney, indemnities, lock-up agreements, underwriting agreements and other customary documents as may be reasonably required

under the terms of such underwriting arrangements.

3.4

Suspension of Sales; Adverse Disclosure. Upon receipt of written notice from Purchaser that a Registration Statement or Prospectus

contains a Misstatement, each of the Holders shall forthwith discontinue disposition of Registrable Securities until he, she or it has

received copies of a supplemented or amended Prospectus correcting the Misstatement (it being understood that Purchaser hereby covenants

to prepare and file such supplement or amendment as soon as practicable after the time of such notice), or until he, she or it is advised

in writing by Purchaser that the use of the Prospectus may be resumed. If the filing, initial effectiveness or continued use of a Registration

Statement in respect of any Registration at any time would require Purchaser to make an Adverse Disclosure or would require the inclusion

in such Registration Statement of financial statements that are unavailable to Purchaser for reasons beyond Purchaser’s control,

Purchaser may, upon giving prompt written notice of such action to the Holders, delay the filing or initial effectiveness of, or suspend

use of, such Registration Statement for the shortest period of time, but in no event more than thirty (30) days, determined in good faith

by Purchaser to be necessary for such purpose. In the event Purchaser exercises its rights under the preceding sentence, the Holders

agree to suspend, immediately upon their receipt of the notice referred to above, their use of the Prospectus relating to any Registration

in connection with any sale or offer to sell Registrable Securities. Purchaser shall immediately notify the Holders of the expiration

of any period during which it exercised its rights under this Section 3.4.

3.5

Reporting Obligations. As long as any Holder shall own Registrable Securities, Purchaser, at all times while it shall be a reporting

company under the Exchange Act, covenants to file timely (or obtain extensions in respect thereof and file within the applicable grace

period) all reports required to be filed by Purchaser after the date hereof pursuant to Sections 13(a) or 15(d) of the Exchange Act and

to promptly furnish the Holders with true and complete copies of all such filings. Purchaser further covenants that it shall take such

further action as any Holder may reasonably request, all to the extent required from time to time to enable such Holder to sell Class

A Shares held by such Holder without registration under the Securities Act within the limitation of the exemptions provided by Rule 144

promulgated under the Securities Act (or any successor rule promulgated thereafter by the Commission), including providing any legal

opinions. Upon the request of any Holder, Purchaser shall deliver to such Holder a written certification of a duly authorized officer

as to whether it has complied with such requirements.

ARTICLE

IV

INDEMNIFICATION

AND CONTRIBUTION

4.1

Indemnification.

4.1.1

Purchaser agrees to indemnify, to the extent permitted by law, each Holder of Registrable Securities, its officers and directors and

each person who controls such Holder (within the meaning of the Securities Act) against all losses, claims, damages, liabilities and

expenses (including attorneys’ fees) caused by any untrue or alleged untrue statement of material fact contained in any Registration

Statement, Prospectus or preliminary Prospectus or any amendment thereof or supplement thereto or any omission or alleged omission of

a material fact required to be stated therein or necessary to make the statements therein not misleading, except insofar as the same

are caused by or contained in any information furnished in writing to Purchaser by such Holder expressly for use therein. Purchaser shall

indemnify the Underwriters, their officers and directors and each person who controls such Underwriters (within the meaning of the Securities

Act) to the same extent as provided in the foregoing with respect to the indemnification of the Holder.

4.1.2

In connection with any Registration Statement in which a Holder of Registrable Securities is participating, such Holder shall furnish

to Purchaser in writing such information and affidavits as Purchaser reasonably requests for use in connection with any such Registration

Statement or Prospectus and, to the extent permitted by law, shall indemnify Purchaser, its directors and officers and agents and each

person who controls Purchaser (within the meaning of the Securities Act) against any losses, claims, damages, liabilities and expenses

(including without limitation reasonable attorneys’ fees) resulting from any untrue statement of material fact contained in the

Registration Statement, Prospectus or preliminary Prospectus or any amendment thereof or supplement thereto or any omission of a material

fact required to be stated therein or necessary to make the statements therein not misleading, but only to the extent that such untrue

statement or omission is contained in any information or affidavit so furnished in writing by such Holder expressly for use therein;

provided, however, that the obligation to indemnify shall be several, not joint and several, among such Holders of Registrable

Securities, and the liability of each such Holder of Registrable Securities shall be in proportion to and limited to the net proceeds

received by such Holder from the sale of Registrable Securities pursuant to such Registration Statement. The Holders of Registrable Securities

shall indemnify the Underwriters, their officers, directors and each person who controls such Underwriters (within the meaning of the

Securities Act) to the same extent as provided in the foregoing with respect to indemnification of Purchaser.

4.1.3

Any person entitled to indemnification herein shall (i) give prompt written notice to the indemnifying party of any claim with respect

to which it seeks indemnification (provided that the failure to give prompt notice shall not impair any person’s right to indemnification

hereunder to the extent such failure has not materially prejudiced the indemnifying party) and (ii) unless in such indemnified party’s

reasonable judgment a conflict of interest between such indemnified and indemnifying parties may exist with respect to such claim, permit

such indemnifying party to assume the defense of such claim with counsel reasonably satisfactory to the indemnified party. If such defense

is assumed, the indemnifying party shall not be subject to any liability for any settlement made by the indemnified party without its

consent (but such consent shall not be unreasonably withheld). An indemnifying party who is not entitled to, or elects not to, assume

the defense of a claim shall not be obligated to pay the fees and expenses of more than one counsel (plus local counsel) for all parties

indemnified by such indemnifying party with respect to such claim, unless in the reasonable judgment of any indemnified party a conflict

of interest may exist between such indemnified party and any other of such indemnified parties with respect to such claim. No indemnifying

party shall, without the consent of the indemnified party, consent to the entry of any judgment or enter into any settlement which cannot

be settled in all respects by the payment of money (and such money is so paid by the indemnifying party pursuant to the terms of such

settlement) or which settlement does not include as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified

party of a release from all liability in respect to such claim or litigation.

4.1.4

The indemnification provided for under this Agreement shall remain in full force and effect regardless of any investigation made by or

on behalf of the indemnified party or any officer, director or controlling person of such indemnified party and shall survive the transfer

of securities. Purchaser and each Holder of Registrable Securities participating in an offering also agrees to make such provisions as

are reasonably requested by any indemnified party for contribution to such party in the event Purchaser’s or such Holder’s

indemnification is unavailable for any reason.

4.1.5

If the indemnification provided under Section 4.1 hereof from the indemnifying party is unavailable or insufficient to hold harmless

an indemnified party in respect of any losses, claims, damages, liabilities and expenses referred to herein (except as provided herein),

then the indemnifying party, in lieu of indemnifying the indemnified party, shall contribute to the amount paid or payable by the indemnified

party as a result of such losses, claims, damages, liabilities and expenses in such proportion as is appropriate to reflect the relative

fault of the indemnifying party and the indemnified party, as well as any other relevant equitable considerations. The relative fault

of the indemnifying party and indemnified party shall be determined by reference to, among other things, whether any action in question,

including any untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact, was made

by, or relates to information supplied by, such indemnifying party or indemnified party, and the indemnifying party’s and indemnified

party’s relative intent, knowledge, access to information and opportunity to correct or prevent such action; provided, however,

that the liability of any Holder under this subsection 4.1.5 shall be limited to the amount of the net proceeds received by such

Holder in such offering giving rise to such liability. The amount paid or payable by a party as a result of the losses or other liabilities

referred to above shall be deemed to include, subject to the limitations set forth in subsections 4.1.1, 4.1.2 and 4.1.3

above, any legal or other fees, charges or expenses reasonably incurred by such party in connection with any investigation or proceeding.

The parties hereto agree that it would not be just and equitable if contribution pursuant to this subsection 4.1.5 were determined

by pro rata allocation or by any other method of allocation, which does not take account of the equitable considerations referred to

in this subsection 4.1.5. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities

Act) shall be entitled to contribution pursuant to this subsection 4.1.5 from any person who was not guilty of such fraudulent

misrepresentation.

ARTICLE

V

MISCELLANEOUS

5.1

Notices. Any notice or communication under this Agreement must be in writing and given by (i) deposit in the United States mail,

addressed to the party to be notified, postage prepaid and registered or certified with return receipt requested, (ii) delivery in person

or by courier service providing evidence of delivery, or (iii) transmission by hand delivery, electronic mail, or facsimile. Each notice

or communication that is mailed, delivered, or transmitted in the manner described above shall be deemed sufficiently given, served,

sent, and received, in the case of mailed notices, on the third business day following the date on which it is mailed and, in the case

of notices delivered by courier service, hand delivery, electronic mail, or facsimile, at such time as it is delivered to the addressee

(with the delivery receipt or the affidavit of messenger) or at such time as delivery is refused by the addressee upon presentation.

Any notice or communication under this Agreement must be addressed:

To

Purchaser, to:

ARC

Group Acquisition I Corp.

398

S Mill Avenue,

Suite

306,

Tempe,

AZ 85284

Attn:

____________________

Telephone

No.: __________________________

E-mail:

___________________

with

a copy to:

Rimon,

P.C.

1050

Connecticut Avenue, NW, Suite 500

Washington,

DC 20006

Attn:

Debbie A. Klis Esq.; Mark C Lee, Esq.

Telephone

No.: (202) 935-3390

Email:

deborrah.klis@rimonlaw.com; mark.c.lee@rimonlaw.com

To

Purchaser, to:

Firstborn

Top Capital Sdn. Bhd.

13A-3A,

Q Sentral, 2A

Jalan

Stesen Sentral 2

KL

Sentral, Kuala Lumpur

Wilayah

Persekutuan 50470

Malaysia

Attn:

Wilson Ow

Telephone

No.:

E-mail:

with

a copy to:

Rohamat

& Ling

Unit

1009, 10th Floor, Menara PJ,

Amcorp

Trade Centre,

No.

18 Jalan Persiaran Barat,

46050

Petaling Jaya, Selangor.

Attn:

Mark Wong Kah Kit

Telephone

No.: 03-7932 5115

E-mail:

mark@r-ling.com

To

a Holder, to the address set forth below such Holder’s name on the signature page hereto.

Any

party may change its address for notice at any time and from time to time by written notice to the other parties hereto, and such change

of address shall become effective thirty (30) days after delivery of such notice as provided in this Section 5.1.

5.2

Assignment; No Third Party Beneficiaries.

5.2.1

This Agreement and the rights, duties and obligations of Purchaser hereunder may not be assigned or delegated by Purchaser in whole or

in part.

5.2.2

Prior to the expiration of the Sponsor Lock-up Period or Consideration Shares Lock-up Period, no Holder of Founder Shares, Private Placement

Shares, the Private Placement Warrants, any Class A Shares issued or issuable upon the exercise of the Private Placement Warrants and

the conversion of the Private Placement Rights, or Consideration Shares may assign or delegate such Holder’s rights, duties or

obligations under this Agreement, in whole or in part, except in connection with a transfer of Registrable Securities by such Holder

to a Permitted Transferee but only if such Permitted Transferee agrees to become bound by the transfer restrictions set forth in this

Agreement.

5.2.3

This Agreement and the provisions hereof shall be binding upon and shall inure to the benefit of each of the parties and its successors

and the permitted assigns of the Holders, which shall include Permitted Transferees.

5.2.4

This Agreement shall not confer any rights or benefits on any persons that are not parties hereto, other than as expressly set forth

in this Agreement and Section 5.2 hereof.

5.2.5

No assignment by any party hereto of such party’s rights, duties and obligations hereunder shall be binding upon or obligate Purchaser

unless and until Purchaser shall have received (i) written notice of such assignment as provided in Section 5.1 hereof and (ii)

the written agreement of the assignee, in a form reasonably satisfactory to Purchaser, to be bound by the terms and provisions of this

Agreement (which may be accomplished by an addendum or certificate of joinder to this Agreement). Any transfer or assignment made other

than as provided in this Section 5.2 shall be null and void.

5.3

Counterparts. This Agreement may be executed in multiple counterparts (including facsimile or PDF counterparts), each of which

shall be deemed an original, and all of which together shall constitute the same instrument, but only one of which need be produced.

5.4

Governing Law; Venue. NOTWITHSTANDING THE PLACE WHERE THIS AGREEMENT MAY BE EXECUTED BY ANY OF THE PARTIES HERETO, THE PARTIES

EXPRESSLY AGREE THAT THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED UNDER THE LAWS OF THE STATE OF DELAWARE AS APPLIED TO AGREEMENTS

AMONG DELAWARE RESIDENTS ENTERED INTO AND TO BE PERFORMED ENTIRELY WITHIN DELAWARE, WITHOUT REGARD TO THE CONFLICT OF LAW PROVISIONS

OF SUCH JURISDICTION. ANY LEGAL SUIT, ACTION OR PROCEEDING ARISING OUT OF OR BASED UPON THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED

HEREBY MAY BE INSTITUTED IN THE FEDERAL COURTS OF THE UNITED STATES LOCATED IN DELAWARE, AND EACH PARTY IRREVOCABLY SUBMITS TO THE EXCLUSIVE

JURISDICTION OF SUCH COURTS IN ANY SUCH SUIT, ACTION OR PROCEEDING.

5.5

Amendments and Modifications. Upon the written consent of (i) Purchaser, (ii) the Sponsor (if the Sponsor holds Registrable Securities

at the time in question), ) (iii) a majority-in-interest of Registrable Securities held by the Founders at the time in question, and

(iv) a majority-in-interest of the Holders of Registrable Securities at the time in question, compliance with any of the provisions,

covenants and conditions set forth in this Agreement may be waived, or any of such provisions, covenants or conditions may be amended

or modified; provided, however, that notwithstanding the foregoing, any amendment hereto or waiver hereof that adversely

affects one Holder, solely in his, her or its capacity as a holder of the capital shares of Purchaser, in a manner that is materially

different from the other Holders (in such capacity) shall require the consent of the Holder so affected. No course of dealing between

any Holder or Purchaser and any other party hereto or any failure or delay on the part of a Holder or Purchaser in exercising any rights

or remedies under this Agreement shall operate as a waiver of any rights or remedies of any Holder or Purchaser. No single or partial

exercise of any rights or remedies under this Agreement by a party shall operate as a waiver or preclude the exercise of any other rights

or remedies hereunder or thereunder by such party.

5.6

Termination of Prior Agreement. The Prior Agreement is hereby terminated in its entirety effective as of the completion of the

Business Combination.

5.7

Term. This Agreement shall terminate upon the earlier of (i) the tenth (10th) anniversary of the date of this Agreement

or (ii) the date as of which (A) all of the Registrable Securities have been sold pursuant to a Registration Statement (but in no event

prior to the applicable period referred to in Section 4(a)(3) of the Securities Act and Rule 174 thereunder (or any successor rule promulgated

thereafter by the Commission)) or (B) the Holders of all Registrable Securities are permitted to sell the Registrable Securities without

registration pursuant to Rule 144 (or any similar provision) under the Securities Act with no volume or other restrictions or limitations.

The provisions of Section 3.5 and Article IV shall survive any termination.

[Signature

Pages Follow]

IN

WITNESS WHEREOF, the undersigned have caused this Agreement to be executed as of the date first written above.

COMPANY:

ARC

GROUP ACQUISITION I CORP.

By:

Name:

Title:

[Signature

Page to Registration Rights Agreement]

IN

WITNESS WHEREOF, the undersigned have caused this Agreement to be executed as of the date first written above.

SPONSOR:

MFH

2, LLC

By:

Name:

Title:

IN

WITNESS WHEREOF, the undersigned have caused this Agreement to be executed as of the date first written above.

HOLDERS:

By:

Name:

Title:

Email:

Address:

[Signature

Page to Registration Rights Agreement]

EX-10.4

EX-10.4

Filename: ex10-4.htm · Sequence: 6

Exhibit 10.4

LOCK-UP

AGREEMENT

THIS

LOCK-UP AGREEMENT (this “Agreement”) is made and entered into as of [●], between BlueCrest Investment, Inc.,

a British Virgin Islands business company (formerly known as ARC Group Acquisition I Corp., hereinafter referred to as “Purchaser”

prior to the Closing and “PubCo” following the Closing)) and (ii) the undersigned (each of such undersigned, a “Holder”

and collectively, the “Holders”). Purchaser or Pubco and the Holders are sometimes referred to herein individually

as a “Party” and, collectively, as the “Parties”. Any capitalized term used but not defined in

this Agreement will have the meaning ascribed to such term in the Share Purchase Agreement (as defined below).

WHEREAS,

Purchaser, Firstborn Top Capital Sdn. Bhd., a Malaysian private limited company (the “Company”), the shareholders

of the Company (the “Selling Shareholders”) and a representative each of Purchaser and the Company entered into a

share purchase agreement, dated ________, 2026 (the “Share Purchase Agreement”), pursuant to which the Selling Shareholders

agreed to sell and transfer to Purchaser, and Purchaser agreed to purchase, acquire and accept from the Selling Shareholders, all of

the issued and outstanding capital shares of the Company, upon the terms and conditions set forth therein (the “Business Combination”);

WHEREAS,

pursuant to the Share Purchase Agreement, and in view of the valuable consideration to be received by the Holders thereunder, the Parties

desire to enter into this Agreement, pursuant to which the Class A ordinary shares, par value $0.0001 per share, of Purchaser to be received

by the Holders pursuant to the Share Purchase Agreement and in accordance with the provisions of applicable Law (together with any securities

paid as bonus share issuance, dividends or distributions with respect to such securities or into which such securities are changed or

exchanged or which are received in any recapitalization, share exchange, share conversion or similar transactions, the “Restricted

Securities”), shall become subject to limitations on disposition as set forth herein; and

WHEREAS,

as of immediately after the Closing Date, each Holder will be the holder of record and beneficial owner (as such term is defined in Rule

13d-3 promulgated under the Exchange Act), with the sole or shared power to dispose of (or power to cause the disposition of) and the

sole or shared power to vote (or power to direct the voting of) such number of Restricted Securities set forth opposite such Holder’s

name on Exhibit A hereto.

NOW,

THEREFORE, in consideration of the premises set forth above, which are incorporated into this Agreement as if fully set forth below,

and intending to be legally bound hereby, the Parties hereby agree as follows:

1.

Lock-Up Provisions.

(a)

For the purposes of this Section 1, “Transfer” shall mean the (i) sale of, offer to sell, contract or agreement

to sell (including, for the avoidance of doubt, by operation of law and through a distribution in specie), hypothecate, pledge, grant

of any option to purchase or otherwise dispose of or agreement to dispose of, directly or indirectly, or establishment or increase of

a put equivalent position or liquidation with respect to or decrease of a call equivalent position within the meaning of Section 16 of

the Securities Exchange Act of 1934, as amended, and the rules and regulations of the U.S. Securities and Exchange Commission promulgated

thereunder with respect to, any security, (ii) entry into any swap or other arrangement that transfers to another, in whole or in part,

any of the economic consequences of ownership of any security, whether any such transaction is to be settled by delivery of such securities,

in cash or otherwise, (iii) deposit any Restricted Securities into a voting trust or enter into a voting agreement or arrangement or

grant any proxy or power of attorney with respect thereto that is inconsistent with this Agreement or (iv) public announcement of any

intention to effect any transaction specified in clause (i), (ii) or (iii).

(b)

Subject to Section 1(c) and the other terms of this Agreement, each Holder agrees that it shall not effectuate a Transfer of the Restricted

Securities during the period commencing on the Closing Date and ending at 11:59 p.m. Eastern time on the date that is the earlier of

(A) one (1) year following the Business Combination, and (B) subsequent to the completion of the Business Combination, (x) the date on

which the last sale price of the Class A Shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations,

reorganizations, recapitalizations and the like) for any twenty (20) trading days within any 30-trading day period commencing at least

one hundred eighty (180) days after the completion of the Business Combination, or (y) the date on which Purchaser completes a liquidation,

merger, amalgamation, capital stock exchange, reorganization or other similar transaction that results in all of Purchaser’s Public

Shareholders having the right to exchange their Class A Shares for cash, securities or other property (the “Lock-Up Period”).

(c)

Notwithstanding the provisions set forth in Section 1(b), the following Transfers of the Restricted Securities that are held by

any of the Holders (and that have complied with this Section 1(c)) are permitted during the Lock-Up Period in the case of any Holder

or its permitted transferees:

(i)

to

any Affiliates or immediate family members of any of the relevant Holder’s officers or directors, any Affiliates of the Holders,

or any employees of such Affiliates;

(ii)

in

the case of an individual, to any immediate family members of such individual;

(iii)

to

any investment funds or vehicles controlled or managed by the securityholder or any of its Affiliates;

(iv)

by

gift to a trust, the beneficiary of which is a Person to whom a Transfer would be permitted under Section 1(c)(i), or to a

charitable organization;

(v)

in

the case of an individual, by virtue of laws of descent and distribution upon death of such individual;

(vi)

in

the case of an individual, pursuant to a qualified domestic relations order;

(vii)

in

the case of an individual, to a partnership, limited liability company or other entity of which such individual and/or the family

members of such individual are the legal and beneficial owner of all of the outstanding equity securities or similar interests;

(viii)

to

a nominee or custodian of a Person to whom a Transfer would be permitted under Section 1(c)(i);

(ix)

pursuant

to any final, non-appealable order of a court or regulatory authority of competent jurisdiction to which such Holder is subject;

(x)

in

the case of an entity that is a trust, to a trustor or beneficiary of the trust or to the estate of a beneficiary of such trust;

(xi)

in

the case of an entity, as part of a distribution to members, partners, shareholders or equityholders of the entity;

(xii)

by

virtue of the laws of an entity’s jurisdiction of incorporation or organization, an entity’s organizational documents

or the rights attaching to the equity interests in the entity upon dissolution of such entity;

(xiii)

in

connection with the exercise of any options, warrants or other convertible securities to purchase Restricted Securities (which exercises

may be effected on a cashless basis to the extent the instruments representing such options or warrants permit exercises on a cashless

basis) to the extent that any Restricted Securities issued upon such exercise are Restricted Securities subject to the applicable restrictions

under Section 1(b) of this Agreement;

(xiv)

in

the case of an entity, to satisfy tax withholding obligations in connection with such entity’s equity incentive plans or arrangements;

(xv)

in

connection with any bona fide mortgage, pledge or encumbrance to a financial institution, as collateral or security in connection

with any bona fide loan or debt transaction or enforcement thereunder, including foreclosure thereof;

(xvi)

in

connection with a transfer pursuant to a bona fide third party tender offer, merger, consolidation, liquidation, share exchange

or other similar transaction made to all holders of Restricted Securities involving a change of control of Purchaser or which results

in all of the holders of Restricted Securities having the right to exchange their Restricted Securities for cash, securities or other

property subsequent to the consummation of such transaction;

(xvii)

the

entry, by the securityholder, at any time on or after the Closing Date, of any trading plan providing for the sale of Restricted

Securities, which trading plan meets the requirements of Rule 10b5-1(c) under the Exchange Act; provided, however, that such plan

does not provide for, or permit, the sale of any Restricted Securities during the applicable Lock-Up Period and no public announcement

or filing is voluntarily made or required regarding such plan during the applicable Lock-Up Period; and

(xviii)

to

satisfy any applicable U.S. or non-U.S. federal, state, or local income tax obligations of a securityholder (or its direct or indirect

owners) arising from a change in applicable tax law after the date on which the Share Purchase Agreement was executed by the parties,

and such change prevents the Business Combination from qualifying as a “reorganization” pursuant to Section 368 of the

Code (and the Business Combination does not qualify for similar tax-free treatment pursuant to any successor or other provision of

the Code or Regulations taking into account such changes), in each case solely and to the extent necessary to cover any tax liability

as a direct result of the transaction.

provided,

that in each of clauses (i) through (xiii), (xv) and (xvi), the transferee must enter into a written joinder agreement, in a form reasonably

acceptable to Purchaser, agreeing to be bound by the terms of the applicable restrictions under Section 1(a) and the Lock-Up Period in

Section 1(b) of this Agreement (unless the transferee is Purchaser). If dividends are declared and payable on any Restricted Securities,

such dividends will also be Restricted Securities subject to the applicable restrictions under Section 1(b) of this Agreement.

(d)

If any Transfer is made or attempted contrary to the provisions of this Agreement, such Transfer shall be null and void ab initio,

and Purchaser shall refuse to recognize any such transferee of the Restricted Securities as one of its equity holders for any purpose.

In order to enforce this Section 1, Purchaser may impose stop-transfer instructions with respect to the Restricted Securities

of the Holder (and any transferees and assigns thereof) until the end of the Lock-Up Period and may pursue any other remedy available

to it at law or in equity.

(e)

During the Lock-Up Period, each certificate and book entry position evidencing any Restricted Securities (if any are issued) shall be

stamped or otherwise imprinted with a legend in substantially the following form, in addition to any other applicable legends:

“THE

SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO RESTRICTIONS ON TRANSFER SET FORTH IN A LOCK-UP AGREEMENT, DATED AS OF [●],

BY AND AMONG THE ISSUER OF SUCH SECURITIES (THE “ISSUER”) AND THE ISSUER’S SECURITY HOLDER NAMED THEREIN. A

COPY OF SUCH LOCK-UP AGREEMENT, AS AMENDED, WILL BE FURNISHED WITHOUT CHARGE BY THE ISSUER TO THE HOLDER HEREOF UPON WRITTEN REQUEST.”

(f)

For the avoidance of any doubt, each Holder shall retain all of its, his or her rights as a shareholder of Purchaser with respect to

the Restricted Securities during the Lock-Up Period, including the right to receive dividends and the right to vote any Restricted Securities

(subject to the other provisions hereof).

2.

Miscellaneous.

(a)

Authorization. Each Holder, severally and not jointly, hereby represents and warrants that he, she or it has full power and authority

to enter into this Agreement and that this Agreement constitutes the legal, valid and binding obligation of such Holder, enforceable

in accordance with its terms. Upon request, each Holder will execute any additional documents as may be necessary in connection with

enforcement hereof.

(b)

Termination. This Agreement shall automatically terminate with respect to each of the Parties when the applicable restrictions

on the securities of such Party hereunder have ended.

(c)

Binding Effect; Assignment. This Agreement and all of the provisions hereof shall be binding upon and inure solely to the benefit

of the Parties hereto and their respective permitted successors and assigns. Except as otherwise provided in this Agreement, this Agreement

shall not be assigned by operation of Law or otherwise without the prior written consent of all Parties hereto, provided, further, that

no consent shall be required in connection with an assignment of rights arising solely from a Transfer permitted under Section 1(c)

of this Agreement. Any assignment without such consent shall be null and void; provided, that no such assignment shall relieve

the assigning Party of its obligations hereunder.

(d)

Third Parties. Nothing contained in this Agreement or in any instrument or document executed by any party in connection with the

transactions contemplated hereby shall create any rights in, or be deemed to have been executed for the benefit of, any person or entity

that is not a Party hereto or thereto or a successor or permitted assign of such a Party.

(e)

Governing Law; Jurisdiction. This Agreement shall be governed by, and construed in accordance with, the internal laws of the State

of Delaware. All legal actions and proceedings arising out of or relating to this Agreement shall be heard and determined exclusively

in any state or federal court located in Delaware (or in any appellate court thereof) (the “Specified Courts”). The

Parties hereby (a) submit to the exclusive jurisdiction of any Specified Court for the purpose of any Action arising out of or relating

to this Agreement brought by any Party hereto and (b) irrevocably waive, and agree not to assert by way of motion, defense or otherwise,

in any such Action, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt

or immune from attachment or execution, that the Action is brought in an inconvenient forum, that the venue of the Action is improper,

or that this Agreement or the Transactions may not be enforced in or by any Specified Court. Each Party agrees that a final judgment

in any Action shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided

by Law.

(f)

WAIVER OF JURY TRIAL. EACH PARTY HEREBY WAIVES TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW ANY RIGHT IT MAY HAVE TO A TRIAL

BY JURY WITH RESPECT TO ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT OR ANY TRANSACTION

CONTEMPLATED HEREIN. EACH PARTY (A) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY

OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (B) ACKNOWLEDGES

THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT AND THE TRANSACTIONS CONTEMPLATED HEREIN, AS APPLICABLE,

BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 2(f).

(g)

Interpretation. The titles and subtitles used in this Agreement are for convenience only and are not to be considered in construing

or interpreting this Agreement. In this Agreement, unless the context otherwise requires: (i) any pronoun used in this Agreement shall

include the corresponding masculine, feminine or neuter forms, and the singular form of nouns, pronouns and verbs shall include the plural

and vice versa; (ii) “including” (and with correlative meaning “include”) means including without limiting the

generality of any description preceding or succeeding such term and shall be deemed in each case to be followed by the words “without

limitation”; (iii) the words “herein,” “hereto,” and “hereby” and other words of similar import

in this Agreement shall be deemed in each case to refer to this Agreement as a whole and not to any particular section or other subdivision

of this Agreement; and (iv) the term “or” means “and/or”. The Parties have participated jointly in the negotiation

and drafting of this Agreement. Consequently, in the event an ambiguity or question of intent or interpretation arises, this Agreement

shall be construed as if drafted jointly by the Parties hereto, and no presumption or burden of proof shall arise favoring or disfavoring

any party by virtue of the authorship of any provision of this Agreement.

(h)

Notices. All notices, consents, waivers and other communications hereunder shall be governed by the provisions under the Share

Purchase Agreement.

(i)

Amendments and Waivers. This Agreement may be amended, supplemented, modified or waived only by execution of a written instrument

signed by each of the Parties. No failure or delay by a Party in exercising any right hereunder shall operate as a waiver thereof. No

waivers of or exceptions to any term, condition, or provision of this Agreement, in any one or more instances, shall be deemed to be

or construed as a further or continuing waiver of any such term, condition, or provision.

(j)

Severability. In case any provision in this Agreement shall be held invalid, illegal or unenforceable in a jurisdiction, such

provision shall be modified or deleted, as to the jurisdiction involved, only to the extent necessary to render the same valid, legal

and enforceable, and the validity, legality and enforceability of the remaining provisions hereof shall not in any way be affected or

impaired thereby nor shall the validity, legality or enforceability of such provision be affected thereby in any other jurisdiction.

Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the Parties will substitute

for any invalid, illegal or unenforceable provision a suitable and equitable provision that carries out, so far as may be valid, legal

and enforceable, the intent and purpose of such invalid, illegal or unenforceable provision.

(k)

Specific Performance. The Parties agree that irreparable damage would occur in the event that any of the provisions of this Agreement

were not performed in accordance with their specific terms or were otherwise breached. The Parties further agree that each party shall

be entitled to seek specific performance of the terms hereof and immediate injunctive relief and other equitable relief to prevent breaches,

or threatened breaches, of this Agreement, without the necessity of proving the inadequacy of money damages as a remedy and without bond

or other security being required, this being in addition to any other remedy to which they are entitled at law or in equity. The Parties

further agree (i) not to assert that a remedy of specific enforcement pursuant to this Section 2(k) is unenforceable, invalid,

contrary to applicable law or inequitable for any reason and (ii) to waive any defenses in any action for specific performance, including

the defense that a remedy at law would be adequate.

(l)

No Partnership, Agency or Joint Venture. This Agreement is intended to create a contractual relationship between the Parties,

and is not intended to create, and does not create, any agency, partnership, joint venture or any like relationship between or among

the Parties.

(m)

Entire Agreement. This Agreement and the Share Purchase Agreement constitute the full and entire understanding and agreement

among the Parties with respect to the subject matter hereof, and any other written or oral agreement relating to the subject matter hereof

existing between the Parties is expressly superseded; provided, that, for the avoidance of doubt, the foregoing shall not affect

the rights and obligations of the Parties under the Share Purchase Agreement or any Ancillary Document. Notwithstanding the foregoing,

nothing in this Agreement shall limit any of the rights, remedies or obligations of the Parties under any other agreement among the Parties

or any certificate or instrument executed by any Holder in favor of Purchaser, and nothing in any other agreement, certificate or instrument

shall limit any of the rights, remedies or obligations of the Parties under this Agreement.

(n)

Further Assurances. From time to time, at another Party’s request and without further consideration (but at the requesting

Party’s reasonable cost and expense), each Party shall execute and deliver such additional documents and take all such further

action as may be reasonably necessary to consummate the transactions contemplated by this Agreement.

(o)

Counterparts; Electronic Signatures. This Agreement may be executed and delivered (including by email, electronic signature (including

via DocuSign or similar platform) or other electronic transmission) in one or more counterparts, and by the different Parties in separate

counterparts, each of which when executed shall be deemed to be an original but all of which taken together shall constitute one and

the same agreement.

[Signature

Pages Follow]

IN

WITNESS WHEREOF, the undersigned have caused this Agreement to be executed as of the date first written above.

PURCHASER:

ARC GROUP ACQUISITION I CORP.

By:

Name:

Title:

IN

WITNESS WHEREOF, the undersigned have caused this Agreement to be executed as of the date first written above.

HOLDERS:

By:

Name:

Title:

Email:

Address:

[Signature

Page to Lock-up Agreement]

Exhibit

A

Restricted

Securities

Party

Restricted

Securities

EX-10.5

EX-10.5

Filename: ex10-5.htm · Sequence: 7

Exhibit 10.5

FORM

OF RESTRICTIVE COVENANT AGREEMENT

THIS

RESTRICTIVE COVENANT AGREEMENT (this “Agreement”) is made and entered into as of [●], between (i) BlueCrest

Investment, Inc., a British Virgin Islands business company (formerly known as ARC Group Acquisition I Corp., hereinafter referred to

as “Purchaser” prior to the Closing and “PubCo” following the Closing), and (ii) the undersigned

(each of such undersigned, a “Holder” and collectively, the “Holders”). Purchaser (or PubCo) and

the Holders are sometimes referred to herein individually as a “Party” and, collectively, as the “Parties”.

Any capitalized term used but not defined in this Agreement will have the meaning ascribed to such term in the Share Purchase Agreement

(as defined below).

WHEREAS,

Purchaser, Firstborn Top Capital Sdn. Bhd., a Malaysian private limited company (the “Company”), the shareholders

of the Company (the “Selling Shareholders”) and a representative each of the Purchaser and the Company, entered into

a share purchase agreement, dated ________, 2026 (the “Share Purchase Agreement”), pursuant to which the Selling Shareholders

agreed to sell and transfer to Purchaser, and Purchaser agreed to purchase, acquire and accept from the Selling Shareholders, all of

the issued and outstanding capital shares of the Company, upon the terms and conditions set forth therein; and

WHEREAS,

pursuant to the Share Purchase Agreement, and in view of the valuable consideration to be received by the Holders thereunder, the Parties

desire to enter into this Agreement, pursuant to which each Holder agrees to the restrictive covenants as set forth herein.

NOW,

THEREFORE, in consideration of the premises set forth above, which are incorporated into this Agreement as if fully set forth below,

and intending to be legally bound hereby, the Parties hereby agree as follows:

1.

Non-Competition and Non-Solicitation.

(a)

During the period commencing on the Closing Date and ending on the twenty four month (24) anniversary of the Closing Date, none of the

Holders or their respective Affiliates will, directly or indirectly, engage in any business in competition with the Business anywhere

in Southeast Asia as the Business is conducted in the twelve (12)-month period prior to the Closing (each, a “Competing Activity”);

provided that the foregoing shall not prohibit (i) any Holder or any of their respective Affiliates from acquiring, holding of

investments in, or direct or indirect ownership (as a passive investor) of, any ownership interest of any Person engaged in a Competing

Activity, so long as such ownership interest represents not more than five percent (5%) of the aggregate voting power or outstanding

equity interests of such Person, or (ii) any Holder from performing services for an on behalf of Pubco or the Company, or any of their

respective Affiliates, in any such case, subject to the terms of any written agreement between such Person, on the one hand, and Pubco,

the Company, or any such Affiliate, on the other hand. “Business” shall mean the moneylending business.

(b)

During the period commencing on the Closing Date and ending on the fourth (4th) anniversary of the Closing Date, none of the

Holders or their respective Affiliates or representatives acting on their behalf will, directly or indirectly, (i) solicit, cause to

be solicited, offer to employ, or recruit for employment or independent contracting or consulting arrangements, any employee of Pubco

or the Company (a “Continuing Employee”), (ii) interfere with, endeavor to entice away or induce any Continuing Employee

to terminate his or her employment with Pubco or its relevant Affiliate (including the Company) or otherwise seek to influence or alter

any Continuing Employee’s relationship with Pubco or its relevant Affiliate (including the Company), (iii) hire, employ, or engage,

in each case, whether on a full-time, part-time, independent contracting, consulting or any other basis, any Continuing Employee, (iv)

interfere with, endeavor to entice away or induce any existing or potential customer of the Business to withdraw, curtail or terminate

its existing business relationship or not enter into a business relationship with the Business or otherwise seek to influence or alter

any such customer’s relationship with the Business, or (v) solicit, cause to be solicited, service or accept any business from

any existing or potential customer of the Business.

(c)

If any provision set forth in this Section 1 is invalid, illegal or incapable of being enforced by any Law or public policy, such

invalidity, illegality or unenforceability shall not affect any other provisions of this Section, but this Section shall be construed

as if such invalid, illegal or unenforceable provision had never been set forth in this Section. It is the intention of the Parties that

if any of the restrictions or covenants contained in this Section 1 is held to cover a geographic area or to be for a length of

time that is not permitted by applicable Law, or in any way construed to be too broad or to any extent invalid, such provision shall

not be construed to be null, void and of no effect, but to the extent such provision would be valid or enforceable under applicable Law,

a court of competent jurisdiction shall construe and interpret or reform this Section to provide for a covenant having the maximum enforceable

geographic area, time period and other provisions, in each case not greater than those contained in this Section, as shall be valid and

enforceable under such applicable Law.

2.

Miscellaneous.

(a)

Authorization. Each Holder, severally and not jointly, hereby represents and warrants that he, she or it has full power and authority

to enter into this Agreement and that this Agreement constitutes the legal, valid and binding obligation of such Holder, enforceable

in accordance with its terms. Upon request, each Holder will execute any additional documents as may be necessary in connection with

enforcement hereof.

(b)

Termination. This Agreement shall automatically terminate with respect to each of the Parties when the applicable restrictive

period applicable to such Party hereunder, have ended.

(c)

Binding Effect; Assignment. This Agreement and all of the provisions hereof shall be binding upon and inure solely to the benefit

of the Parties hereto and their respective permitted successors and assigns. Except as otherwise provided in this Agreement, this Agreement

shall not be assigned by operation of Law or otherwise without the prior written consent of all Parties hereto. Any assignment without

such consent shall be null and void; provided, that no such assignment shall relieve the assigning Party of its obligations hereunder.

(d)

Governing Law; Jurisdiction. This Agreement shall be governed by, construed and enforced in accordance with the Laws of the State

of Delaware without regard to the conflict of laws principles thereof. All Actions arising out of or relating to this Agreement shall

be heard and determined exclusively in the Chancery Court of the State of Delaware (or in any other court in the State of Delaware or

any appellate court thereof) (the “Specified Courts”). Each Party hereto hereby (a) submits to the exclusive jurisdiction

of any Specified Court for the purpose of any Action arising out of or relating to this Agreement brought by any Party hereto and (b)

irrevocably waives, and agrees not to assert by way of motion, defense or otherwise, in any such Action, any claim that it is not subject

personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that the

Action is brought in an inconvenient forum, that the venue of the Action is improper, or that this Agreement or the transactions contemplated

hereby may not be enforced in or by any Specified Court. Each Party agrees that a final judgment in any Action shall be conclusive and

may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by Law.

2

(e)

WAIVER OF JURY TRIAL. EACH PARTY HEREBY WAIVES TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW ANY RIGHT IT MAY HAVE TO A TRIAL

BY JURY WITH RESPECT TO ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT OR ANY TRANSACTION

CONTEMPLATED HEREIN. EACH PARTY (A) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY

OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (B) ACKNOWLEDGES

THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT AND THE TRANSACTIONS CONTEMPLATED HEREIN, AS APPLICABLE,

BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 2(e).

(f)

Notices. All notices, consents, waivers and other communications hereunder shall be governed by the provisions under the Share

Purchase Agreement.

(g)

Amendments and Waivers. This Agreement may be amended, supplemented, modified or waived only by execution of a written instrument

signed by each of the Parties. No failure or delay by a Party in exercising any right hereunder shall operate as a waiver thereof. No

waivers of or exceptions to any term, condition, or provision of this Agreement, in any one or more instances, shall be deemed to be

or construed as a further or continuing waiver of any such term, condition, or provision.

(h)

Severability. In case any provision in this Agreement shall be held invalid, illegal or unenforceable in a jurisdiction, such

provision shall be modified or deleted, as to the jurisdiction involved, only to the extent necessary to render the same valid, legal

and enforceable, and the validity, legality and enforceability of the remaining provisions hereof shall not in any way be affected or

impaired thereby nor shall the validity, legality or enforceability of such provision be affected thereby in any other jurisdiction.

Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the Parties will substitute

for any invalid, illegal or unenforceable provision a suitable and equitable provision that carries out, so far as may be valid, legal

and enforceable, the intent and purpose of such invalid, illegal or unenforceable provision.

(i)

Specific Performance. The Parties agree that irreparable damage would occur in the event that any of the provisions of this Agreement

were not performed in accordance with their specific terms or were otherwise breached. The Parties further agree that each party shall

be entitled to seek specific performance of the terms hereof and immediate injunctive relief and other equitable relief to prevent breaches,

or threatened breaches, of this Agreement, without the necessity of proving the inadequacy of money damages as a remedy and without bond

or other security being required, this being in addition to any other remedy to which they are entitled at law or in equity. The Parties

further agree (i) not to assert that a remedy of specific enforcement pursuant to this Section 2(i) is unenforceable, invalid,

contrary to applicable Law or inequitable for any reason and (ii) to waive any defenses in any action for specific performance, including

the defense that a remedy at law would be adequate.

(j)

Entire Agreement. This Agreement and the Share Purchase Agreement constitute the full and entire understanding and agreement

among the Parties with respect to the subject matter hereof, and any other written or oral agreement relating to the subject matter hereof

existing between the Parties is expressly superseded; provided, that, for the avoidance of doubt, the foregoing shall not affect

the rights and obligations of the Parties under the Share Purchase Agreement or any Ancillary Document. Notwithstanding the foregoing,

nothing in this Agreement shall limit any of the rights, remedies or obligations of the Parties under any other agreement among the Parties

or any certificate or instrument executed by any Holder in favor of PubCo, and nothing in any other agreement, certificate or instrument

shall limit any of the rights, remedies or obligations of the Parties under this Agreement.

(k)

Further Assurances. From time to time, at another Party’s request and without further consideration (but at the requesting

Party’s reasonable cost and expense), each Party shall execute and deliver such additional documents and take all such further

action as may be reasonably necessary to consummate the transactions contemplated by this Agreement.

(l)

Counterparts; Electronic Signatures. This Agreement may be executed and delivered (including by email, electronic signature (including

via DocuSign or similar platform) or other electronic transmission) in one or more counterparts, and by the different Parties in separate

counterparts, each of which when executed shall be deemed to be an original but all of which taken together shall constitute one and

the same agreement.

[Signature

Pages Follow]

3

IN

WITNESS WHEREOF, the Parties have executed this Agreement as of the date first written above.

PUBCO

[_________________]

By:

Name:

Title:

HOLDER

By:

Name:

Address:

EX-10.6

EX-10.6

Filename: ex10-6.htm · Sequence: 8

Exhibit 10.6

INDEMNIFICATION

AGREEMENT

THIS

INDEMNIFICATION AGREEMENT (the “Agreement”) is made and entered into as of ___________, between BlueCrest Investment,

Inc., a British Virgin Islands business company (formerly known as ARC Group Acquisition I Corp., hereinafter referred to as the “Company”),

and ______________ (“Indemnitee”).

WITNESSETH

THAT:

WHEREAS,

highly competent persons have become more reluctant to serve corporations as directors or in other capacities unless they are provided

with adequate protection through insurance or adequate indemnification against inordinate risks of claims and actions against them arising

out of their service to and activities on behalf of the Company;

WHEREAS,

the Board of Directors of the Company (the “Board”) has determined that, in order to attract and retain qualified

individuals, the Company will attempt to maintain on an ongoing basis, at its sole expense, liability insurance to protect persons serving

the Company and its subsidiaries from certain liabilities;

WHEREAS,

the uncertainties relating to such insurance and to indemnification have increased the difficulty of attracting and retaining such persons;

WHEREAS,

the Board has determined that the increased difficulty in attracting and retaining such persons is detrimental to the best interests

of the Company’s shareholders and that the Company should act to assure such persons that there will be increased certainty of

such protection in the future;

WHEREAS,

it is reasonable, prudent and necessary for the Company contractually to obligate itself to indemnify, and to advance expenses on behalf

of, such persons to the fullest extent permitted by applicable law and the Articles so that they will serve or continue to serve the

Company free from undue concern that they will not be so indemnified; and

NOW,

THEREFORE, in consideration of Indemnitee’s agreement to serve as a director or officer from and after the date hereof, the parties

hereto agree as follows:

1.

Indemnity of Indemnitee. The Company hereby agrees to hold harmless and indemnify Indemnitee to the fullest extent permitted by

applicable law and the Articles (as hereinafter defined). In furtherance of the foregoing indemnification, and without limiting the generality

thereof:

(a)

Proceedings Other Than Proceedings by or in the Right of the Company. Indemnitee shall be entitled to the rights of indemnification

provided in this Section 1(a) if, by reason of Indemnitee’s Corporate Status (as hereinafter defined), the Indemnitee is,

or is threatened to be made, a party to or participant in any Proceeding (as hereinafter defined) other than a Proceeding by or in the

right of the Company. Pursuant to this Section 1(a), Indemnitee shall be indemnified against all Expenses (as hereinafter defined),

judgments, penalties, fines and amounts paid in settlement actually and reasonably incurred by Indemnitee, or on Indemnitee’s behalf,

in connection with such Proceeding or any claim, issue or matter therein, if the Indemnitee acted in good faith and in a manner the Indemnitee

reasonably believed to be in or not opposed to the best interests of the Company, and with respect to any criminal Proceeding, had no

reasonable cause to believe the Indemnitee’s conduct was unlawful, provided, however, no indemnification under this subsection

shall be made in respect of any claim, issue or matter as to which the Indemnitee shall have been adjudicated by final judgment by a

court of competent jurisdiction to be liable to the Company for willful neglect, willful default or actual fraud in the performance of

his/her duty to the Company.

(b)

Proceedings by or in the Right of the Company. The Company shall indemnify the Indemnitee if the Indemnitee is a party to or threatened

to be made a party to or is otherwise involved in any Proceeding by or in the right of the Company to procure a judgment in its favor

against all Expenses which are actually and reasonably incurred by the Indemnitee in connection with such a Proceeding, if the Indemnitee

acted in good faith and in a manner the Indemnitee reasonably believed to be in, or not opposed to, the best interests of the Company;

except that no indemnification under this subsection shall be made in respect of any claim, issue or matter as to which the Indemnitee

shall have been adjudicated by final judgment by a court of competent jurisdiction to be liable to the Company for willful neglect, willful

default or actual fraud in the performance of Indemnitee’s duty to the Company, unless and only to the extent that the court in

which such Proceeding was brought shall determine upon application that, despite the adjudication of liability but in view of all the

circumstances of the case, the Indemnitee is fairly and reasonably entitled to indemnity for such amounts which such court shall deem

proper, in each case, to the maximum extent permitted by the Articles.

(c)

Indemnification for Expenses of a Party Who is Wholly or Partly Successful. Notwithstanding any other provision of this Agreement,

to the extent that Indemnitee is, by reason of Indemnitee’s Corporate Status, a party to and is successful, on the merits or otherwise,

in any Proceeding, Indemnitee shall be indemnified to the maximum extent permitted by applicable law and the Articles against all Expenses

actually and reasonably incurred by Indemnitee or on Indemnitee’s behalf in connection therewith. If Indemnitee is not wholly successful

in such Proceeding but is successful, on the merits or otherwise, as to one or more but less than all claims, issues or matters in such

Proceeding, the Company shall indemnify Indemnitee against all Expenses actually and reasonably incurred by Indemnitee or on Indemnitee’s

behalf in connection with each successfully resolved claim, issue or matter. For purposes of this Section and without limitation, the

termination of any claim, issue or matter in such a Proceeding by dismissal, with or without prejudice, shall be deemed to be a successful

result as to such claim, issue or matter.

2.

Additional Indemnity. In addition to, and without regard to any limitations on, the indemnification provided for in Section

1 of this Agreement, the Company shall and hereby does indemnify and hold harmless Indemnitee to the fullest extent permitted by

applicable law and the Articles against all Expenses, judgments, penalties, fines and amounts paid in settlement (including all interest,

assessments and other charges paid or payable in connection with or in respect thereof) actually and reasonably incurred by Indemnitee

or on Indemnitee’s behalf if, by reason of Indemnitee’s Corporate Status, Indemnitee is, or is threatened to be made, a party

to or participant in any Proceeding (including a Proceeding by or in the right of the Company to procure a judgement in its favor); provided,

however, that (i) no indemnification against such Expenses, judgments, penalties, fines and amounts shall be made in respect of any claim,

issue or matter in any such Proceeding as to which Indemnitee shall have been finally adjudged by a court of competent jurisdiction to

be liable to the Company for willful default, willful neglect or actual fraud in the performance of Indemnitee’s duty to the Company,

and (ii) that the Company shall not be obligated to make any payment to Indemnitee that is finally determined (under the procedures,

and subject to the presumptions, set forth in Sections 6 and 7 hereof) to be unlawful.

3.

Contribution.

(a)

To the fullest extent permissible under applicable law and the Articles, whether or not the indemnification provided in Sections 1

and 2 hereof is available, in respect of any threatened, pending or completed action, suit or proceeding in which the Company

is jointly liable with Indemnitee (or would be if joined in such action, suit or Proceeding), the Company shall pay, in the first instance,

the entire amount of any judgment or settlement of such action, suit or proceeding without requiring Indemnitee to contribute to such

payment and the Company hereby waives and relinquishes any right of contribution it may have against Indemnitee. The Company shall not

enter into any settlement of any action, suit or proceeding in which the Company is jointly liable with Indemnitee (or would be if joined

in such action, suit or proceeding) unless such settlement provides for a full and final release of all claims asserted against Indemnitee.

(b)

Without diminishing or impairing the obligations of the Company set forth in the preceding subparagraph, if, for any reason, Indemnitee

shall elect or be required to pay all or any portion of any judgment or settlement in any threatened, pending or completed action, suit

or proceeding in which the Company is jointly liable with Indemnitee (or would be if joined in such action, suit or proceeding), the

Company shall contribute to the amount of Expenses, judgments, fines and amounts paid in settlement actually and reasonably incurred

and paid or payable by Indemnitee in proportion to the relative benefits received by the Company and all officers, directors or employees

of the Company, other than Indemnitee, who are jointly liable with Indemnitee (or would be if joined in such action, suit or proceeding),

on the one hand, and Indemnitee, on the other hand, from the transaction from which such action, suit or proceeding arose; provided,

however, that the proportion determined on the basis of relative benefit may, to the extent necessary to conform to law, be further adjusted

by reference to the relative fault of the Company and all officers, directors or employees of the Company other than Indemnitee who are

jointly liable with Indemnitee (or would be if joined in such action, suit or proceeding), on the one hand, and Indemnitee, on the other

hand, in connection with the events that resulted in such expenses, judgments, fines or settlement amounts, as well as any other equitable

considerations which the Law may require to be considered. The relative fault of the Company and all officers, directors or employees

of the Company, other than Indemnitee, who are jointly liable with Indemnitee (or would be if joined in such action, suit or proceeding),

on the one hand, and Indemnitee, on the other hand, shall be determined by reference to, among other things, the degree to which their

actions were motivated by intent to gain personal profit or advantage, the degree to which their liability is primary or secondary and

the degree to which their conduct is active or passive.

(c)

To the fullest extent permissible under applicable law and the Articles, the Company hereby agrees to fully indemnify and hold Indemnitee

harmless from any claims of contribution which may be brought by officers, directors or employees of the Company, other than Indemnitee,

who may be jointly liable with Indemnitee.

(d)

To the fullest extent permissible under applicable law and the Articles, if the indemnification provided for in this Agreement is unavailable

to Indemnitee for any reason whatsoever, the Company, in lieu of indemnifying Indemnitee, shall contribute to the amount incurred by

Indemnitee, whether for judgments, fines, penalties, excise taxes, amounts paid or to be paid in settlement and/or for Expenses, in connection

with any claim relating to an indemnifiable event under this Agreement, in such proportion as is deemed fair and reasonable in light

of all of the circumstances of such Proceeding in order to reflect (i) the relative benefits received by the Company and Indemnitee as

a result of the event(s) and/or transaction(s) giving cause to such Proceeding; and/or (ii) the relative fault of the Company (and its

directors, officers, employees and agents) and Indemnitee in connection with such event(s) and/or transaction(s).

(e)

The Company shall not enter into any settlement of any Proceeding in which the Company is jointly liable with Indemnitee (or would be

if joined in such Proceeding) unless such settlement provides for a full and final release of all claims asserted against Indemnitee.

4.

Indemnification for Expenses of a Witness. Notwithstanding any other provision of this Agreement, to the extent that Indemnitee

is, by reason of his Corporate Status, a witness, or is made (or asked to) respond to discovery requests, in any Proceeding to which

Indemnitee is not a party or is threatened to be a party, Indemnitee shall, to the fullest extent permissible under applicable law and

the Articles, be indemnified against all Expenses actually and reasonably incurred by Indemnitee or on Indemnitee’s behalf in connection

therewith.

5.

Advancement of Expenses.

(a)

Notwithstanding any other provision of this Agreement, and to the fullest extent not prohibited by applicable law and the Articles, the

Company shall advance all Expenses incurred by or on behalf of Indemnitee in connection with any Proceeding by reason of Indemnitee’s

Corporate Status within thirty (30) days after the receipt by the Company of a statement or statements from Indemnitee requesting such

advance or advances from time to time, whether prior to or after final disposition of such Proceeding. Such statement or statements shall

reasonably evidence the Expenses incurred by Indemnitee and shall include or be preceded or accompanied by a written undertaking by or

on behalf of Indemnitee to repay any Expenses advanced if it shall ultimately be determined that Indemnitee is not entitled to be indemnified

against such Expenses. Any advances and undertakings to repay pursuant to this Section 5 shall be unsecured and interest free.

Advances shall include any and all reasonable Expenses incurred (or reasonably expected by Indemnitee to be incurred by Indemnitee within

three months) pursuing an Enforcement Proceeding (as such term is defined in Section 7 below), including Expenses incurred preparing

and forwarding statements to the Company to support the advances claimed. For the purposes of this paragraph, assume all references to

a “Proceeding” in the definition of Expenses refer to an Enforcement Proceeding). To the fullest extent permitted by applicable

law, the Indemnitee shall not be required to reimburse the Company such amounts advanced until a final determination has been made with

respect to Indemnitee’s entitlement to indemnification under any such Enforcement Proceeding pursuant to Section 6(d). This

Section 5(a) shall not apply to any claim made by Indemnitee for which an indemnification, hold harmless or exoneration payment

is excluded pursuant to Section 9, but shall apply to any Proceeding referenced in Section 9(b) prior to a final determination

that Indemnitee is liable therefor.

(b)

The Company will be entitled to participate in the Proceeding at its own expense.

(c)

The Company shall not settle any action, claim or Proceeding (in whole or in part) which would impose any Expense, judgment, liability,

fine, penalty or limitation on Indemnitee without Indemnitee’s prior written consent.

6.

Procedures and Presumptions for Determination of Entitlement to Indemnification. The parties agree that the following procedures

and presumptions shall apply in the event of any question as to whether Indemnitee is entitled to indemnification under this Agreement:

(a)

To obtain indemnification under this Agreement, Indemnitee shall submit to the Board a written request, including therein or therewith

such documentation and information as is reasonably available to Indemnitee and is reasonably necessary to determine whether and to what

extent Indemnitee is entitled to indemnification. Notwithstanding the foregoing, any failure of Indemnitee to provide such a request

to the Company, or to provide such a request in a timely fashion, shall not relieve the Company of any liability that it may have to

Indemnitee unless, and to the extent that, such failure actually and materially prejudices the interests of the Company.

(b)

Upon written request by Indemnitee for indemnification pursuant to the first sentence of Section 6(a) hereof, a determination

with respect to Indemnitee’s entitlement thereto shall be made in the specific case by one of the following four methods, which

shall be at the election of the Board: (1) by a majority vote of the Disinterested Directors, even though less than a quorum, (2) by

a committee of disinterested directors designated by a majority vote of the disinterested directors, even though less than a quorum,

(3) if there are no disinterested directors or if the disinterested directors so direct, by Independent Counsel in a written opinion

to the Board, a copy of which shall be delivered to the Indemnitee, or (4) if so directed by the Board, by the shareholders of the Company.

For purposes hereof, disinterested directors are those members of the Board who are not parties to the action, suit or proceeding in

respect of which indemnification is sought by Indemnitee.

(c)

If the determination of entitlement to indemnification is to be made by Independent Counsel pursuant to Section 6(b) hereof, the

Independent Counsel shall be selected as provided in this Section 6(c). The Independent Counsel shall be selected by the Board.

Indemnitee may, within ten (10) days after such written notice of selection shall have been given, deliver to the Company a written objection

to such selection; provided, however, that such objection may be asserted only on the ground that the Independent Counsel so selected

does not meet the requirements of “Independent Counsel” as defined in Section 13 of this Agreement, and the

objection shall set forth with particularity the factual basis of such assertion. Absent a proper and timely objection, the person so

selected shall act as Independent Counsel. If a written objection is made and substantiated, the Independent Counsel selected may not

serve as Independent Counsel unless and until such objection is withdrawn or a court of competent jurisdiction has determined that such

objection is without merit. If, within twenty (20) days after submission by Indemnitee of a written request for indemnification pursuant

to Section 6(a) hereof, no Independent Counsel shall have been selected and not objected to, either the Company or Indemnitee

may petition a court of competent jurisdiction for resolution of any objection which shall have been made by the Indemnitee to the Company’s

selection of Independent Counsel and/or for the appointment as Independent Counsel of a person selected by the court or by such other

person as the court shall designate, and the person with respect to whom all objections are so resolved or the person so appointed shall

act as Independent Counsel under Section 6(b) hereof. The Company shall pay any and all reasonable fees and expenses of Independent

Counsel incurred by such Independent Counsel in connection with acting pursuant to Section 6(b) hereof, and the Company shall

pay all reasonable fees and expenses incident to the procedures of this Section 6(c), regardless of the manner in which such Independent

Counsel was selected or appointed.

(d)

In making a determination with respect to entitlement to indemnification hereunder, the person or persons or entity making such determination

shall presume that Indemnitee is entitled to indemnification under this Agreement. Anyone seeking to overcome this presumption shall

have the burden of proof and the burden of persuasion by clear and convincing evidence. Neither the failure of the Company (including

by its directors or independent legal counsel) to have made a determination prior to the commencement of any action pursuant to this

Agreement that indemnification is proper in the circumstances because Indemnitee has met the applicable standard of conduct, nor an actual

determination by the Company (including by Disinterested Directors or Independent Counsel) that Indemnitee has not met such applicable

standard of conduct, shall be a defense to the action or create a presumption that Indemnitee has not met the applicable standard of

conduct.

(e)

Indemnitee shall be deemed to have acted in good faith if Indemnitee’s action is based on the records or books of account of the

Enterprise, including financial statements, or on information supplied to Indemnitee by the officers of the Enterprise (as hereinafter

defined) in the course of their duties, or on the advice of legal counsel for the Enterprise or on information or records given or reports

made to the Enterprise by an independent certified public accountant or by an appraiser or other expert selected with reasonable care

by the Enterprise. In addition, the knowledge and/or actions, or failure to act, of any director, officer, agent or employee of the Enterprise

shall not be imputed to Indemnitee for purposes of determining the right to indemnification under this Agreement. Whether or not the

foregoing provisions of this Section 6(e) are satisfied, it shall in any event be presumed that Indemnitee has at all times acted

in good faith and in a manner he reasonably believed to be in or not opposed to the best interests of the Company. Anyone seeking to

overcome this presumption shall have the burden of proof and the burden of persuasion by clear and convincing evidence.

(f)

If the person, persons or entity empowered or selected under Section 6 to determine whether Indemnitee is entitled to indemnification

shall not have made a determination within sixty (60) days after receipt by the Company of the request therefor, the requisite determination

of entitlement to indemnification shall be deemed to have been made and Indemnitee shall be entitled to such indemnification absent (i)

a misstatement by Indemnitee of a material fact, or an omission of a material fact necessary to make Indemnitee’s statement not

materially misleading, in connection with the request for indemnification, or (ii) a prohibition of such indemnification under applicable

law; provided, however, that such 60-day period may be extended for a reasonable time, not to exceed an additional thirty (30) days,

if the person, persons or entity making such determination with respect to entitlement to indemnification in good faith requires such

additional time to obtain or evaluate documentation and/or information relating thereto; and provided, further, that the foregoing provisions

of this Section 6(f) shall not apply (i) if the determination of entitlement to indemnification is to be made by the shareholders

pursuant to Section 6(b) of this Agreement and if (A) within fifteen (15) days after receipt by the Company of the request for

such determination, the Board or the Disinterested Directors, if appropriate, resolve to submit such determination to the shareholders

for their consideration at an annual general meeting thereof to be held within seventy-five (75) days after such receipt and such determination

is made thereat, or (B) an extraordinary general meeting of shareholders is called within fifteen (15) days after such receipt for the

purpose of making such determination, such meeting is held for such purpose within sixty (60) days after having been so called and such

determination is made thereat, or (ii) if the determination of entitlement to indemnification is to be made by Independent Counsel pursuant

to Section 6(c) of this Agreement

(g)

If it is so determined that Indemnitee is entitled to indemnification, payment to Indemnitee shall be made within ten (10) days after

such determination. Indemnitee shall cooperate with the person, persons or entity making such determination with respect to Indemnitee’s

entitlement to indemnification, including providing to such person, persons or entity upon reasonable advance request any documentation

or information which is not privileged or otherwise protected from disclosure and which is reasonably available to Indemnitee and reasonably

necessary to such determination. Any Independent Counsel, member of the Board or shareholder of the Company shall act reasonably and

in good faith in making a determination regarding the Indemnitee’s entitlement to indemnification under this Agreement. Any costs

or expenses (including attorneys’ fees and disbursements) incurred by Indemnitee in so cooperating with the person, persons or

entity making such determination shall be borne by the Company (irrespective of the determination as to Indemnitee’s entitlement

to indemnification) and the Company hereby indemnifies and agrees to hold Indemnitee harmless therefrom.

(h)

The Company acknowledges that a settlement or other disposition short of final judgment may be successful if it permits a party to avoid

expense, delay, distraction, disruption and uncertainty. In the event that any action, claim or proceeding to which Indemnitee is a party

is resolved in any manner other than by adverse judgment against Indemnitee (including, without limitation, settlement of such action,

claim or proceeding with or without payment of money or other consideration) it shall be presumed that Indemnitee has been successful

on the merits or otherwise in such action, suit or proceeding. Anyone seeking to overcome this presumption shall have the burden of proof

and the burden of persuasion by clear and convincing evidence.

(i)

The Company agrees to pay the reasonable fees and expenses of Independent Counsel and to fully indemnify and hold harmless such Independent

Counsel against any and all Expenses, claims, liabilities and damages arising out of or relating to this Agreement or its engagement

pursuant hereto.

(j)

The termination of any Proceeding or of any claim, issue or matter therein, by judgment, order, settlement or conviction, or upon a plea

of nolo contendere or its equivalent, shall not (except as otherwise expressly provided in this Agreement) of itself adversely affect

the right of Indemnitee to indemnification or create a presumption that Indemnitee did not act in good faith and in a manner which he

reasonably believed to be in or not opposed to the best interests of the Company or, with respect to any criminal Proceeding, that Indemnitee

had reasonable cause to believe that his conduct was unlawful.

7.

Remedies of Indemnitee.

(a)

In the event that (i) a determination is made pursuant to Section 6 of this Agreement that Indemnitee is not entitled to indemnification

under this Agreement, (ii) advancement of Expenses is not timely made pursuant to Section 5 of this Agreement, (iii) no determination

of entitlement to indemnification is made pursuant to Section 6(b) of this Agreement within thirty (30) days after receipt by

the Company of the request for indemnification, (iv) payment of indemnification is not made pursuant to this Agreement within ten (10)

days after receipt by the Company of a written request therefor or (v) a contribution payment is not made in a timely manner pursuant

to Section 3 of this Agreement, (vi) payment of indemnification is not made within ten (10) days after a determination has been

made that Indemnitee is entitled to indemnification or such determination is deemed to have been made pursuant to Section 6 of

this Agreement or (vii) payment to Indemnitee pursuant to any hold harmless or exoneration rights under this Agreement or otherwise is

not made in accordance with this Agreement, Indemnitee shall be entitled to an adjudication in an appropriate court of in Delaware, or

in any other court of competent jurisdiction, of Indemnitee’s entitlement to such indemnification. Indemnitee shall commence such

proceeding seeking an adjudication within one hundred eighty (180) days following the date on which Indemnitee first has the right to

commence such proceeding pursuant to this Section 7(a). The Company shall not oppose Indemnitee’s right to seek any such

adjudication. Alternatively, Indemnitee, at Indemnitee’s option, may seek an award in arbitration to be conducted by a single arbitrator

pursuant to the Commercial Rules of the American Arbitration Association. Except as set forth herein, the Commercial Rules of the American

Arbitration Association shall apply to any such arbitration. The Company shall not oppose Indemnitee’s right to seek any such adjudication

or award in arbitration. Such adjudication or arbitration proceeding is referred to herein as “Enforcement Proceeding.”

(b)

In the event that a determination shall have been made pursuant to Section 6(b) of this Agreement that Indemnitee is not entitled

to indemnification, any judicial proceeding commenced pursuant to this Section 7 shall be conducted in all respects as a de novo

trial on the merits, and Indemnitee shall not be prejudiced by reason of the adverse determination under Section 6(b).

(c)

If a determination shall have been made pursuant to Section 6(b) of this Agreement that Indemnitee is entitled to indemnification,

the Company shall be bound by such determination in any judicial proceeding commenced pursuant to this Section 7, absent (i) a

misstatement by Indemnitee of a material fact, or an omission of a material fact necessary to make Indemnitee’s misstatement not

materially misleading in connection with the application for indemnification, or (ii) a prohibition of such indemnification under applicable

law.

(d)

In the event that Indemnitee, pursuant to this Section 7, seeks a judicial adjudication of his rights under, or to recover damages

for breach of, this Agreement, or to recover under any directors’ and officers’ liability insurance policies maintained by

the Company, the Company shall pay on his behalf, in advance, any and all expenses (of the types described in the definition of Expenses

in Section 13 of this Agreement) actually and reasonably incurred by him in such judicial adjudication, regardless of whether

Indemnitee ultimately is determined to be entitled to such indemnification, advancement of expenses or insurance recovery.

(e)

The Company shall be precluded from asserting in any judicial proceeding commenced pursuant to this Section 7 that the procedures

and presumptions of this Agreement are not valid, binding and enforceable and shall stipulate in any such court that the Company is bound

by all the provisions of this Agreement. To the fullest extent permitted by law and the Articles, the Company shall indemnify Indemnitee

against any and all Expenses and, if requested by Indemnitee, shall (within ten (10) days after receipt by the Company of a written request

therefore) advance, to the extent not prohibited by law, such expenses to Indemnitee, which are incurred by Indemnitee in connection

with any action brought by Indemnitee for indemnification or advance of Expenses from the Company under this Agreement or under any directors’

and officers’ liability insurance policies maintained by the Company, if, in the case of indemnification, Indemnitee is wholly

successful on the underlying claims; if Indemnitee is not wholly successful on the underlying claims, then such indemnification shall

be only to the extent Indemnitee is successful on such underlying claims or otherwise as permitted by applicable law and the Articles,

whichever is greater.

(f)

Notwithstanding anything in this Agreement to the contrary, no determination as to entitlement to indemnification under this Agreement

shall be required to be made prior to the final disposition of the Proceeding.

8.

Non-Exclusivity; Survival of Rights; Insurance; Primacy of Indemnification; Subrogation.

(a)

The rights of indemnification as provided by this Agreement shall not be deemed exclusive of any other rights to which Indemnitee may

at any time be entitled under applicable law, the Articles, any agreement, a vote of shareholders, a resolution of directors or otherwise,

of the Company. No amendment, alteration or repeal of this Agreement or of any provision hereof shall limit or restrict any right of

Indemnitee under this Agreement in respect of any action taken or omitted by such Indemnitee in his Corporate Status prior to such amendment,

alteration or repeal. No right or remedy herein conferred is intended to be exclusive of any other right or remedy, and every other right

and remedy shall be cumulative and in addition to every other right and remedy given hereunder or now or hereafter existing at law or

in equity or otherwise. The assertion or employment of any right or remedy hereunder, or otherwise, shall not prevent the concurrent

assertion or employment of any other right or remedy.

(b)

To the extent that the Company maintains an insurance policy or policies providing liability insurance for directors, officers, employees,

or agents or fiduciaries of the Company or of any other corporation, partnership, joint venture, trust, employee benefit plan or other

enterprise that such person serves at the request of the Company, Indemnitee shall be covered by such policy or policies in accordance

with its or their terms to the maximum extent of the coverage available for any director, officer, employee, agent or fiduciary under

such policy or policies. If, at the time of the receipt of a notice of a claim pursuant to the terms hereof, the Company has director

and officer liability insurance in effect, the Company shall give prompt notice of the commencement of such proceeding to the insurers

in accordance with the procedures set forth in the respective policies. The Company shall thereafter take all necessary or desirable

action to cause such insurers to pay, on behalf of the Indemnitee, all amounts payable as a result of such proceeding in accordance with

the terms of such policies.

(c)

In the event of any payment under this Agreement, the Company shall be subrogated to the extent of such payment to all of the rights

of recovery of Indemnitee, who shall execute all papers required and take all action necessary to secure such rights, including execution

of such documents as are necessary to enable the Company to bring suit to enforce such rights.

(d)

The Company shall not be liable under this Agreement to make any payment of amounts otherwise indemnifiable hereunder if and to the extent

that Indemnitee has otherwise actually received such payment under any insurance policy, contract, agreement or otherwise.

(e)

The Company’s obligation to indemnify or advance Expenses hereunder to Indemnitee who is or was serving at the request of the Company

as a director, officer, employee or agent of any other corporation, partnership, joint venture, trust, employee benefit plan or other

enterprise shall be reduced by any amount Indemnitee has actually received as indemnification or advancement of expenses from such other

corporation, partnership, joint venture, trust, employee benefit plan or other enterprise.

9.

Exception to Right of Indemnification. Notwithstanding any provision in this Agreement, the Company shall not be obligated under

this Agreement to make any indemnity in connection with any claim made against Indemnitee:

(a)

for which payment has actually been made to or on behalf of Indemnitee under any insurance policy or other indemnity provision, except

with respect to any excess beyond the amount paid under any insurance policy or other indemnity provision; or

(b)

for an accounting of profits made from the purchase and sale (or sale and purchase) by Indemnitee of securities of the Company within

the meaning of Section 16(b) of the Securities Exchange Act of 1934, as amended, or similar provisions of state statutory law or common

law;

(c)

except as provided in Section 7(e) of this Agreement, in connection with any Proceeding (or any part of any Proceeding) initiated

by Indemnitee, including any Proceeding (or any part of any Proceeding) initiated by Indemnitee against the Company or its directors,

officers, employees or other indemnitees, unless (i) the Board of the Company authorized the Proceeding (or any part of any Proceeding)

prior to its initiation or (ii) the Company provides the indemnification, in its sole discretion, pursuant to the powers vested in the

Company under applicable law; or

(d)

which results from Indemnitee’s willful default, willful neglect or actual fraud or any other acts, omissions or transactions for

which Indemnitee is prohibited from receiving indemnification under applicable law or the Articles.

10.

Duration of Agreement. All agreements and obligations of the Company contained herein shall continue during the period Indemnitee

is an officer or director of the Company (or is or was serving at the request of the Company as a director, officer, employee or agent

of another corporation, partnership, joint venture, trust or other enterprise) and shall continue for five (5) years thereafter or, if

longer, so long as Indemnitee shall be subject to any Proceeding (or any proceeding commenced under Section 7 hereof) by reason

of his Corporate Status, whether or not he is acting or serving in any such capacity at the time any liability or expense is incurred

for which indemnification can be provided under this Agreement. This Agreement shall be binding upon and inure to the benefit of and

be enforceable by the parties hereto and their respective successors (including any direct or indirect successor by purchase, merger,

consolidation or otherwise to all or substantially all of the business or assets of the Company), assigns, spouses, heirs, executors

and personal and legal representatives.

11.

Security. To the extent requested by Indemnitee and approved by the Board of the Company, the Company may at any time and from

time to time provide security to Indemnitee for the Company’s obligations hereunder through an irrevocable bank line of credit,

funded trust or other collateral. Any such security, once provided to Indemnitee, may not be revoked or released without the prior written

consent of the Indemnitee.

12.

Enforcement.

(a)

The Company expressly confirms and agrees that it has entered into this Agreement and assumes the obligations imposed on it hereby in

order to induce Indemnitee to serve as an officer or director of the Company, and the Company acknowledges that Indemnitee is relying

upon this Agreement in serving as an officer or director of the Company.

(b)

This Agreement constitutes the entire agreement between the parties hereto with respect to the subject matter hereof and supersedes all

prior agreements and understandings, oral, written and implied, between the parties hereto with respect to the subject matter hereof.

13.

Definitions. For purposes of this Agreement:

(a)

“Articles” means the memorandum and articles of association of the Company, as amended, restated or supplemented from

time to time.

(b)

“Corporate Status” describes the status of a person who is or was a director, officer, employee, agent or fiduciary

of the Company or of any other corporation, partnership, joint venture, trust, employee benefit plan or other enterprise that such person

is or was serving at the express written request of the Company.

(c)

“Disinterested Director” means a director of the Company who is not and was not a party to the Proceeding in respect

of which indemnification is sought by Indemnitee.

(d)

“Enterprise” shall mean the Company and any other corporation, partnership, joint venture, trust, employee benefit

plan or other enterprise that Indemnitee is or was serving at the express written request of the Company as a director, officer, employee,

agent or fiduciary.

(e)

“Expenses” shall include all reasonable attorneys’ fees, retainers, court costs, transcript costs, fees of experts,

witness fees, travel expenses, duplicating costs, printing and binding costs, telephone charges, postage, delivery service fees and all

other disbursements or expenses of the types customarily incurred in connection with prosecuting, defending, preparing to prosecute or

defend, investigating, participating, or being or preparing to be a witness in a Proceeding, or responding to, or objecting to, a request

to provide discovery in any Proceeding. Expenses also shall include Expenses incurred in connection with any appeal resulting from any

Proceeding and any federal, state, local or foreign taxes imposed on the Indemnitee as a result of the actual or deemed receipt of any

payments under this Agreement, including without limitation the premium, security for, and other costs relating to any cost bond, supersedeas

bond, or other appeal bond or its equivalent. Expenses, however, shall not include amounts paid in settlement by Indemnitee or the amount

of judgments or fines against Indemnitee.

(f)

“Independent Counsel” means a law firm, or a member of a law firm, that is experienced in matters of corporation law

and neither presently is, nor in the past five (5) years has been, retained to represent: (i) the Company or Indemnitee in any matter

material to either such party (other than with respect to matters concerning Indemnitee under this Agreement, or of other indemnitees

under similar indemnification agreements), or (ii) any other party to the Proceeding giving rise to a claim for indemnification hereunder.

Notwithstanding the foregoing, the term “Independent Counsel” shall not include any person who, under the applicable standards

of professional conduct then prevailing, would have a conflict of interest in representing either the Company or Indemnitee in an action

to determine Indemnitee’s rights under this Agreement. The Company agrees to pay the reasonable fees of the Independent Counsel

referred to above and to fully indemnify such counsel against any and all Expenses, claims, liabilities and damages arising out of or

relating to this Agreement or its engagement pursuant hereto.

(g)

“Proceeding” includes any threatened, pending or completed action, suit, arbitration, alternate dispute resolution

mechanism, investigation, inquiry, administrative hearing or any other actual, threatened or completed proceeding, whether brought by

or in the right of the Company or otherwise and whether civil, criminal, administrative or investigative, in which Indemnitee was, is

or will be involved as a party or otherwise, by reason of the fact that Indemnitee is or was an officer or director of the Company, by

reason of any action taken by him or of any inaction on his part while acting as an officer or director of the Company, or by reason

of the fact that he is or was serving at the request of the Company as a director, officer, employee, agent or fiduciary of another corporation,

partnership, joint venture, trust or other Enterprise; in each case whether or not he is acting or serving in any such capacity at the

time any liability or expense is incurred for which indemnification can be provided under this Agreement; including one pending on or

before the date of this Agreement, but excluding one initiated by an Indemnitee pursuant to Section 7 of this Agreement to enforce

his rights under this Agreement.

(h)

“Enforcement Proceeding” shall mean an adjudication or arbitration proceeding initiated by Indemnitee.

14.

Severability. The invalidity or unenforceability of any provision hereof shall in no way affect the validity or enforceability

of any other provision. Without limiting the generality of the foregoing, this Agreement is intended to confer upon Indemnitee indemnification

rights to the fullest extent permitted by applicable law and the Articles. In the event any provision hereof conflicts with any applicable

law or the Articles, such provision shall be deemed modified, consistent with the aforementioned intent, to the extent necessary to resolve

such conflict.

15.

Modification and Waiver. No supplement, modification, termination or amendment of this Agreement shall be binding unless executed

in writing by both of the parties hereto. No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a

waiver of any other provisions hereof (whether or not similar) nor shall such waiver constitute a continuing waiver.

16.

Notice by Indemnitee. Indemnitee agrees promptly to notify the Company in writing upon being served with or otherwise receiving

any summons, citation, subpoena, complaint, indictment, information or other document relating to any Proceeding or matter which may

be subject to indemnification covered hereunder. The failure to so notify the Company shall not relieve the Company of any obligation

which it may have to Indemnitee under this Agreement or otherwise unless and only to the extent that such failure or delay materially

prejudices the Company.

17.

Notices. All notices and other communications given or made pursuant to this Agreement shall be in writing and shall be deemed

effectively given: (a) upon personal delivery to the party to be notified, (b) when sent by confirmed electronic mail or facsimile if

sent during normal business hours of the recipient, and if not so confirmed, then on the next business day, (c) five (5) days after having

been sent by registered or certified mail, return receipt requested, postage prepaid, or (d) one (1) day after deposit with a nationally

recognized overnight courier, specifying next day delivery, with written verification of receipt. All communications shall be sent:

(a)

To

Indemnitee at the address set forth below Indemnitee’s signature hereto.

(b)

To

the Company at:

Firstborn

Top Capital

398

S Mill Avenue,

Suite

306,

Tempe,

AZ 85284

Attn:

____________________

Telephone

No.: ____________

E-mail:

___________________

or

to such other address as may have been furnished to Indemnitee by the Company or to the Company by Indemnitee, as the case may be.

18.

Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of

which together shall constitute one and the same Agreement. This Agreement may also be executed and delivered by facsimile signature

and in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same

instrument.

19.

Headings. The headings of the paragraphs of this Agreement are inserted for convenience only and shall not be deemed to constitute

part of this Agreement or to affect the construction thereof.

20.

Interpretation. This Agreement shall be construed as a whole and in accordance with its fair meaning and any ambiguities shall

not be construed for or against either party. The words “execution”, “signed”, and “signature” herein shall

be deemed to include electronic signatures, including any electronic signatures as defined in the Electronic Transactions Act (Revised)

(the “Electronic Signature Act”), or the keeping of records in electronic form including any electronic record, as defined

in the Electronic Signature Act, each of which shall be of the same legal effect, validity and enforceability as a manually executed

signature or the use of paper-based recordkeeping systems, as the case may be, to the extent and as provided for in any applicable law,

including without limitation the Electronic Signature Act; provided, however that sections 8 and 19(3) of the Electronic Signature Act

shall not apply to this agreement or the execution or delivery thereof.

21.

Governing Law and Consent to Jurisdiction. This Agreement shall be governed by, construed and enforced in accordance with the

Laws of the State of Delaware without regard to the conflict of laws principles thereof. All Actions arising out of or relating to this

Agreement shall be heard and determined exclusively in the Chancery Court of the State of Delaware (or in any other court in the State

of Delaware or any appellate court thereof) (the “Specified Courts”). Each party hereto hereby (a) submits to the

exclusive jurisdiction of any Specified Court for the purpose of any Action arising out of or relating to this Agreement brought by any

party hereto and (b) irrevocably waives, and agrees not to assert by way of motion, defense or otherwise, in any such Action, any claim

that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment

or execution, that the Action is brought in an inconvenient forum, that the venue of the Action is improper, or that this Agreement or

the transactions contemplated hereby may not be enforced in or by any Specified Court. Each party agrees that a final judgment in any

Action shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by applicable

law. “Action” means any notice of noncompliance or violation, or any claim, demand, charge, action, suit, litigation,

audit, settlement, complaint, stipulation, assessment or arbitration, or any request (including any request for information), inquiry,

hearing, proceeding or investigation, by or before any governmental authority.

SIGNATURE

PAGE TO FOLLOW

IN

WITNESS WHEREOF, the parties hereto have executed this Agreement as a deed on and as of the day and year first above written.

COMPANY

By:

Name:

Title:

INDEMNITEE

Name:

Address:

In the presence of:

Name:

Address:

Occupation:______________________________________________

EX-10.7

EX-10.7

Filename: ex10-7.htm · Sequence: 9

Exhibit 10.7

Firstborn

Top Capital

2026

OMNIBUS equity incentive PLAN

SECTION

1.

ESTABLISHMENT,

OBJECTIVES AND DURATION

1.1.

ESTABLISHMENT. Subject to the approval of the shareholders of ARC Group Acquisition

I Corp. (the “Company”), the Company has established the BlueCrest Investment, Inc. 2026 Omnibus Equity Incentive

Plan (the “Plan”), as set forth herein, conditioned upon and effective as of the closing of the transactions contemplated

by the Share Purchase Agreement (“Effective Date”). Following the Effective Date, references to the Company shall

be construed as references to BlueCrest Investment, Inc., a British Virgin Islands business company, and the Plan shall be administered

subject to the Company’s memorandum and articles of association and the BVI Business Companies Act, as amended from time to time.

1.2.

PURPOSE. The purpose of the Plan is to enhance shareholder value by linking long-term

incentive compensation to the financial performance of the Company and to further align Participants’ financial rewards with the

financial rewards realized by the Company and its shareholders. The Plan is also a vehicle to attract and retain key personnel. To accomplish

the foregoing, the Plan provides that the Company may grant Incentive Share Options, Nonqualified Share Options, Share Appreciation Rights,

Restricted Shares, Restricted Share Units, Performance Shares and/or Performance Units.

1.3.

DURATION. The Plan shall remain in effect, subject to the right of the Company’s

Board of Directors to amend or terminate the Plan at any time pursuant to Section 14, until the earlier of ten (10) years following its

Effective Date or the date that all Shares subject to the Plan shall have been purchased or granted according to the Plan’s provisions.

1.4.

APPROVAL BY SHAREHOLDERS. The Plan has been adopted by the Board of Directors subject

to approval by the shareholders of the Company at an extraordinary general meeting of shareholders held following the adoption by the

Board. Awards may be granted prior to shareholder approval, but no Award may be exercised or settled until the Plan is approved by the

shareholders, and if the Plan is not so approved within twelve (12) months before or after the Effective Date, the Plan and all Awards

granted under the Plan shall be null and void.

SECTION

2.

DEFINITIONS

Whenever

used in the Plan, the following capitalized terms shall have the meanings set forth below:

2.1.

“ARTICLES” means the memorandum and articles of association of the Company,

as amended, restated or supplemented from time to time.

2.2.

“AWARD” means, individually or collectively, a grant under the Plan

of Nonqualified Share Options, Incentive Share Options, Share Appreciation Rights, Restricted Shares, Restricted Share Units, Performance

Shares, or Performance Units.

2.3.

“AWARD AGREEMENT” means a written (or electronic) document setting

forth the terms and provisions applicable to an Award granted to the Participant under the Plan, which need not be executed unless required

by the Committee, and is a condition to the grant of an Award hereunder.

2.4.

“BOARD” means the Board of Directors of the Company.

2.5.

“CHANGE IN CONTROL” means the occurrence of a “change in the

ownership,” a “change in the effective control” or a “change in the ownership of a substantial portion of the

assets” of the Company, as determined in accordance with this Section 2.5. In determining whether an event shall be considered

a “change in the ownership,” a “change in the effective control” or a “change in the ownership of a substantial

portion of the assets” of the Company, the following provisions shall apply:

(a)

A “change in the ownership” of the Company shall occur on the date on which any one person, or more than one person acting

as a group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Securities Exchange Act of 1934, as amended (a “Person”)),

acquires ownership of the equity securities of the Company that, together with the equity securities held by such Person, constitutes

more than 50% of the total fair market value or total voting power of the Company, as determined in accordance with Treas. Reg. §1.409A-3(i)(5)(v).

If a Person is considered either to own more than 50% of the total fair market value or total voting power of the equity securities of

the Company, or to have effective control of the Company within the meaning of subsection (B), and such Person acquires additional equity

securities of the Company, the acquisition of additional equity securities by such Person shall not be considered to cause a “change

in the ownership” of the Company.

(b)

A “change in the effective control” of the Company shall occur on either of the following dates:

(i)

The date on which any Person acquires (or has acquired during the 12-month period ending on the date of the most recent acquisition by

such Person) ownership of equity securities of the Company possessing 30% or more of the total voting power of the Company’s equity

securities, as determined in accordance with Treas. Reg. §1.409A-3(i)(5)(vi). If a Person is considered to possess 30% or more of

the total voting power of the Company’s equity securities, and such Person acquires additional equity securities of the Company,

the acquisition of additional equity securities by such Person shall not be considered to cause a “change in the effective control”

of the Company; or

(ii)

The date on which a majority of the members of the Board of Directors of the Company is replaced during any 12-month period by directors

whose appointment or election is not endorsed by a majority of the members of the Board of Directors before the date of the appointment

or election, as determined in accordance with Treas. Reg. §1.409A-3(i)(5)(vi).

(c)

A “change in the ownership of a substantial portion of the assets” of the Company shall occur on the date on which any one

Person acquires (or has acquired during the 12-month period ending on the date of the most recent acquisition by such Person) assets

from the Company that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the

assets of the Company immediately before such acquisition or acquisitions, as determined in accordance with Treas. Reg. §1.409A-3(i)(5)(vii).

A transfer of assets shall not be treated as a “change in the ownership of a substantial portion of the assets” when such

transfer is made to an entity that is controlled by the holders of the Company’s equity securities, as determined in accordance

with Treas. Reg. §1.409A-3(i)(5)(vii)(B).

(d)

For the purposes of this Plan and this Section 2.5, the following acquisitions shall not constitute a Change in Control: (i) an acquisition

by the Company or entity controlled by the Company, or (ii) an acquisition by an employee benefit plan (or related trust) sponsored or

maintained by the Company or any entity controlled by the Company.

The

above definition of “Change in Control” shall be interpreted by the Board, in good faith, and to comply with Code Section

409A.

2.6

“CHIEF EXECUTIVE OFFICER” or “CEO” shall mean the chief executive officer of the Company or his

or her designee.

2.7.

“CODE” means the Internal Revenue Code of 1986, and all regulations

and formal guidance issued thereunder, as amended from time to time, or any successor legislation thereto.

2.8.

“COMMITTEE” means the Compensation Committee of the Board, or such

other committee as shall be appointed by the Board as provided in Section 3 to administer the Plan, or in the absence of either, the

Board.

2.9.

“COMPANY” means ARC Group Acquisition I Corp., a British Virgin Islands

business company, and any successor to all or substantially all of the assets or shares of such entity as provided in Section 17. Following

the Effective Date, references to the Company shall be construed as references to BlueCrest Investment, Inc., a British Virgin Islands

business company. The Company is subject to the BVI Business Companies Act and the Articles.

2.10.

“BVI BUSINESS COMPANIES ACT” means the BVI Business Companies Act,

as amended, revised or re-enacted from time to time, and all regulations and statutory instruments made thereunder.

2.11.

“DIRECTOR” means any individual who is a member of the Board or the

board of directors of any Subsidiary.

2.12.

“DISABILITY” means, unless otherwise provided in the Award Agreement

or in an employment, change of control or similar agreement in effect between the Participant and the Company or a Subsidiary, the Participant

is unable to engage in any substantial gainful activity by reason of any medically-determinable physical or mental impairment which can

be expected to result in death or can be expected to last for a continuous period of not less than 12 months; or, by reason of any medically-determinable

physical or mental impairment which can be expected to result in death or can be expected to last for a continuous period of not less

than 12 months, receiving income replacement benefits for a period of not less than 3 months under an accident and health plan covering

employees of the Company or a Subsidiary.

2.13.

“EFFECTIVE DATE” means the date specified in Section 1.1.

2.14.

“EMPLOYEE” means any employee of the Company or any Subsidiary.

2.15.

“EXCHANGE ACT” means the Securities Exchange Act of 1934, and all rules

and formal guidance issued thereunder, as amended from time to time, or any successor act thereto.

2.16.

“FAIR MARKET VALUE” means, with respect to the relevant date, the fair

market value of the Shares for such date, as determined by the Committee in good faith and, if applicable, in compliance with Code Section

409A or, in the case of ISOs, Code Section 422(b)(4). In the case of NSOs or SARs, this may include but is not limited to any of the

following valuation methods if the Shares are duly listed on a national securities exchange or on The Nasdaq Stock Market:

(i) the closing price

of a Share on such date, or, if there are no sales on such date, on the next preceding day on which there were sales,

(ii) the last sale before or the first sale after the grant,

(iii) the closing price on the trading day before or the trading day of the grant,

(iv) the arithmetic mean of the high and low prices on the trading day before or the trading day of the grant, or

(v)

an average selling price during a specified period that is within 30 days before or 30 days after the applicable valuation date; provided

that the average selling price method described in this clause (v) is irrevocably approved by the Committee for use with the applicable

Award before the beginning of the specified period (for this purpose, the term average selling price refers to the arithmetic mean of

the high and low selling prices on all trading days during the specified period, or the average of such prices over the specified period

weighted based on the volume of trading of such Share on each trading day during such specified period); and provided, further,

that the Committee must designate the Participant who will be granted the Award, the number of Shares that are subject to the Award,

and the method for determining the exercise price or base price including the period over which the averaging will occur, before the

beginning of the specified averaging period.

Such

price shall be subject to adjustment as provided in Section 4.3.

2.17.

“INCENTIVE SHARE OPTION” or “ISO”

means the right to purchase Shares pursuant to terms and conditions that are intended to qualify as, and that satisfy the requirements

applicable to, an incentive stock option within the meaning of Code Section 422, as described in Section 6.

2.18.

“NaMED EXECUTIVE OFFICERS” means the CEO, the Chief Financial Officer,

and each of the three most highly compensated executive officers of the Company other than the

CEO and Chief Financial Officer, at the end of the most recently completed financial year of the Company.

2.19.

“NONQUALIFIED SHARE OPTION” or “NSO”

means the right to purchase Shares pursuant to terms and conditions that are not intended to be, or do not qualify as, an Incentive Share

Option as described in Section 6.

2.20.

“OPTION” means an Incentive Share Option or a Nonqualified Share Option,

as described in Section 6.

2.21.

“OPTION PRICE” means the per Share purchase price of a Share purchased

pursuant to an Option.

2.22.

“PARTICIPANT” means an Employee, prospective Employee, Director, or

consultant, advisor or contractor to the Company or any Subsidiary who has outstanding an Award granted under the Plan and includes those

former Employees and former Directors who have certain post-termination rights under the terms of an Award.

2.23.

“PERFORMANCE PERIOD” means the time period during which performance

goals must be achieved with respect to an Award, as determined by the Committee.

2.24.

“PERFORMANCE SHARE” means an Award granted to a Participant that entitles

the Participant to delivery of Shares upon achievement of performance goals, as described in Section 9.

2.25.

“PERFORMANCE UNIT” means an Award that entitles the Participant to

a cash payment upon achievement of performance goals, as described in Section 9.

2.26.

“PERIOD OF RESTRICTION” means the period or periods during which the

transfer of an Award or the Shares is limited in some way (based on the passage of time, the achievement of performance goals, or upon

the occurrence of other events as determined by the Committee, at its discretion), and the Award or Shares are subject to a substantial

risk of forfeiture, as provided in Sections 8 and 9.

2.27.

“PERSON” shall mean an individual or a corporation, partnership, limited liability company, association, trust, unincorporated

organization, or other legal entity or organization.

2.28.

“PLAN” means this Firstborn Top Capital 2026 Omnibus Equity Incentive

Plan, as set forth herein.

2.29.

“RESTRICTED SHARES” means an Award of Shares subject to vesting conditions,

which is granted to a Participant pursuant to Section 8.

2.30.

“RESTRICTED SHARE UNIT” or “RSUs”

shall mean a right to receive Shares or cash upon vesting pursuant to Section 8.

2.31.

“SERVICE” shall mean the performance of services for the Company (or any Subsidiary) within the meaning of Code Section

409A, except to the extent otherwise specifically provided in the Award Agreement.

2.32.

“SETTLED” shall mean, with respect to an Award, when the Award is fully exercised, vested, forfeited, canceled, expired

or otherwise terminated in accordance with the terms of such Award.

2.33.

“SHARE” or “SHARES”

means Class A ordinary shares, par value $0.0001 per share of the Company.

2.34.

“SHARE APPRECIATION RIGHT” or “SAR”

means a right, designated as an SAR, to receive the appreciation in the Fair Market Value of Shares pursuant to the terms of Section

7.

2.35.

“SHARE PURCHASE AGREEMENT” means that certain share purchase agreement by and among ARC Group Acquisition I Corp.,

Firstborn Top Capital Sdn. Bhd., the shareholders of Firstborn Top Capital Sdn. Bhd. and a representative each of ARC Group Acquisition

I Corp. and Firstborn Top Capital Sdn. Bhd. dated ______________.

2.36.

“SUBSIDIARY” means any corporation or other entity in a chain of corporations

or other entities in which each corporation or other entity has a controlling interest in another corporation or entity in the chain,

commencing with the Company; provided, however, that with respect to any ISO, the term “Subsidiary” means any entity

during any period in which it is a “parent corporation” (as that term is defined in Code Section 424(e)) with respect to

the corporation or a “subsidiary corporation” (as that term is defined in Code Section 424(f)) with respect to the Company.

2.35

“VESTING TRANCHE” shall mean the portion of an Award that vests or with respect to which restrictions lapse on a certain

date due to attainment of specified vesting conditions as stated in the Award Agreement or Plan.

SECTION

3.

ADMINISTRATION

3.1.

PLAN ADMINISTRATION. The Committee shall administer the Plan. The Committee shall

consist of not fewer than two Directors who are non-Employee Directors of the Company, within the meaning of Rule 16b-3 of the Exchange

Act; and “independent directors” for purposes of the rules of the exchange on which the Shares are traded. The Board may,

from time to time, remove members from, or add members to, the Committee, or may function as the Committee. Any vacancies on the Committee

shall be filled by members of the Board. Acts of a majority of the Committee at which a quorum is present, or acts reduced to or approved

in writing by unanimous consent of the members of the Committee, shall be valid acts of the Committee.

3.2.

AUTHORITY OF THE COMMITTEE. Except as limited by applicable law, including the

BVI Business Companies Act, or by the Articles, and subject to the provisions herein, the Committee shall have full power to select Participants

to participate in the Plan; determine the sizes and types of Awards; determine the terms and conditions of Awards in a manner consistent

with the Plan; construe and interpret the Plan and any agreement or instrument entered into under the Plan; establish, amend, or waive

rules and regulations consistent with the terms of the Plan for the Plan’s administration; and amend the terms and conditions of

any outstanding Award to the extent such terms and conditions are within the sole discretion of the Committee as provided in the Plan

and subject to Section 14; provided that the Committee shall not have the authority to amend any Option or SAR to reduce its Option

Price or base price except in accordance with Sections 4.3 and 4.4. Further, the Committee shall make all other determinations which

may be necessary or advisable for the administration of the Plan, including establishing administrative methods for the exercise of Options

and SARs. No authority conferred under the Plan shall be exercised in a manner that would cause the Company to act outside the powers,

restrictions or procedures set out in the Articles or the BVI Business Companies Act. The Committee’s determinations, interpretations

and actions under the Plan need not be uniform and may be made selectively among Participants and their estates and beneficiaries.

3.3.

DECISIONS BINDING. All determinations and decisions made by the Committee (or its

delegate) pursuant to the provisions of the Plan and all related orders and resolutions of the Board shall be final, conclusive and binding

on all Persons, including the Company, its shareholders, Employees, Directors, Participants, and their estates and beneficiaries.

3.4.

DELEGATION BY COMMITTEE. Unless prohibited by applicable law, the Articles or the applicable rules of a stock exchange, the Committee

may delegate all or some of its responsibilities and powers to any one or more of its members. The Committee also may delegate some or

all of its administrative duties to any officer of the Company and may delegate some or all of its administrative powers to the CEO.

The Committee may delegate to the CEO the authority to grant Awards under the Plan to Participants and potential Participants who are

not Directors or Named Executive Officers of the Company or any Subsidiaries, provided that the terms and conditions of such Awards

shall be set forth in an Award Agreement approved in substantial form by the Committee prior to the grant of said Awards, the Committee

in its delegation shall specify the maximum Shares that may be awarded to one Participant pursuant to such delegation in any calendar

year, and the CEO shall report any such grants to the Committee at its next meeting. In the case of any such delegation, references in

this Plan to the “Committee” shall include any such delegate, as applicable. The Committee hereby delegates to each of the

Company’s Corporate Secretary and Chief Legal Officer (or his or her equivalent) the authority to document any and all Awards made

by the Committee and/or the CEO under the Plan. The Committee may revoke any such allocation or delegation at any time.

3.5.

INFORMATION TO BE FURNISHED TO COMMITTEE. The records of the Company and Subsidiaries as to an Employee’s, Director’s

or Participant’s employment, termination of employment, performance of Services, termination of Services, leave of absence, reemployment

and compensation shall be conclusive on all persons unless determined to be manifestly incorrect. Participants and other persons entitled

to benefits under the Plan must, as a condition to the receipt or settlement of any Award hereunder, furnish the Committee with such

evidence, data or information as the Committee reasonably considers desirable to carry out the terms of the Plan.

3.6.

INDEMNIFICATION. In addition to such other rights of indemnification that they have as members of the Board or the Committee,

the Company shall indemnify the members of the Committee (and any delegates of the Committee, as permitted under Section 3.4), to the

extent permitted by applicable law and the Articles, against reasonable expenses (including, without limitation, attorney’s fees)

actually and necessarily incurred in connection with the defense of any action, suit or proceeding, or in connection with any appeal,

to which they or any of them may be a party by reason of any action taken or failure to act under or in connection with the Plan or any

Award awarded hereunder, and against all amounts paid by them in settlement thereof (provided such settlement is approved to the

extent required by and in the manner provided by the Articles relating to indemnification of the members of the Board) or paid by them

in satisfaction of a judgment in any such action, suit or proceeding, except in relation to such matters as to which it is adjudged in

such action, suit or proceeding that such Committee member or members (or their delegates) did not act in good faith and in a manner

reasonably believed to be in or not opposed to the best interests of the Company; provided, however, that no such indemnification may

be made in respect of any matter arising out of such Committee member’s or members’ willful default, willful neglect or actual

fraud.

SECTION

4.

SHARES

SUBJECT TO THE PLAN AND MAXIMUM AWARDS

4.1.

SHARES AVAILABLE FOR AWARDS.

(a)

The Shares available for Awards shall be authorized and unissued Shares or treasury Shares, if and to the extent permitted by the BVI

Business Companies Act and the Articles. The aggregate number of Shares that may be issued or used for reference purposes under the Plan

or with respect to which Awards, including but not limited to ISOs, may be granted shall not exceed twenty percent (20%) of the Company’s

total issued and outstanding Shares from time to time (the “Share Reserve”) subject to adjustment as provided in Section

4.3 for any share split made on or immediately after the Effective Date. This Plan is considered an “evergreen” plan, since

the shares covered by Awards which have been exercised or terminated shall be available for subsequent grants under the Plan and the

number of Awards available to grant increases as the number of issued and outstanding Shares increases. The Share Reserve shall in all

events be subject to further adjustment as provided in Section 4.3. In no event shall fractional Shares be issued under the Plan unless

the Articles and the BVI Business Companies Act permit the Company to issue fractional Shares and the Committee determines to do so.

For clarity, the Share Reserve in this Section 4.1(a) is a limitation on the number of Shares that may be issued pursuant to this Plan.

Shares may be issued in connection with a merger or acquisition as permitted by NASDAQ Listing Rule 5635(c) or other applicable exchange

rule, and any such issuance will not reduce the number of Shares available for issuance under this Plan. No Shares shall be issued under

the Plan unless the Board or Committee, as applicable, has determined that the consideration for such Shares is adequate and that the

issuance complies with the BVI Business Companies Act, the Articles and all applicable securities exchange rules.

(b)

Upon:

(i)

a payout of a SAR, RSU, or Performance Unit Award under this Plan in the form of cash; or

(ii)

a cancellation, termination, expiration without exercise, forfeiture, or lapse for any reason, of any Award under this Plan, the number

of Shares underlying any such Award that were not issued as a result of any of the foregoing actions shall again be available for the

purposes of Awards under the Plan. In addition, in the case of any Award granted in substitution for an award of a company or business

acquired by the Company or a Subsidiary, Shares issued or issuable in connection with such substitute Award shall not be counted against

the number of Shares reserved under the Plan but shall be available under the Plan by virtue of the Company’s assumption of the

plan or arrangement of the acquired company or business.

All

Restricted Share Awards which vest, and all Shares issued in settlement of an Option, SAR, Restricted Share Award, Restricted Share Unit,

or Performance Share Award, or withheld for payment of the Option Price or any tax imposed when the Award is exercised or settled, shall

reduce the total number of Shares available under the Plan and shall not again be available for the grant of any Award hereunder.

Notwithstanding

the foregoing, when a share-settled SAR is exercised under the Plan, the total number of Shares subject to the SAR shall not be available

for subsequent issuance under the Plan, regardless of the number of Shares used to settle the SAR.

4.2.

INDIVIDUAL PARTICIPANT LIMITATIONS. The Board may provide for a limit on the dollar

value or maximum aggregate number of Shares underlying Awards that may be granted to any one Named Executive Officer of the Company or

any Subsidiary in any financial year, subject to adjustment as provided in Section 4.3.

4.3.

ADJUSTMENTS. (a) Recapitalization. Notwithstanding any other provision of

the Plan, if the Company is involved in a corporate transaction or any other event which affects the Shares (including, without limitation,

any recapitalization, reclassification, reverse or forward share split, share dividend, extraordinary cash dividend, split-up, spin-off,

combination or exchange of shares), then the Committee shall make or provide for such adjustments to Awards to prevent the dilution or

enlargement of rights of the Awards as follows:

(i)

The Committee shall take action to adjust the number and kind of Shares that are issuable under the Plan and the maximum limits for each

type of Award;

(ii)

The Committee shall take action to adjust the number and kind of Shares subject to outstanding Awards;

(iii)

The Committee shall take action to adjust the Exercise Price or base price of outstanding Options and Share Appreciation Rights; and

(iv)

The Committee shall make any other equitable adjustments.

Only

whole Shares shall be issued in making the above adjustments. Further, the number of Shares available under the Plan or the number of

Shares subject to any outstanding Awards shall be the next lower number of Shares, so that fractions are rounded downward. Any adjustment

to or assumption of ISOs under this Section shall be made in accordance with Code Section 424. If the Company issues any rights to subscribe

for additional Shares pro rata to holders of outstanding Shares of the class or classes of shares then set aside for the Plan, then each

Participant shall be entitled to the same rights on the same basis as holders of outstanding Shares with respect to such portion of the

Participant’s Award as is exercised on or prior to the record date for determining shareholders entitled to receive or exercise

such rights.

(b)

Reorganization. If the Company is part of any reorganization involving merger, consolidation, acquisition of the Share or acquisition

of the assets of the Company, the Committee, in its discretion, may decide that:

(i)

any or all outstanding Awards shall pertain to and apply, with appropriate adjustment as determined by the Committee, to the securities

of the resulting corporation to which a holder of the number of Shares subject to each such Award would have been entitled;

(ii)

any or all outstanding Options or SARs shall become immediately fully exercisable (to the extent permitted under federal or state securities

laws) and shall remain exercisable for the remaining term of the Options or SARs under the terms of the Plan;

(iii)

any or all Options or SARs shall become immediately fully exercisable (to the extent permitted under federal or state securities laws)

and shall be terminated after giving at least 30 days’ notice to the Participants to whom such Options or SARs have been granted;

and/or

(iv)

any or all unvested Awards and/or Awards on which restrictions have not yet lapsed shall become immediately fully vested, nonforfeitable

and payable.

(c)

Limits on Adjustments. Any issuance by the Company of shares of any class other than the Shares of the Company, or securities

convertible into shares of any class, shall not affect, and no adjustment by reason thereof shall be made with respect to, the number

or price of Shares subject to any Award, except as specifically provided otherwise in this Plan. The grant of Awards under the Plan shall

not affect in any way the right or authority of the Company to make adjustments, reclassifications, reorganizations or changes of its

capital or business structure or to merge, consolidate or dissolve, or to liquidate, sell or transfer all or any part of its business

or assets. All adjustments that the Committee makes under this Plan shall be conclusive.

4.4.

PROHIBITION ON REPRICING. Anything else contained herein to the contrary notwithstanding,

except as provided in Section 4.3, the Committee shall not amend any Option or SAR to reduce its Option Price or base price, and shall

not issue to any Participant a new Award in exchange for the surrender and cancellation of any other Award, if such new Award has an

Option Price or base price (as applicable) lower than that of the Award for which it is exchanged, or take any other action that would

have the effect of reducing the Option Price or base price of an Option or SAR.

SECTION

5.

ELIGIBILITY

AND PARTICIPATION

5.1.

ELIGIBILITY. Persons eligible to participate in the Plan include current and future

Employees (including officers), consultants, advisors or contractors to the Company or a Subsidiary, and Directors, as designated by

the Committee; provided that persons who have been offered employment by or an engagement with the Company or a Subsidiary may

not receive any payment or exercise any right relating to an Award until such person begins employment or service with the Company or

Subsidiary; and provided, further, however, that ISOs may only be granted to current or prospective U.S. Employees. All

non-U.S. Employees will be granted NSOs.

5.2.

PARTICIPATION. Subject to the provisions of the Plan, the Committee shall determine

and designate, from time to time, the Participants to whom Awards shall be granted, the terms of such Awards, and the number of Shares

subject to such Award.

SECTION

6.

SHARE

OPTIONS

6.1.

GRANT OF OPTIONS AND AWARD AGREEMENT. Options shall constitute contractual rights

only and shall not constitute Shares or confer any shareholder rights unless and until Shares are issued to the Participant and the Participant

is entered in the Company’s register of members in accordance with the BVI Business Companies Act and the Articles.

(a)

Option Grant. Subject to the terms and provisions of the Plan and the Articles, Options may be granted to one or more Participants

in such number, upon such terms and provisions, and at any time and from time to time, as determined by the Committee, in its sole discretion.

The Committee may grant either Nonqualified Share Options or Incentive Share Options and shall have complete discretion in determining

the number of Options of each granted to each Participant, subject to the limitations of Section 4.

(b)

Award Agreement. Each Award shall be evidenced by an Award Agreement, effective as of the grant date, which shall specify the

Option Price, the term of the Option, the number of Shares subject to the Option, and such other provisions as the Committee shall determine,

and which are not inconsistent with the terms and provisions of the Plan. The Award Agreement shall also specify whether the Option is

to be treated as an ISO within the meaning of Code Section 422. If such Option is not designated as an ISO, such Option shall be deemed

an NSO. No ISO may be granted to any person more than 10 years after the Effective Date of the Plan.

6.2.

OPTION PRICE. The Committee shall designate the Option Price for each Share subject

to an Option under the Plan; provided that such Option Price shall not be less than 100% of the Fair Market Value of Shares subject

to an Option on the date the Option is granted, and which Option Price may not be subsequently decreased by the Committee except pursuant

to Section 4.3 and in compliance with Code Section 409A; provided further that Shares cannot in any event be issued at less than

par value and with respect to a Participant who owns, directly or indirectly, more than 10% of the total combined voting power of all

classes of shares of the Company or any Subsidiary, the Option Price of Shares subject to an ISO shall be at least 110% of the Fair Market

Value of such Shares on the ISO’s grant date.

6.3.

TERM OF OPTIONS. Each Option granted to a Participant shall expire at such time

as the Committee shall determine at the time of grant, but in no event shall be exercisable later than the tenth (10th) anniversary

of the grant date. Notwithstanding the foregoing, with respect to ISOs, in the case of a Participant who owns, directly or indirectly,

more than 10% of the total combined voting power of all classes of the shares of the Company or any Subsidiary, no such ISO shall be

exercisable later than the fifth (5th) anniversary of the grant date.

6.4.

EXERCISE OF OPTIONS. Options granted under this Section 6 shall be exercisable

at such times and be subject to such restrictions and conditions as the Committee shall in each instance approve, which need not be the

same for each Award or for each Participant, and shall be set forth in the applicable Award Agreement, subject to Section 10. Notwithstanding

the preceding sentence, the Fair Market Value of Shares to which ISOs are exercisable for the first time by any Participant during any

calendar year may not exceed $100,000. Any ISOs that become exercisable in excess of such amount shall be deemed NSOs to the extent of

such excess. The Committee, in its sole discretion and at any time, may establish procedures setting a minimum number of Shares that

must be exercised at any one time.

6.5.

EXERCISE AND PAYMENT. Options granted under this Section 6 shall be exercised by

the delivery of a written (or electronic) notice of exercise to the Company, setting forth the number of Shares with respect to which

the Option is to be exercised, accompanied by full payment for the Shares and all applicable tax withholding. The Option Price and applicable

tax withholding upon exercise of any Option shall be payable to the Company in full either:

(a)

in cash or its equivalent,

(b)

by tendering previously acquired whole Shares (held for any minimum period needed to avoid adverse impacts to the Company’s earnings

for financial reporting purposes), valued at their Fair Market Value at the time of exercise, with such documentation as the Committee

may require, or

(c)

a combination of (a) and (b).

In

addition, payment of the Option Price and applicable tax withholding may be payable by one or more of the following methods upon written

consent from the Committee if such method will not result in a charge to the Company’s earnings for financial reporting purposes:

(d)

by a “net exercise” in which whole Shares that otherwise would be acquired on exercise are withheld (valued at their Fair

Market Value at the time of exercise),

(e)

by tendering other Awards payable under the Plan, or

(f)

by cashless exercise through delivery of irrevocable instructions to a broker to promptly deliver to the Company the amount of proceeds

from a sale of all or a portion of the whole Shares being exercised.

To

the extent the Option Price and applicable tax withholding would require the sale or delivery of a fractional Share, any Shares sold

or delivered shall be rounded down to the next whole Share and the Participant shall pay the remainder using method (a) above. As soon

as practicable after receipt of a written (or electronic) notification of exercise and full payment, the Company shall deliver, electronically

or in paper form, the Shares to the Participant and, where required by the BVI Business Companies Act, shall enter the Participant in

the register of members as the holder of such Shares. No Participant shall have any rights of a shareholder with respect to Shares subject

to an Option, including any right to receive dividends, to vote, or to participate in the equity of the Company, until such Option has

been exercised and payment made in full as provided herein and the Participant has become the holder of record of the Shares in accordance

with the BVI Business Companies Act and the Articles.

SECTION

7.

SHARE

APPRECIATION RIGHTS

7.1.

GRANT OF SARS AND AWARD AGREEMENT.

(a)

SAR Grant. Subject to the terms and conditions of the Plan and the Articles, SARs may be granted to Participants and at any time

and from time to time, as determined by the Committee, in its sole discretion. The Committee shall have complete discretion in determining

the number of SARs granted to each Participant (subject to Section 4) and, consistent with the provisions of the Plan, in determining

the terms and conditions pertaining to such SARs. The Committee shall designate, at the time of grant, the base price of the SAR, which

base price shall be at least equal to the Fair Market Value of a Share on the grant date of the SAR. Base prices of SARs shall not subsequently

be decreased by the Committee, except pursuant to Section 4.3, provided always that SARs cannot in any event be granted at less than

the par value of the Shares they refer to. The Committee, in its sole discretion, may provide a maximum dollar limit on the total aggregate

payment due under a SAR.

(b)

Award Agreement. Each Award shall be evidenced by an Award Agreement that shall specify the base price, the term of the SAR, and

such other provisions as the Committee shall determine, and which are not inconsistent with the terms and provisions of the Plan.

7.2.

TERM OF SARS. The term of a SAR granted under the Plan shall be determined by the

Committee, in its sole discretion; provided, however, that unless otherwise designated by the Committee, such term shall not exceed

ten (10) years from the grant date.

7.3.

EXERCISE OF SARS. SARs shall be exercisable at such times and be subject to such

restrictions and conditions as the Committee shall in each instance approve, which need not be the same for each Award or for each Participant

and shall be set forth in the applicable Award Agreement, subject to Section 10. The Committee, in its sole discretion and at any time,

may establish procedures setting a minimum number of Shares with respect to which the SAR must be exercised at any one time.

7.4.

EXERCISE AND PAYMENT. SARs granted under this Section 7 shall be exercised by the

delivery of a written (or electronic) notice of exercise to the Company, setting forth the number of Shares with respect to which the

SAR is to be exercised, accompanied by full payment for all applicable tax withholding. The applicable tax withholding upon exercise

of any SAR shall be payable to the Company in full in the same manner as set forth in Section 6.5 above. As soon as administratively

practicable following exercise of a SAR, a Participant shall be entitled to receive payment from the Company in an amount determined

by multiplying:

(a)

The excess of the Fair Market Value of a Share on the date of exercise over the base price per Share; by

(b)

The number of Shares with respect to which the SAR is exercised.

At

the sole discretion of the Committee, exercisable at any time, the payment upon SAR exercise may be in cash, in Shares of equivalent

value, or in some combination thereof.

SECTION

8.

RESTRICTED

SHAREs and RESTRICTED SHARE UNITS

8.1.

GRANT OF RESTRICTED SHARES OR RSUS AND AWARD AGREEMENT.

(a)

Grant of Restricted Shares/Restricted Share Units. Subject to the terms and provisions of the Plan and the Articles, the Committee,

at any time and from time to time, may grant Restricted Shares or RSUs to Participants in such amounts as the Committee shall determine

in its sole discretion. The Committee shall have complete discretion in determining the number of Shares underlying each Award (subject

to Section 4) and, consistent with the provisions of the Plan, in determining the terms and conditions, including the vesting, pertaining

to such Award. The Committee may designate an RSU as payable in cash, in Shares, or a combination thereof.

(b)

Award Agreement. Each Award shall be evidenced by an Award Agreement that shall specify the vesting for each Vesting Tranche,

the number of Shares granted, and such other provisions as the Committee shall determine pursuant to Section 8.3 or otherwise, and which

shall not be inconsistent with the terms and provisions of the Plan.

8.2.

TRANSFERABILITY OF RESTRICTED shares. Except as provided in this Section 8, a Restricted

Share granted herein may not be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated, voluntarily or involuntarily,

until (i) they vest with respect to their Vesting Tranche, or (ii) upon earlier satisfaction of any other conditions, as specified by

the Committee in its sole discretion (subject to Section 10) and set forth in the Award Agreement.

8.3.

settlement of award. Except as otherwise provided in Section 17.5 or in any Award

Agreement, and subject to any deferral elected pursuant to Section 12.2, the Company shall retain the certificates representing Restricted

Shares in the Company’s possession, or may deposit or transfer such Restricted Shares electronically to a custodian designated

by the Committee, until such time as all conditions and/or restrictions applicable to such Restricted Shares have been satisfied. As

soon as administratively practicable after a Restricted Share Award or RSU Award vests (for example, as part of a Vesting Tranche), Shares

covered by the portion of such Restricted Share Award that vested, or in the case of RSUs cash and/or Shares covered by such vested RSU

that vested, shall be delivered (in the case of Shares, electronically or in paper form) to the Participant.

8.4.

SHAREHOLDER RIGHTS. Unless otherwise designated by the Committee in an Award Agreement:

(i) a Participant shall have no shareholder rights with respect to the Shares subject to an RSU Award, including voting and cash dividend

rights, and (ii) the Participant shall have voting rights but shall not have cash dividend rights with respect to Shares subject to a

Restricted Share Award, until they vest (e.g., as part of a Vesting Tranche) and the Participant has received and become a holder of

record of the Shares; provided, however, that in the event that any dividend constitutes a derivative security or an equity security

pursuant to the rules under Section 16 of the Exchange Act, such dividend shall be added to the Restricted Share Award and subject to

the same vesting conditions and Vesting Tranches as are applicable to the Restricted Shares with respect to which the dividend is paid.

SECTION

9.

PERFORMANCE

UNITS AND PERFORMANCE SHARES

9.1.

GRANT OF PERFORMANCE UNITS/SHARES AND AWARD AGREEMENT.

(a)

Grant of Performance Unit/Shares. Subject to the terms of the Plan and the Articles, Performance Units and/or Performance Shares

may be granted to Participants in such amounts and upon such terms, and at any time and from time to time, as shall be determined by

the Committee in its sole discretion, which shall not be inconsistent with the terms and provisions of the Plan and shall be set forth

in an Award Agreement.

(b)

Award Agreement. Each Award shall be evidenced by an Award Agreement that shall specify the initial value of the Award, the performance

goals and the Performance Period, as the Committee shall determine, and which are not inconsistent with the terms and provisions of the

Plan.

9.2.

VALUE OF PERFORMANCE UNITS/SHARES. Each Performance Share shall represent the Participant’s

right to receive a Share (subject to Section 9.4) upon satisfaction of performance goals established by the Committee. Each Performance

Unit shall represent the Participant’s right to receive a cash payment equal to the value of the Performance Unit (as determined

by the Committee on the grant date, and subject to Section 9.4), upon satisfaction of the performance goals established by the Committee.

The Committee shall set performance goals in its sole discretion which, depending on the extent to which they are met, will determine

the number and/or value of Performance Shares and/or Performance Units that will be paid out to the Participant. For purposes of this

Section 9, the time period during which the performance goals must be met shall be called a Performance Period.

9.3.

EARNING OF PERFORMANCE UNITS/SHARES. Subject to the terms of the Plan, after the

applicable Performance Period has ended, the holder of Performance Units and/or Performance Shares shall be entitled to receive payment

on his or her Performance Units and/or Performance Shares earned by the Participant over the Performance Period, based on the extent

to which the corresponding performance goals have been achieved, as determined by the Committee. The Committee shall have the sole discretion

to adjust the determination of the degree of attainment of the preestablished performance goals.

9.4.

FORM AND TIMING OF PAYMENT OF PERFORMANCE UNITS/SHARES. Except as provided below,

and subject to any deferral elected pursuant to Section 12.2, payment of earned Performance Units and/or Performance Shares shall be

made in a single lump sum as soon as reasonably practicable following the close of the applicable Performance Period. Any Shares paid

to a Participant may be subject to any restrictions deemed appropriate by the Committee.

9.5.

PERFORMANCE MEASURES. The performance goals to be used for purposes of such grants shall be established by the Committee in writing

and stated in terms of the attainment of specified levels of or percentage changes in any one or more of the following measurements:

revenue; primary or fully-diluted earnings per Share; earnings before interest, taxes, depreciation, and/or amortization; pretax income;

operating income; cash flow from operations; total cash flow; return on equity; return on capital; return on assets; net operating profits

after taxes; economic value added; capital expenditures; expense levels; share price; debt levels; market share; total shareholder return

or return on sales; or any individual performance objective which is measured solely in terms of quantitative targets related to the

Company or the Company’s business; any other measurement approved by the Committee, in its sole discretion; or any combination

thereof. In addition, such performance goals may be based in whole or in part upon the performance of the Participant or the Company

or a Subsidiary, or a division and/or other operational unit thereof under one or more of such measures.

9.6.

SHAREHOLDER RIGHTS. Unless otherwise designated by the Committee in the Award Agreement,

the Participant shall have no shareholder rights with respect to the Shares subject to the Performance Share Award, including voting

and cash dividend rights, until after the Award has vested and the Participant has received and become a holder of record of the Shares;

provided, however, that in the event that any dividend constitutes a derivative security or an equity security pursuant to the

rules under Section 16 of the Exchange Act, such dividend shall be added to the Award and subject to the same accrual, forfeiture, and

payout restrictions as apply to the underlying Award with respect to which the dividend is paid.

SECTION

10.

VESTING

AND FORFEITURES

10.1.

Vesting. As part of making any Award, the Committee may determine the time and

conditions under which the Award will vest and may specify partial vesting in one or more Vesting Tranches. Vesting may, in the Committee’s

discretion, be based solely upon continued employment or Service for a specified period of time or may be based upon the achievement

of specific performance goals as described in Section 9.5 above, which shall be established by the Committee in its discretion. For all

purposes of this Plan, “vesting” of an Award shall mean:

(a)

In the case of an Option or SAR, the time at which the Participant has the right to exercise the Award.

(b)

In the case of Restricted Shares, all conditions for vesting, as stated in the Award Agreement or Plan, are satisfied.

(c)

In the case of Restricted Share Units, all conditions for vesting, as stated in the Award Agreement or Plan, are satisfied.

(d)

In the case of Performance Shares or Performance Units, the time at which the Participant has satisfied the requirements to receive payment

on such Performance Shares or Performance Units, which shall not be less than one year from the grant date, except as otherwise provided

in Section 10.2.

Vesting

need not be uniform among Awards granted at the same time or to persons similarly situated. Vesting requirements shall be set forth in

the applicable Award Agreement.

10.2.

VESTING ON TERMINATION OF EMPLOYMENT. Unless otherwise approved by the Committee either at the time of grant or at some later

date in accordance with Code Sections 409A and 422, upon the termination of the Participant’s employment or Service with the Company

and its Subsidiaries, all outstanding Awards shall be cancelled and no longer exercisable on the date of the termination. To the extent

that the Committee approves extended vesting or exercise provisions, such provisions need not be uniform among all Awards issued pursuant

to the Plan, and may reflect distinctions based on the reasons for such termination.

10.3.

ACCELERATION OF VESTING. The Committee may, in its sole discretion, accelerate

the vesting, in whole or in part, with respect to any Award, but no such acceleration shall be effective unless evidenced by a writing

signed by a duly authorized officer of the Company. The Committee may, in its sole discretion, delegate to the CEO its power to accelerate

the vesting of an Award granted to Participants who are not Directors or Named Executive Officers of the Company or any Subsidiaries.

In addition, the Committee may impose additional conditions on Awards, by inclusion of appropriate provisions in the document evidencing

or governing any such Award.

10.4.

EXTENSION OF EXERCISE PERIOD. The Committee may, in its sole discretion, subject to the terms of the Plan, exercisable either

at the time an Award is granted or at any time while the Award remains outstanding, extend the period of time for which the Option or

SAR is to remain exercisable following the Participant’s termination of employment or Service from the limited exercise period

otherwise in effect for that Option or SAR to such greater period of time as the Committee shall deem appropriate, but in no event beyond

the expiration of the maximum Option or SAR term permitted under this Plan, and/or to permit the Option or SAR to be exercised, during

the applicable post-termination exercise period, not only with respect to the number of vested Shares for which such Option or SAR is

exercisable at the time of the Participant’s termination of Service but also with respect to one or more additional installments

in which the Participant would have vested had the Participant continued in Service. Such an extension may result in recharacterization

of an ISO as a NSO.

SECTION

11.

TRANSFERABILITY

OF AWARDS; BENEFICIARY DESIGNATION

11.1.

LIMITS ON TRANSFERABILITY OF AWARDS.

(a)

Except as otherwise provided below, Awards may be exercisable only by the Participant during the Participant’s lifetime, and Awards

shall not be transferable other than by will or the laws of descent and distribution. Any purported transfer of any Award or any interest

therein that does not comply with the terms of this Plan shall be null and void and confer no rights of any kind upon the purported transferee.

(b)

The Committee may, in its discretion, permit a Participant to transfer any Award other than an ISO to any family member of such Participant,

subject to such restrictions and limitations as the Committee may provide; provided, however, that any such Award shall remain

subject to all vesting, forfeiture, and other restrictions provided herein and in the Award Agreement to the same extent as if it had

not been transferred; and provided further that in no event shall any transfer for value be permitted. For purposes of this Section

11.1(b), the terms “family member” and “transfer for value” have the same meaning as in the General Instructions

to SEC Form S-8, or such other form as the SEC may promulgate in replacement thereof.

(c)

To the maximum extent permitted by law, no Award shall be subject, in whole or in part, to attachment, execution or levy of any kind;

provided, however, that nothing contained herein shall affect the right of setoff set forth in Section 13.3.

(d)

Nothing contained in this Section 11.1 shall preclude a Participant from transferring Restricted Shares that have vested or Shares that

are issued in settlement of an Option, SAR, RSU, or Award of Performance Shares or Performance Units, subject to the remaining provisions

of this Plan, the Articles and applicable law, including any transfer requirements, restrictions or procedures under the BVI Business

Companies Act and the Articles and any requirement that the transferee be entered in the register of members.

11.2.

DESIGNATION OF BENEFICIARY. Each Participant under the Plan may, from time to time,

name any beneficiary or beneficiaries (who may be named contingently or successively) to whom any benefit under the Plan is to be paid

in case of his or her death before he or she receives any or all of such benefit. Each such designation shall revoke all prior designations

by the same Participant, shall be in a form prescribed by the Company, and will be effective only when filed by the Participant in writing

(or electronically, if permitted by the Committee) with the Secretary of the Company (or its designee) during the Participant’s

lifetime. In the absence of any such designation, benefits remaining unpaid at the Participant’s death shall be paid to the Participant’s

estate.

SECTION

12.

DEFERRALS;

COMPLIANCE WITH SECTION 409A

12.1.

PROHIBITION ON DEFERRALS OF OPTIONS, SARS, AND RESTRICTED SHAREs. No Participant

shall have the right to defer the amount of Shares or cash payable upon the exercise or settlement of any Option or SAR, or the transfer

of any Restricted Shares upon the vesting thereof.

12.2.

DEFERRALS OF Restricted share units, PERFORMANCE UNITS AND PERFORMANCE SHARES.

The Committee may permit a Participant to defer such Participant’s receipt of the payment of cash or the delivery of Shares that

would otherwise be due to such Participant upon the satisfaction of any requirements or goals with respect to Restricted Share Units,

Performance Units or Performance Shares. If any such deferral election is required or permitted, the Committee shall, in its sole discretion,

establish rules and procedures for such payment deferrals, subject to the following:

(a)

A deferral election may be made only at one of the following two times:

(i)

In the case of an Award that cannot vest (other than by reason of death, Disability, or a Change in Control) earlier than the first anniversary

of the date of grant, not later than the earlier of thirty (30) days after the date of grant or one (1) year prior to the earliest date

on which the Award may vest.

(ii)

In the case of an Award that is subject to a Performance Period of not less than one (1) year, and the vesting of which is subject to

the attainment of Performance Criteria that are established within the first ninety (90) days of the Performance Period and that are

not substantially certain of being achieved at the time of grant, not later than six (6) months prior to the end of the Performance Period.

(b)

A deferral election shall state the time and manner of payment. Payment must either be on a specified date, at the time of the Participant’s

separation from Service with the Company and its Subsidiaries (as defined in Code Section 409A), death, or Disability, or upon the occurrence

of a Change in Control. Notwithstanding the foregoing:

(i)

An amount payable by reason of a separation from Service to an Employee who is a “key employee” of the Company, as defined

in Code Section 409A, shall not be paid until six (6) months after the separation from Service, and any portion of such amount that would

otherwise be payable during such six (6)month period shall be paid instead at the end of such period;

(ii)

Payment of any amount that the Company reasonably determines would not be deductible by reason of Code Section 162(m) shall be deferred

until the earlier of the earliest date on which the Company reasonably determines that the deductibility of the payment will not be so

limited, or the year following the separation from Service.

(iii)

Any payment that the Company reasonably determines will violate a term of a loan agreement to which the Company is a party, or other

similar contract to which the Company is a party, and such violation will cause material harm to the Company shall be deferred until

the earliest date at which the Company reasonably anticipates that the making of the payment will not cause such violation, or such violation

will not cause material harm to the Company;

(iv)

Any payment that the Company reasonably anticipates that will violate Federal securities laws or other applicable law will be deferred

until the earliest date at which the Company reasonably anticipates that the making of the payment will not cause such violation; and

(v)

The Committee may permit Participants to elect to further defer payments, provided that any such election is made not less than

one (1) year prior to the date on which the payment would otherwise be made, and that the deferral is for a period of at least five (5)

years.

(c)

No payment that a Participant has elected to defer pursuant to this Section 12.2 may be paid at any earlier date, except in accordance

with procedures adopted by the Committee in compliance with Code Section 409A.

12.3.

COMPLIANCE WITH SECTION 409A. The provisions of this Plan, including but not limited

to this Section 12, are intended to comply with the restrictions of Code Section 409A, and, notwithstanding the Participant consent requirements

of Section 14.1, the Committee reserves the right to amend any provision of this Plan, or any outstanding Award, to the extent necessary

to comply with Section 409A.

SECTION

13.

RIGHTS

AND OBLIGATIONS OF PARTIES

13.1.

NO GUARANTEE OF EMPLOYMENT OR SERVICE RIGHTS. Nothing in the Plan shall interfere

with or limit in any way the right of the Company or any Subsidiary to terminate any Participant’s employment or Service at any

time, nor confer upon any Participant any right to continue in the employ or Service of the Company or any Subsidiary.

For

purposes of the Plan, temporary absence from employment or Service because of illness, vacation, approved leaves of absence, and transfers

of employment or Service among the Company and its Subsidiaries, shall not be considered to terminate employment or Service or to interrupt

continuous employment or Service. Conversion of a Participant’s employment relationship to a Service arrangement, and vice versa,

shall not result in termination of previously granted Awards (although it may result in an ISO being recharacterized as an NSO).

13.2.

PARTICIPATION. No Employee or Director shall have the right to be selected to receive

an Award under the Plan, or, having been so selected, to be selected to receive a future Award.

13.3.

RIGHT OF SETOFF AND CLAW-BACK. The Company or any Subsidiary may, to the extent

permitted by applicable law (including Code Section 409A), deduct from and set off against any amounts the Company or Subsidiary may

owe to the Participant from time to time, including amounts payable in connection with any Award, owed as wages, fringe benefits, or

other compensation owed to the Participant, such amounts as may be owed by the Participant to the Company or a Subsidiary, although the

Participant shall remain liable for any part of the Participant’s payment obligation not satisfied through such deduction and setoff.

All Awards (including any proceeds, gains or other economic benefit the Participant actually or constructively receives upon receipt

or exercise of any Award) will be subject to any Company claw-back policy, as set forth in such claw-back policy or the Award Agreement.

By accepting any Award granted hereunder, the Participant agrees to any deduction, claw-back or setoff under this Section 13.

13.4.

SECTION 83(B) ELECTION. No election under Section 83(b) of the Code (to include

in gross income in the year of transfer the amounts specified in Code Section 83(b)) or under a similar provision of the laws of a jurisdiction

outside the U.S. may be made, unless expressly permitted by the terms of the Award Agreement or by action of the Committee in writing

before the making of such election. In any case in which a Participant is permitted to make such an election in connection with an Award,

the Participant shall notify the Company of such election within ten (10) days of filing notice of the election with the Internal Revenue

Service or other governmental authority, in addition to any filing and notification required pursuant to regulations issued under Code

Section 83(b) or other applicable provision.

13.5.

DISQUALIFYING DISPOSITION NOTIFICATION. If any Participant shall make any disposition

of Shares delivered pursuant to the exercise of an Incentive Share Option under the circumstances described in Code Section 421(b) (relating

to certain disqualifying dispositions), such Participant shall notify the Company of such disposition within ten (10) days thereof.

SECTION

14.

AMENDMENT,

MODIFICATION, AND TERMINATION

14.1.

AMENDMENT, MODIFICATION, AND TERMINATION. Except as otherwise provided in this

Section 14.1 and subject to Section 14.2, at any time the Board may wholly or partially amend, modify, suspend or terminate the Plan

or the Committee’s authority to grant Awards under the Plan without the consent of shareholders or Participants. However, without

the approval of the Company’s shareholders given twelve months before or after the action by the Board if such shareholder approval

is required by any federal or state law or regulation or the rules of any share exchange or automated quotation system on which the Shares

may then be listed or quoted, no action of the Board may (i) increase the limit on the Share Reserve, (ii) reduce the exercise price

per share of any outstanding Option or SAR granted under this Plan, (iii) cancel any Option or SAR in exchange for cash, another Award

or an Option or SAR with a price per share that is less than the price per share of the original Option or SAR, or (iv) materially modify

the requirements as to eligibility for participation in this Plan. The Committee shall have no authority to waive or modify any other

Award term after the Award has been granted to the extent that the waived or modified term was mandatory under the Plan.

14.2.

AWARDS PREVIOUSLY GRANTED. No termination, amendment, suspension, or modification

of the Plan, other than to the extent necessary to comply with applicable U.S. or foreign laws, shall adversely affect in any material

way any Award previously granted under the Plan, without the written (or electronic) consent of the Participant holding such Award.

SECTION

15.

WITHHOLDING

15.1.

The Company and its Subsidiaries shall have the power and the right to deduct or withhold from amounts due to the Participant by the

Company or the Subsidiary, or require a Participant to remit to the Company or the Subsidiary as a condition of any Award, an amount

(in cash or in kind, subject to the approval of the Company) equal to the minimum Federal, State and local taxes, domestic or foreign,

required by law or regulation to be withheld with respect to any taxable event arising as a result of the Plan, provided that any withholding

or net settlement in Shares shall comply with the BVI Business Companies Act, the Articles and any applicable solvency, distribution,

purchase or redemption requirements. Notwithstanding the above, in the case of Options or SARs, such tax withholding shall be accomplished

as set forth in Section 6.5 and 7.4. With respect to an Award of Restricted Shares or RSU, the Participant may direct that any withholding

of Federal, State and local taxes, domestic or foreign, resulting from vesting of such Award be accomplished in any manner set forth

in Section 6.5. If the date of the vesting of any Award, other than an Option or SAR, held by Participant who is subject to the Company’s

policy regarding trading of its Shares by its officers and directors and Shares (the “original vesting date”) is not within

a “window period” applicable to the Participant, as determined by the Company in accordance with such policy, then withholding

shall be at the applicable statutory withholding amount accomplished by one or more of the methods provided for in Section 6.5(a) or

(f).

SECTION

16.

SUCCESSORS

All

obligations of the Company under the Plan with respect to Awards granted hereunder shall be binding on any successor to the Company,

whether the existence of such successor is the result of a direct or indirect merger, consolidation, purchase of all or substantially

all of the business and/or assets of the Company or otherwise.

SECTION

17.

MISCELLANEOUS

17.1.

UNFUNDED PLAN. The Plan is intended to constitute an “unfunded” plan

for incentive and deferred compensation. With respect to any payments not yet made to a Participant or the obligation to deliver Shares

pursuant to an Award, nothing contained in the Plan or any Award shall give any such Participant any rights that are greater than those

of a general creditor of the Company; provided that the Committee may authorize the creation of trusts and deposit therein cash,

Shares, other Awards or other property, or make other arrangements to meet the Company’s obligations under the Plan. Such trusts

or other arrangements shall be consistent with the “unfunded” status of the Plan unless the Committee otherwise determines

with the consent of each affected Participant.

17.2.

AWARDS TO PARTICIPANTS OUTSIDE THE UNITED STATES. The Committee may modify the

terms of any Award under the Plan made to or held by a Participant who is then resident or primarily employed outside the U.S. in any

manner deemed by the Committee to be necessary or appropriate in order that the Award shall conform to laws, regulations, and customs

of the country in which the Participant is then resident or primarily employed, or so that the value and other benefits of the Award

to the Participant, as affected by foreign tax laws and other restrictions applicable as a result of the Participant’s residence

or employment abroad, shall be comparable to the value of such an Award to a Participant who is resident or primarily employed in the

U.S.. Such authorization shall extend to and include establishing one or more separate sub-plans which include provisions not inconsistent

with the Plan that comply with statutory or regulatory requirements imposed by the foreign country or countries in which the Participant

resides. If determined advisable by the Committee, an Award may be modified under this Section in a manner that is inconsistent with

the express terms of the Plan, so long as such modifications will not contravene any applicable law or result in actual liability under

Section 16(b) of the Exchange Act for the Participant whose Award is modified.

17.3.

GENDER AND NUMBER; HEADINGS. Except where otherwise indicated by the context, any

masculine term used herein also shall include the feminine; the plural shall include the singular and the singular shall include the

plural. Headings are included for the convenience of reference only and shall not be used in the interpretation or construction of any

such provision contained in the Plan.

17.4.

SEVERABILITY. In the event any provision of the Plan shall be held illegal or invalid

for any reason, the illegality or invalidity shall not affect the remaining parts of the Plan, and the Plan shall be construed and enforced

as if the illegal or invalid provision had not been included.

17.5.

REQUIREMENTS OF LAW. The granting of Awards and the issuance of Shares under the

Plan shall be subject to all applicable laws, rules, and regulations, including, without limitation, the BVI Business Companies Act and

the Articles, and to such approvals by any governmental agencies or national securities exchanges as may be required. If at any time

on or after the Effective Date, the Committee, in its discretion, shall determine that the requirements of any applicable law (including,

without limitation, U.S. federal or state securities laws and British Virgin Islands law) should fail to be met, no Shares issuable under

Awards and no Options or SARs shall be exercisable until the Committee has determined that these requirements have again been met. The

Committee may suspend the right to exercise an Option or SAR at any time when it determines that allowing the exercise and issuance of

Shares would violate any federal or state securities or other laws or the BVI Business Companies Act or the Articles, and may provide

that any time periods to exercise the Option or SAR are extended during a period of suspension. With respect to “Insiders,”

transactions under this Plan are intended to comply with all applicable conditions of Rule 16b-3 under the Exchange Act. To the extent

any provision of the Plan or action by the Committee fails to so comply, it shall be deemed null and void, to the extent permitted by

law and deemed advisable by the Committee. Each Award Agreement and each certificate representing securities granted pursuant to the

Plan (including securities issuable pursuant to the terms of derivative securities) may bear such restrictive legend(s) as the Company

deems necessary or advisable under applicable law, including federal and state securities laws and British Virgin Islands law. If the

date of the vesting of any Award, other than an Option or SAR, held by Participant who is subject to the Company’s policy regarding

trading of its Shares by its officers and directors and Shares (the “original vesting date”) is not within a “window

period” applicable to the Participant, as determined by the Company in accordance with such policy, then the vesting of such Award

shall not occur on such original vesting date and shall instead occur on the first day of the next “window period” applicable

to the Participant pursuant to such policy.

17.6.

ADDITIONAL RESTRICTIONS ON TRANSFERS. The Committee may impose such restrictions

on any Shares acquired pursuant to an Award, including Restricted Shares, Performance Shares, or Shares received upon exercise of an

Option or SAR or under an RSU, as it may deem advisable and as are consistent with the Articles, the BVI Business Companies Act and applicable

securities laws. Subject to the approval of the Board or the CEO, an Option or SAR may be transferred pursuant to the terms of a domestic

relations order, official marital settlement agreement or other divorce or separation instrument as permitted by the Code and regulations

issued thereunder, and provided that if an Option is an ISO such option may be deemed a non-statutory share option as a result of such

transfer. Any transfer of Shares shall be effective only in accordance with the Articles and applicable law.

17.7.

GOVERNING LAW. The Plan and any agreements hereunder shall be administered, interpreted

and enforced under the internal laws of the British Virgin Islands without regard to conflicts of laws thereof. To the extent any provision

of the Plan or any Award Agreement is inconsistent with the Articles or the BVI Business Companies Act, the Articles and the BVI Business

Companies Act shall prevail, and the Plan or Award Agreement shall be construed, amended or limited to the minimum extent necessary to

comply with British Virgin Islands law.

EX-10.8

EX-10.8

Filename: ex10-8.htm · Sequence: 10

Exhibit

10.8

Executive

Employment Agreement

This

EXECUTIVE EMPLOYMENT AGREEMENT (“Agreement”) is made as of [_________] (the “Effective Date”),

by and between Firstborn Top Capital Sdn Bhd. (together with its successors and assigns, the “Company”), and [____________]

(“Executive”). As the context of this Agreement so requires, Executive and the Company are sometimes individually

referred to herein as a “Party” and collectively as the “Parties.”

RECITALS

WHEREAS,

the Company desires to employ Executive, and Executive desires to be employed by the Company, as the Company’s [●].

NOW,

THEREFORE, in consideration of the foregoing recitals, the mutual covenants and conditions herein, and other good and valuable consideration,

the receipt and adequacy of which is hereby acknowledged, the parties hereby agree as follows:

AGREEMENT

1. Employment

and Term. The Company hereby agrees to employ Executive, and Executive hereby accepts

employment by the Company, on the terms and conditions hereinafter set forth. Executive’s

term of employment by the Company under this Agreement (the “Term”) shall

commence on the Effective Date and end on the date on which the term of employment is terminated

in accordance with Section 5. Executive shall be employed under a contract of service for

purposes of Malaysian law, and this Agreement shall be read subject to the Employment Act

1955, the Industrial Relations Act 1967 and all other applicable Malaysian employment, social

security, tax and data protection laws, as amended from time to time.

2. Position,

Duties and Responsibilities, Location, and Commuting.

(a) Position

and Duties. During the Term, the Company shall employ Executive as [●]. Executive

shall report directly to, and subject to the specific direction of, the Company’s Board

of Directors (the “Board”). Executive shall have general overall authority

and responsibility for [description of duties]. Executive shall also have such other duties,

powers, and authority as are commensurate with his or her position as [●] and such

other duties and responsibilities that are commensurate with his or her positions as specifically

delegated to him or her from time to time by the Board.

(b) Exclusive

Services and Efforts. Executive agrees to devote his or her efforts, energies, and skill

to the discharge of the duties and responsibilities attributable to his or her position and,

except as set forth herein, agrees to devote all of his or her professional time and attention

to the business and affairs of the Company. Executive shall be entitled to engage in service

on the board of directors of one (1) not-for-profit organization to the extent such service

does not interfere with the performance of his or her duties and responsibilities to the

Company, as determined by the Company in its sole reasonable discretion.

1

(c) Compliance

with Company Policies. Executive shall be subject to the charter, policies, practices,

procedures and rules of the Company, including those policies and procedures set forth in

the Company’s Code of Conduct and Ethics, all of which shall form an integral part

of the terms of this Agreement. Executive’s violation of the terms of such documents

shall be considered a breach of the terms of this Agreement.

(d) Location

of Employment. Executive’s principal office, and principal place of employment,

shall be at the Company’s offices in Malaysia; provided that Executive may be required

under business circumstances to travel outside of such location in connection with performing

his or her duties under this Agreement.

3. Salary

and Incentives.

(a) Base

Salary. During the Term, the Company shall pay to Executive a monthly salary of RM[Amount]

(“Base Salary”). The Compensation Committee of the Board (the “Committee”)

may increase the Base Salary, in its sole discretion, taking into account Company and individual

performance objectives; provided that any reduction in Base Salary shall not be made except

with Executive’s prior written consent and in compliance with applicable Malaysian

law, and the Base Salary shall in no event be less than the applicable statutory minimum

wage.

(b) Annual

Cash Bonus. During the Term, Executive may be eligible to receive an annual cash bonus,

on terms and conditions as determined by the Committee in its sole discretion, taking into

account Company and individual performance objectives.

(c) Transaction

Incentive Bonus. The Executive may be eligible and receive a certain incentive bonus

provided on terms and conditions as approved by the Committee, taking into account Company

and Company growth objectives.

(d) Statutory

Contributions & Monthly Tax Deduction. The Company

shall make necessary statutory contribution to the Employees Provident Fund (EPF), the Social

Security Organisation (SOCSO) and the Employee’s Insurance Scheme (EIS) in accordance

with the prevailing statutory requirements. The Company shall deduct such sums as may be

required from your monthly salary for the contribution of EPF, SOCSO, scheduled monthly income

tax deductions (PCB) and other similar contributions and/or payments as required by law.

(e) Long-Term

Incentive Award. During the Term, Executive shall be eligible to participate in the Company’s

long-term incentive plan, on terms and conditions as determined by the Committee in its sole

discretion taking into account Company and individual performance objectives.

4. Employee

Benefits and Perquisites.

(a) Benefits.

Executive shall be entitled to participate in such health, group insurance, welfare, pension,

and other employee benefit plans, programs, and arrangements as are made generally available

from time to time to other employees of the Company, subject to Executive’s satisfaction

of all applicable eligibility conditions of such plans, programs, and arrangements. Nothing

herein shall be construed to limit the Company’s ability to amend or terminate any

employee benefit plan or program in its sole discretion.

2

(b) Fringe

Benefits, Perquisites, and Annual Leave. During the Term, Executive shall be entitled

to participate in all fringe benefits and perquisites made available to other employees of

the Company, subject to Executive’s satisfaction of all applicable eligibility conditions

to receive such fringe benefits and perquisites. In addition, Executive shall be eligible

for up to [14 days] of Annual Leave (“Annual Leave”) per calendar year

in accordance with the Company’s vacation and Annual Leave policy, inclusive of vacation

days and excluding medical leaves and standard paid Company holidays, in the same manner

as Annual Leave days for employees of the Company generally accrue; provided that Executive

shall receive no less than the minimum annual leave, paid public holidays, sick leave, hospitalization

leave, maternity/paternity benefits and other statutory benefits required under applicable

Malaysian law. Further, such Annual Leave shall be less than the statutory minimum based

on the tenure under the Employment Act 1955.

(c) Reimbursement

of Expenses. The Company shall reimburse Executive for all reasonable pre-approved business

and travel expenses incurred in the performance of his or her job duties, promptly upon presentation

of appropriate supporting documentation and otherwise in accordance with and subject to the

expense reimbursement policy of the Company.

(d) Maternity/Paternity

Leave. During the Term, the Executive shall be eligible to ninety eight (98) consecutive

days of paid Maternity Leave for an eligible female Executive and seven (7) consecutive days

of paid Paternity Leave for an eligible male Executive.

5. Termination.

(a) General.

The Company may terminate Executive’s employment only in accordance with this Agreement

and applicable Malaysian law, including any requirement for just cause or excuse, due inquiry,

procedural fairness and/or statutory notice or payment in lieu of notice, as applicable.

Executive may terminate his or her employment in accordance with this Agreement and applicable

Malaysian law; provided, however, that the Company and the Executive are required to provide

to the other party at least sixty (60) days’ written notice of intent to terminate

employment for any reason unless the Company specifies an earlier date of termination or

in lieu thereof, payment in lieu of such notice, and provided further that where a longer

notice period or greater benefit is required by applicable Malaysian law, such longer notice

period or greater benefit shall apply. For purposes of this Agreement, the following terms

have the following meanings:

(i) “Accrued

Benefits” shall mean: (i) accrued but unpaid Base Salary through the Termination

Date; (ii) reimbursement for any unreimbursed pre-approved reasonable business expenses incurred

through the Termination Date; (iii) accrued but unused Annual Leave days; and (iv) all other

payments, benefits, or fringe benefits to which Executive shall be entitled as of the Termination

Date under the terms of any applicable compensation arrangement or benefit, equity, or fringe

benefit plan or program or grant; all payable within thirty (30) days following the Termination

Date.

3

(ii) “Cause”

shall mean: (i) a breach by Executive of his or her fiduciary duties to the Company; (ii)

Executive’s breach of this Agreement, which, if curable, remains uncured or continues

after ten days’ notice by the Company thereof; (iii) the commission of any criminal

offence under applicable law or any other criminal act involving embezzlement, misappropriation

of money, fraud, theft, or bribery; (iv) illegal or controlled substance abuse or insobriety

by Executive; (v) Executive’s material negligence or dereliction in the performance

of, or failure to perform Executive’s duties of employment with the Company, which

remains uncured or continues after ten days’ notice by the Company thereof; (vi) Executive’s

refusal or failure to carry out a lawful directive of the Company or any member of the Board

or any of their respective designees, which directive is consistent with the scope and nature

of Executive’s responsibilities; or (vii) any conduct, action or behavior by Executive

that is, or is reasonably expected to be, materially damaging to the Company, whether to

the business interests, finance or reputation; provided that, where required by Malaysian

law, the Company shall conduct a due inquiry and provide Executive with a reasonable opportunity

to be heard before any dismissal for misconduct. In addition, Executive’s employment

shall be deemed to have terminated for Cause if, on the date Executive’s employment

terminates, facts and circumstances exist that would have justified a termination for Cause,

even if such facts and circumstances are discovered after such termination.

(iii) “Just

Cause” shall mean a material breach by the Company of its obligations under this

Agreement, upon which Executive notifies the Board in writing of such material breach within

thirty (30) days of such occurrence, and such material breach shall have not been cured within

thirty (30) days after the Board’s receipt of written notice thereof from Executive.

(iv) “Termination

Date” shall mean the date on which Executive’s employment hereunder terminates

in accordance with this Agreement.

(b) Termination

Without Cause or Termination by Executive for Just Cause. In the event that Executive’s

employment hereunder is terminated by the Company without Cause or by Executive for Just

Cause, Executive shall be entitled to receive the Accrued Benefits. In addition, commencing

on the first payroll date following the date that is sixty (60) days following the Termination

Date, the Company shall continue to pay Executive his or her Base Salary, in accordance with

customary payroll practices and subject to applicable withholding, statutory contributions

and income taxes (the “Severance Payments”), for [six (6) months] (the

“Severance Period”); provided, however, that the Severance Payments shall

be conditioned upon the execution, non-revocation, and delivery of a general release of claims

by Executive, in a form reasonably satisfactory to the Company, within sixty (60) days following

the Termination Date. In the event that Executive fails to timely execute and deliver such

a release, the Company shall have no obligation to pay Severance Payments under this Agreement.

(c) All

Other Terminations. In the event that Executive’s employment hereunder is terminated

by the Company for Cause, by Executive without Just Cause, or due to Executive’s death

or disability, Executive shall be entitled to receive the Accrued Benefits.

(d) Return

of Company Property. Upon termination of Executive’s employment for any reason

or under any circumstances, Executive shall promptly return any and all of the property of

the Company and any affiliates (including, without limitation, all computers, keys, credit

cards, identification tags, documents, data, confidential information, work product, and

other proprietary materials).

4

(e) Post-Termination

Cooperation. Executive agrees and covenants that, following the Term, he or she shall,

to the extent requested by the Company, cooperate in good faith with the Company to assist

the Company in the pursuit or defense of (except if Executive is adverse with respect to)

any claim, administrative charge, or cause of action by or against the Company as to which

Executive, by virtue of his or her employment with the Company or any other position that

Executive holds that is affiliated with or was held at the request of the Company, has relevant

knowledge or information, including by acting as the Company’s representative in any

such proceeding and, without the necessity of a subpoena, providing truthful testimony in

any jurisdiction or forum. The Company shall reimburse Executive for his or her reasonable

out-of-pocket expenses incurred in compliance with this Section.

6. Other

Tax Matters & Statutory Contributions.

(a) The

Company shall be entitled to withhold and make payment/ contribution of all applicable Malaysian

income tax, monthly tax deductions (PCB), Employees Provident Fund (EPF), Social Security

Organisation (SOCSO), Employment Insurance System (EIS), Human Resources Development Corporation

levy where applicable, workmen’s compensation contributions and other statutory contributions

as may be required by law with respect to compensation payable to Executive pursuant to this

Agreement. No deduction from wages shall be made except as permitted by applicable Malaysian

law or with Executive’s written authorization where required.

(b) Notwithstanding

anything herein to the contrary, this Agreement is intended to be interpreted and applied

so that the payment of the benefits set forth herein shall comply with the requirements regarding

the deferred annuity under the Income Tax Act 1967, as amended (the “ITA 1967”).

(c) All

reimbursements and in-kind benefits provided under this Agreement shall be made or provided

in accordance with the requirements of ITA 1967. To the extent that any reimbursements are

taxable to Executive, such reimbursements shall be paid to Executive on or before the last

day of Executive’s taxable year following the taxable year in which the related expense

was incurred. Reimbursements shall not be subject to liquidation or exchange for another

benefit and the amount of such reimbursements that Executive receives in one taxable year

shall not affect the amount of such reimbursements that Executive receives in any other taxable

year.

7. Non-Solicitation.

(a) During

the Term and for twelve (12) months following the Termination Date (the “Restricted

Period”), Executive shall not misuse or disclose Confidential Information, trade

secrets or personal data of the Company, and shall not, by using such Confidential Information

or trade secrets, directly solicit any customer, supplier or material business relation with

whom Executive had material dealings during the twelve (12) months preceding the Termination

Date. This Section is intended to protect the Company’s confidential information, trade

secrets and legitimate business interests and shall not be construed as restraining Executive

from exercising any lawful profession, trade or business in contravention of Section 28 of

the Contracts Act 1950.

(b) During

the Restricted Period, Executive will not, and will cause his or her affiliates not to, directly

or indirectly, through or in association with any third party (1) solicit, induce, recruit,

or encourage any employees or independent contractors of or consultants to the Company to

terminate their relationship with the Company or take away or hire such employees, independent

contractors, or consultants or (2) attempt to do any of the foregoing, either for Executive’s

own purposes or for any other third party.

5

8. Nondisclosure

and Nonuse of Confidential Information.

(a) Executive

acknowledges that: (i) the Confidential Information (as hereinafter defined) is a valuable,

special, and unique asset of the Company, the unauthorized disclosure or use of which could

cause substantial injury and loss of profits and goodwill to the Company; (ii) Executive

is in a position of trust and subject to a duty of loyalty to the Company, and (iii) by reason

of his or her employment and service to the Company, Executive will have access to the Confidential

Information. Executive, therefore, acknowledges that it is in the Company’s legitimate

business interest to restrict Executive’s disclosure or use of Confidential Information

for any purpose other than in connection with Executive’s performance of Executive’s

duties for the Company, and to limit any potential misappropriation of such Confidential

Information by Executive.

(b) Executive

will not disclose or use at any time, either during the Term or thereafter, any Confidential

Information (as hereinafter defined) of which Executive is or becomes aware, whether or not

such information is developed by him or her, except to the extent that such disclosure or

use is directly related to and required by Executive’s performance in good faith of

duties assigned to Executive by the Company or has been expressly authorized by the Board;

provided, however, that this sentence shall not be deemed to prohibit Executive from complying

with any subpoena, order, judgment, or decree of a court or governmental or regulatory agency

of competent jurisdiction (an “Order”); provided, further, however, that

(i) Executive agrees to provide the Company with prompt written notice of any such Order

and to assist the Company, at the Company’s expense, in asserting any legal challenges

to or appeals of such Order that the Company in its sole discretion pursues, and (ii) in

complying with any such Order, Executive shall limit his or her disclosure only to the Confidential

Information that is expressly required to be disclosed by such Order. Executive will take

all appropriate steps to safeguard Confidential Information and to protect it against disclosure,

misuse, espionage, loss, and theft. Executive shall deliver to the Company at the Termination

Date, or at any time the Company may request, all memoranda, notes, plans, records, reports,

electronic information, files and software, and other documents and data (and copies thereof)

relating to the Confidential Information or the Work Product (as hereinafter defined) of

the business of the Company which Executive may then possess or have under his or her control.

(c) As

used in this Agreement, the term “Confidential Information” means information

that is not generally known to the public (including the existence and content of this Agreement)

and that is used, developed, or obtained by the Company in connection with its business,

including, but not limited to, information, observations, and data obtained by Executive

while employed by the Company or any predecessors thereof (including those obtained prior

to the date of this Agreement) concerning (i) the business or affairs of the Company (or

such predecessors), (ii) products or services, (iii) fees, costs and pricing structures,

(iv) designs, (v) analyses, (vi) drawings, photographs and reports, (vii) computer software

and hardware, including operating systems, applications and program listings, (viii) flow

charts, manuals and documentation, (ix) databases and data, (x) accounting and business methods,

(xi) inventions, devices, new developments, methods, and processes, whether patentable or

unpatentable and whether or not reduced to practice, (xii) customers and clients (and all

information with respect to such persons) and customer or client lists, (xiii) suppliers

(and all information with respect to such persons) or supplier lists, (xiv) other copyrightable

works, (xv) all production methods, processes, technology, and trade secrets, and (xvi) all

similar and related information in whatever form. Confidential Information will not include

any information that has been published in a form generally available to the public prior

to the date Executive proposes to disclose or use such information. Confidential Information

will not be deemed to have been published merely because individual portions of the information

have been separately published, but only if all material features comprising such information

have been published in combination.

6

(d) Executive

shall comply with the Personal Data Protection Act 2010 and all Company policies relating

to the collection, processing, use, disclosure, retention and security of personal data.

Executive shall process personal data only for lawful employment or business purposes authorized

by the Company and shall promptly notify the Company of any actual or suspected unauthorized

access, disclosure, loss or misuse of personal data.

9. Property;

Inventions and Patents.

(a) Property.

Executive agrees that all inventions, innovations, improvements, technical information, systems,

software developments, methods, designs, analyses, drawings, reports, service marks, trademarks,

trade names, logos, products, equipment, and all similar or related information and materials

(whether patentable or unpatentable) (collectively, “Inventions”) which

relate to the Company’s actual or anticipated business, research and development, or

existing or future products or services and which are conceived, developed, or made by Executive

(whether or not during usual business hours and whether or not alone or in conjunction with

any other person) while employed (and for the Restricted Period if and to the extent such

Inventions result from any work performed for the Company, any use of the Company’s

premises or property or any use of the Company’s Confidential Information) by the Company

(including those conceived, developed, or made prior to the date of this Agreement) together

with all patent applications, letters patent, trademark, brands, tradename and service mark

applications or registrations, copyrights, and reissues thereof that may be granted for or

upon any of the foregoing (collectively referred to herein as, the “Work Product”),

belong in all instances to such member of the Company. Executive will promptly disclose such

Work Product to the Company and perform all actions reasonably requested by the Company (whether

during or after the Term) to establish and confirm the Company’s ownership of such

Work Product (including, without limitation, the execution and delivery of assignments, consents,

powers of attorney, and other instruments) and to provide reasonable assistance to the Company

(whether during or after the Term) in connection with the prosecution of any applications

for patents, trademarks, brands, trade names, service marks, or reissues thereof or in the

prosecution or defense of interferences relating to any Work Product. Executive recognizes

and agrees that the Work Product, to the extent copyrightable, constitutes works created

in the course of employment and shall vest in the Company to the fullest extent permitted

under the Copyright Act 1987 and other applicable Malaysian intellectual property laws and

that to the extent Work Product constitutes such works, the Work Product is the exclusive

property of the Company, and all right, title, and interest in the Work Product vests in

the Company. To the extent Work Product does not automatically vest in the Company, the Work

Product, and all of Executive’s right, title, and interest in Work Product, including

without limitation every priority right, is hereby assigned to the Company.

7

(b) Cooperation.

Executive shall, during the Term and at any time thereafter, assist and cooperate fully with

the Company in obtaining for the Company the grant of a certificate of patent, copyrights,

and any other intellectual property rights relating to the Work Product in Malaysia and/or

such other countries as the Company may designate. With respect to Work Product, Executive

shall, during the Term and at any time thereafter, execute all applications, statements,

instruments of transfer, assignment, conveyance or confirmation, or other documents, furnish

all such information to the Company and take all such other appropriate lawful actions as

the Company requests that are necessary to establish the Company’s ownership of such

Work Product. Executive will not assert or make a claim of ownership of any Work Product,

and Executive will not file any applications for patents or copyright or trademark registration

relating to any Work Product.

(c) No

Designation as Inventor; Waiver of Moral Rights. Executive agrees that the Company shall

not be required to designate Executive as the inventor or author of any Work Product. Executive

hereby irrevocably and unconditionally waives and releases, to the extent permitted by applicable

law, all of Executive’s rights to such designation and any rights concerning future

modifications to any Work Product. To the extent permitted by applicable law, Executive hereby

waives all claims to moral rights in and to any Work Product.

(d) Pre-Existing

and Third-Party Materials. Executive will not, in the course of employment with the Company,

incorporate into or in any way use in creating any Work Product any pre-existing invention,

improvement, development, concept, discovery, works, or other proprietary right or information

owned by Executive or in which Executive has an interest without the Company’s prior

written permission. Executive hereby grants the Company a nonexclusive, royalty-free, fully-paid,

perpetual, irrevocable, sublicensable, worldwide license to make, have made, modify, use,

sell, copy, and distribute, and to use or exploit in any way and in any medium, whether or

not now known or existing, such item as part of or in connection with such Work Product.

Executive will not incorporate any invention, improvement, development, concept, discovery,

intellectual property, or other proprietary information owned by any party other than Executive

into any Work Product without the Company’s prior written permission.

(e) Attorney-in-Fact.

Executive hereby irrevocably designates and appoints the Company and its duly authorized

officers and agents as Executive’s agent and attorney-in-fact, to act for and on Executive’s

behalf to execute and file any such applications and to do all other lawfully permitted acts

to further the prosecution and issuance of patents, copyright, trademark, and mask work registrations

with the same legal force and effect as if executed by Executive, if the Company is unable

because of Executive’s unavailability, dissolution, mental or physical incapacity,

or for any other reason, to secure Executive’s signature for the purpose of applying

for or pursuing any application for any United States, Malaysia or foreign patents or mask

work or copyright or trademark registrations covering the Work Product owned by the Company

pursuant to this Section.

10. Enforcement.

Because Executive’s services are special, unique, and extraordinary and because Executive

has access to Confidential Information and Work Product, the parties hereto agree that money

damages would be an inadequate remedy for any breach of this Agreement. Therefore, in the

event of a breach or threatened breach of this Agreement, the Company, or any of its successors

or assigns may, in addition to other rights and remedies existing in their favor at law or

in equity, apply to any court of competent jurisdiction for specific performance and/or injunctive

or other relief in order to enforce, or prevent any violations of, the provisions hereof

(without posting a bond or other security).

8

11. Assurances

by Executive. Executive represents and warrants to the Company that he or she may enter

into and fully perform all of his or her obligations under this Agreement and as an employee

of the Company without breaching, violating, or conflicting with (i) any judgment, order,

writ, decree, or injunction of any court, arbitrator, government agency, or other tribunal

that applies to Executive or (ii) any agreement, contract, obligation, or understanding to

which Executive is a party or may be bound.

12. Termination

or Repayment of Severance Payments. In addition to the foregoing, and not in any way

in limitation thereof, or in limitation of any right or remedy otherwise available to the

Company, if Executive violates any provision of this Agreement, any obligation of the Company

to pay Severance Payments shall be terminated and of no further force or effect, and Executive

shall promptly repay to the Company any Severance Payments previously made to Executive,

in each case, without limiting or affecting Executive’s obligations under this Agreement

the Company’s other rights and remedies available at law or equity.

13. Notices.

Except as otherwise specifically provided herein, any notice, consent, demand, or other communication

to be given under or in connection with this Agreement shall be in writing and shall be deemed

duly given when delivered personally, when transmitted by facsimile transmission, one day

after being deposited with Federal Express, registered post or other nationally recognized

overnight delivery service, or three days after being mailed by first class mail, charges

or postage prepaid, properly addressed, if to the Company, at its principal office, and,

if to Executive, at his or her address set forth following his or her signature below. Either

party may change such address from time to time by notice to the other.

14. Governing

Law and Jurisdiction. This Agreement shall be governed by and construed and interpreted

in accordance with the laws of Malaysia, without giving effect to any choice of law rules

or other conflicting provision or rule that would cause the laws of any jurisdiction to be

applied. Subject to any mandatory jurisdiction of the Malaysian labor authorities, Industrial

Court or other competent statutory tribunal, the courts of Malaysia shall have jurisdiction

over any dispute arising out of or in connection with this Agreement. In the event of any

contest or dispute relating to this Agreement or the termination of Executive’s employment

hereunder, each of the parties shall bear its own costs and expenses. Nothing in this Agreement

shall exclude or restrict any right or remedy available to Executive under the Employment

Act 1955, the Industrial Relations Act 1967 or any other applicable Malaysian law.

15. Amendments;

Waivers. This Agreement may not be modified or amended or terminated except by an instrument

in writing, signed by Executive and a duly authorized representative of the Company (other

than Executive). By an instrument in writing similarly executed (and not by any other means),

either party may waive compliance by the other party with any provision of this Agreement

that such other party was or is obligated to comply with or perform; provided, however, that

such waiver shall not operate as a waiver of, or estoppel with respect to, any other or subsequent

failure. No failure to exercise and no delay in exercising any right, remedy, or power hereunder

shall operate as a waiver thereof, nor shall any single or partial exercise of any right,

remedy, or power hereunder preclude any other or further exercise thereof or the exercise

of any other right, remedy, or power provided herein or by law or in equity. To be effective,

any written waiver must specifically refer to the condition(s) or provision(s) of this Agreement

being waived.

9

16. Inconsistencies.

In the event of any inconsistency between any provision of this Agreement and any provision

of any Company arrangement, the provisions of this Agreement shall control, unless Executive

and the Company otherwise agree in writing that expressly refers to the provision of this

Agreement that is being waived.

17. Assignment.

This Agreement is personal to Executive and without the prior written consent of the Company

shall not be assignable by Executive. The obligations of Executive hereunder shall be binding

upon Executive’s heirs, administrators, executors, assigns, and other legal representatives.

This Agreement shall be binding upon and shall inure to the benefit of and be enforceable

by the Company’s successors and assigns.

18. Voluntary

Execution; Representations. Executive acknowledges that (a) he or she has consulted with

or has had the opportunity to consult with independent counsel of his or her own choosing

concerning this Agreement and has been advised to do so by the Company, and (b) he or she

has read and understands this Agreement, is competent and of sound mind to execute this Agreement,

is fully aware of the legal effect of this Agreement, and has entered into it freely based

on his or her own judgment and without duress.

19. Headings.

The headings of the Sections and subsections contained in this Agreement are for convenience

only and shall not be deemed to control or affect the meaning or construction of any provision

of this Agreement.

20. Construction.

The language used in this Agreement shall be deemed to be the language chosen by the parties

to express their mutual intent, and no rule of strict construction shall be applied against

any party.

21. Beneficiaries/References.

Executive shall be entitled, to the extent permitted under applicable law, to select and

change a beneficiary or beneficiaries to receive any compensation or benefit hereunder following

Executive’s death by giving written notice thereof. In the event of Executive’s

death or a judicial determination of his or her incompetence, references in this Agreement

to Executive shall be deemed, where appropriate, to refer to his or her beneficiary, estate,

or other legal representative.

22. Survivorship.

Except as otherwise set forth in this Agreement, the respective rights and obligations of

the parties shall survive any termination of Executive’s employment.

23. Severability.

It is fully the desire and intent of the parties hereto that the provisions of this Agreement

be enforced as permissible under the laws and public policies applied in each jurisdiction

in which enforcement is sought. Accordingly, if any particular provision of this Agreement

shall be adjudicated by a court of competent jurisdiction or arbitrator to be invalid, prohibited,

or unenforceable for any reason, such provision, as to such jurisdiction, shall be ineffective,

without invalidating the remaining provisions of this Agreement or affecting the validity

or enforceability of such provision in any other jurisdiction. Notwithstanding the foregoing,

if such provision could be more narrowly drawn so as not to be invalid, prohibited, or unenforceable

in such jurisdiction, it shall, as to such jurisdiction, be so narrowly drawn, without invalidating

the remaining provisions of this Agreement or affecting the validity or enforceability of

such provision in any other jurisdiction.

24. Counterparts.

This Agreement may be executed in any number of counterparts, each of which shall be deemed

an original, but all such counterparts shall together constitute one and the same instrument.

Signatures delivered by facsimile or PDF shall be effective for all purposes.

25. Entire

Agreement. This Agreement contains the entire agreement of the parties and supersedes

all prior or contemporaneous negotiations, correspondence, understandings and agreements

between the parties, regarding the subject matter of this Agreement.

[Remainder

of this page is intentionally left blank]

10

Firstborn Top Capital

By:

[Name]

Title:

[Title]

EXECUTIVE:

By:

[Name]

[Signature

Page to Employment Agreement]

EX-99.1

EX-99.1

Filename: ex99-1.htm · Sequence: 11

Exhibit

99.1

Firstborn

Top Capital, a Licensed Private Financing Company in Malaysia, to Become Publicly Traded Via Business Combination with ARC Group

Acquisition I Corp

~

Transaction values Firstborn Top Capital at pro forma enterprise value of approximately $1,091.2 million ~

~

Firstborn Top Capital is a licensed private financing company committed to providing responsible, transparent and accessible financial

solutions to individuals and businesses across Malaysia ~

~

Executive Director, Ow Ruey Shen, will continue to lead Firstborn Top Capital ~

~

Transaction provides Firstborn Top Capital the capital to accelerate growth throughout Malaysia, then Southeast Asia ~

~

Business combination expected to close in the first quarter of 2027 ~

~

All Firstborn Top Capital shareholders to sell 100% of their equity to ARC Group Acquisition I Corp ~

Kuala

Lumpur, Malaysia, September 10, 2026 (GLOBE NEWSWIRE) — ARC Group Acquisition I Corp (“ARCL”) (Nasdaq: ARCL,

ARCLR, ARCLW), a special purpose acquisition company, today announced that it has entered into a definitive share purchase agreement

with Firstborn Top Capital Sdn. Bhd., a Malaysian private limited company (“Firstborn Top Capital” or the “Company”),

pursuant to which Firstborn Top Capital will become a wholly-owned subsidiary of ARCL. Upon completion of the transaction, ARCL will

be renamed BlueCrest Investment, Inc. and is expected to be listed on the Nasdaq Global Market under the new ticker symbol “BCIN.”

Firstborn

Top Capital is a licensed private financing company committed to providing responsible, transparent and accessible financial solutions

to individuals (vehicle, property, personal expense, share/IPO financing, loan consolidation, etc.) and corporations (working capital,

capex, contract financing, M&A, share financing, loan consolidation, etc.). Firstborn Top Capital offers one-working-day approval

and a transparent business and revenue model offering fixed monthly interest, with the annualized rate depending on collateral, no hidden

fees or upfront costs, and loan terms up to five years. Upon the closing of the transaction, Firstborn Top Capital will continue to be

led by its Executive Director, Mr. Ow Ruey Shen, an experienced senior corporate executive in Malaysia. After the transaction

closing, BlueCrest Investment, Inc. will continue to be led by Datuk Dr. Doris Wong Sing Ee, Chief Executive Officer and Executive Director.

Datuk

Dr. Wong is a seasoned corporate leader with more than 20 years of management experience spanning multiple sectors including oil and

gas, property development, solar energy, engineering, advertising, food and beverage, and raw materials. She also currently serves as

Chief Executive Officer and Executive Director of Bio Green Med Solution, Inc. (Nasdaq: BGMS), a Nasdaq-listed diversified enterprise,

and as Executive Director of Metronic Global Berhad. Datuk Dr. Wong brings deep expertise in business development, strategic

consultancy, and corporate advisory, with a particular focus on mergers and acquisitions and joint ventures across Malaysia, Singapore,

China, Japan, Thailand, and Indonesia. She holds a Doctor of Business Administration specializing in ESG from HELP University, Malaysia.

Mr.

Ow, Executive Director of Firstborn Top Capital, commented, “This is a transformative milestone for Firstborn Top Capital. Combining

with ARC Group Acquisition I Corp and becoming a publicly traded company on the Nasdaq Global Market under the BlueCrest Investment banner

will provide us with the capital, visibility, and platform to accelerate our growth strategy to expand our lending operations throughout

Malaysia and, ultimately, across Southeast Asia. We remain committed to delivering responsible, transparent, and accessible financial

solutions, and this transaction positions us to do so on a much larger scale.”

Datuk

Dr. Doris Wong, Chief Executive Officer of ARC Group Acquisition I Corp, added, “After evaluating numerous potential business combination

targets, Firstborn Top Capital stood out for its revenue model, strong management team, and compelling growth trajectory in Malaysia’s

licensed private financing market. Firstborn Top Capital’s one-working-day approval process, transparent fee structure, and diversified

loan portfolio across both individual and corporate borrowers demonstrate exactly the kind of operationally sound, high-growth business

we set out to find. We are confident that this combination, with the Nasdaq listing and the resources of the public markets behind it,

will unlock significant value for shareholders and position BlueCrest Investment as a leading financial services platform in Southeast

Asia.”

Transaction

Overview

Under

the terms of the proposed transaction, ARC Group Acquisition I Corp will purchase 100% of the issued and outstanding ordinary shares

of Firstborn Top Capital such that Firstborn Top Capital will become a wholly-owned subsidiary of ARC Group Acquisition I Corp. In the

process, Firstborn Top Capital will become a publicly traded entity under the name “BlueCrest Investment, Inc.” The transaction

reflects an implied pro forma enterprise value at closing of approximately $1,091.2 million assuming ARCL raises $5 million in

PIPE financing and assuming 0% redemption from $120.8 million in ARCL’s trust account. The combined company intends to use the

proceeds for market expansion, lending infrastructure development, and marketing capability development.

At

the closing of the proposed transaction, approximately 12.4% of the outstanding shares of the combined company is expected to be held

by public investors, with existing Firstborn Top Capital shareholders owning approximately 82.39%. The boards of directors of ARC Group

Acquisition I Corp and Firstborn Top Capital have approved the transaction. The proposed transaction will also require the approval of

the shareholders of ARC Group Acquisition I Corp and is subject to other customary closing conditions. The proposed transaction is expected

to close during first quarter 2027. Additional information about the proposed transaction, including a copy of the share purchase agreement

and investor presentation, will be provided in a Current Report on Form 8-K to be filed by ARC Group Acquisition I Corp today with the

Securities and Exchange Commission (“SEC”) and available at www.sec.gov.

Advisors

ARC

Group Limited is acting as sole financial advisor to ARC Group Acquisition I Corp and ARC Group Securities, LLC is acting as its sole

capital markets advisor.

Rimon

P.C. is acting as U.S. legal counsel to ARC Group Acquisition I Corp and Forbes Hare serves as BVI counsel. Rohamat & Ling (Malayasia)

is acting as legal counsel to Firstborn Top Capital.

About

Firstborn Top Capital Sdn. Bhd.

Founded

in 2019, Firstborn Top Capital Sdn. Bhd. is a licensed private financing company based in Malaysia, committed to providing responsible,

transparent, and accessible financing solutions to individuals and businesses across the country. The Company offers a comprehensive

suite of credit products for individuals, including vehicle financing, property-backed loans, personal expense financing, share and IPO

financing, and loan consolidation, as well as tailored corporate financing solutions encompassing working capital facilities, capital

expenditure financing, contract financing, M&A financing, share financing, and debt consolidation. Firstborn Top Capital distinguishes

itself through its streamlined one-working-day credit approval process, a transparent and predictable revenue model featuring fixed monthly

interest rates (annualized based on collateral value), no hidden fees or upfront costs, and flexible loan terms of up to five years.

For more information, please visit https://firstborntopcapital.com.my.

About

ARC Group Acquisition I Corp

ARC

Group Acquisition I Corp (Nasdaq: ARCL) is a blank check company formed for the purposes of effecting a merger, capital share exchange,

asset acquisition, share purchase, reorganization, or similar business combination with one or more energy and/or sustainable natural

resource companies. On May 1, 2026, ARCL consummated its initial public offering of 12,075,000 units which includes the full exercise

of the over-allotment option of 1,575,000 additional units granted to ARC Group Securities LLC, as representative of the underwriters

in ARCL’s initial public offering generating total gross proceeds of $120,750,000.

Non-GAAP

Financial Measures

This

press release includes certain non-GAAP financial measures that are not prepared in accordance with generally accepted accounting principles

in the United States (“GAAP”) and that may be different from non-GAAP financial measures used by other companies. ARC Group

Acquisition I Corp and Firstborn Top Capital Sdn. Bhd. believe that the use of these non-GAAP financial measures provides an additional

tool for investors to use in evaluating ongoing operating results and trends of Firstborn Top Capital. These non-GAAP measures should

not be considered in isolation from, or as an alternative to, financial measures determined in accordance with GAAP. Additionally, to

the extent that forward-looking non-GAAP financial measures are provided, they are presented on a non-GAAP basis without reconciliations

of such forward-looking non-GAAP measures due to the inherent difficulty in forecasting and quantifying certain amounts that are necessary

for such reconciliation.

Important

Information About the Proposed Business Combination and Where to Find It

For

additional information on the proposed transaction, see ARCL’s Current Report on Form 8-K, which will be filed concurrently with

this press release. In connection with the proposed transaction, ARCL intends to file relevant materials with the SEC, including a registration

statement on Form S-4 with the Securities Exchange Commission (SEC), which will include a proxy statement/prospectus, and will file other

documents regarding the proposed transaction with the SEC. ARCL’s shareholders and other interested persons are advised to read,

when available, the preliminary proxy statement/prospectus and the amendments thereto and the definitive proxy statement and documents

incorporated by reference therein filed in connection with the proposed transaction, as these materials will contain important information

about Firstborn Top Capital and ARCL and the proposed transaction. Promptly after the Form S-4 is declared effective by the SEC, ARCL

will mail the definitive proxy statement/prospectus and a proxy card to each shareholder entitled to vote at the meeting relating to

the approval of the proposed transaction and other proposals set forth in the proxy statement/prospectus. Before making any voting

or investment decision, investors and shareholders of ARCL are urged to carefully read the entire registration statement and proxy statement/prospectus,

when they become available, and any other relevant documents filed with the SEC, as well as any amendments or supplements to these documents,

because they will contain important information about the proposed transaction. The documents filed by ARCL with the SEC may be obtained

free of charge at the SEC’s website at www.sec.gov, or by directing a request to ARC Group Acquisition I Corp, 398 S. Mill

Avenue, Suite 306, Tempe, Arizona 85284.

Participants

in the Solicitation

ARC

Group Acquisition I Corp and certain of its directors, executive officers and other members of management and employees may, under SEC

rules, be deemed to be participants in the solicitation of proxies from ARCL’s shareholders in connection with the proposed transaction.

A list of the names of those directors and executive officers and a description of their interests in ARCL will be included in the proxy

statement/prospectus for the proposed transaction when available at www.sec.gov. Information about ARCL’s directors and

executive officers and their ownership of ARCL ordinary shares is set forth in ARCL’s final prospectus dated April 29, 2026 and

filed with the SEC on April 30, 2026, as modified or supplemented by any Form 3 or Form 4 filed with the SEC since the date of such filing.

Other information regarding the interests of the participants in the proxy solicitation will be included in the proxy statement/prospectus

pertaining to the proposed transaction when it becomes available. These documents can be obtained free of charge from the source indicated

above.

Firstborn

Top Capital Sdn. Bhd. and its directors and executive officers may also be deemed to be participants in the solicitation of proxies from

the shareholders of ARCL in connection with the proposed transaction. A list of the names of such directors and executive officers and

information regarding their interests in the proposed transaction will be included in the proxy statement/prospectus for the proposed

transaction. Additional information regarding the participants in the proxy solicitation and a description of their direct and indirect

interests is included in the proxy statement/prospectus filed with the SEC on Form S-4. Shareholders, potential investors and other interested

persons should read the proxy statement/prospectus carefully when it becomes available before making any voting or investment decisions.

You may obtain free copies of these documents from the sources indicated above.

Cautionary

Statement Regarding Forward-Looking Statements

Certain

statements contained in this press release constitute “forward-looking statements” within the meaning of U.S. federal securities

laws. Forward-looking statements may include, but are not limited to, statements with respect to (i) trends in the Malaysian lending

industry, including changes in technology and competition related to Firstborn Top Capital’s products; (ii) Firstborn Top Capital’s

growth prospects and its market size; (iii) Firstborn Top Capital projected financial and operational performance including relative

to its competitors; (iv) new financial products and technology that Firstborn Top Capital may introduce in the future; (v) the potential

transaction, including the implied enterprise value, the expected post-closing ownership structure and the likelihood and ability of

the parties to consummate the potential transaction successfully; (vi) the risk the proposed transaction may not be completed in a timely

manner or at all, which may adversely affect the price of ARCL’s securities; (vii) the failure to satisfy the conditions to the

consummation of the proposed transaction, including the approval of the proposed transaction by the shareholders of ARC Group Acquisition

I Corp; (viii) the effect of the announcement or pendency of the proposed transaction on ARCL’s or Firstborn Top Capital’s

business relationships, performance and business generally; (ix) the outcome of any legal proceedings that be instituted against ARCL

or Firstborn Top Capital related to the proposed transaction or any agreement related thereto; (x) the ability to maintain the listing

of ARCL on Nasdaq; (xi) the price of ARCL’s securities, including volatility resulting from changes in the competitive and regulated

industry in which Firstborn Top Capital operates, variations in performance across competitors, changes in laws and regulations affecting

Firstborn Top Capital’s business and changes in the combined capital structure; (xii) the ability to implement business plans,

forecasts, and other expectations after the completion of the proposed transaction and identify and realize additional opportunities;

and (xiii) other statements regarding ARCL’s or Firstborn Top Capital’s expectations, hopes, beliefs, intentions and strategies

regarding the future.

In

addition, any statements that refer to projections forecasts or other characterizations of future events or circumstances, including

any underlying assumptions are forward-looking statements. The words “anticipate,” “believe,” “continue,”

“could,” “estimate,” “expect,” “intends,” “outlook,” “may,” “might,”

“plan,” “possible,” “potential,” “predict,” “project,” “should,”

“would,” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that

a statement is not forward-looking. Forward-looking statements are predictions, projections and other statements about future events

that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties.

You

should carefully consider the risks and uncertainties described in the “Risk Factors” section of ARC Group Acquisition I

Corp final prospectus dated April 29, 2026 and filed with the SEC on April 30, 2026 for its initial public offering and, the proxy statement/prospectus

relating to the proposed transaction, which is expected to be filed by ARC Group Acquisition I Corp with the SEC, other documents filed

by ARC Group Acquisition I Corp from time to time with SEC, and any risk factors made available to you in connection with ARC Group Acquisition

I Corp, Firstborn Top Capital, and the proposed transaction. These forward-looking statements involve a number of risks and uncertainties

(some of which are beyond the control of Firstborn Top Capital and ARC Group Acquisition I Corp) and other assumptions, that may cause

the actual results or performance to be materially different from those expressed or implied by these forward-looking statements. ARCL

and Firstborn Top Capital caution that the foregoing list of factors is not exclusive.

No

Offer or Solicitation

This

press release relates to a proposed transaction between ARC Group Acquisition I Corp and Firstborn Top Capital Sdn. Bhd., and does not

constitute a proxy statement or solicitation of a proxy and does not constitute an offer to sell or a solicitation of an offer to buy

the securities of ARC Group Acquisition I Corp or Firstborn Top Capital, nor shall there be any sale of any such securities in any state

or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities

laws of such state or jurisdiction.

Contacts

ARC

Group Acquisition I Corp

398

S. Mill Avenue, Suite 306

Tempe,

Arizona 85284

Attn:

Datuk Dr. Doris Wong Sing Ee

Chief

Executive Officer

Tel:

(928) 625-0928

GRAPHIC

GRAPHIC

Filename: ex99-1_001.jpg · Sequence: 12

Binary file (10207 bytes)

Download ex99-1_001.jpg

GRAPHIC

GRAPHIC

Filename: ex99-1_002.jpg · Sequence: 13

Binary file (4972 bytes)

Download ex99-1_002.jpg

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 30

v3.26.1

Cover

Sep. 10, 2026

Document Type

8-K

Amendment Flag

false

Document Period End Date

Sep. 10, 2026

Entity File Number

001-43253

Entity Registrant Name

ARC

Group Acquisition I Corp

Entity Central Index Key

0002073515

Entity Tax Identification Number

00-0000000

Entity Incorporation, State or Country Code

D8

Entity Address, Address Line One

398

S Mill Avenue

Entity Address, Address Line Two

Suite 306

Entity Address, City or Town

Tempe

Entity Address, State or Province

AZ

Entity Address, Postal Zip Code

85284

City Area Code

(928)

Local Phone Number

625-0928

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Entity Emerging Growth Company

true

Elected Not To Use the Extended Transition Period

false

Units, each consisting of one Class A ordinary share, par value $0.0001 per share, one warrant, and one right to acquire 1/4

Title of 12(b) Security

Units, each consisting of

one Class A ordinary share, par value $0.0001 per share, one warrant, and one right to acquire 1/4

Trading Symbol

ARCLU

Security Exchange Name

NASDAQ

Class A ordinary shares included as part of the Units

Title of 12(b) Security

Class A ordinary shares

included as part of the Units

Trading Symbol

ARCL

Security Exchange Name

NASDAQ

Rights included as part of the Units

Title of 12(b) Security

Rights included as part

of the Units

Trading Symbol

ARCLR

Security Exchange Name

NASDAQ

Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share

Title of 12(b) Security

Warrants, each warrant exercisable

for one Class A ordinary share at an exercise price of $11.50 per share

Trading Symbol

ARCLW

Security Exchange Name

NASDAQ

X

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

na

Period Type:

duration

X

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Address Line 2 such as Street or Suite number

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine2

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

na

Period Type:

duration

X

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 7A

-Section B

-Subsection 2

+ Details

Name:

dei_EntityExTransitionPeriod

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

na

Period Type:

duration

X

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Details

Name:

us-gaap_StatementClassOfStockAxis=ARCLU_UnitsEachConsistingOfOneClassOrdinaryShareParValue0.0001PerShareOneWarrantAndOneRightToAcquire14Member

Namespace Prefix:

Data Type:

na

Balance Type:

Period Type:

X

- Details

Name:

us-gaap_StatementClassOfStockAxis=ARCLU_ClassOrdinarySharesIncludedAsPartOfUnitsMember

Namespace Prefix:

Data Type:

na

Balance Type:

Period Type:

X

- Details

Name:

us-gaap_StatementClassOfStockAxis=ARCLU_RightsIncludedAsPartOfUnitsMember

Namespace Prefix:

Data Type:

na

Balance Type:

Period Type:

X

- Details

Name:

us-gaap_StatementClassOfStockAxis=ARCLU_WarrantsEachWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember

Namespace Prefix:

Data Type:

na

Balance Type:

Period Type: